Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type

Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

56841989 215881 None 6 Human Functional pEC50 = 8.8 8.8 -3 6
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4281479 215881 None 6 Human Functional pEC50 = 8.8 8.8 -3 6
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
56841989 215881 None 6 Human Functional pEC50 = 8.8 8.8 -3 6
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4281479 215881 None 6 Human Functional pEC50 = 8.8 8.8 -3 6
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
45498171 196298 None 9 Human Functional pEC50 = 8.7 8.7 -114 6
Positive allosteric modulation of YFP tagged human Y5 receptor transfected with COS-7 cells co-transfected with delta6Galphaqi4-myr measured after 24 hrs by calcium 2+ flux assay (Rvb = 2.43 nM )Positive allosteric modulation of YFP tagged human Y5 receptor transfected with COS-7 cells co-transfected with delta6Galphaqi4-myr measured after 24 hrs by calcium 2+ flux assay (Rvb = 2.43 nM )
ChEMBL 369 5 1 5 1.9 Cc1ccccc1OCC(=O)Nc1cc(C(=O)N2CCCC2)cn(C)c1=O 10.1021/acs.jmedchem.3c00383
CHEMBL5420881 196298 None 9 Human Functional pEC50 = 8.7 8.7 -114 6
Positive allosteric modulation of YFP tagged human Y5 receptor transfected with COS-7 cells co-transfected with delta6Galphaqi4-myr measured after 24 hrs by calcium 2+ flux assay (Rvb = 2.43 nM )Positive allosteric modulation of YFP tagged human Y5 receptor transfected with COS-7 cells co-transfected with delta6Galphaqi4-myr measured after 24 hrs by calcium 2+ flux assay (Rvb = 2.43 nM )
ChEMBL 369 5 1 5 1.9 Cc1ccccc1OCC(=O)Nc1cc(C(=O)N2CCCC2)cn(C)c1=O 10.1021/acs.jmedchem.3c00383
CHEMBL4288294 215939 None 0 Human Functional pEC50 = 7 7.0 -3 2
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL3099727 213485 None 0 Human Functional pEC50 = 7.0 7.0 -30 2
Agonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assayAgonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)O[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C 10.1021/ml400335g
162676875 183678 None 0 Human Functional pEC50 = 5.9 5.9 -1995 2
Agonist activity at NPY5R (unknown origin) by CRE-luciferase reporter gene assayAgonist activity at NPY5R (unknown origin) by CRE-luciferase reporter gene assay
ChEMBL 4218 130 63 56 -15.0 CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O 10.1021/acs.jmedchem.0c00740
CHEMBL4800389 183678 None 0 Human Functional pEC50 = 5.9 5.9 -1995 2
Agonist activity at NPY5R (unknown origin) by CRE-luciferase reporter gene assayAgonist activity at NPY5R (unknown origin) by CRE-luciferase reporter gene assay
ChEMBL 4218 130 63 56 -15.0 CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O 10.1021/acs.jmedchem.0c00740
CHEMBL4277676 215836 None 0 Human Functional pEC50 = 6.8 6.8 -31 3
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4290445 215956 None 0 Human Functional pEC50 = 6.8 6.8 -100 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4277676 215836 None 0 Human Functional pEC50 = 6.8 6.8 -31 3
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4290445 215956 None 0 Human Functional pEC50 = 6.8 6.8 -100 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL3099723 213481 None 0 Human Functional pEC50 = 6.8 6.8 -2 4
Agonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assayAgonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C 10.1021/ml400335g
CHEMBL3099722 213480 None 0 Human Functional pEC50 = 6.7 6.7 -85 4
Agonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assayAgonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)O[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C 10.1021/ml400335g
CHEMBL4284905 215911 None 0 Human Functional pEC50 = 8.6 8.6 -12 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC 10.1021/acs.jmedchem.8b01046
CHEMBL4284905 215911 None 0 Human Functional pEC50 = 8.6 8.6 -12 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC 10.1021/acs.jmedchem.8b01046
CHEMBL2110365 211672 None 1 Human Functional pEC50 = 5.7 5.7 -213 3
Agonist potency for the inhibition of Forskolin stimulated cAMP synthesis in cells expressing cloned Y5 receptorsAgonist potency for the inhibition of Forskolin stimulated cAMP synthesis in cells expressing cloned Y5 receptors
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@H]1CCC(=O)NC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)CC)CCC(=O)NC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@@H]2CCCN2C1=O 10.1021/jm010031k
CHEMBL4280392 215867 None 0 Human Functional pEC50 = 6.6 6.6 -31 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4280392 215867 None 0 Human Functional pEC50 = 6.6 6.6 -31 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL3099721 213479 None 0 Human Functional pEC50 = 7.5 7.5 -95 4
Agonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assayAgonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C 10.1021/ml400335g
CHEMBL439904 216315 None 12 Human Functional pEC50 = 7.5 7.5 -53 4
Agonist activity at human Y5R expressed in HEK293 cells by FLIPR assayAgonist activity at human Y5R expressed in HEK293 cells by FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C 10.1016/j.ejmech.2022.115036
CHEMBL4277590 215834 None 0 Human Functional pEC50 = 8.5 8.5 -1 3
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
12607 3784 None 35 Human Functional pEC50 = 8.5 8.5 -79 4
Positive allosteric modulation of human C-terminal eYFP-fused human NY5 receptor expressed in African green monkey COS7 cells co-expressing delta6Galphaqi4-myr assessed as potentiation of neuropeptide Y-mediated Ca2+ flux by measuring pancreatic polypeptide EC50 at 30 uM treated at 20 secs post baseline detection followed by addition of neuropeptide Y after 140 secs by Fluo2-AM fluorescent dye-based assay (Rvb = 8.5 +/- 0.1 No_unit)Positive allosteric modulation of human C-terminal eYFP-fused human NY5 receptor expressed in African green monkey COS7 cells co-expressing delta6Galphaqi4-myr assessed as potentiation of neuropeptide Y-mediated Ca2+ flux by measuring pancreatic polypeptide EC50 at 30 uM treated at 20 secs post baseline detection followed by addition of neuropeptide Y after 140 secs by Fluo2-AM fluorescent dye-based assay (Rvb = 8.5 +/- 0.1 No_unit)
ChEMBL 248 2 1 2 3.7 CC(C)(C)C1=CC=C(C=C1)OC2CCCCC2O 10.1021/acs.jmedchem.7b00976
16033 3784 None 35 Human Functional pEC50 = 8.5 8.5 -79 4
Positive allosteric modulation of human C-terminal eYFP-fused human NY5 receptor expressed in African green monkey COS7 cells co-expressing delta6Galphaqi4-myr assessed as potentiation of neuropeptide Y-mediated Ca2+ flux by measuring pancreatic polypeptide EC50 at 30 uM treated at 20 secs post baseline detection followed by addition of neuropeptide Y after 140 secs by Fluo2-AM fluorescent dye-based assay (Rvb = 8.5 +/- 0.1 No_unit)Positive allosteric modulation of human C-terminal eYFP-fused human NY5 receptor expressed in African green monkey COS7 cells co-expressing delta6Galphaqi4-myr assessed as potentiation of neuropeptide Y-mediated Ca2+ flux by measuring pancreatic polypeptide EC50 at 30 uM treated at 20 secs post baseline detection followed by addition of neuropeptide Y after 140 secs by Fluo2-AM fluorescent dye-based assay (Rvb = 8.5 +/- 0.1 No_unit)
ChEMBL 248 2 1 2 3.7 CC(C)(C)C1=CC=C(C=C1)OC2CCCCC2O 10.1021/acs.jmedchem.7b00976
CHEMBL3559801 3784 None 35 Human Functional pEC50 = 8.5 8.5 -79 4
Positive allosteric modulation of human C-terminal eYFP-fused human NY5 receptor expressed in African green monkey COS7 cells co-expressing delta6Galphaqi4-myr assessed as potentiation of neuropeptide Y-mediated Ca2+ flux by measuring pancreatic polypeptide EC50 at 30 uM treated at 20 secs post baseline detection followed by addition of neuropeptide Y after 140 secs by Fluo2-AM fluorescent dye-based assay (Rvb = 8.5 +/- 0.1 No_unit)Positive allosteric modulation of human C-terminal eYFP-fused human NY5 receptor expressed in African green monkey COS7 cells co-expressing delta6Galphaqi4-myr assessed as potentiation of neuropeptide Y-mediated Ca2+ flux by measuring pancreatic polypeptide EC50 at 30 uM treated at 20 secs post baseline detection followed by addition of neuropeptide Y after 140 secs by Fluo2-AM fluorescent dye-based assay (Rvb = 8.5 +/- 0.1 No_unit)
ChEMBL 248 2 1 2 3.7 CC(C)(C)C1=CC=C(C=C1)OC2CCCCC2O 10.1021/acs.jmedchem.7b00976
CHEMBL4277590 215834 None 0 Human Functional pEC50 = 8.5 8.5 -1 3
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4279973 215862 None 0 Human Functional pEC50 = 8.4 8.4 -19 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL3099724 213482 None 0 Human Functional pEC50 = 7.4 7.4 -35 4
Agonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assayAgonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C 10.1021/ml400335g
CHEMBL4294418 215992 None 0 Human Functional pEC50 = 6.4 6.4 -199 2
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CCC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)[C@@H](C)O)C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC1=O 10.1021/acs.jmedchem.8b01046
CHEMBL4279973 215862 None 0 Human Functional pEC50 = 8.4 8.4 -19 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4294418 215992 None 0 Human Functional pEC50 = 6.4 6.4 -199 2
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CCC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)[C@@H](C)O)C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC1=O 10.1021/acs.jmedchem.8b01046
CHEMBL439904 216315 None 12 Human Functional pEC50 = 6.4 6.4 -53 4
Agonist activity at NPY5R (unknown origin) by CRE-luciferase reporter gene assayAgonist activity at NPY5R (unknown origin) by CRE-luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.0c00740
CHEMBL3099724 213482 None 0 Human Functional pEC50 = 7.4 7.4 -35 4
Agonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assayAgonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C 10.1021/ml400335g
CHEMBL4276961 215829 None 0 Human Functional pEC50 = 8.3 8.3 -50 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O 10.1021/acs.jmedchem.8b01046
CHEMBL4286615 215925 None 0 Human Functional pEC50 = 8.3 8.3 -31 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O 10.1021/acs.jmedchem.8b01046
CHEMBL4276961 215829 None 0 Human Functional pEC50 = 8.3 8.3 -50 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O 10.1021/acs.jmedchem.8b01046
CHEMBL4286615 215925 None 0 Human Functional pEC50 = 8.3 8.3 -31 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O 10.1021/acs.jmedchem.8b01046
CHEMBL4285633 215918 None 0 Human Functional pEC50 = 7.3 7.3 -6 2
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4294277 215991 None 0 Human Functional pEC50 = 7.3 7.3 -5 3
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4285633 215918 None 0 Human Functional pEC50 = 7.3 7.3 -6 2
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4294277 215991 None 0 Human Functional pEC50 = 7.3 7.3 -5 3
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4281010 215874 None 0 Human Functional pEC50 = 6.3 6.3 -63 2
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CCC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)[C@@H](C)O)[C@@H](C)CC)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01046
CHEMBL4281010 215874 None 0 Human Functional pEC50 = 6.3 6.3 -63 2
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CCC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)[C@@H](C)O)[C@@H](C)CC)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01046
172440190 195396 None 0 Human Functional pEC50 = 6.3 6.3 -512 2
Agonist activity at human Y5R expressed in HEK293 cells by FLIPR assayAgonist activity at human Y5R expressed in HEK293 cells by FLIPR assay
ChEMBL 4217 130 63 56 -15.1 CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(N)cc1)C(N)=O)[C@@H](C)O 10.1016/j.ejmech.2022.115036
CHEMBL5402820 195396 None 0 Human Functional pEC50 = 6.3 6.3 -512 2
Agonist activity at human Y5R expressed in HEK293 cells by FLIPR assayAgonist activity at human Y5R expressed in HEK293 cells by FLIPR assay
ChEMBL 4217 130 63 56 -15.1 CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(N)cc1)C(N)=O)[C@@H](C)O 10.1016/j.ejmech.2022.115036
CHEMBL4278700 215851 None 0 Human Functional pEC50 = 8.2 8.2 -31 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O 10.1021/acs.jmedchem.8b01046
CHEMBL4278700 215851 None 0 Human Functional pEC50 = 8.2 8.2 -31 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O 10.1021/acs.jmedchem.8b01046
CHEMBL429531 215998 None 17 Human Functional pEC50 = 8.1 8.1 -29 2
Agonist potency for the inhibition of Forskolin stimulated cAMP synthesis in cells expressing cloned Y5 receptorsAgonist potency for the inhibition of Forskolin stimulated cAMP synthesis in cells expressing cloned Y5 receptors
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O 10.1021/jm010031k
CHEMBL4279794 215860 None 0 Human Functional pEC50 = 8.1 8.1 -7 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4292105 215974 None 0 Human Functional pEC50 = 8.1 8.1 -7 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4279794 215860 None 0 Human Functional pEC50 = 8.1 8.1 -7 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4292105 215974 None 0 Human Functional pEC50 = 8.1 8.1 -7 4
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4282168 215890 None 0 Human Functional pEC50 = 6.1 6.1 -158 2
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4283257 215898 None 0 Human Functional pEC50 = 6.1 6.1 -158 3
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4282168 215890 None 0 Human Functional pEC50 = 6.1 6.1 -158 2
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4283257 215898 None 0 Human Functional pEC50 = 6.1 6.1 -158 3
Activation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assayActivation of human Y5R expressed in HEK293 cells assessed as inhibition of isoproterenol-induced increase in intracellular cAMP levels by calcium 5 dye-based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL439904 216315 None 12 Human Functional pEC50 = 8.1 8.1 -53 4
Agonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assayAgonist activity at human NPYY5 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C 10.1021/ml400335g
22253974 65998 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 411 9 2 6 4.0 CCS(=O)(=O)NCCCCCNc1nc2c(s1)CCSc1ccccc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836324 65998 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 411 9 2 6 4.0 CCS(=O)(=O)NCCCCCNc1nc2c(s1)CCSc1ccccc1-2 10.1016/j.bmcl.2011.06.124
44271559 98210 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 418 7 2 6 5.1 CCS(=O)(=O)Cc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
CHEMBL273811 98210 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 418 7 2 6 5.1 CCS(=O)(=O)Cc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
9908801 65993 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 397 8 2 5 3.6 CS(=O)(=O)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836319 65993 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 397 8 2 5 3.6 CS(=O)(=O)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
44271542 64608 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 433 7 2 6 4.5 CN(C)S(=O)(=O)Cc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
CHEMBL18163 64608 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 433 7 2 6 4.5 CN(C)S(=O)(=O)Cc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
22325336 189066 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ levelAntagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ level
ChEMBL 353 1 1 4 3.9 O=C1OC2(CCN(c3nc4cc(Cl)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL508271 189066 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ levelAntagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ level
ChEMBL 353 1 1 4 3.9 O=C1OC2(CCN(c3nc4cc(Cl)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
11491176 202499 None 36 Human Functional pIC50 = 8.9 8.9 1 2
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4F)n3)CC2)c2cnccc21 10.1016/j.bmcl.2010.09.064
CHEMBL595573 202499 None 36 Human Functional pIC50 = 8.9 8.9 1 2
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4F)n3)CC2)c2cnccc21 10.1016/j.bmcl.2010.09.064
9887852 65996 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 411 9 2 5 4.0 CCS(=O)(=O)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836322 65996 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 411 9 2 5 4.0 CCS(=O)(=O)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
44580050 184310 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ levelAntagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ level
ChEMBL 387 1 1 4 4.5 O=C1OC2(CCN(c3nc4cc(Cl)c(Cl)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL483251 184310 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ levelAntagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ level
ChEMBL 387 1 1 4 4.5 O=C1OC2(CCN(c3nc4cc(Cl)c(Cl)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
20587808 187962 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ levelAntagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ level
ChEMBL 377 2 1 6 3.0 COC(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
CHEMBL496327 187962 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ levelAntagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ level
ChEMBL 377 2 1 6 3.0 COC(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
12071667 188127 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ levelAntagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ level
ChEMBL 395 2 1 4 4.9 O=C1OC2(CCN(c3nc4cc(-c5ccccc5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL497569 188127 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ levelAntagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ level
ChEMBL 395 2 1 4 4.9 O=C1OC2(CCN(c3nc4cc(-c5ccccc5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
22254068 65991 None 26 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 423 5 2 6 4.0 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
CHEMBL1836317 65991 None 26 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 423 5 2 6 4.0 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
20651581 66000 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 451 8 2 5 4.1 O=S(=O)(CC(F)(F)F)NCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836326 66000 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 451 8 2 5 4.1 O=S(=O)(CC(F)(F)F)NCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
22254003 65989 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 489 6 2 8 4.1 Cn1cnc(S(=O)(=O)NC[C@H]2CC[C@H](Nc3nc4c(s3)CCSc3ccccc3-4)CC2)c1 10.1016/j.bmcl.2011.06.124
CHEMBL1836315 65989 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 489 6 2 8 4.1 Cn1cnc(S(=O)(=O)NC[C@H]2CC[C@H](Nc3nc4c(s3)CCSc3ccccc3-4)CC2)c1 10.1016/j.bmcl.2011.06.124
57393057 71264 None 0 Mouse Functional pIC50 = 7 7.0 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 370 4 1 5 4.4 CCS(=O)(=O)c1ccc2oc(Nc3ccc(C(F)(F)F)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956843 71264 None 0 Mouse Functional pIC50 = 7 7.0 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 370 4 1 5 4.4 CCS(=O)(=O)c1ccc2oc(Nc3ccc(C(F)(F)F)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
44271459 59973 None 1 Human Functional pIC50 = 7 7.0 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 346 4 2 4 5.8 Clc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
CHEMBL17326 59973 None 1 Human Functional pIC50 = 7 7.0 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 346 4 2 4 5.8 Clc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
57391285 71291 None 0 Mouse Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 371 4 1 6 3.8 CCS(=O)(=O)c1ccc2oc(Nc3ccc(C(F)(F)F)cn3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956938 71291 None 0 Mouse Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 371 4 1 6 3.8 CCS(=O)(=O)c1ccc2oc(Nc3ccc(C(F)(F)F)cn3)nc2c1 10.1016/j.bmcl.2012.01.027
57399999 71289 None 0 Mouse Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 316 5 1 5 3.2 CCS(=O)(=O)c1ccc2oc(NCc3ccccc3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956935 71289 None 0 Mouse Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 316 5 1 5 3.2 CCS(=O)(=O)c1ccc2oc(NCc3ccccc3)nc2c1 10.1016/j.bmcl.2012.01.027
24950871 178634 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 446 1 1 4 6.9 O=C1CC2(CCCCC2)CC(O)=C1C1C2=C(CC3(CCCCC3)CC2=O)Oc2ccccc21 10.1021/jm8003587
CHEMBL466756 178634 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 446 1 1 4 6.9 O=C1CC2(CCCCC2)CC(O)=C1C1C2=C(CC3(CCCCC3)CC2=O)Oc2ccccc21 10.1021/jm8003587
10969955 110651 None 0 Human Functional pIC50 = 8.0 8.0 1 2
In vitro human Neuropeptide Y receptor Y5 functional antagonism (reporter gene assay)In vitro human Neuropeptide Y receptor Y5 functional antagonism (reporter gene assay)
ChEMBL 343 5 1 3 4.8 CCn1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
CHEMBL325475 110651 None 0 Human Functional pIC50 = 8.0 8.0 1 2
In vitro human Neuropeptide Y receptor Y5 functional antagonism (reporter gene assay)In vitro human Neuropeptide Y receptor Y5 functional antagonism (reporter gene assay)
ChEMBL 343 5 1 3 4.8 CCn1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
44271442 63268 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 489 7 2 6 4.9 CN(C[C@H]1CC[C@H](CNc2nc(N)c3ccccc3n2)CC1)S(=O)(=O)c1cccc2ccccc12 10.1016/s0960-894x(00)00177-3
CHEMBL17911 63268 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 489 7 2 6 4.9 CN(C[C@H]1CC[C@H](CNc2nc(N)c3ccccc3n2)CC1)S(=O)(=O)c1cccc2ccccc12 10.1016/s0960-894x(00)00177-3
24950557 178927 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 380 1 1 4 5.3 Cc1ccc2c(c1)OC1=C(C(=O)CC(C)(C)C1)C2C1=C(O)CC(C)(C)CC1=O 10.1021/jm8003587
CHEMBL469256 178927 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 380 1 1 4 5.3 Cc1ccc2c(c1)OC1=C(C(=O)CC(C)(C)C1)C2C1=C(O)CC(C)(C)CC1=O 10.1021/jm8003587
9907999 164963 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonistic activity of compound was determined by its ability to inhibit NPY induced [Ca2+]i increases in CHO cells which expressed the recombinant human Neuropeptide Y receptor type 5Antagonistic activity of compound was determined by its ability to inhibit NPY induced [Ca2+]i increases in CHO cells which expressed the recombinant human Neuropeptide Y receptor type 5
ChEMBL 382 4 2 3 4.5 CCc1cc(-c2cc(NC(=O)C3Cc4ccc5ccccc5c4C3)[nH]n2)ccn1 10.1021/jm025513q
CHEMBL422012 164963 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonistic activity of compound was determined by its ability to inhibit NPY induced [Ca2+]i increases in CHO cells which expressed the recombinant human Neuropeptide Y receptor type 5Antagonistic activity of compound was determined by its ability to inhibit NPY induced [Ca2+]i increases in CHO cells which expressed the recombinant human Neuropeptide Y receptor type 5
ChEMBL 382 4 2 3 4.5 CCc1cc(-c2cc(NC(=O)C3Cc4ccc5ccccc5c4C3)[nH]n2)ccn1 10.1021/jm025513q
57398333 71287 None 0 Mouse Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 308 4 1 5 3.4 CCS(=O)(=O)c1ccc2oc(NC3CCCCC3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956933 71287 None 0 Mouse Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 308 4 1 5 3.4 CCS(=O)(=O)c1ccc2oc(NC3CCCCC3)nc2c1 10.1016/j.bmcl.2012.01.027
57391273 71265 None 0 Mouse Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 370 4 1 5 4.4 CCS(=O)(=O)c1ccc2oc(Nc3cccc(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956844 71265 None 0 Mouse Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 370 4 1 5 4.4 CCS(=O)(=O)c1ccc2oc(Nc3cccc(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.01.027
2418871 71262 None 0 Mouse Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 302 4 1 5 3.4 CCS(=O)(=O)c1ccc2oc(Nc3ccccc3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956841 71262 None 0 Mouse Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 302 4 1 5 3.4 CCS(=O)(=O)c1ccc2oc(Nc3ccccc3)nc2c1 10.1016/j.bmcl.2012.01.027
10046270 62816 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk- cells co-expressing Gqi5 assessed as inhibition of NPY-induced calcium increaseAntagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk- cells co-expressing Gqi5 assessed as inhibition of NPY-induced calcium increase
ChEMBL 396 4 1 6 2.3 COn1cc(C2=N[C@@](c3ccc(F)cc3)(c3ccc(F)nc3)[C@H](C)N2)ccc1=O 10.1016/j.bmc.2009.05.069
CHEMBL1784131 62816 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk- cells co-expressing Gqi5 assessed as inhibition of NPY-induced calcium increaseAntagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk- cells co-expressing Gqi5 assessed as inhibition of NPY-induced calcium increase
ChEMBL 396 4 1 6 2.3 COn1cc(C2=N[C@@](c3ccc(F)cc3)(c3ccc(F)nc3)[C@H](C)N2)ccc1=O 10.1016/j.bmc.2009.05.069
57391275 71270 None 0 Mouse Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 433 5 1 7 4.1 CCS(=O)(=O)c1ccc2oc(Nc3ccc(N4C[C@H](C)O[C@H](C)C4)c(F)c3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956850 71270 None 0 Mouse Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 433 5 1 7 4.1 CCS(=O)(=O)c1ccc2oc(Nc3ccc(N4C[C@H](C)O[C@H](C)C4)c(F)c3)nc2c1 10.1016/j.bmcl.2012.01.027
44271493 98634 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 489 7 2 6 4.6 CN(C[C@H]1CC[C@H](CNS(=O)(=O)c2cccc3ccccc23)CC1)c1nc(N)c2ccccc2n1 10.1016/s0960-894x(00)00177-3
CHEMBL276768 98634 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 489 7 2 6 4.6 CN(C[C@H]1CC[C@H](CNS(=O)(=O)c2cccc3ccccc23)CC1)c1nc(N)c2ccccc2n1 10.1016/s0960-894x(00)00177-3
57401791 71282 None 0 Mouse Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 361 7 2 6 3.7 CCOc1ccc(Nc2nc3cc(NS(=O)(=O)CC)ccc3o2)cc1 10.1016/j.bmcl.2012.01.027
CHEMBL1956928 71282 None 0 Mouse Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 361 7 2 6 3.7 CCOc1ccc(Nc2nc3cc(NS(=O)(=O)CC)ccc3o2)cc1 10.1016/j.bmcl.2012.01.027
42630820 187184 None 7 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO-K1 cells coexpressing Gqi5 assessed as inhibition of NPY-induced increase in intracellular Ca2+ level by FLIPR assayAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO-K1 cells coexpressing Gqi5 assessed as inhibition of NPY-induced increase in intracellular Ca2+ level by FLIPR assay
ChEMBL 375 3 1 5 3.3 C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL491288 187184 None 7 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO-K1 cells coexpressing Gqi5 assessed as inhibition of NPY-induced increase in intracellular Ca2+ level by FLIPR assayAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO-K1 cells coexpressing Gqi5 assessed as inhibition of NPY-induced increase in intracellular Ca2+ level by FLIPR assay
ChEMBL 375 3 1 5 3.3 C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
44271549 61069 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 425 7 3 6 3.9 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(Nc3ccccc3)c3ccccc3n2)CC1 10.1016/s0960-894x(00)00177-3
CHEMBL17632 61069 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 425 7 3 6 3.9 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(Nc3ccccc3)c3ccccc3n2)CC1 10.1016/s0960-894x(00)00177-3
57396549 71285 None 0 Mouse Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 389 6 2 6 4.5 CCOc1ccc(Nc2nc3ccc(NS(=O)(=O)C(C)(C)C)cc3o2)cc1 10.1016/j.bmcl.2012.01.027
CHEMBL1956931 71285 None 0 Mouse Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 389 6 2 6 4.5 CCOc1ccc(Nc2nc3ccc(NS(=O)(=O)C(C)(C)C)cc3o2)cc1 10.1016/j.bmcl.2012.01.027
9923839 187146 None 1 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells assessed as inhibition of neuropeptide-induced increase in intracellular calcium levelAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells assessed as inhibition of neuropeptide-induced increase in intracellular calcium level
ChEMBL 336 3 1 4 3.0 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cnccn3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL490937 187146 None 1 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells assessed as inhibition of neuropeptide-induced increase in intracellular calcium levelAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells assessed as inhibition of neuropeptide-induced increase in intracellular calcium level
ChEMBL 336 3 1 4 3.0 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cnccn3)=N2)cc1 10.1016/j.bmcl.2009.01.101
44271565 98184 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 461 6 3 6 4.3 Nc1nc(N[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 10.1016/s0960-894x(00)00177-3
CHEMBL273597 98184 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 461 6 3 6 4.3 Nc1nc(N[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 10.1016/s0960-894x(00)00177-3
44271531 98904 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 489 8 3 6 5.0 Nc1nc(NCC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 10.1016/s0960-894x(00)00177-3
CHEMBL278881 98904 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 489 8 3 6 5.0 Nc1nc(NCC[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 10.1016/s0960-894x(00)00177-3
1562 899 None 11 Human Functional pIC50 = 8.5 8.5 -1 7
Compound was tested for its antagonistic activity against Neuropeptide Y receptor Y5 subtype stably expressed in LM(tk-)cellsCompound was tested for its antagonistic activity against Neuropeptide Y receptor Y5 subtype stably expressed in LM(tk-)cells
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/s0960-894x(00)00177-3
5312114 899 None 11 Human Functional pIC50 = 8.5 8.5 -1 7
Compound was tested for its antagonistic activity against Neuropeptide Y receptor Y5 subtype stably expressed in LM(tk-)cellsCompound was tested for its antagonistic activity against Neuropeptide Y receptor Y5 subtype stably expressed in LM(tk-)cells
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/s0960-894x(00)00177-3
CHEMBL17645 899 None 11 Human Functional pIC50 = 8.5 8.5 -1 7
Compound was tested for its antagonistic activity against Neuropeptide Y receptor Y5 subtype stably expressed in LM(tk-)cellsCompound was tested for its antagonistic activity against Neuropeptide Y receptor Y5 subtype stably expressed in LM(tk-)cells
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/s0960-894x(00)00177-3
CHEMBL195380 899 None 11 Human Functional pIC50 = 8.5 8.5 -1 7
Compound was tested for its antagonistic activity against Neuropeptide Y receptor Y5 subtype stably expressed in LM(tk-)cellsCompound was tested for its antagonistic activity against Neuropeptide Y receptor Y5 subtype stably expressed in LM(tk-)cells
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/s0960-894x(00)00177-3
2350190 51872 None 3 Mouse Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 423 5 1 5 3.5 O=S(=O)(c1ccc2[nH]c(SCc3cccc(Cl)c3)nc2c1)N1CCOCC1 10.1016/j.bmcl.2012.01.027
CHEMBL1585484 51872 None 3 Mouse Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 423 5 1 5 3.5 O=S(=O)(c1ccc2[nH]c(SCc3cccc(Cl)c3)nc2c1)N1CCOCC1 10.1016/j.bmcl.2012.01.027
44271517 59053 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 394 5 2 4 7.2 c1ccc(Nc2nc(Nc3ccc(C4CCCCC4)cc3)nc3ccccc23)cc1 10.1016/s0960-894x(00)00177-3
CHEMBL16936 59053 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 394 5 2 4 7.2 c1ccc(Nc2nc(Nc3ccc(C4CCCCC4)cc3)nc3ccccc23)cc1 10.1016/s0960-894x(00)00177-3
44271450 167230 None 1 Human Functional pIC50 = 6.7 6.7 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 326 4 2 4 5.4 Cc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
CHEMBL429053 167230 None 1 Human Functional pIC50 = 6.7 6.7 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 326 4 2 4 5.4 Cc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
57391274 71268 None 0 Mouse Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 387 5 1 7 3.2 CCS(=O)(=O)c1ccc2oc(Nc3ccc(N4CCOCC4)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956848 71268 None 0 Mouse Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 387 5 1 7 3.2 CCS(=O)(=O)c1ccc2oc(Nc3ccc(N4CCOCC4)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
57401790 71279 None 0 Mouse Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 332 5 1 6 3.4 CCOc1ccc(Nc2nc3cc(S(C)(=O)=O)ccc3o2)cc1 10.1016/j.bmcl.2012.01.027
CHEMBL1956925 71279 None 0 Mouse Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 332 5 1 6 3.4 CCOc1ccc(Nc2nc3cc(S(C)(=O)=O)ccc3o2)cc1 10.1016/j.bmcl.2012.01.027
44271541 60310 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 499 7 2 5 6.8 CN(C[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ccccc3n2)CC1)C(=O)c1ccccc1 10.1016/s0960-894x(00)00177-3
CHEMBL17427 60310 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 499 7 2 5 6.8 CN(C[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ccccc3n2)CC1)C(=O)c1ccccc1 10.1016/s0960-894x(00)00177-3
44271532 59763 None 1 Human Functional pIC50 = 6.6 6.6 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 380 4 2 4 6.4 Clc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1Cl 10.1016/s0960-894x(00)00177-3
CHEMBL17247 59763 None 1 Human Functional pIC50 = 6.6 6.6 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 380 4 2 4 6.4 Clc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1Cl 10.1016/s0960-894x(00)00177-3
9955360 98607 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 449 10 3 6 4.3 Nc1nc(NCCCCCCNS(=O)(=O)c2cccc3ccccc23)nc2ccccc12 10.1016/s0960-894x(00)00177-3
CHEMBL276551 98607 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 449 10 3 6 4.3 Nc1nc(NCCCCCCNS(=O)(=O)c2cccc3ccccc23)nc2ccccc12 10.1016/s0960-894x(00)00177-3
9907999 164963 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonistic activity of compound was determined by its ability to inhibit NPY induced [Ca2+]i increases in CHO cells which expressed the recombinant human Neuropeptide Y receptor type 5Antagonistic activity of compound was determined by its ability to inhibit NPY induced [Ca2+]i increases in CHO cells which expressed the recombinant human Neuropeptide Y receptor type 5
ChEMBL 382 4 2 3 4.5 CCc1cc(-c2cc(NC(=O)C3Cc4ccc5ccccc5c4C3)[nH]n2)ccn1 10.1021/jm025513q
CHEMBL422012 164963 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonistic activity of compound was determined by its ability to inhibit NPY induced [Ca2+]i increases in CHO cells which expressed the recombinant human Neuropeptide Y receptor type 5Antagonistic activity of compound was determined by its ability to inhibit NPY induced [Ca2+]i increases in CHO cells which expressed the recombinant human Neuropeptide Y receptor type 5
ChEMBL 382 4 2 3 4.5 CCc1cc(-c2cc(NC(=O)C3Cc4ccc5ccccc5c4C3)[nH]n2)ccn1 10.1021/jm025513q
44271484 98877 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 469 7 3 6 4.5 Nc1nc(NCc2ccc(CNS(=O)(=O)c3cccc4ccccc34)cc2)nc2ccccc12 10.1016/s0960-894x(00)00177-3
CHEMBL278677 98877 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 469 7 3 6 4.5 Nc1nc(NCc2ccc(CNS(=O)(=O)c3cccc4ccccc34)cc2)nc2ccccc12 10.1016/s0960-894x(00)00177-3
22254020 65990 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 491 6 2 7 5.5 O=S(=O)(NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1)c1cccs1 10.1016/j.bmcl.2011.06.124
CHEMBL1836316 65990 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 491 6 2 7 5.5 O=S(=O)(NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1)c1cccs1 10.1016/j.bmcl.2011.06.124
20651572 66006 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 407 5 2 6 3.3 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCOc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
CHEMBL1836332 66006 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 407 5 2 6 3.3 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCOc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
22254050 65992 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 437 6 2 6 4.4 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
CHEMBL1836318 65992 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 437 6 2 6 4.4 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
25346026 71266 None 2 Mouse Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 386 5 1 6 4.3 CCS(=O)(=O)c1ccc2oc(Nc3ccc(OC(F)(F)F)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956846 71266 None 2 Mouse Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 386 5 1 6 4.3 CCS(=O)(=O)c1ccc2oc(Nc3ccc(OC(F)(F)F)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
57399997 71278 None 0 Mouse Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 416 5 1 8 3.4 CCS(=O)(=O)c1ccc2oc(Nc3ccc(N4C[C@H](C)O[C@H](C)C4)nc3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956923 71278 None 0 Mouse Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 416 5 1 8 3.4 CCS(=O)(=O)c1ccc2oc(Nc3ccc(N4C[C@H](C)O[C@H](C)C4)nc3)nc2c1 10.1016/j.bmcl.2012.01.027
44271468 98945 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 485 7 3 5 6.4 O=C(NC[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ccccc3n2)CC1)c1ccccc1 10.1016/s0960-894x(00)00177-3
CHEMBL279181 98945 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 485 7 3 5 6.4 O=C(NC[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ccccc3n2)CC1)c1ccccc1 10.1016/s0960-894x(00)00177-3
57403501 71263 None 0 Mouse Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 336 4 1 5 4.0 CCS(=O)(=O)c1ccc2oc(Nc3ccc(Cl)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956842 71263 None 0 Mouse Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 336 4 1 5 4.0 CCS(=O)(=O)c1ccc2oc(Nc3ccc(Cl)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
44271506 60034 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 342 5 2 5 5.1 COc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
CHEMBL17352 60034 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 342 5 2 5 5.1 COc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
44271550 61390 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 462 10 2 7 6.9 CCOP(=O)(Cc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1)OCC 10.1016/s0960-894x(00)00177-3
CHEMBL17686 61390 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 462 10 2 7 6.9 CCOP(=O)(Cc1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1)OCC 10.1016/s0960-894x(00)00177-3
1202745 189110 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 366 1 1 4 5.0 CC1(C)CC(=O)C([C@H]2C3=C(CC(C)(C)CC3=O)Oc3ccccc32)=C(O)C1 10.1021/jm8003587
CHEMBL508770 189110 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 366 1 1 4 5.0 CC1(C)CC(=O)C([C@H]2C3=C(CC(C)(C)CC3=O)Oc3ccccc32)=C(O)C1 10.1021/jm8003587
22254131 65973 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 529 7 2 7 5.7 COc1ccc(C)cc1S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
CHEMBL1836103 65973 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 529 7 2 7 5.7 COc1ccc(C)cc1S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
57403512 71284 None 0 Mouse Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 361 7 2 6 3.7 CCOc1ccc(Nc2nc3ccc(NS(=O)(=O)CC)cc3o2)cc1 10.1016/j.bmcl.2012.01.027
CHEMBL1956930 71284 None 0 Mouse Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 361 7 2 6 3.7 CCOc1ccc(Nc2nc3ccc(NS(=O)(=O)CC)cc3o2)cc1 10.1016/j.bmcl.2012.01.027
9884833 110615 None 33 Human Functional pIC50 = 7.4 7.4 - 1
The compound was evaluated in vitro for: human Neuropeptide Y receptor Y5 functional antagonismThe compound was evaluated in vitro for: human Neuropeptide Y receptor Y5 functional antagonism
ChEMBL 351 2 1 3 4.5 Cc1c(NC(=O)N2CCOCC2)ccc2c1c1ccccc1n2C(C)C 10.1021/jm011125x
CHEMBL325226 110615 None 33 Human Functional pIC50 = 7.4 7.4 - 1
The compound was evaluated in vitro for: human Neuropeptide Y receptor Y5 functional antagonismThe compound was evaluated in vitro for: human Neuropeptide Y receptor Y5 functional antagonism
ChEMBL 351 2 1 3 4.5 Cc1c(NC(=O)N2CCOCC2)ccc2c1c1ccccc1n2C(C)C 10.1021/jm011125x
44271486 163319 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCCC(CNS(=O)(=O)c3cccc4ccccc34)C2)nc2ccccc12 10.1016/s0960-894x(00)00177-3
CHEMBL418359 163319 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCCC(CNS(=O)(=O)c3cccc4ccccc34)C2)nc2ccccc12 10.1016/s0960-894x(00)00177-3
44271529 59107 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 469 7 3 6 4.5 Nc1nc(NCc2cccc(CNS(=O)(=O)c3cccc4ccccc34)c2)nc2ccccc12 10.1016/s0960-894x(00)00177-3
CHEMBL16965 59107 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 469 7 3 6 4.5 Nc1nc(NCc2cccc(CNS(=O)(=O)c3cccc4ccccc34)c2)nc2ccccc12 10.1016/s0960-894x(00)00177-3
44271525 60205 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 423 6 3 5 5.1 CC(=O)NC[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ccccc3n2)CC1 10.1016/s0960-894x(00)00177-3
CHEMBL17398 60205 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 423 6 3 5 5.1 CC(=O)NC[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ccccc3n2)CC1 10.1016/s0960-894x(00)00177-3
44271478 60458 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 501 8 3 6 5.6 Cc1ccc(S(=O)(=O)NC[C@H]2CC[C@H](Nc3nc(Nc4ccccc4)c4ccccc4n3)CC2)cc1 10.1016/s0960-894x(00)00177-3
CHEMBL17521 60458 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 501 8 3 6 5.6 Cc1ccc(S(=O)(=O)NC[C@H]2CC[C@H](Nc3nc(Nc4ccccc4)c4ccccc4n3)CC2)cc1 10.1016/s0960-894x(00)00177-3
44271487 98976 None 3 Human Functional pIC50 = 8.4 8.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 383 7 2 5 6.0 CCN(CC)c1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
CHEMBL279408 98976 None 3 Human Functional pIC50 = 8.4 8.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 383 7 2 5 6.0 CCN(CC)c1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
44271638 60422 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 438 6 2 6 6.0 O=C(O[C@H]1CC[C@H](Nc2nc(Nc3ccccc3)c3ccccc3n2)CC1)c1ccccc1 10.1016/s0960-894x(00)00177-3
CHEMBL17496 60422 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 438 6 2 6 6.0 O=C(O[C@H]1CC[C@H](Nc2nc(Nc3ccccc3)c3ccccc3n2)CC1)c1ccccc1 10.1016/s0960-894x(00)00177-3
22254119 65988 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 535 6 2 6 6.6 O=S(=O)(NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1)c1cccc2ccccc12 10.1016/j.bmcl.2011.06.124
CHEMBL1836314 65988 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 535 6 2 6 6.6 O=S(=O)(NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1)c1cccc2ccccc12 10.1016/j.bmcl.2011.06.124
44271637 59630 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 463 11 3 6 4.7 Nc1nc(NCCCCCCCNS(=O)(=O)c2cccc3ccccc23)nc2ccccc12 10.1016/s0960-894x(00)00177-3
CHEMBL17196 59630 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 463 11 3 6 4.7 Nc1nc(NCCCCCCCNS(=O)(=O)c2cccc3ccccc23)nc2ccccc12 10.1016/s0960-894x(00)00177-3
9886706 178747 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 390 1 1 4 5.3 O=C1CC2(CCC2)CC(O)=C1C1C2=C(CC3(CCC3)CC2=O)Oc2ccccc21 10.1021/jm8003587
CHEMBL467558 178747 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 390 1 1 4 5.3 O=C1CC2(CCC2)CC(O)=C1C1C2=C(CC3(CCC3)CC2=O)Oc2ccccc21 10.1021/jm8003587
44271592 61409 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 477 12 3 6 5.1 Nc1nc(NCCCCCCCCNS(=O)(=O)c2cccc3ccccc23)nc2ccccc12 10.1016/s0960-894x(00)00177-3
CHEMBL17701 61409 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 477 12 3 6 5.1 Nc1nc(NCCCCCCCCNS(=O)(=O)c2cccc3ccccc23)nc2ccccc12 10.1016/s0960-894x(00)00177-3
57394791 71283 None 0 Mouse Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 346 6 1 6 3.8 CCOc1ccc(Nc2nc3ccc(S(=O)(=O)CC)cc3o2)cc1 10.1016/j.bmcl.2012.01.027
CHEMBL1956929 71283 None 0 Mouse Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 346 6 1 6 3.8 CCOc1ccc(Nc2nc3ccc(S(=O)(=O)CC)cc3o2)cc1 10.1016/j.bmcl.2012.01.027
44271562 98744 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 447 5 3 6 4.1 Nc1nc(N[C@H]2CCCC[C@H]2NS(=O)(=O)c2cccc3ccccc23)nc2ccccc12 10.1016/s0960-894x(00)00177-3
CHEMBL277551 98744 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 447 5 3 6 4.1 Nc1nc(N[C@H]2CCCC[C@H]2NS(=O)(=O)c2cccc3ccccc23)nc2ccccc12 10.1016/s0960-894x(00)00177-3
56683832 65997 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 397 8 2 6 3.6 CS(=O)(=O)NCCCCCNc1nc2c(s1)CCSc1ccccc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836323 65997 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 397 8 2 6 3.6 CS(=O)(=O)NCCCCCNc1nc2c(s1)CCSc1ccccc1-2 10.1016/j.bmcl.2011.06.124
25067562 187077 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk cells assessed as inhibition of NPY-induced calcium increaseAntagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk cells assessed as inhibition of NPY-induced calcium increase
ChEMBL 400 2 1 6 4.6 Cc1nnc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)o1 10.1016/j.bmcl.2008.08.021
CHEMBL490427 187077 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk cells assessed as inhibition of NPY-induced calcium increaseAntagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk cells assessed as inhibition of NPY-induced calcium increase
ChEMBL 400 2 1 6 4.6 Cc1nnc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)o1 10.1016/j.bmcl.2008.08.021
44271691 63279 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 318 4 2 4 5.1 c1ccc(Nc2nc(NC3CCCCC3)nc3ccccc23)cc1 10.1016/s0960-894x(00)00177-3
CHEMBL17914 63279 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 318 4 2 4 5.1 c1ccc(Nc2nc(NC3CCCCC3)nc3ccccc23)cc1 10.1016/s0960-894x(00)00177-3
2387945 43733 None 5 Mouse Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 346 6 1 6 3.8 CCOc1ccc(Nc2nc3cc(S(=O)(=O)CC)ccc3o2)cc1 10.1016/j.bmcl.2012.01.027
CHEMBL1510429 43733 None 5 Mouse Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 346 6 1 6 3.8 CCOc1ccc(Nc2nc3cc(S(=O)(=O)CC)ccc3o2)cc1 10.1016/j.bmcl.2012.01.027
44271482 60289 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 461 6 2 6 4.3 Nc1nc(NCCC2CCN(S(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 10.1016/s0960-894x(00)00177-3
CHEMBL17417 60289 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 461 6 2 6 4.3 Nc1nc(NCCC2CCN(S(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 10.1016/s0960-894x(00)00177-3
44271467 60370 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 395 6 3 5 5.2 CNC[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ccccc3n2)CC1 10.1016/s0960-894x(00)00177-3
CHEMBL17454 60370 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 395 6 3 5 5.2 CNC[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ccccc3n2)CC1 10.1016/s0960-894x(00)00177-3
57403513 71286 None 0 Mouse Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 458 5 2 7 4.7 C[C@H]1CN(c2ccc(Nc3nc4ccc(NS(=O)(=O)C(C)(C)C)cc4o3)cc2)C[C@@H](C)O1 10.1016/j.bmcl.2012.01.027
CHEMBL1956932 71286 None 0 Mouse Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 458 5 2 7 4.7 C[C@H]1CN(c2ccc(Nc3nc4ccc(NS(=O)(=O)C(C)(C)C)cc4o3)cc2)C[C@@H](C)O1 10.1016/j.bmcl.2012.01.027
24950710 178920 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 418 1 1 4 6.1 O=C1CC2(CCCC2)CC(O)=C1C1C2=C(CC3(CCCC3)CC2=O)Oc2ccccc21 10.1021/jm8003587
CHEMBL469173 178920 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 418 1 1 4 6.1 O=C1CC2(CCCC2)CC(O)=C1C1C2=C(CC3(CCCC3)CC2=O)Oc2ccccc21 10.1021/jm8003587
44271533 60141 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 437 6 2 5 5.5 CC(=O)N(C)C[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ccccc3n2)CC1 10.1016/s0960-894x(00)00177-3
CHEMBL17395 60141 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 437 6 2 5 5.5 CC(=O)N(C)C[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ccccc3n2)CC1 10.1016/s0960-894x(00)00177-3
22639804 98604 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 376 5 2 6 4.7 CC(=O)O[C@H]1CC[C@H](Nc2nc(Nc3ccccc3)c3ccccc3n2)CC1 10.1016/s0960-894x(00)00177-3
CHEMBL276530 98604 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 376 5 2 6 4.7 CC(=O)O[C@H]1CC[C@H](Nc2nc(Nc3ccccc3)c3ccccc3n2)CC1 10.1016/s0960-894x(00)00177-3
9884833 110615 None 33 Human Functional pIC50 = 8.2 8.2 - 1
Compound was evaluated for functional antagonism of Neuropeptide Y receptor Y5 activity in cellular Ca fluxCompound was evaluated for functional antagonism of Neuropeptide Y receptor Y5 activity in cellular Ca flux
ChEMBL 351 2 1 3 4.5 Cc1c(NC(=O)N2CCOCC2)ccc2c1c1ccccc1n2C(C)C 10.1021/jm011125x
CHEMBL325226 110615 None 33 Human Functional pIC50 = 8.2 8.2 - 1
Compound was evaluated for functional antagonism of Neuropeptide Y receptor Y5 activity in cellular Ca fluxCompound was evaluated for functional antagonism of Neuropeptide Y receptor Y5 activity in cellular Ca flux
ChEMBL 351 2 1 3 4.5 Cc1c(NC(=O)N2CCOCC2)ccc2c1c1ccccc1n2C(C)C 10.1021/jm011125x
9887225 187254 None 2 Human Functional pIC50 = 8.2 8.2 -2 3
Antagonist activity at human recombinant NPY Y5 receptor expressed in mouse LMtk- cells assessed as inhibition of NPY-induced Ca2+ increaseAntagonist activity at human recombinant NPY Y5 receptor expressed in mouse LMtk- cells assessed as inhibition of NPY-induced Ca2+ increase
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL491930 187254 None 2 Human Functional pIC50 = 8.2 8.2 -2 3
Antagonist activity at human recombinant NPY Y5 receptor expressed in mouse LMtk- cells assessed as inhibition of NPY-induced Ca2+ increaseAntagonist activity at human recombinant NPY Y5 receptor expressed in mouse LMtk- cells assessed as inhibition of NPY-induced Ca2+ increase
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
1565 2207 None 11 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 366 1 1 4 5.0 OC1=C(C(=O)CC(C1)(C)C)C1C2=C(Oc3c1cccc3)CC(CC2=O)(C)C 10.1021/jm8003587
624746 2207 None 11 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 366 1 1 4 5.0 OC1=C(C(=O)CC(C1)(C)C)C1C2=C(Oc3c1cccc3)CC(CC2=O)(C)C 10.1021/jm8003587
CHEMBL491762 2207 None 11 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 366 1 1 4 5.0 OC1=C(C(=O)CC(C1)(C)C)C1C2=C(Oc3c1cccc3)CC(CC2=O)(C)C 10.1021/jm8003587
24950556 189580 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 384 1 1 4 5.1 CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3cc(F)ccc32)=C(O)C1 10.1021/jm8003587
CHEMBL513701 189580 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 384 1 1 4 5.1 CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3cc(F)ccc32)=C(O)C1 10.1021/jm8003587
10110741 188106 None 2 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ levelAntagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ level
ChEMBL 387 1 1 4 4.2 O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL497359 188106 None 2 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ levelAntagonist activity at human NPY Y5 receptor transfected in mouse LMtk cells assessed as inhibition of neuropeptide Y-induced increase in intercellular Ca2+ level
ChEMBL 387 1 1 4 4.2 O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
57403511 71281 None 0 Mouse Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 374 5 1 6 4.5 CCOc1ccc(Nc2nc3cc(S(=O)(=O)C(C)(C)C)ccc3o2)cc1 10.1016/j.bmcl.2012.01.027
CHEMBL1956927 71281 None 0 Mouse Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 374 5 1 6 4.5 CCOc1ccc(Nc2nc3cc(S(=O)(=O)C(C)(C)C)ccc3o2)cc1 10.1016/j.bmcl.2012.01.027
57393069 71292 None 0 Mouse Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 388 5 1 8 2.6 CCS(=O)(=O)c1ccc2oc(Nc3ccc(N4CCOCC4)nc3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956939 71292 None 0 Mouse Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 388 5 1 8 2.6 CCS(=O)(=O)c1ccc2oc(Nc3ccc(N4CCOCC4)nc3)nc2c1 10.1016/j.bmcl.2012.01.027
44579887 193202 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk cells assessed as inhibition of NPY-induced calcium increaseAntagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk cells assessed as inhibition of NPY-induced calcium increase
ChEMBL 400 2 1 6 4.6 Cc1nc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)no1 10.1016/j.bmcl.2008.08.021
CHEMBL522589 193202 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk cells assessed as inhibition of NPY-induced calcium increaseAntagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk cells assessed as inhibition of NPY-induced calcium increase
ChEMBL 400 2 1 6 4.6 Cc1nc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)no1 10.1016/j.bmcl.2008.08.021
25211875 192758 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk cells assessed as inhibition of NPY-induced calcium increaseAntagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk cells assessed as inhibition of NPY-induced calcium increase
ChEMBL 400 2 1 7 3.5 Cn1nnc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)n1 10.1016/j.bmcl.2008.08.021
CHEMBL521750 192758 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk cells assessed as inhibition of NPY-induced calcium increaseAntagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk cells assessed as inhibition of NPY-induced calcium increase
ChEMBL 400 2 1 7 3.5 Cn1nnc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)n1 10.1016/j.bmcl.2008.08.021
57328464 71269 None 0 Mouse Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 415 5 1 7 4.0 CCS(=O)(=O)c1ccc2oc(Nc3ccc(N4C[C@H](C)O[C@H](C)C4)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956849 71269 None 0 Mouse Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 415 5 1 7 4.0 CCS(=O)(=O)c1ccc2oc(Nc3ccc(N4C[C@H](C)O[C@H](C)C4)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
44271437 98518 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 503 7 1 6 4.9 CN(C[C@H]1CC[C@H](CN(C)S(=O)(=O)c2cccc3ccccc23)CC1)c1nc(N)c2ccccc2n1 10.1016/s0960-894x(00)00177-3
CHEMBL275845 98518 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 503 7 1 6 4.9 CN(C[C@H]1CC[C@H](CN(C)S(=O)(=O)c2cccc3ccccc23)CC1)c1nc(N)c2ccccc2n1 10.1016/s0960-894x(00)00177-3
57396550 71288 None 0 Mouse Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 364 4 1 5 4.6 CCS(=O)(=O)c1ccc2oc(NC3CCC(C(C)(C)C)CC3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956934 71288 None 0 Mouse Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 364 4 1 5 4.6 CCS(=O)(=O)c1ccc2oc(NC3CCC(C(C)(C)C)CC3)nc2c1 10.1016/j.bmcl.2012.01.027
2418891 51027 None 4 Mouse Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 358 4 1 5 4.7 CCS(=O)(=O)c1ccc2oc(Nc3ccc(C(C)(C)C)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1578465 51027 None 4 Mouse Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 358 4 1 5 4.7 CCS(=O)(=O)c1ccc2oc(Nc3ccc(C(C)(C)C)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
24950714 178804 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 384 1 1 4 5.1 CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3c(F)cccc32)=C(O)C1 10.1021/jm8003587
CHEMBL468225 178804 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 384 1 1 4 5.1 CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3c(F)cccc32)=C(O)C1 10.1021/jm8003587
57398334 71290 None 0 Mouse Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 371 4 1 6 3.8 CCS(=O)(=O)c1ccc2oc(Nc3ccc(C(F)(F)F)nc3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956937 71290 None 0 Mouse Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 371 4 1 6 3.8 CCS(=O)(=O)c1ccc2oc(Nc3ccc(C(F)(F)F)nc3)nc2c1 10.1016/j.bmcl.2012.01.027
10047509 62815 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk- cells co-expressing Gqi5 assessed as inhibition of NPY-induced calcium increaseAntagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk- cells co-expressing Gqi5 assessed as inhibition of NPY-induced calcium increase
ChEMBL 416 4 1 5 3.6 C[C@@H]1NC(c2ccc(=O)n(C(F)F)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
CHEMBL1784130 62815 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk- cells co-expressing Gqi5 assessed as inhibition of NPY-induced calcium increaseAntagonist activity at human recombinant NPYY5 receptor expressed in mouse LMtk- cells co-expressing Gqi5 assessed as inhibition of NPY-induced calcium increase
ChEMBL 416 4 1 5 3.6 C[C@@H]1NC(c2ccc(=O)n(C(F)F)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
9801629 65999 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 409 4 2 5 3.7 CS(=O)(=O)N[C@H]1CC[C@H](Nc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2011.06.124
CHEMBL1836325 65999 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 409 4 2 5 3.7 CS(=O)(=O)N[C@H]1CC[C@H](Nc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2011.06.124
213847 60404 None 3 Human Functional pIC50 = 7.1 7.1 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 312 4 2 4 5.1 c1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
CHEMBL17483 60404 None 3 Human Functional pIC50 = 7.1 7.1 - 1
Antagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cellsAntagonistic activity against neuropeptide Y receptor type 5 subtype stably expressed in LM(tk-)cells
ChEMBL 312 4 2 4 5.1 c1ccc(Nc2nc(Nc3ccccc3)c3ccccc3n2)cc1 10.1016/s0960-894x(00)00177-3
9803547 178745 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 444 1 1 4 5.8 CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3cc(Br)ccc32)=C(O)C1 10.1021/jm8003587
CHEMBL467550 178745 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 444 1 1 4 5.8 CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3cc(Br)ccc32)=C(O)C1 10.1021/jm8003587
24950712 189476 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 400 1 1 4 5.7 CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3cc(Cl)ccc32)=C(O)C1 10.1021/jm8003587
CHEMBL512787 189476 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 400 1 1 4 5.7 CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3cc(Cl)ccc32)=C(O)C1 10.1021/jm8003587
57393058 71267 None 0 Mouse Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 360 6 1 6 4.2 CCS(=O)(=O)c1ccc2oc(Nc3ccc(OC(C)C)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
CHEMBL1956847 71267 None 0 Mouse Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 360 6 1 6 4.2 CCS(=O)(=O)c1ccc2oc(Nc3ccc(OC(C)C)cc3)nc2c1 10.1016/j.bmcl.2012.01.027
9847327 65995 None 0 Human Functional pIC50 = 8 8.0 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 465 9 2 5 4.5 O=S(=O)(CC(F)(F)F)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836321 65995 None 0 Human Functional pIC50 = 8 8.0 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 465 9 2 5 4.5 O=S(=O)(CC(F)(F)F)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
44577739 189500 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 422 5 1 4 6.6 CCC1(CC)CC(=O)C(C2C3=C(CC(CC)(CC)CC3=O)Oc3ccccc32)=C(O)C1 10.1021/jm8003587
CHEMBL512996 189500 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentrationAntagonist activity at human recombinant neuropeptide Y5 receptor expressed in CHO cells coexpressing Gqi5 assessed as inhibition of neuropeptide Y-induced increase in intracellular calcium concentration
ChEMBL 422 5 1 4 6.6 CCC1(CC)CC(=O)C(C2C3=C(CC(CC)(CC)CC3=O)Oc3ccccc32)=C(O)C1 10.1021/jm8003587
20651605 65994 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 425 9 2 5 4.3 CC(C)S(=O)(=O)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836320 65994 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 425 9 2 5 4.3 CC(C)S(=O)(=O)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
57399998 71280 None 0 Mouse Functional pIC50 = 7 7.0 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 360 6 1 6 4.2 CCOc1ccc(Nc2nc3cc(S(=O)(=O)C(C)C)ccc3o2)cc1 10.1016/j.bmcl.2012.01.027
CHEMBL1956926 71280 None 0 Mouse Functional pIC50 = 7 7.0 - 1
Antagonist activity at mouse neuropeptide Y5 receptorAntagonist activity at mouse neuropeptide Y5 receptor
ChEMBL 360 6 1 6 4.2 CCOc1ccc(Nc2nc3cc(S(=O)(=O)C(C)C)ccc3o2)cc1 10.1016/j.bmcl.2012.01.027
44158542 17552 None 0 Human Functional pKi = 10.6 10.6 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 433 5 1 6 4.7 O=C1O[C@]2(CC[C@H](CNc3cnc(-c4ccccc4F)cn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
CHEMBL1257993 17552 None 0 Human Functional pKi = 10.6 10.6 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 433 5 1 6 4.7 O=C1O[C@]2(CC[C@H](CNc3cnc(-c4ccccc4F)cn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
24994659 17587 None 0 Human Functional pKi = 10.5 10.5 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 421 5 1 6 4.4 O=C1O[C@]2(CC[C@H](CNc3ccn(-c4ccccc4F)n3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
CHEMBL1258111 17587 None 0 Human Functional pKi = 10.5 10.5 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 421 5 1 6 4.4 O=C1O[C@]2(CC[C@H](CNc3ccn(-c4ccccc4F)n3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
52944983 17618 None 0 Human Functional pKi = 10.4 10.4 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 422 5 1 7 3.8 O=C1O[C@]2(CC[C@H](CNc3cnn(-c4ccccc4F)c3)CC2)CN1c1cncnc1 10.1016/j.bmcl.2010.08.041
CHEMBL1258225 17618 None 0 Human Functional pKi = 10.4 10.4 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 422 5 1 7 3.8 O=C1O[C@]2(CC[C@H](CNc3cnn(-c4ccccc4F)c3)CC2)CN1c1cncnc1 10.1016/j.bmcl.2010.08.041
44158762 17551 None 0 Human Functional pKi = 10.2 10.2 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 433 5 1 6 4.7 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4ccccc4F)nn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
CHEMBL1257992 17551 None 0 Human Functional pKi = 10.2 10.2 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 433 5 1 6 4.7 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4ccccc4F)nn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
52941430 17649 None 0 Human Functional pKi = 10.2 10.2 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 422 5 1 7 3.8 O=C1O[C@]2(CC[C@H](CNc3cnn(-c4ccccc4F)c3)CC2)CN1c1cnccn1 10.1016/j.bmcl.2010.08.041
CHEMBL1258341 17649 None 0 Human Functional pKi = 10.2 10.2 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 422 5 1 7 3.8 O=C1O[C@]2(CC[C@H](CNc3cnn(-c4ccccc4F)c3)CC2)CN1c1cnccn1 10.1016/j.bmcl.2010.08.041
44158764 17796 None 0 Human Functional pKi = 10.2 10.2 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 430 5 1 7 4.2 Cc1ccccc1-c1ccc(NC[C@H]2CC[C@]3(CC2)CN(c2cccnn2)C(=O)O3)nn1 10.1016/j.bmcl.2010.08.041
CHEMBL1258787 17796 None 0 Human Functional pKi = 10.2 10.2 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 430 5 1 7 4.2 Cc1ccccc1-c1ccc(NC[C@H]2CC[C@]3(CC2)CN(c2cccnn2)C(=O)O3)nn1 10.1016/j.bmcl.2010.08.041
24996879 17586 None 0 Human Functional pKi = 10.1 10.1 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 421 5 1 7 4.6 O=C1O[C@]2(CC[C@H](CNc3nc(-c4ccccn4)cs3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
CHEMBL1258110 17586 None 0 Human Functional pKi = 10.1 10.1 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 421 5 1 7 4.6 O=C1O[C@]2(CC[C@H](CNc3nc(-c4ccccn4)cs3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
52942650 17448 None 0 Human Functional pKi = 10 10.0 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 421 5 1 6 4.4 O=C1O[C@]2(CC[C@H](CNc3cnn(-c4ccccc4F)c3)CC2)CN1c1cccnc1 10.1016/j.bmcl.2010.08.041
CHEMBL1257636 17448 None 0 Human Functional pKi = 10 10.0 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 421 5 1 6 4.4 O=C1O[C@]2(CC[C@H](CNc3cnn(-c4ccccc4F)c3)CC2)CN1c1cccnc1 10.1016/j.bmcl.2010.08.041
52942663 17648 None 0 Human Functional pKi = 10 10.0 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 439 5 1 6 4.5 O=C1O[C@]2(CC[C@H](CNc3cnn(-c4ccccc4F)c3)CC2)CN1c1cccnc1F 10.1016/j.bmcl.2010.08.041
CHEMBL1258340 17648 None 0 Human Functional pKi = 10 10.0 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 439 5 1 6 4.5 O=C1O[C@]2(CC[C@H](CNc3cnn(-c4ccccc4F)c3)CC2)CN1c1cccnc1F 10.1016/j.bmcl.2010.08.041
52942671 17686 None 0 Human Functional pKi = 10 10.0 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 422 5 1 7 3.8 O=C1O[C@]2(CC[C@H](CNc3cnn(-c4ccccc4F)c3)CC2)CN1c1cccnn1 10.1016/j.bmcl.2010.08.041
CHEMBL1258453 17686 None 0 Human Functional pKi = 10 10.0 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 422 5 1 7 3.8 O=C1O[C@]2(CC[C@H](CNc3cnn(-c4ccccc4F)c3)CC2)CN1c1cccnn1 10.1016/j.bmcl.2010.08.041
44158763 17759 None 0 Human Functional pKi = 10 10.0 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 452 5 1 7 4.2 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4cc(F)cc(F)c4)nn3)CC2)CN1c1cccnn1 10.1016/j.bmcl.2010.08.041
CHEMBL1258674 17759 None 0 Human Functional pKi = 10 10.0 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 452 5 1 7 4.2 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4cc(F)cc(F)c4)nn3)CC2)CN1c1cccnn1 10.1016/j.bmcl.2010.08.041
44159473 17449 None 0 Human Functional pKi = 9.9 9.9 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 421 5 1 7 4.6 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4nccs4)cn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
CHEMBL1257637 17449 None 0 Human Functional pKi = 9.9 9.9 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 421 5 1 7 4.6 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4nccs4)cn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
44159236 17486 None 0 Human Functional pKi = 9.8 9.8 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 416 5 1 7 3.9 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4ncccn4)cn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
CHEMBL1257760 17486 None 0 Human Functional pKi = 9.8 9.8 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 416 5 1 7 3.9 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4ncccn4)cn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
44159353 17487 None 0 Human Functional pKi = 9.8 9.8 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 408 6 1 6 4.4 O=C1O[C@]2(CC[C@H](CNc3ccc(OC4CCC4)cn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
CHEMBL1257761 17487 None 0 Human Functional pKi = 9.8 9.8 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 408 6 1 6 4.4 O=C1O[C@]2(CC[C@H](CNc3ccc(OC4CCC4)cn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
52950004 17758 None 0 Human Functional pKi = 9.8 9.8 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 434 5 1 7 4.1 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4ccccc4F)nn3)CC2)CN1c1cccnn1 10.1016/j.bmcl.2010.08.041
CHEMBL1258673 17758 None 0 Human Functional pKi = 9.8 9.8 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 434 5 1 7 4.1 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4ccccc4F)nn3)CC2)CN1c1cccnn1 10.1016/j.bmcl.2010.08.041
25071621 19107 None 0 Human Functional pKi = 9.8 9.8 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.5 O=C1OC2(CCN(c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289154 19107 None 0 Human Functional pKi = 9.8 9.8 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.5 O=C1OC2(CCN(c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
52948742 17687 None 0 Human Functional pKi = 9.7 9.7 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 422 5 1 7 3.8 O=C1O[C@]2(CC[C@H](CNc3cnn(-c4ccccc4F)c3)CC2)CN1c1ccnnc1 10.1016/j.bmcl.2010.08.041
CHEMBL1258454 17687 None 0 Human Functional pKi = 9.7 9.7 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 422 5 1 7 3.8 O=C1O[C@]2(CC[C@H](CNc3cnn(-c4ccccc4F)c3)CC2)CN1c1ccnnc1 10.1016/j.bmcl.2010.08.041
52948986 17723 None 0 Human Functional pKi = 9.7 9.7 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 442 5 1 8 4.2 Cc1nnc(N2C[C@]3(CC[C@@H](CNc4cnn(-c5ccccc5F)c4)CC3)OC2=O)s1 10.1016/j.bmcl.2010.08.041
CHEMBL1258562 17723 None 0 Human Functional pKi = 9.7 9.7 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 442 5 1 8 4.2 Cc1nnc(N2C[C@]3(CC[C@@H](CNc4cnn(-c5ccccc5F)c4)CC3)OC2=O)s1 10.1016/j.bmcl.2010.08.041
25071620 19106 None 0 Human Functional pKi = 9.7 9.7 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 442 3 1 4 5.4 O=C1OC2(CCN(c3nc4cc(-c5ccc(F)cc5)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289153 19106 None 0 Human Functional pKi = 9.7 9.7 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 442 3 1 4 5.4 O=C1OC2(CCN(c3nc4cc(-c5ccc(F)cc5)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
44160200 17797 None 0 Human Functional pKi = 9.6 9.6 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 430 5 1 7 4.2 Cc1cccc(-c2ccc(NC[C@H]3CC[C@]4(CC3)CN(c3cccnn3)C(=O)O4)nc2)n1 10.1016/j.bmcl.2010.08.041
CHEMBL1258788 17797 None 0 Human Functional pKi = 9.6 9.6 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 430 5 1 7 4.2 Cc1cccc(-c2ccc(NC[C@H]3CC[C@]4(CC3)CN(c3cccnn3)C(=O)O4)nc2)n1 10.1016/j.bmcl.2010.08.041
44158545 17617 None 0 Human Functional pKi = 9.5 9.5 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 433 5 1 6 4.7 O=C1O[C@]2(CC[C@H](CNc3ncc(-c4ccccc4F)cn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
CHEMBL1258224 17617 None 0 Human Functional pKi = 9.5 9.5 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 433 5 1 6 4.7 O=C1O[C@]2(CC[C@H](CNc3ncc(-c4ccccc4F)cn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
44160199 17829 None 0 Human Functional pKi = 9.5 9.5 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 434 5 1 7 4.1 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4ncccc4F)cn3)CC2)CN1c1cccnn1 10.1016/j.bmcl.2010.08.041
CHEMBL1258907 17829 None 0 Human Functional pKi = 9.5 9.5 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 434 5 1 7 4.1 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4ncccc4F)cn3)CC2)CN1c1cccnn1 10.1016/j.bmcl.2010.08.041
25071310 19121 None 0 Human Functional pKi = 9.5 9.5 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 431 3 1 4 5.5 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289267 19121 None 0 Human Functional pKi = 9.5 9.5 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 431 3 1 4 5.5 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25072880 19141 None 0 Human Functional pKi = 9.5 9.5 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccc(F)cc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289386 19141 None 0 Human Functional pKi = 9.5 9.5 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccc(F)cc1 10.1016/j.bmcl.2010.09.064
25073190 19234 None 0 Human Functional pKi = 9.5 9.5 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 372 2 1 4 4.5 N#Cc1ccc2[nH]c([C@H]3CC[C@]4(CC3)CN(c3ccccc3)C(=O)O4)nc2c1 10.1016/j.bmcl.2010.09.064
CHEMBL1290037 19234 None 0 Human Functional pKi = 9.5 9.5 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 372 2 1 4 4.5 N#Cc1ccc2[nH]c([C@H]3CC[C@]4(CC3)CN(c3ccccc3)C(=O)O4)nc2c1 10.1016/j.bmcl.2010.09.064
49862239 15015 None 0 Human Functional pKi = 9.4 9.4 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 404 6 1 5 4.1 CC(C(=O)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1)c1ccccc1 10.1016/j.bmcl.2010.06.140
CHEMBL1209159 15015 None 0 Human Functional pKi = 9.4 9.4 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 404 6 1 5 4.1 CC(C(=O)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1)c1ccccc1 10.1016/j.bmcl.2010.06.140
25072875 19174 None 0 Human Functional pKi = 9.4 9.4 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 446 3 1 5 5.2 Cc1cccc(N2C[C@]3(CC[C@@H](c4nc5cc(OC(F)(F)F)ccc5[nH]4)CC3)OC2=O)n1 10.1016/j.bmcl.2010.09.064
CHEMBL1289609 19174 None 0 Human Functional pKi = 9.4 9.4 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 446 3 1 5 5.2 Cc1cccc(N2C[C@]3(CC[C@@H](c4nc5cc(OC(F)(F)F)ccc5[nH]4)CC3)OC2=O)n1 10.1016/j.bmcl.2010.09.064
52943793 17411 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 435 5 1 6 4.7 Cc1ncccc1N1C[C@]2(CC[C@@H](CNc3cnn(-c4ccccc4F)c3)CC2)OC1=O 10.1016/j.bmcl.2010.08.041
CHEMBL1257520 17411 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 435 5 1 6 4.7 Cc1ncccc1N1C[C@]2(CC[C@@H](CNc3cnn(-c4ccccc4F)c3)CC2)OC1=O 10.1016/j.bmcl.2010.08.041
49862241 15018 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 404 7 1 5 4.0 O=C(CCc1ccccc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209162 15018 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 404 7 1 5 4.0 O=C(CCc1ccccc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
49862400 15059 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 398 6 1 5 4.3 Fc1cc(F)cc(CN2C[C@H]3[C@@H](CNc4nc(-c5ccccn5)cs4)[C@H]3C2)c1 10.1016/j.bmcl.2010.06.140
CHEMBL1209345 15059 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 398 6 1 5 4.3 Fc1cc(F)cc(CN2C[C@H]3[C@@H](CNc4nc(-c5ccccn5)cs4)[C@H]3C2)c1 10.1016/j.bmcl.2010.06.140
25073189 19122 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1F 10.1016/j.bmcl.2010.09.064
CHEMBL1289268 19122 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1F 10.1016/j.bmcl.2010.09.064
25071931 19208 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 415 2 1 3 5.6 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289820 19208 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 415 2 1 3 5.6 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25072877 19235 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 390 2 1 4 4.6 N#Cc1ccc2[nH]c([C@H]3CC[C@]4(CC3)CN(c3ccc(F)cc3)C(=O)O4)nc2c1 10.1016/j.bmcl.2010.09.064
CHEMBL1290038 19235 None 0 Human Functional pKi = 9.2 9.2 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 390 2 1 4 4.6 N#Cc1ccc2[nH]c([C@H]3CC[C@]4(CC3)CN(c3ccc(F)cc3)C(=O)O4)nc2c1 10.1016/j.bmcl.2010.09.064
49862240 15016 None 0 Human Functional pKi = 9.1 9.1 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 6 1 5 4.1 O=C(N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1)C1(c2ccccc2)CC1 10.1016/j.bmcl.2010.06.140
CHEMBL1209160 15016 None 0 Human Functional pKi = 9.1 9.1 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 6 1 5 4.1 O=C(N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1)C1(c2ccccc2)CC1 10.1016/j.bmcl.2010.06.140
49862289 15029 None 0 Human Functional pKi = 9.1 9.1 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 6 1 5 4.1 O=C([C@H]1C[C@@H]1c1ccccc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209216 15029 None 0 Human Functional pKi = 9.1 9.1 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 6 1 5 4.1 O=C([C@H]1C[C@@H]1c1ccccc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
22253974 65998 None 0 Human Functional pKi = 9.1 9.1 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 411 9 2 6 4.0 CCS(=O)(=O)NCCCCCNc1nc2c(s1)CCSc1ccccc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836324 65998 None 0 Human Functional pKi = 9.1 9.1 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 411 9 2 6 4.0 CCS(=O)(=O)NCCCCCNc1nc2c(s1)CCSc1ccccc1-2 10.1016/j.bmcl.2011.06.124
9887852 65996 None 0 Human Functional pKi = 9.1 9.1 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 411 9 2 5 4.0 CCS(=O)(=O)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836322 65996 None 0 Human Functional pKi = 9.1 9.1 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 411 9 2 5 4.0 CCS(=O)(=O)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
44159235 17521 None 0 Human Functional pKi = 9 9.0 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 406 4 1 5 4.5 O=C1O[C@]2(CC[C@H](CNc3ccc(C(F)(F)F)cn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
CHEMBL1257881 17521 None 0 Human Functional pKi = 9 9.0 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 406 4 1 5 4.5 O=C1O[C@]2(CC[C@H](CNc3ccc(C(F)(F)F)cn3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
49862157 14997 None 0 Human Functional pKi = 9 9.0 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 394 5 1 5 3.8 O=C(c1cccc(F)c1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209052 14997 None 0 Human Functional pKi = 9 9.0 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 394 5 1 5 3.8 O=C(c1cccc(F)c1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
49862200 15004 None 0 Human Functional pKi = 9 9.0 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 390 6 1 5 3.6 O=C(Cc1ccccc1)N1C[C@H]2[C@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209101 15004 None 0 Human Functional pKi = 9 9.0 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 390 6 1 5 3.6 O=C(Cc1ccccc1)N1C[C@H]2[C@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
49862200 15005 None 0 Human Functional pKi = 9 9.0 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 390 6 1 5 3.6 O=C(Cc1ccccc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209102 15005 None 0 Human Functional pKi = 9 9.0 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 390 6 1 5 3.6 O=C(Cc1ccccc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
9845943 66003 None 0 Human Functional pKi = 9.0 9.0 - 0
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 437 6 2 7 3.3 COc1cccc2c1OCCc1sc(N[C@H]3CC[C@H](CNS(C)(=O)=O)CC3)nc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836329 66003 None 0 Human Functional pKi = 9.0 9.0 - 0
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 437 6 2 7 3.3 COc1cccc2c1OCCc1sc(N[C@H]3CC[C@H](CNS(C)(=O)=O)CC3)nc1-2 10.1016/j.bmcl.2011.06.124
9888553 66005 None 0 Human Functional pKi = 9.0 9.0 - 0
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 423 5 2 5 4.0 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2011.06.124
CHEMBL1836331 66005 None 0 Human Functional pKi = 9.0 9.0 - 0
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 423 5 2 5 4.0 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2011.06.124
49862401 15060 None 0 Human Functional pKi = 8.9 8.9 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 376 6 1 5 4.6 CC(c1ccccc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209346 15060 None 0 Human Functional pKi = 8.9 8.9 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 376 6 1 5 4.6 CC(c1ccccc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
25071929 19086 None 0 Human Functional pKi = 8.9 8.9 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 426 2 1 4 4.3 O=C1OC2(CCN(c3nc4cc(Br)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289038 19086 None 0 Human Functional pKi = 8.9 8.9 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 426 2 1 4 4.3 O=C1OC2(CCN(c3nc4cc(Br)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25073191 19158 None 0 Human Functional pKi = 8.9 8.9 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.9 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
CHEMBL1289503 19158 None 0 Human Functional pKi = 8.9 8.9 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.9 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
25073801 19191 None 0 Human Functional pKi = 8.9 8.9 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 450 3 1 5 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccc(F)n1 10.1016/j.bmcl.2010.09.064
CHEMBL1289714 19191 None 0 Human Functional pKi = 8.9 8.9 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 450 3 1 5 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccc(F)n1 10.1016/j.bmcl.2010.09.064
9908801 65993 None 0 Human Functional pKi = 8.9 8.9 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 397 8 2 5 3.6 CS(=O)(=O)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836319 65993 None 0 Human Functional pKi = 8.9 8.9 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 397 8 2 5 3.6 CS(=O)(=O)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
22254068 65991 None 26 Rat Functional pKi = 8.9 8.9 - 1
Antagonist activity at rat NPY5 receptorAntagonist activity at rat NPY5 receptor
ChEMBL 423 5 2 6 4.0 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
CHEMBL1836317 65991 None 26 Rat Functional pKi = 8.9 8.9 - 1
Antagonist activity at rat NPY5 receptorAntagonist activity at rat NPY5 receptor
ChEMBL 423 5 2 6 4.0 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
22254068 65991 None 26 Human Functional pKi = 8.8 8.8 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 423 5 2 6 4.0 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
CHEMBL1836317 65991 None 26 Human Functional pKi = 8.8 8.8 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 423 5 2 6 4.0 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
44159706 17724 None 0 Human Functional pKi = 8.8 8.8 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 417 5 1 8 3.3 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4ncccn4)cn3)CC2)CN1c1cccnn1 10.1016/j.bmcl.2010.08.041
CHEMBL1258563 17724 None 0 Human Functional pKi = 8.8 8.8 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 417 5 1 8 3.3 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4ncccn4)cn3)CC2)CN1c1cccnn1 10.1016/j.bmcl.2010.08.041
49862158 14998 None 0 Human Functional pKi = 8.8 8.8 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 412 5 1 5 3.9 O=C(c1cc(F)cc(F)c1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209053 14998 None 0 Human Functional pKi = 8.8 8.8 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 412 5 1 5 3.9 O=C(c1cc(F)cc(F)c1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
49862339 15042 None 0 Human Functional pKi = 8.8 8.8 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 362 6 1 5 4.0 c1ccc(CN2C[C@H]3[C@@H](CNc4nc(-c5ccccn5)cs4)[C@H]3C2)cc1 10.1016/j.bmcl.2010.06.140
CHEMBL1209280 15042 None 0 Human Functional pKi = 8.8 8.8 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 362 6 1 5 4.0 c1ccc(CN2C[C@H]3[C@@H](CNc4nc(-c5ccccn5)cs4)[C@H]3C2)cc1 10.1016/j.bmcl.2010.06.140
25072242 19345 None 0 Human Functional pKi = 8.8 8.8 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 4.6 O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1290706 19345 None 0 Human Functional pKi = 8.8 8.8 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 4.6 O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
22254110 66004 None 0 Human Functional pKi = 8.8 8.8 - 0
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 415 8 2 6 3.7 CS(=O)(=O)NCCCCCNc1nc2c(s1)CCSc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836330 66004 None 0 Human Functional pKi = 8.8 8.8 - 0
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 415 8 2 6 3.7 CS(=O)(=O)NCCCCCNc1nc2c(s1)CCSc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
22254020 65990 None 0 Human Functional pKi = 8.7 8.7 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 491 6 2 7 5.5 O=S(=O)(NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1)c1cccs1 10.1016/j.bmcl.2011.06.124
CHEMBL1836316 65990 None 0 Human Functional pKi = 8.7 8.7 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 491 6 2 7 5.5 O=S(=O)(NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1)c1cccs1 10.1016/j.bmcl.2011.06.124
24987242 17303 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 435 3 1 6 4.2 O=C(Nc1nc(-c2ccccn2)cs1)N1CCC2(CC1)CN(c1ccccc1)C(=O)O2 10.1016/j.bmcl.2010.08.041
CHEMBL1257173 17303 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 435 3 1 6 4.2 O=C(Nc1nc(-c2ccccn2)cs1)N1CCC2(CC1)CN(c1ccccc1)C(=O)O2 10.1016/j.bmcl.2010.08.041
24987242 17303 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 435 3 1 6 4.2 O=C(Nc1nc(-c2ccccn2)cs1)N1CCC2(CC1)CN(c1ccccc1)C(=O)O2 10.1016/j.bmcl.2010.09.064
CHEMBL1257173 17303 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 435 3 1 6 4.2 O=C(Nc1nc(-c2ccccn2)cs1)N1CCC2(CC1)CN(c1ccccc1)C(=O)O2 10.1016/j.bmcl.2010.09.064
49862337 15040 None 0 Human Functional pKi = 6 6.0 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 272 4 2 5 2.1 c1ccc(-c2csc(NC[C@@H]3[C@H]4CNC[C@H]43)n2)nc1 10.1016/j.bmcl.2010.06.140
CHEMBL1209278 15040 None 0 Human Functional pKi = 6 6.0 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 272 4 2 5 2.1 c1ccc(-c2csc(NC[C@@H]3[C@H]4CNC[C@H]43)n2)nc1 10.1016/j.bmcl.2010.06.140
10872843 102993 None 0 Human Functional pKi = 7 7.0 - 1
Tested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptorTested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptor
ChEMBL 390 7 2 3 4.9 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(OCc2ccccc2)cc1 10.1021/jm0004547
CHEMBL306277 102993 None 0 Human Functional pKi = 7 7.0 - 1
Tested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptorTested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptor
ChEMBL 390 7 2 3 4.9 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(OCc2ccccc2)cc1 10.1021/jm0004547
49862156 14995 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 376 5 1 5 3.6 O=C(c1ccccc1)N1C[C@H]2[C@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209050 14995 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 376 5 1 5 3.6 O=C(c1ccccc1)N1C[C@H]2[C@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
22254119 65988 None 0 Human Functional pKi = 7.9 7.9 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 535 6 2 6 6.6 O=S(=O)(NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1)c1cccc2ccccc12 10.1016/j.bmcl.2011.06.124
CHEMBL1836314 65988 None 0 Human Functional pKi = 7.9 7.9 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 535 6 2 6 6.6 O=S(=O)(NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1)c1cccc2ccccc12 10.1016/j.bmcl.2011.06.124
4527770 15061 None 2 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 321 3 1 4 5.0 FC(F)(F)c1ccc(Nc2nc(-c3ccccn3)cs2)cc1 10.1016/j.bmcl.2010.08.041
CHEMBL1209347 15061 None 2 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 321 3 1 4 5.0 FC(F)(F)c1ccc(Nc2nc(-c3ccccn3)cs2)cc1 10.1016/j.bmcl.2010.08.041
4527770 15061 None 2 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 321 3 1 4 5.0 FC(F)(F)c1ccc(Nc2nc(-c3ccccn3)cs2)cc1 10.1016/j.bmcl.2010.06.140
CHEMBL1209347 15061 None 2 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 321 3 1 4 5.0 FC(F)(F)c1ccc(Nc2nc(-c3ccccn3)cs2)cc1 10.1016/j.bmcl.2010.06.140
20651572 66006 None 0 Human Functional pKi = 7.8 7.8 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 407 5 2 6 3.3 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCOc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
CHEMBL1836332 66006 None 0 Human Functional pKi = 7.8 7.8 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 407 5 2 6 3.3 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCOc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
9982218 101819 None 5 Rat Functional pKi = 7.8 7.8 - 1
Functional response of NPY to inhibit forskolin-stimulated cAMP in cells stably transfected with rat Neuropeptide Y receptor type 5Functional response of NPY to inhibit forskolin-stimulated cAMP in cells stably transfected with rat Neuropeptide Y receptor type 5
ChEMBL 471 9 2 5 4.1 O=[N+]([O-])c1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1 10.1016/s0960-894x(02)00287-1
CHEMBL1435188 101819 None 5 Rat Functional pKi = 7.8 7.8 - 1
Functional response of NPY to inhibit forskolin-stimulated cAMP in cells stably transfected with rat Neuropeptide Y receptor type 5Functional response of NPY to inhibit forskolin-stimulated cAMP in cells stably transfected with rat Neuropeptide Y receptor type 5
ChEMBL 471 9 2 5 4.1 O=[N+]([O-])c1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1 10.1016/s0960-894x(02)00287-1
CHEMBL299879 101819 None 5 Rat Functional pKi = 7.8 7.8 - 1
Functional response of NPY to inhibit forskolin-stimulated cAMP in cells stably transfected with rat Neuropeptide Y receptor type 5Functional response of NPY to inhibit forskolin-stimulated cAMP in cells stably transfected with rat Neuropeptide Y receptor type 5
ChEMBL 471 9 2 5 4.1 O=[N+]([O-])c1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1 10.1016/s0960-894x(02)00287-1
25071930 19087 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 366 2 1 4 3.7 O=C1OC2(CCN(c3nc4cc(F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289039 19087 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 366 2 1 4 3.7 O=C1OC2(CCN(c3nc4cc(F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25072244 19207 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 450 3 1 5 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccnc1F 10.1016/j.bmcl.2010.09.064
CHEMBL1289819 19207 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 450 3 1 5 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccnc1F 10.1016/j.bmcl.2010.09.064
20651606 66001 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 427 9 2 6 3.2 CC(C)S(=O)(=O)NCCOCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836327 66001 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 427 9 2 6 3.2 CC(C)S(=O)(=O)NCCOCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
49862155 14994 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 342 5 1 5 3.0 CC(C)C(=O)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209049 14994 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 342 5 1 5 3.0 CC(C)C(=O)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
49862156 14996 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 376 5 1 5 3.6 O=C(c1ccccc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209051 14996 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 376 5 1 5 3.6 O=C(c1ccccc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
25072245 19157 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 465 3 1 4 6.2 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1Cl 10.1016/j.bmcl.2010.09.064
CHEMBL1289502 19157 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 465 3 1 4 6.2 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1Cl 10.1016/j.bmcl.2010.09.064
22254050 65992 None 1 Human Functional pKi = 8.6 8.6 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 437 6 2 6 4.4 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
CHEMBL1836318 65992 None 1 Human Functional pKi = 8.6 8.6 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 437 6 2 6 4.4 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
22254003 65989 None 0 Human Functional pKi = 7.7 7.7 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 489 6 2 8 4.1 Cn1cnc(S(=O)(=O)NC[C@H]2CC[C@H](Nc3nc4c(s3)CCSc3ccccc3-4)CC2)c1 10.1016/j.bmcl.2011.06.124
CHEMBL1836315 65989 None 0 Human Functional pKi = 7.7 7.7 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 489 6 2 8 4.1 Cn1cnc(S(=O)(=O)NC[C@H]2CC[C@H](Nc3nc4c(s3)CCSc3ccccc3-4)CC2)c1 10.1016/j.bmcl.2011.06.124
9885994 207556 None 0 Human Functional pKi = 7.6 7.6 - 1
Tested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptorTested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptor
ChEMBL 376 6 2 3 5.1 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL77639 207556 None 0 Human Functional pKi = 7.6 7.6 - 1
Tested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptorTested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptor
ChEMBL 376 6 2 3 5.1 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
25072246 19192 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.9 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccnc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289715 19192 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.9 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccnc1 10.1016/j.bmcl.2010.09.064
46927904 14988 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 314 4 1 5 2.3 CC(=O)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1208996 14988 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 314 4 1 5 2.3 CC(=O)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
9801629 65999 None 0 Human Functional pKi = 7.6 7.6 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 409 4 2 5 3.7 CS(=O)(=O)N[C@H]1CC[C@H](Nc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2011.06.124
CHEMBL1836325 65999 None 0 Human Functional pKi = 7.6 7.6 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 409 4 2 5 3.7 CS(=O)(=O)N[C@H]1CC[C@H](Nc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2011.06.124
20651581 66000 None 0 Human Functional pKi = 8.5 8.5 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 451 8 2 5 4.1 O=S(=O)(CC(F)(F)F)NCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836326 66000 None 0 Human Functional pKi = 8.5 8.5 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 451 8 2 5 4.1 O=S(=O)(CC(F)(F)F)NCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
49862338 15041 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 328 6 1 5 3.5 CC(C)CN1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209279 15041 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 328 6 1 5 3.5 CC(C)CN1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
49862340 15043 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 390 6 1 5 4.6 Cc1cc(C)cc(CN2C[C@H]3[C@@H](CNc4nc(-c5ccccn5)cs4)[C@H]3C2)c1 10.1016/j.bmcl.2010.06.140
CHEMBL1209281 15043 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 390 6 1 5 4.6 Cc1cc(C)cc(CN2C[C@H]3[C@@H](CNc4nc(-c5ccccn5)cs4)[C@H]3C2)c1 10.1016/j.bmcl.2010.06.140
25074110 19220 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 434 2 1 4 5.2 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1cccc(F)n1 10.1016/j.bmcl.2010.09.064
CHEMBL1289937 19220 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 434 2 1 4 5.2 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1cccc(F)n1 10.1016/j.bmcl.2010.09.064
49862336 15039 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 384 5 1 6 2.7 O=C(C1CCOCC1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209277 15039 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 384 5 1 6 2.7 O=C(C1CCOCC1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
25022356 19346 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 348 2 1 4 3.6 O=C1OC2(CCN(c3nc4ccccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1290707 19346 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 348 2 1 4 3.6 O=C1OC2(CCN(c3nc4ccccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
22254131 65973 None 0 Human Functional pKi = 8.3 8.3 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 529 7 2 7 5.7 COc1ccc(C)cc1S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
CHEMBL1836103 65973 None 0 Human Functional pKi = 8.3 8.3 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 529 7 2 7 5.7 COc1ccc(C)cc1S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccccc2-3)CC1 10.1016/j.bmcl.2011.06.124
20651605 65994 None 0 Human Functional pKi = 7.3 7.3 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 425 9 2 5 4.3 CC(C)S(=O)(=O)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836320 65994 None 0 Human Functional pKi = 7.3 7.3 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 425 9 2 5 4.3 CC(C)S(=O)(=O)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
10429613 163434 None 0 Human Functional pKi = 6.3 6.3 60 2
Tested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptorTested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptor
ChEMBL 376 6 2 3 5.1 C[C@H]([C@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL419086 163434 None 0 Human Functional pKi = 6.3 6.3 60 2
Tested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptorTested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptor
ChEMBL 376 6 2 3 5.1 C[C@H]([C@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
44158441 17522 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 432 5 1 5 5.3 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4ccccc4F)nc3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
CHEMBL1257882 17522 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human NPY Y5 receptorAntagonist activity at human NPY Y5 receptor
ChEMBL 432 5 1 5 5.3 O=C1O[C@]2(CC[C@H](CNc3ccc(-c4ccccc4F)nc3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.08.041
49862198 15003 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 377 5 1 6 3.0 O=C(c1cccnc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209100 15003 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 377 5 1 6 3.0 O=C(c1cccnc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
49862288 15028 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 7 1 5 4.8 CC(C(=O)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1)C(C)c1ccccc1 10.1016/j.bmcl.2010.06.140
CHEMBL1209215 15028 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 7 1 5 4.8 CC(C(=O)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1)C(C)c1ccccc1 10.1016/j.bmcl.2010.06.140
49862290 15031 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 370 5 1 6 2.5 O=C(C1CCCO1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209218 15031 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 370 5 1 6 2.5 O=C(C1CCCO1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
25072243 19142 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 445 3 1 4 5.8 Cc1ccccc1N1C[C@]2(CC[C@@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)OC1=O 10.1016/j.bmcl.2010.09.064
CHEMBL1289387 19142 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 445 3 1 4 5.8 Cc1ccccc1N1C[C@]2(CC[C@@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)OC1=O 10.1016/j.bmcl.2010.09.064
25072876 19219 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
CHEMBL1289936 19219 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
54752621 67841 None 0 Rat Functional pKi = 8.3 8.3 - 0
Antagonist activity at rat NPY Y5 receptorAntagonist activity at rat NPY Y5 receptor
ChEMBL 369 10 2 6 2.2 CN(C)S(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
CHEMBL1909725 67841 None 0 Rat Functional pKi = 8.3 8.3 - 0
Antagonist activity at rat NPY Y5 receptorAntagonist activity at rat NPY Y5 receptor
ChEMBL 369 10 2 6 2.2 CN(C)S(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
49862199 14974 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 377 5 1 6 3.0 O=C(c1ccncc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1208795 14974 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 377 5 1 6 3.0 O=C(c1ccncc1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
11824961 207628 None 0 Human Functional pKi = 6.3 6.3 - 1
Tested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptorTested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptor
ChEMBL 376 6 2 3 5.1 C[C@@H]([C@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL78265 207628 None 0 Human Functional pKi = 6.3 6.3 - 1
Tested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptorTested in a cellular assay measuring forskolin-induced cyclic AMP accumulation in 293 cells transfected with the human NPY5 receptor
ChEMBL 376 6 2 3 5.1 C[C@@H]([C@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
49862241 15017 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 404 7 1 5 4.0 O=C(CCc1ccccc1)N1C[C@H]2[C@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209161 15017 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 404 7 1 5 4.0 O=C(CCc1ccccc1)N1C[C@H]2[C@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
20651616 66002 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 437 6 2 7 3.3 COc1ccc2c(c1)OCCc1sc(NC[C@H]3CC[C@H](NS(C)(=O)=O)CC3)nc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836328 66002 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 437 6 2 7 3.3 COc1ccc2c(c1)OCCc1sc(NC[C@H]3CC[C@H](NS(C)(=O)=O)CC3)nc1-2 10.1016/j.bmcl.2011.06.124
9847327 65995 None 0 Human Functional pKi = 8.1 8.1 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 465 9 2 5 4.5 O=S(=O)(CC(F)(F)F)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836321 65995 None 0 Human Functional pKi = 8.1 8.1 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 465 9 2 5 4.5 O=S(=O)(CC(F)(F)F)NCCCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2011.06.124
46927903 15030 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 370 5 1 6 2.4 O=C(C1CCOC1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
CHEMBL1209217 15030 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 370 5 1 6 2.4 O=C(C1CCOC1)N1C[C@H]2[C@@H](CNc3nc(-c4ccccn4)cs3)[C@H]2C1 10.1016/j.bmcl.2010.06.140
25073188 19250 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 373 2 1 5 3.9 N#Cc1ccc2[nH]c([C@H]3CC[C@]4(CC3)CN(c3ccccn3)C(=O)O4)nc2c1 10.1016/j.bmcl.2010.09.064
CHEMBL1290147 19250 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 373 2 1 5 3.9 N#Cc1ccc2[nH]c([C@H]3CC[C@]4(CC3)CN(c3ccccn3)C(=O)O4)nc2c1 10.1016/j.bmcl.2010.09.064
25072568 19175 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 446 3 1 5 5.2 Cc1ncccc1N1C[C@]2(CC[C@@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)OC1=O 10.1016/j.bmcl.2010.09.064
CHEMBL1289610 19175 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 446 3 1 5 5.2 Cc1ncccc1N1C[C@]2(CC[C@@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)OC1=O 10.1016/j.bmcl.2010.09.064
56683832 65997 None 0 Human Functional pKi = 8.1 8.1 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 397 8 2 6 3.6 CS(=O)(=O)NCCCCCNc1nc2c(s1)CCSc1ccccc1-2 10.1016/j.bmcl.2011.06.124
CHEMBL1836323 65997 None 0 Human Functional pKi = 8.1 8.1 - 1
Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayAntagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assay
ChEMBL 397 8 2 6 3.6 CS(=O)(=O)NCCCCCNc1nc2c(s1)CCSc1ccccc1-2 10.1016/j.bmcl.2011.06.124
1522 336 None 0 Human Functional pIC50 = 8.2 8.2 1 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12069595
1522 336 None 0 Rat Functional pIC50 = 8.2 8.2 -1 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12069595
11589975 1674 None 0 Human Functional pIC50 None 8.4 8.4 - 1
UnclassifiedUnclassified
Guide to Pharmacology 390 5 1 3 5.2 O=C(N(CCc1ccncc1)C)Nc1ccc2c(c1)c1CCCCc1n2C(C)C 16436501
1563 1674 None 0 Human Functional pIC50 None 8.4 8.4 - 1
UnclassifiedUnclassified
Guide to Pharmacology 390 5 1 3 5.2 O=C(N(CCc1ccncc1)C)Nc1ccc2c(c1)c1CCCCc1n2C(C)C 16436501




Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type
Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

56841989 215881 None 6 Mouse Binding pEC50 = 9.3 9.3 -17 7
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4281479 215881 None 6 Mouse Binding pEC50 = 9.3 9.3 -17 7
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
56841989 215881 None 6 Mouse Binding pEC50 = 9.3 9.3 -17 7
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4281479 215881 None 6 Mouse Binding pEC50 = 9.3 9.3 -17 7
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4280392 215867 None 0 Mouse Binding pEC50 = 6.7 6.7 - 4
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4283257 215898 None 0 Mouse Binding pEC50 = 5.7 5.7 - 4
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4276961 215829 None 0 Mouse Binding pEC50 = 8.6 8.6 - 4
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O 10.1021/acs.jmedchem.8b01046
CHEMBL4276961 215829 None 0 Mouse Binding pEC50 = 8.6 8.6 - 4
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O 10.1021/acs.jmedchem.8b01046
CHEMBL4280392 215867 None 0 Mouse Binding pEC50 = 6.7 6.7 - 4
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4283257 215898 None 0 Mouse Binding pEC50 = 5.7 5.7 - 4
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4292105 215974 None 0 Mouse Binding pEC50 = 7.6 7.6 - 4
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4292105 215974 None 0 Mouse Binding pEC50 = 7.6 7.6 - 4
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4287058 215928 None 0 Mouse Binding pEC50 = 6.2 6.2 - 4
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4290445 215956 None 0 Mouse Binding pEC50 = 6.2 6.2 - 4
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4287058 215928 None 0 Mouse Binding pEC50 = 6.2 6.2 - 4
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4290445 215956 None 0 Mouse Binding pEC50 = 6.2 6.2 - 4
Displacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from mouse Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
70675708 128549 None 0 Mouse Binding pIC50 = 9.9 9.9 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 378 7 2 6 3.0 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccccc3)no2)CC1 nan
CHEMBL3666784 128549 None 0 Mouse Binding pIC50 = 9.9 9.9 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 378 7 2 6 3.0 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccccc3)no2)CC1 nan
70682528 76930 None 0 Mouse Binding pIC50 = 9.8 9.8 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 380 4 1 3 4.8 CCS(=O)(=O)c1ccc2[nH]c(-c3ccc(F)c(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070148 76930 None 0 Mouse Binding pIC50 = 9.8 9.8 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 380 4 1 3 4.8 CCS(=O)(=O)c1ccc2[nH]c(-c3ccc(F)c(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
70695120 76933 None 0 Mouse Binding pIC50 = 9.8 9.8 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 396 4 1 3 5.3 CCS(=O)(=O)c1ccc2[nH]c(-c3ccc(Cl)c(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070151 76933 None 0 Mouse Binding pIC50 = 9.8 9.8 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 396 4 1 3 5.3 CCS(=O)(=O)c1ccc2[nH]c(-c3ccc(Cl)c(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
70675728 128552 None 0 Mouse Binding pIC50 = 9.7 9.7 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 400 7 2 6 2.9 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)cc3F)no2)CC1 nan
CHEMBL3666787 128552 None 0 Mouse Binding pIC50 = 9.7 9.7 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 400 7 2 6 2.9 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)cc3F)no2)CC1 nan
10758227 119042 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 286 5 1 3 3.9 CCCCCc1cc2[nH]c(C)nc(N3CCCCC3)c-2n1 10.1021/jm000269t
CHEMBL342438 119042 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 286 5 1 3 3.9 CCCCCc1cc2[nH]c(C)nc(N3CCCCC3)c-2n1 10.1021/jm000269t
70675706 128547 None 0 Mouse Binding pIC50 = 9.7 9.7 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 396 7 2 6 3.2 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3cccc(F)c3)no2)CC1 nan
CHEMBL3666782 128547 None 0 Mouse Binding pIC50 = 9.7 9.7 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 396 7 2 6 3.2 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3cccc(F)c3)no2)CC1 nan
18004956 187310 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 453 2 1 3 4.3 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL492370 187310 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 453 2 1 3 4.3 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
70688847 76829 None 0 Mouse Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 376 4 1 3 5.0 CCS(=O)(=O)c1ccc2[nH]c(-c3ccc(C)c(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2069316 76829 None 0 Mouse Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 376 4 1 3 5.0 CCS(=O)(=O)c1ccc2[nH]c(-c3ccc(C)c(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
71453237 81379 None 0 Mouse Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 425 4 1 5 3.5 O=S(=O)(CC(F)(F)F)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159167 81379 None 0 Mouse Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 425 4 1 5 3.5 O=S(=O)(CC(F)(F)F)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
70675705 128546 None 0 Mouse Binding pIC50 = 9.7 9.7 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 382 7 2 6 2.8 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3cccc(F)c3)no2)CC1 nan
CHEMBL3666781 128546 None 0 Mouse Binding pIC50 = 9.7 9.7 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 382 7 2 6 2.8 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3cccc(F)c3)no2)CC1 nan
70675727 128551 None 0 Mouse Binding pIC50 = 9.7 9.7 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 400 7 2 6 2.9 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)c(F)c3)no2)CC1 nan
CHEMBL3666786 128551 None 0 Mouse Binding pIC50 = 9.7 9.7 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 400 7 2 6 2.9 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)c(F)c3)no2)CC1 nan
70675729 128553 None 0 Mouse Binding pIC50 = 9.6 9.6 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 400 7 2 6 2.9 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3cc(F)cc(F)c3)no2)CC1 nan
CHEMBL3666788 128553 None 0 Mouse Binding pIC50 = 9.6 9.6 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 400 7 2 6 2.9 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3cc(F)cc(F)c3)no2)CC1 nan
10255890 98516 None 0 Human Binding pIC50 = 9.6 9.6 - 0
Tested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptorTested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor
ChEMBL 513 4 1 5 5.4 O=C(Nc1ccc(Cl)c2ccccc12)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL275841 98516 None 0 Human Binding pIC50 = 9.6 9.6 - 0
Tested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptorTested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor
ChEMBL 513 4 1 5 5.4 O=C(Nc1ccc(Cl)c2ccccc12)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
68613905 125509 None 0 Mouse Binding pIC50 = 9.6 9.6 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 404 4 2 4 4.8 O=C(N[C@H]1CC[C@@H](c2nc(-c3ccc(Cl)c(Cl)c3)c[nH]2)CC1)c1ccon1 nan
CHEMBL3646136 125509 None 0 Mouse Binding pIC50 = 9.6 9.6 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 404 4 2 4 4.8 O=C(N[C@H]1CC[C@@H](c2nc(-c3ccc(Cl)c(Cl)c3)c[nH]2)CC1)c1ccon1 nan
71454971 81377 None 0 Mouse Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 399 5 1 5 3.6 CC(C)CS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159165 81377 None 0 Mouse Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 399 5 1 5 3.6 CC(C)CS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
70688848 76943 None 0 Mouse Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 433 4 1 5 3.7 O=c1ccc(-c2nc3cc(S(=O)(=O)CC(F)(F)F)ccc3[nH]2)cn1-c1ccccc1 10.1016/j.bmcl.2012.07.020
CHEMBL2070161 76943 None 0 Mouse Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 433 4 1 5 3.7 O=c1ccc(-c2nc3cc(S(=O)(=O)CC(F)(F)F)ccc3[nH]2)cn1-c1ccccc1 10.1016/j.bmcl.2012.07.020
71458601 81370 None 0 Mouse Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 383 5 1 4 4.1 CCCS(=O)(=O)c1ccc2[nH]c(N3CCCC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159158 81370 None 0 Mouse Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 383 5 1 4 4.1 CCCS(=O)(=O)c1ccc2[nH]c(N3CCCC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
10471957 25597 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 332 2 1 4 4.7 Cc1nc(N2CCCCC2)c2[nH]c(-c3cc4ccccc4o3)cc2n1 10.1021/jm000269t
CHEMBL135143 25597 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 332 2 1 4 4.7 Cc1nc(N2CCCCC2)c2[nH]c(-c3cc4ccccc4o3)cc2n1 10.1021/jm000269t
10712643 29394 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 310 2 1 3 4.1 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccc(F)cc3)cc2n1 10.1021/jm000269t
CHEMBL138379 29394 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 310 2 1 3 4.1 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccc(F)cc3)cc2n1 10.1021/jm000269t
10783815 119346 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 310 2 1 3 4.1 Cc1nc(N2CCCCC2)c2[nH]c(-c3cccc(F)c3)cc2n1 10.1021/jm000269t
CHEMBL343817 119346 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 310 2 1 3 4.1 Cc1nc(N2CCCCC2)c2[nH]c(-c3cccc(F)c3)cc2n1 10.1021/jm000269t
70697155 76939 None 0 Mouse Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 363 4 1 4 4.1 CCS(=O)(=O)c1ccc2[nH]c(-c3ccnc(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070157 76939 None 0 Mouse Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 363 4 1 4 4.1 CCS(=O)(=O)c1ccc2[nH]c(-c3ccnc(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
70675703 128544 None 0 Mouse Binding pIC50 = 9.5 9.5 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 382 7 2 6 2.8 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)cc3)no2)CC1 nan
CHEMBL3666779 128544 None 0 Mouse Binding pIC50 = 9.5 9.5 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 382 7 2 6 2.8 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)cc3)no2)CC1 nan
70675704 128545 None 0 Mouse Binding pIC50 = 9.5 9.5 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 364 7 2 6 2.6 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccccc3)no2)CC1 nan
CHEMBL3666780 128545 None 0 Mouse Binding pIC50 = 9.5 9.5 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 364 7 2 6 2.6 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccccc3)no2)CC1 nan
11793187 28226 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 328 2 1 3 4.2 Cc1nc(N2CCCCC2)c2[nH]c(-c3cc(F)cc(F)c3)cc2n1 10.1021/jm000269t
CHEMBL137378 28226 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 328 2 1 3 4.2 Cc1nc(N2CCCCC2)c2[nH]c(-c3cc(F)cc(F)c3)cc2n1 10.1021/jm000269t
10266238 170908 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 290 2 1 3 3.7 Cc1nc(N2CC=CCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL445328 170908 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 290 2 1 3 3.7 Cc1nc(N2CC=CCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
68059511 125519 None 0 Mouse Binding pIC50 = 9.4 9.4 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 463 5 1 6 5.2 CC(C)n1c(=O)oc2cc(NC(=O)[C@H]3CC[C@@H](Oc4cc(C(F)(F)F)ccn4)CC3)ccc21 nan
CHEMBL3646146 125519 None 0 Mouse Binding pIC50 = 9.4 9.4 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 463 5 1 6 5.2 CC(C)n1c(=O)oc2cc(NC(=O)[C@H]3CC[C@@H](Oc4cc(C(F)(F)F)ccn4)CC3)ccc21 nan
66575661 76922 None 0 Mouse Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 376 5 1 3 5.1 CCCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070140 76922 None 0 Mouse Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 376 5 1 3 5.1 CCCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
56835982 81374 None 0 Mouse Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 371 4 1 5 2.9 CCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159162 81374 None 0 Mouse Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 371 4 1 5 2.9 CCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
56835982 81374 None 0 Mouse Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 371 4 1 5 2.9 CCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2159162 81374 None 0 Mouse Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 371 4 1 5 2.9 CCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.11.005
56649677 76919 None 0 Mouse Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 362 4 1 3 4.7 CCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070137 76919 None 0 Mouse Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 362 4 1 3 4.7 CCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
9868487 205244 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Binding affinity against human Neuropeptide Y receptor type 5 in HEK 293 cell line by using [125I]PYY as radioligandBinding affinity against human Neuropeptide Y receptor type 5 in HEK 293 cell line by using [125I]PYY as radioligand
ChEMBL 452 4 2 6 4.2 O=C(CN1CCC(n2c(O)nc3ccccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2=O 10.1016/s0960-894x(01)00448-6
CHEMBL62166 205244 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Binding affinity against human Neuropeptide Y receptor type 5 in HEK 293 cell line by using [125I]PYY as radioligandBinding affinity against human Neuropeptide Y receptor type 5 in HEK 293 cell line by using [125I]PYY as radioligand
ChEMBL 452 4 2 6 4.2 O=C(CN1CCC(n2c(O)nc3ccccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2=O 10.1016/s0960-894x(01)00448-6
9868487 205244 None 0 Human Binding pIC50 = 9.3 9.3 - 0
The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratThe compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in rat
ChEMBL 452 4 2 6 4.2 O=C(CN1CCC(n2c(O)nc3ccccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2=O 10.1021/jm980521l
CHEMBL62166 205244 None 0 Human Binding pIC50 = 9.3 9.3 - 0
The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratThe compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in rat
ChEMBL 452 4 2 6 4.2 O=C(CN1CCC(n2c(O)nc3ccccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2=O 10.1021/jm980521l
10736124 28319 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 306 2 1 3 4.2 Cc1ccc(-c2cc3[nH]c(C)nc(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
CHEMBL137449 28319 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 306 2 1 3 4.2 Cc1ccc(-c2cc3[nH]c(C)nc(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
10040233 119277 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 296 2 1 4 3.8 Cc1nc(N2CCCCC2)c2nc(-c3ccc(C)o3)cc-2[nH]1 10.1021/jm000269t
CHEMBL343318 119277 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 296 2 1 4 3.8 Cc1nc(N2CCCCC2)c2nc(-c3ccc(C)o3)cc-2[nH]1 10.1021/jm000269t
89986727 128560 None 0 Mouse Binding pIC50 = 9.3 9.3 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 374 7 2 6 2.7 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C3(F)CCCC3)no2)CC1 nan
CHEMBL3666794 128560 None 0 Mouse Binding pIC50 = 9.3 9.3 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 374 7 2 6 2.7 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C3(F)CCCC3)no2)CC1 nan
10915401 207605 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 361 6 1 3 5.0 CC(Cc1ccncc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL78089 207605 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 361 6 1 3 5.0 CC(Cc1ccncc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
70697153 76929 None 0 Mouse Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 380 4 1 3 4.8 CCS(=O)(=O)c1ccc2[nH]c(-c3cc(-c4ccccc4)ccc3F)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070147 76929 None 0 Mouse Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 380 4 1 3 4.8 CCS(=O)(=O)c1ccc2[nH]c(-c3cc(-c4ccccc4)ccc3F)nc2c1 10.1016/j.bmcl.2012.07.020
10030142 58171 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 537 10 3 6 3.7 COc1ccc2c(c1)C(O)(CNCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00018-5
CHEMBL167991 58171 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 537 10 3 6 3.7 COc1ccc2c(c1)C(O)(CNCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00018-5
70684603 76937 None 0 Mouse Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 363 4 1 4 4.1 CCS(=O)(=O)c1ccc2[nH]c(-c3cc(-c4ccccc4)ccn3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070155 76937 None 0 Mouse Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 363 4 1 4 4.1 CCS(=O)(=O)c1ccc2[nH]c(-c3cc(-c4ccccc4)ccn3)nc2c1 10.1016/j.bmcl.2012.07.020
68601225 124469 None 0 Mouse Binding pIC50 = 9.3 9.3 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 453 5 1 6 5.3 CC(C)n1c(=O)oc2cc(NC(=O)[C@H]3CC[C@@H](Oc4cc(Cl)ccc4C#N)CC3)ccc21 nan
CHEMBL3639450 124469 None 0 Mouse Binding pIC50 = 9.3 9.3 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 453 5 1 6 5.3 CC(C)n1c(=O)oc2cc(NC(=O)[C@H]3CC[C@@H](Oc4cc(Cl)ccc4C#N)CC3)ccc21 nan
18004895 187786 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL495169 187786 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
18004895 187786 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL495169 187786 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
68598300 125521 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 456 4 1 6 3.7 O=C(Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@@H](N2c3ccccc3OS2(=O)=O)CC1 nan
CHEMBL3646148 125521 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 456 4 1 6 3.7 O=C(Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@@H](N2c3ccccc3OS2(=O)=O)CC1 nan
44271202 59151 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 515 4 1 5 4.8 O=C(Nc1ccc(F)c(C(F)(F)F)c1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL16986 59151 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 515 4 1 5 4.8 O=C(Nc1ccc(F)c(C(F)(F)F)c1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
44271276 59975 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 471 5 1 6 3.8 CC(=O)c1cccc(NC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)c1 10.1016/s0960-894x(02)00113-0
CHEMBL17327 59975 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 471 5 1 6 3.8 CC(=O)c1cccc(NC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)c1 10.1016/s0960-894x(02)00113-0
71454968 81368 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 385 5 1 5 3.3 CCCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159156 81368 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 385 5 1 5 3.3 CCCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
91755094 128564 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 406 7 2 6 3.1 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C3(C)CC(F)(F)C3)no2)CC1 nan
CHEMBL3666798 128564 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 406 7 2 6 3.1 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C3(C)CC(F)(F)C3)no2)CC1 nan
9930807 200056 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 399 3 1 5 4.3 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.07.103
CHEMBL570633 200056 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 399 3 1 5 4.3 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.07.103
89986736 128568 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 420 7 2 6 3.0 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)C(F)(F)F)no2)CC1 nan
CHEMBL3666801 128568 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 420 7 2 6 3.0 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)C(F)(F)F)no2)CC1 nan
68606925 125508 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 389 5 2 4 4.3 O=C(N[C@H]1CC[C@@H](C(=O)Nc2ccc(-c3ccccc3)cc2)CC1)c1ccon1 nan
CHEMBL3646135 125508 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 389 5 2 4 4.3 O=C(N[C@H]1CC[C@@H](C(=O)Nc2ccc(-c3ccccc3)cc2)CC1)c1ccon1 nan
9908945 193171 None 0 Rat Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]PYY from rat NPY Y5 receptorDisplacement of [125I]PYY from rat NPY Y5 receptor
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL522388 193171 None 0 Rat Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]PYY from rat NPY Y5 receptorDisplacement of [125I]PYY from rat NPY Y5 receptor
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
68059308 125518 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 487 5 1 6 5.6 CC(C)n1c(=O)oc2cc(NC(=O)[C@H]3CC[C@@H](Oc4cc(C(F)(F)F)ccc4C#N)CC3)ccc21 nan
CHEMBL3646145 125518 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 487 5 1 6 5.6 CC(C)n1c(=O)oc2cc(NC(=O)[C@H]3CC[C@@H](Oc4cc(C(F)(F)F)ccc4C#N)CC3)ccc21 nan
9957190 200668 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 489 4 1 4 4.3 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(C(=O)c4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL575214 200668 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 489 4 1 4 4.3 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(C(=O)c4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
68594586 125520 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 414 5 1 5 4.6 O=C(Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@@H](Oc2cc(Cl)ccn2)CC1 nan
CHEMBL3646147 125520 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 414 5 1 5 4.6 O=C(Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@@H](Oc2cc(Cl)ccn2)CC1 nan
44583541 193410 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 423 2 1 5 4.7 O=C1OC2(CCN(C(=O)Nc3cc(-c4ccc(Cl)cc4)no3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL524085 193410 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 423 2 1 5 4.7 O=C1OC2(CCN(C(=O)Nc3cc(-c4ccc(Cl)cc4)no3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
10786956 27805 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 360 2 1 3 4.9 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccc(C(F)(F)F)cc3)cc2n1 10.1021/jm000269t
CHEMBL137086 27805 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 360 2 1 3 4.9 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccc(C(F)(F)F)cc3)cc2n1 10.1021/jm000269t
9882119 118628 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 278 2 1 3 3.5 Cc1nc(N2CCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL341563 118628 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 278 2 1 3 3.5 Cc1nc(N2CCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
89986726 128558 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 434 7 2 6 4.1 CC(C)(c1ccccc1)c1noc(N[C@H]2CC[C@H](CNS(=O)(=O)C(C)(C)C)CC2)n1 nan
CHEMBL3666792 128558 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 434 7 2 6 4.1 CC(C)(c1ccccc1)c1noc(N[C@H]2CC[C@H](CNS(=O)(=O)C(C)(C)C)CC2)n1 nan
10052173 57590 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 513 6 1 6 4.5 COc1ccc2c(c1)CC(NCC1CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC1)CCC2 10.1016/s0960-894x(02)00018-5
CHEMBL166606 57590 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 513 6 1 6 4.5 COc1ccc2c(c1)CC(NCC1CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC1)CCC2 10.1016/s0960-894x(02)00018-5
44271202 59151 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 515 4 1 5 4.8 O=C(Nc1ccc(F)c(C(F)(F)F)c1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL16986 59151 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 515 4 1 5 4.8 O=C(Nc1ccc(F)c(C(F)(F)F)c1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
68601090 125506 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 407 5 2 4 4.4 O=C(N[C@H]1CC[C@@H](C(=O)Nc2ccc(-c3ccccc3F)cc2)CC1)c1ccon1 nan
CHEMBL3646133 125506 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 407 5 2 4 4.4 O=C(N[C@H]1CC[C@@H](C(=O)Nc2ccc(-c3ccccc3F)cc2)CC1)c1ccon1 nan
23442592 169440 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 459 10 2 7 3.8 COc1ccc(C)cc1S(=O)(=O)NCCCNc1ncc(C(=O)c2ccccc2C)s1 10.1016/j.bmcl.2005.05.009
CHEMBL441850 169440 None 0 Mouse Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 459 10 2 7 3.8 COc1ccc(C)cc1S(=O)(=O)NCCCNc1ncc(C(=O)c2ccccc2C)s1 10.1016/j.bmcl.2005.05.009
44271382 98580 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 479 4 1 5 4.7 O=C(Nc1cccc2ccccc12)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL276283 98580 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 479 4 1 5 4.7 O=C(Nc1cccc2ccccc12)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
71458603 81378 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 411 3 1 5 3.4 O=S(=O)(c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1)C(F)(F)F 10.1016/j.bmcl.2012.09.025
CHEMBL2159166 81378 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 411 3 1 5 3.4 O=S(=O)(c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1)C(F)(F)F 10.1016/j.bmcl.2012.09.025
70675731 128556 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 397 7 2 7 2.6 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)cn3)no2)CC1 nan
CHEMBL3666790 128556 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 397 7 2 7 2.6 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)cn3)no2)CC1 nan
89986749 128561 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 420 6 2 6 3.4 CC1(c2noc(N[C@H]3CC[C@H](CNS(=O)(=O)C(C)(C)C)CC3)n2)CC(F)(F)C1 nan
CHEMBL3666795 128561 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 420 6 2 6 3.4 CC1(c2noc(N[C@H]3CC[C@H](CNS(=O)(=O)C(C)(C)C)CC3)n2)CC(F)(F)C1 nan
71458605 81383 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 385 4 1 5 3.2 CCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccc(C)cc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159171 81383 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 385 4 1 5 3.2 CCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccc(C)cc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
70675705 128546 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a human NPY Y5 receptor (WO96/16542) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Inbitrogen) according to the instruction manual. The cells that stably express human NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing human NPY Y5 receptor, the compound of this invention and 30,000 cpm [1251] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a human NPY Y5 receptor (WO96/16542) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Inbitrogen) according to the instruction manual. The cells that stably express human NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing human NPY Y5 receptor, the compound of this invention and 30,000 cpm [1251] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 382 7 2 6 2.8 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3cccc(F)c3)no2)CC1 nan
CHEMBL3666781 128546 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a human NPY Y5 receptor (WO96/16542) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Inbitrogen) according to the instruction manual. The cells that stably express human NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing human NPY Y5 receptor, the compound of this invention and 30,000 cpm [1251] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a human NPY Y5 receptor (WO96/16542) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Inbitrogen) according to the instruction manual. The cells that stably express human NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing human NPY Y5 receptor, the compound of this invention and 30,000 cpm [1251] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 382 7 2 6 2.8 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3cccc(F)c3)no2)CC1 nan
18004997 193196 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)nc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL522540 193196 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)nc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
18004997 193196 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)nc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL522540 193196 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)nc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
44583539 193533 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 423 2 1 5 4.7 O=C1OC2(CCN(C(=O)Nc3cc(-c4ccccc4Cl)no3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL526084 193533 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 423 2 1 5 4.7 O=C1OC2(CCN(C(=O)Nc3cc(-c4ccccc4Cl)no3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
9908374 187853 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 389 2 1 5 4.0 O=C1OC2(CCN(C(=O)Nc3cc(-c4ccccc4)no3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL495580 187853 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 389 2 1 5 4.0 O=C1OC2(CCN(C(=O)Nc3cc(-c4ccccc4)no3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
9869232 188149 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 468 2 1 5 4.9 O=C1OC2(CCN(C(=O)Nc3ncc(-c4cccc(C(F)(F)F)c4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL497641 188149 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 468 2 1 5 4.9 O=C1OC2(CCN(C(=O)Nc3ncc(-c4cccc(C(F)(F)F)c4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
18004896 187340 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 461 3 1 3 4.7 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL492568 187340 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 461 3 1 3 4.7 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
71462130 81382 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 405 4 1 5 3.6 CCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccc(Cl)cc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159170 81382 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 405 4 1 5 3.6 CCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccc(Cl)cc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
23442647 67176 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 517 9 2 6 5.1 Cc1ccccc1C(=O)c1cnc(NCCCNS(=O)(=O)c2cc(C(F)(F)F)ccc2Cl)s1 10.1016/j.bmcl.2005.05.009
CHEMBL187607 67176 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 517 9 2 6 5.1 Cc1ccccc1C(=O)c1cnc(NCCCNS(=O)(=O)c2cc(C(F)(F)F)ccc2Cl)s1 10.1016/j.bmcl.2005.05.009
44271207 98962 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 521 6 1 6 5.4 O=C(Nc1ccc(Oc2ccccc2)cc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL279309 98962 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 521 6 1 6 5.4 O=C(Nc1ccc(Oc2ccccc2)cc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
70675727 128551 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a human NPY Y5 receptor (WO96/16542) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Inbitrogen) according to the instruction manual. The cells that stably express human NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing human NPY Y5 receptor, the compound of this invention and 30,000 cpm [1251] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a human NPY Y5 receptor (WO96/16542) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Inbitrogen) according to the instruction manual. The cells that stably express human NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing human NPY Y5 receptor, the compound of this invention and 30,000 cpm [1251] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 400 7 2 6 2.9 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)c(F)c3)no2)CC1 nan
CHEMBL3666786 128551 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a human NPY Y5 receptor (WO96/16542) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Inbitrogen) according to the instruction manual. The cells that stably express human NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing human NPY Y5 receptor, the compound of this invention and 30,000 cpm [1251] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a human NPY Y5 receptor (WO96/16542) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Inbitrogen) according to the instruction manual. The cells that stably express human NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing human NPY Y5 receptor, the compound of this invention and 30,000 cpm [1251] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 400 7 2 6 2.9 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)c(F)c3)no2)CC1 nan
70675709 128550 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 368 6 2 6 2.4 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3cccc(F)c3)no2)CC1 nan
CHEMBL3666785 128550 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 368 6 2 6 2.4 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3cccc(F)c3)no2)CC1 nan
18004939 193349 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cnc(-c4ccccc4)nc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL523715 193349 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cnc(-c4ccccc4)nc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
18004939 193349 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cnc(-c4ccccc4)nc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL523715 193349 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cnc(-c4ccccc4)nc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
11349780 202182 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 389 3 1 7 2.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnn(-c4ccccc4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL593465 202182 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 389 3 1 7 2.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnn(-c4ccccc4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
44271385 60572 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 533 6 1 6 4.8 O=C(c1ccccc1)c1cccc(NC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)c1 10.1016/s0960-894x(02)00113-0
CHEMBL17590 60572 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 533 6 1 6 4.8 O=C(c1ccccc1)c1cccc(NC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)c1 10.1016/s0960-894x(02)00113-0
70675730 128554 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 384 6 2 6 2.9 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3cccc(Cl)c3)no2)CC1 nan
CHEMBL3666789 128554 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 384 6 2 6 2.9 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3cccc(Cl)c3)no2)CC1 nan
70675732 128557 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 411 6 2 7 3.0 CC(C)(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)cn3)no2)CC1 nan
CHEMBL3666791 128557 None 0 Mouse Binding pIC50 = 9.1 9.1 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 411 6 2 7 3.0 CC(C)(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)cn3)no2)CC1 nan
10927348 169488 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 394 6 1 2 6.2 CC(Cc1ccc(Cl)cc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL442182 169488 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 394 6 1 2 6.2 CC(Cc1ccc(Cl)cc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
9889156 192716 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 434 2 1 5 4.5 O=C1OC2(CCN(C(=O)Nc3ncc(-c4cccc(Cl)c4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL521545 192716 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 434 2 1 5 4.5 O=C1OC2(CCN(C(=O)Nc3ncc(-c4cccc(Cl)c4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
11407098 202526 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccc(F)cc4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL595790 202526 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccc(F)cc4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
18004955 187675 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL494593 187675 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
18004955 187675 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL494593 187675 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
12108781 187796 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL495201 187796 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
12108781 187796 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL495201 187796 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
44583438 192714 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 418 2 1 5 4.0 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccccc4F)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL521537 192714 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 418 2 1 5 4.0 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccccc4F)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
135543802 206501 None 0 Human Binding pIC50 = 9 9.0 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 467 6 3 5 4.0 O=S(=O)(NC[C@H]1CC[C@H](CNC2=NC3CCc4cc(O)ccc4C3C2)CC1)c1ccccc1 10.1016/s0960-894x(99)00676-9
CHEMBL69881 206501 None 0 Human Binding pIC50 = 9 9.0 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 467 6 3 5 4.0 O=S(=O)(NC[C@H]1CC[C@H](CNC2=NC3CCc4cc(O)ccc4C3C2)CC1)c1ccccc1 10.1016/s0960-894x(99)00676-9
10926406 14048 None 0 Human Binding pIC50 = 9 9.0 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 357 5 1 3 5.3 CC(C)n1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
CHEMBL119743 14048 None 0 Human Binding pIC50 = 9 9.0 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 357 5 1 3 5.3 CC(C)n1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
11111992 110652 None 0 Human Binding pIC50 = 9 9.0 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 393 5 1 5 3.6 CS(=O)(=O)n1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
CHEMBL325486 110652 None 0 Human Binding pIC50 = 9 9.0 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 393 5 1 5 3.6 CS(=O)(=O)n1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
44583540 188144 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 423 2 1 5 4.7 O=C1OC2(CCN(C(=O)Nc3cc(-c4cccc(Cl)c4)no3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL497621 188144 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 423 2 1 5 4.7 O=C1OC2(CCN(C(=O)Nc3cc(-c4cccc(Cl)c4)no3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
44461023 208117 None 0 Human Binding pIC50 = 9 9.0 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 429 4 1 5 4.1 O=C(C1CCOC1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL81994 208117 None 0 Human Binding pIC50 = 9 9.0 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 429 4 1 5 4.1 O=C(C1CCOC1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44379101 119991 None 0 Human Binding pIC50 = 9 9.0 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 543 6 2 7 3.3 COc1ccc2c(c1)C(O)(CNC(=O)C1CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC1)CCC2 10.1016/s0960-894x(02)00018-5
CHEMBL349486 119991 None 0 Human Binding pIC50 = 9 9.0 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 543 6 2 7 3.3 COc1ccc2c(c1)C(O)(CNC(=O)C1CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC1)CCC2 10.1016/s0960-894x(02)00018-5
44344243 113378 None 0 Human Binding pIC50 = 9 9.0 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 526 12 4 6 3.6 N[C@@H](CCCCNS(=O)(=O)c1ccccc1F)CNC1CCc2cc(O)ccc2C1Cc1cccnc1 10.1021/jm990468g
CHEMBL331551 113378 None 0 Human Binding pIC50 = 9 9.0 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 526 12 4 6 3.6 N[C@@H](CCCCNS(=O)(=O)c1ccccc1F)CNC1CCc2cc(O)ccc2C1Cc1cccnc1 10.1021/jm990468g
20616896 125113 None 0 Mouse Binding pIC50 = 9 9.0 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 421 9 2 7 3.5 Cc1ccccc1C(=O)c1cnc(NCCCNS(=O)(=O)c2cccs2)s1 10.1016/j.bmcl.2005.05.009
CHEMBL364386 125113 None 0 Mouse Binding pIC50 = 9 9.0 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 421 9 2 7 3.5 Cc1ccccc1C(=O)c1cnc(NCCCNS(=O)(=O)c2cccs2)s1 10.1016/j.bmcl.2005.05.009
71454972 81385 None 0 Mouse Binding pIC50 = 9 9.0 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 369 5 1 4 3.7 CCCS(=O)(=O)c1ccc2[nH]c(N3CCC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159174 81385 None 0 Mouse Binding pIC50 = 9 9.0 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 369 5 1 4 3.7 CCCS(=O)(=O)c1ccc2[nH]c(N3CCC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
70675757 128565 None 0 Mouse Binding pIC50 = 9.0 9.0 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 434 6 2 6 3.4 CC(C)(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)C(F)(F)F)no2)CC1 nan
CHEMBL3666799 128565 None 0 Mouse Binding pIC50 = 9.0 9.0 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 434 6 2 6 3.4 CC(C)(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)C(F)(F)F)no2)CC1 nan
71451430 81381 None 0 Mouse Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 389 4 1 5 3.1 CCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccc(F)cc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159169 81381 None 0 Mouse Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 389 4 1 5 3.1 CCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccc(F)cc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
9796081 115485 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 292 2 1 3 3.9 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL335039 115485 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 292 2 1 3 3.9 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
68606301 125517 None 0 Mouse Binding pIC50 = 9.0 9.0 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 467 5 1 5 5.4 C[C@H]1CN(c2ccc(NC(=O)[C@H]3CC[C@@H](Oc4cc(Cl)ccc4C#N)CC3)cc2)C[C@@H](C)O1 nan
CHEMBL3646144 125517 None 0 Mouse Binding pIC50 = 9.0 9.0 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 467 5 1 5 5.4 C[C@H]1CN(c2ccc(NC(=O)[C@H]3CC[C@@H](Oc4cc(Cl)ccc4C#N)CC3)cc2)C[C@@H](C)O1 nan
9953800 187861 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 418 2 1 5 4.0 O=C1OC2(CCN(C(=O)Nc3ncc(-c4cccc(F)c4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL495630 187861 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 418 2 1 5 4.0 O=C1OC2(CCN(C(=O)Nc3ncc(-c4cccc(F)c4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
44583394 187948 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 434 2 1 5 4.5 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccccc4Cl)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL496196 187948 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 434 2 1 5 4.5 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccccc4Cl)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
44583435 193268 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 430 3 1 6 3.8 COc1ccccc1-c1cnc(NC(=O)N2CCC3(CC2)OC(=O)c2ccccc23)nc1 10.1016/j.bmcl.2009.05.013
CHEMBL523060 193268 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 430 3 1 6 3.8 COc1ccccc1-c1cnc(NC(=O)N2CCC3(CC2)OC(=O)c2ccccc23)nc1 10.1016/j.bmcl.2009.05.013
44271223 98586 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 473 6 2 6 2.8 O=C(NCC(O)c1ccccc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL276322 98586 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 473 6 2 6 2.8 O=C(NCC(O)c1ccccc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
10685135 26332 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 293 2 2 4 3.2 Nc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL135883 26332 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 293 2 2 4 3.2 Nc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
9953150 188014 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 406 2 1 6 3.9 O=C1OC2(CCN(C(=O)Nc3nsc(-c4ccccc4)n3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL496621 188014 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 406 2 1 6 3.9 O=C1OC2(CCN(C(=O)Nc3nsc(-c4ccccc4)n3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
46226641 204286 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 405 3 1 6 4.4 O=C1O[C@]2(CC[C@H](C(=O)Nc3csc(-c4ccccc4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL607037 204286 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 405 3 1 6 4.4 O=C1O[C@]2(CC[C@H](C(=O)Nc3csc(-c4ccccc4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
44573574 193302 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 441 5 1 3 4.4 CCCCc1ccc(NC(=O)N2CCC3(CC2)CN(S(C)(=O)=O)c2ccccc23)cc1 10.1016/j.bmcl.2009.02.035
CHEMBL523330 193302 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 441 5 1 3 4.4 CCCCc1ccc(NC(=O)N2CCC3(CC2)CN(S(C)(=O)=O)c2ccccc23)cc1 10.1016/j.bmcl.2009.02.035
44379095 58143 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 541 6 1 6 4.3 COc1ccc2c(c1)CC(CNC(=O)C1CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC1)CCC2 10.1016/s0960-894x(02)00018-5
CHEMBL167709 58143 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 541 6 1 6 4.3 COc1ccc2c(c1)CC(CNC(=O)C1CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC1)CCC2 10.1016/s0960-894x(02)00018-5
44271223 98586 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 473 6 2 6 2.8 O=C(NCC(O)c1ccccc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL276322 98586 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 473 6 2 6 2.8 O=C(NCC(O)c1ccccc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
18004944 200838 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 452 3 1 5 3.7 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cc(-c4ccccc4)no3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL576727 200838 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 452 3 1 5 3.7 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cc(-c4ccccc4)no3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
44583463 193590 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 468 2 1 5 4.9 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccccc4C(F)(F)F)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL526645 193590 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 468 2 1 5 4.9 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccccc4C(F)(F)F)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
9952232 202425 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnn(-c4ccccc4)c3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
CHEMBL595120 202425 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnn(-c4ccccc4)c3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
11491176 202499 None 36 Human Binding pIC50 = 8.9 8.9 2238 2
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4F)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL595573 202499 None 36 Human Binding pIC50 = 8.9 8.9 2238 2
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4F)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
12108783 193403 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 461 3 1 3 4.7 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cccc(-c4ccccc4)c3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL524051 193403 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 461 3 1 3 4.7 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cccc(-c4ccccc4)c3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
44583541 193410 None 0 Rat Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from rat NPY Y5 receptorDisplacement of [125I]PYY from rat NPY Y5 receptor
ChEMBL 423 2 1 5 4.7 O=C1OC2(CCN(C(=O)Nc3cc(-c4ccc(Cl)cc4)no3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL524085 193410 None 0 Rat Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from rat NPY Y5 receptorDisplacement of [125I]PYY from rat NPY Y5 receptor
ChEMBL 423 2 1 5 4.7 O=C1OC2(CCN(C(=O)Nc3cc(-c4ccc(Cl)cc4)no3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
1562 899 None 11 Human Binding pIC50 = 8.9 8.9 - 2
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2005.03.052
5312114 899 None 11 Human Binding pIC50 = 8.9 8.9 - 2
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2005.03.052
CHEMBL17645 899 None 11 Human Binding pIC50 = 8.9 8.9 - 2
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2005.03.052
CHEMBL195380 899 None 11 Human Binding pIC50 = 8.9 8.9 - 2
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2005.03.052
44271289 169292 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 493 12 1 5 5.2 CCCCCCCCCCNC(=O)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL440647 169292 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 493 12 1 5 5.2 CCCCCCCCCCNC(=O)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
71453236 81375 None 0 Mouse Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 385 4 1 5 3.3 CC(C)S(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159163 81375 None 0 Mouse Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 385 4 1 5 3.3 CC(C)S(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
70675707 128548 None 0 Mouse Binding pIC50 = 8.9 8.9 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 368 6 2 6 2.4 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)cc3)no2)CC1 nan
CHEMBL3666783 128548 None 0 Mouse Binding pIC50 = 8.9 8.9 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 368 6 2 6 2.4 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)cc3)no2)CC1 nan
45481798 200509 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 451 3 2 4 3.4 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cc(-c4ccccc4)n[nH]3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL574084 200509 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 451 3 2 4 3.4 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cc(-c4ccccc4)n[nH]3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
1562 899 None 11 Rat Binding pIC50 = 8.9 8.9 2 2
Compound was tested for rat Neuropeptide Y receptor type 5Compound was tested for rat Neuropeptide Y receptor type 5
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/s0960-894x(00)00177-3
5312114 899 None 11 Rat Binding pIC50 = 8.9 8.9 2 2
Compound was tested for rat Neuropeptide Y receptor type 5Compound was tested for rat Neuropeptide Y receptor type 5
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/s0960-894x(00)00177-3
CHEMBL17645 899 None 11 Rat Binding pIC50 = 8.9 8.9 2 2
Compound was tested for rat Neuropeptide Y receptor type 5Compound was tested for rat Neuropeptide Y receptor type 5
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/s0960-894x(00)00177-3
CHEMBL195380 899 None 11 Rat Binding pIC50 = 8.9 8.9 2 2
Compound was tested for rat Neuropeptide Y receptor type 5Compound was tested for rat Neuropeptide Y receptor type 5
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/s0960-894x(00)00177-3
9908945 193171 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL522388 193171 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
44573541 193424 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 474 5 3 5 3.5 CS(=O)(=O)Nc1ccccc1N1CCN(C(=O)Nc2cc(-c3ccc(Cl)cc3)n[nH]2)CC1 10.1016/j.bmcl.2009.02.035
CHEMBL524192 193424 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 474 5 3 5 3.5 CS(=O)(=O)Nc1ccccc1N1CCN(C(=O)Nc2cc(-c3ccc(Cl)cc3)n[nH]2)CC1 10.1016/j.bmcl.2009.02.035
44271284 58106 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 459 4 2 6 3.6 Cc1cc(O)ccc1NC(=O)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL16740 58106 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 459 4 2 6 3.6 Cc1cc(O)ccc1NC(=O)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
44271317 60431 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 473 6 1 6 3.3 COc1ccc(CNC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)cc1 10.1016/s0960-894x(02)00113-0
CHEMBL17502 60431 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 473 6 1 6 3.3 COc1ccc(CNC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)cc1 10.1016/s0960-894x(02)00113-0
44271385 60572 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 533 6 1 6 4.8 O=C(c1ccccc1)c1cccc(NC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)c1 10.1016/s0960-894x(02)00113-0
CHEMBL17590 60572 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 533 6 1 6 4.8 O=C(c1ccccc1)c1cccc(NC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)c1 10.1016/s0960-894x(02)00113-0
71458604 81380 None 0 Mouse Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 453 4 1 5 4.3 CC(C)(C(F)(F)F)S(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159168 81380 None 0 Mouse Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 453 4 1 5 4.3 CC(C)(C(F)(F)F)S(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
70675779 128559 None 0 Mouse Binding pIC50 = 8.8 8.8 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 384 5 2 6 2.8 CC(C)(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)F)no2)CC1 nan
CHEMBL3666793 128559 None 0 Mouse Binding pIC50 = 8.8 8.8 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 384 5 2 6 2.8 CC(C)(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)F)no2)CC1 nan
68605769 125513 None 0 Mouse Binding pIC50 = 8.8 8.8 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 412 5 2 6 4.3 CC(C)n1c(=O)oc2cc(NC(=O)[C@H]3CC[C@@H](Nc4cccc(F)n4)CC3)ccc21 nan
CHEMBL3646140 125513 None 0 Mouse Binding pIC50 = 8.8 8.8 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 412 5 2 6 4.3 CC(C)n1c(=O)oc2cc(NC(=O)[C@H]3CC[C@@H](Nc4cccc(F)n4)CC3)ccc21 nan
68606747 125514 None 0 Mouse Binding pIC50 = 8.8 8.8 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 443 5 1 5 4.9 C[C@H]1CN(c2ccc(NC(=O)[C@H]3CC[C@@H](Oc4cc(Cl)ccn4)CC3)cc2)C[C@@H](C)O1 nan
CHEMBL3646141 125514 None 0 Mouse Binding pIC50 = 8.8 8.8 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 443 5 1 5 4.9 C[C@H]1CN(c2ccc(NC(=O)[C@H]3CC[C@@H](Oc4cc(Cl)ccn4)CC3)cc2)C[C@@H](C)O1 nan
9802119 199537 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4F)cn3)CC2)c2ccncc21 10.1016/j.bmcl.2009.07.103
CHEMBL567495 199537 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4F)cn3)CC2)c2ccncc21 10.1016/j.bmcl.2009.07.103
9802118 201369 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(F)c4)cn3)CC2)c2ccncc21 10.1016/j.bmcl.2009.07.103
CHEMBL584526 201369 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(F)c4)cn3)CC2)c2ccncc21 10.1016/j.bmcl.2009.07.103
9908890 202241 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 399 3 1 5 4.3 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.08.019
CHEMBL593934 202241 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 399 3 1 5 4.3 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.08.019
18004985 193164 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 460 4 1 3 5.2 CS(=O)(=O)N1C[C@]2(CC[C@H](C(=O)Nc3ccc(-c4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL522321 193164 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 460 4 1 3 5.2 CS(=O)(=O)N1C[C@]2(CC[C@H](C(=O)Nc3ccc(-c4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
44271207 98962 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 521 6 1 6 5.4 O=C(Nc1ccc(Oc2ccccc2)cc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL279309 98962 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 521 6 1 6 5.4 O=C(Nc1ccc(Oc2ccccc2)cc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
46912808 125500 None 0 Mouse Binding pIC50 = 8.8 8.8 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 425 5 2 5 3.5 O=C(N[C@H]1CC[C@@H](C(=O)Nc2ccn(-c3ccccc3F)n2)CC1)c1cccc(F)n1 nan
CHEMBL3646127 125500 None 0 Mouse Binding pIC50 = 8.8 8.8 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 425 5 2 5 3.5 O=C(N[C@H]1CC[C@@H](C(=O)Nc2ccn(-c3ccccc3F)n2)CC1)c1cccc(F)n1 nan
44580050 184310 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 387 1 1 4 4.5 O=C1OC2(CCN(c3nc4cc(Cl)c(Cl)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL483251 184310 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 387 1 1 4 4.5 O=C1OC2(CCN(c3nc4cc(Cl)c(Cl)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
44401591 68919 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 587 8 3 7 5.1 Nc1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL192266 68919 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 587 8 3 7 5.1 Nc1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
23442776 125865 None 0 Mouse Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 475 11 2 8 3.5 COc1ccc(OC)c(S(=O)(=O)NCCCNc2ncc(C(=O)c3ccccc3C)s2)c1 10.1016/j.bmcl.2005.05.009
CHEMBL364796 125865 None 0 Mouse Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 475 11 2 8 3.5 COc1ccc(OC)c(S(=O)(=O)NCCCNc2ncc(C(=O)c3ccccc3C)s2)c1 10.1016/j.bmcl.2005.05.009
89986718 128569 None 0 Mouse Binding pIC50 = 8.8 8.8 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 406 7 2 6 2.6 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)C(F)(F)F)no2)CC1 nan
CHEMBL3666802 128569 None 0 Mouse Binding pIC50 = 8.8 8.8 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 406 7 2 6 2.6 CCS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)C(F)(F)F)no2)CC1 nan
10565529 116794 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 291 2 1 2 4.5 Cc1cc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL337427 116794 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 291 2 1 2 4.5 Cc1cc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
9796164 97009 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 294 1 1 1 4.9 Clc1ccc2c(c1)-c1nc(-c3ccccc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
CHEMBL266241 97009 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 294 1 1 1 4.9 Clc1ccc2c(c1)-c1nc(-c3ccccc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
9823032 187977 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 413 2 2 4 3.3 O=C1Cc2ccccc2C2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)N1 10.1016/j.bmcl.2009.05.013
CHEMBL496392 187977 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 413 2 2 4 3.3 O=C1Cc2ccccc2C2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)N1 10.1016/j.bmcl.2009.05.013
9979057 187175 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 412 2 1 3 6.1 O=C1O[C@]2(CC[C@H](c3nc4cc(-c5ccc(F)cc5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
CHEMBL491229 187175 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 412 2 1 3 6.1 O=C1O[C@]2(CC[C@H](c3nc4cc(-c5ccc(F)cc5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
9887225 187254 None 2 Mouse Binding pIC50 = 8.8 8.8 - 1
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL491930 187254 None 2 Mouse Binding pIC50 = 8.8 8.8 - 1
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
9887225 187254 None 2 Rat Binding pIC50 = 8.8 8.8 - 1
Displacement of [125I]PYY from rat NPY Y5 receptorDisplacement of [125I]PYY from rat NPY Y5 receptor
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL491930 187254 None 2 Rat Binding pIC50 = 8.8 8.8 - 1
Displacement of [125I]PYY from rat NPY Y5 receptorDisplacement of [125I]PYY from rat NPY Y5 receptor
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
9952231 202276 None 0 Rat Binding pIC50 = 8.8 8.8 - 0
Inhibition of rat Y5 receptorInhibition of rat Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4)n3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
CHEMBL594163 202276 None 0 Rat Binding pIC50 = 8.8 8.8 - 0
Inhibition of rat Y5 receptorInhibition of rat Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4)n3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
44271267 98840 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 473 6 2 6 3.1 O=C(Nc1ccc(CCO)cc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL278280 98840 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 473 6 2 6 3.1 O=C(Nc1ccc(CCO)cc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
9926566 28035 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 306 2 1 3 4.3 Cc1nc(N2CCCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL137259 28035 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 306 2 1 3 4.3 Cc1nc(N2CCCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
68616467 125511 None 0 Mouse Binding pIC50 = 8.7 8.7 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 404 4 2 4 4.5 O=C(N[C@H]1CC[C@@H](c2nc(-c3cccc(C(F)(F)F)c3)c[nH]2)CC1)c1ccon1 nan
CHEMBL3646138 125511 None 0 Mouse Binding pIC50 = 8.7 8.7 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 404 4 2 4 4.5 O=C(N[C@H]1CC[C@@H](c2nc(-c3cccc(C(F)(F)F)c3)c[nH]2)CC1)c1ccon1 nan
68607021 125516 None 0 Mouse Binding pIC50 = 8.7 8.7 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 501 5 1 5 5.8 C[C@H]1CN(c2ccc(NC(=O)[C@H]3CC[C@@H](Oc4cc(C(F)(F)F)ccc4C#N)CC3)cc2)C[C@@H](C)O1 nan
CHEMBL3646143 125516 None 0 Mouse Binding pIC50 = 8.7 8.7 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 501 5 1 5 5.8 C[C@H]1CN(c2ccc(NC(=O)[C@H]3CC[C@@H](Oc4cc(C(F)(F)F)ccc4C#N)CC3)cc2)C[C@@H](C)O1 nan
44580708 187961 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 375 3 1 4 4.4 CC(C)Cc1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
CHEMBL496326 187961 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 375 3 1 4 4.4 CC(C)Cc1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
45481809 200479 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 469 3 1 5 3.4 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4cccc(F)c4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL573860 200479 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 469 3 1 5 3.4 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4cccc(F)c4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
9933356 199515 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 448 5 1 7 4.0 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(OCF)c4)cn3)CC2)c2ccncc21 10.1016/j.bmcl.2009.07.103
CHEMBL567310 199515 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 448 5 1 7 4.0 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(OCF)c4)cn3)CC2)c2ccncc21 10.1016/j.bmcl.2009.07.103
9952815 199544 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
CHEMBL567527 199544 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
9953802 200097 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(F)c4)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
CHEMBL570864 200097 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(F)c4)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
11224238 201424 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 432 4 1 6 4.2 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(CF)c4)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
CHEMBL585107 201424 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 432 4 1 6 4.2 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(CF)c4)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
11633103 201435 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4F)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
CHEMBL585203 201435 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4F)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
44583436 187860 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 430 3 1 6 3.8 COc1cccc(-c2cnc(NC(=O)N3CCC4(CC3)OC(=O)c3ccccc34)nc2)c1 10.1016/j.bmcl.2009.05.013
CHEMBL495625 187860 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 430 3 1 6 3.8 COc1cccc(-c2cnc(NC(=O)N3CCC4(CC3)OC(=O)c3ccccc34)nc2)c1 10.1016/j.bmcl.2009.05.013
44583559 187979 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 405 2 1 5 4.5 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccccc4)s3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL496399 187979 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 405 2 1 5 4.5 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccccc4)s3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
9952815 199544 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL567527 199544 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
70682529 76938 None 0 Mouse Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 363 4 1 4 4.1 CCS(=O)(=O)c1ccc2[nH]c(-c3cncc(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070156 76938 None 0 Mouse Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 363 4 1 4 4.1 CCS(=O)(=O)c1ccc2[nH]c(-c3cncc(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
70675752 128570 None 0 Mouse Binding pIC50 = 8.7 8.7 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 424 6 2 6 3.4 CC(C)(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C3(F)CC(F)(F)C3)no2)CC1 nan
CHEMBL3666803 128570 None 0 Mouse Binding pIC50 = 8.7 8.7 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 424 6 2 6 3.4 CC(C)(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C3(F)CC(F)(F)C3)no2)CC1 nan
9955287 199516 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 448 5 1 7 4.0 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(OCF)c4)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
CHEMBL567318 199516 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 448 5 1 7 4.0 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(OCF)c4)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
9886573 188086 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 388 2 2 4 3.8 O=C1OC2(CCN(C(=O)Nc3cc(-c4ccccc4)n[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL497211 188086 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 388 2 2 4 3.8 O=C1OC2(CCN(C(=O)Nc3cc(-c4ccccc4)n[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
70688845 76925 None 0 Mouse Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 384 5 1 4 4.3 CCCS(=O)(=O)c1ccc2[nH]c(-c3cccc(OC(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070143 76925 None 0 Mouse Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 384 5 1 4 4.3 CCCS(=O)(=O)c1ccc2[nH]c(-c3cccc(OC(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.07.020
70684604 76940 None 0 Mouse Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 393 5 1 5 3.6 CCCS(=O)(=O)c1ccc2[nH]c(-c3ccc(=O)n(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070158 76940 None 0 Mouse Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 393 5 1 5 3.6 CCCS(=O)(=O)c1ccc2[nH]c(-c3ccc(=O)n(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
10757242 28560 None 0 Human Binding pIC50 = 8 8.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 272 4 1 3 3.6 CCCCc1cc2[nH]c(C)nc(N3CCCCC3)c-2n1 10.1021/jm000269t
CHEMBL137638 28560 None 0 Human Binding pIC50 = 8 8.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 272 4 1 3 3.6 CCCCc1cc2[nH]c(C)nc(N3CCCCC3)c-2n1 10.1021/jm000269t
44580667 188073 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 364 2 1 6 3.1 O=C1OC2(CCN(c3nc4cc([N+](=O)[O-])ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL497152 188073 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 364 2 1 6 3.1 O=C1OC2(CCN(c3nc4cc([N+](=O)[O-])ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
44580666 188128 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 397 1 1 4 4.0 O=C1OC2(CCN(c3nc4cc(Br)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL497570 188128 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 397 1 1 4 4.0 O=C1OC2(CCN(c3nc4cc(Br)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
10186456 103468 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line by using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line by using [125I]PYY as radioligand
ChEMBL 523 7 2 7 4.6 Nc1cc(C2CCC(CNS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL3084802 103468 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line by using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line by using [125I]PYY as radioligand
ChEMBL 523 7 2 7 4.6 Nc1cc(C2CCC(CNS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
44312780 103467 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 523 7 2 7 4.6 Nc1cc(C2CCC(CNS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)nn1-c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL3084801 103467 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 523 7 2 7 4.6 Nc1cc(C2CCC(CNS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)nn1-c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(01)00448-6
9924627 193184 None 0 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 352 3 1 2 4.4 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccc(F)c3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL522489 193184 None 0 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 352 3 1 2 4.4 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccc(F)c3)=N2)cc1 10.1016/j.bmcl.2009.01.101
9850107 11016 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 536 8 2 5 3.4 O=C(CN1CCC(NS(=O)(=O)c2ccccc2)CC1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1021/jm990468g
CHEMBL117400 11016 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 536 8 2 5 3.4 O=C(CN1CCC(NS(=O)(=O)c2ccccc2)CC1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1021/jm990468g
44344497 103498 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 533 10 2 5 5.1 COc1ccc2c(c1)CCC(NC[C@H]1CC[C@H](CNS(=O)(=O)c3ccccc3)CC1)C2Cc1cccnc1 10.1021/jm990468g
CHEMBL3084895 103498 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 533 10 2 5 5.1 COc1ccc2c(c1)CCC(NC[C@H]1CC[C@H](CNS(=O)(=O)c3ccccc3)CC1)C2Cc1cccnc1 10.1021/jm990468g
44271355 59672 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 500 4 1 7 4.5 Cc1ccc2nc(NC(=O)C3CCN(C(=O)Cn4c(=O)sc5ccc(Cl)cc54)CC3)sc2c1 10.1016/s0960-894x(02)00113-0
CHEMBL17214 59672 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 500 4 1 7 4.5 Cc1ccc2nc(NC(=O)C3CCN(C(=O)Cn4c(=O)sc5ccc(Cl)cc54)CC3)sc2c1 10.1016/s0960-894x(02)00113-0
3087469 28255 None 1 Human Binding pIC50 = 7 7.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 294 2 1 4 2.8 Cc1nc(N2CCOCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL137404 28255 None 1 Human Binding pIC50 = 7 7.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 294 2 1 4 2.8 Cc1nc(N2CCOCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
10664487 30684 None 0 Human Binding pIC50 = 7 7.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 298 2 1 4 4.0 Cc1nc(N2CCCCC2)c2[nH]c(-c3cccs3)cc2n1 10.1021/jm000269t
CHEMBL139483 30684 None 0 Human Binding pIC50 = 7 7.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 298 2 1 4 4.0 Cc1nc(N2CCCCC2)c2[nH]c(-c3cccs3)cc2n1 10.1021/jm000269t
44313331 207318 None 0 Human Binding pIC50 = 7 7.0 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 420 6 2 6 3.9 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4ccccc4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL75662 207318 None 0 Human Binding pIC50 = 7 7.0 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 420 6 2 6 3.9 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4ccccc4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
10295464 208159 None 0 Human Binding pIC50 = 7 7.0 - 0
In vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ responseIn vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ response
ChEMBL 417 6 1 5 4.7 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL82374 208159 None 0 Human Binding pIC50 = 7 7.0 - 0
In vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ responseIn vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ response
ChEMBL 417 6 1 5 4.7 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
10257065 12892 None 0 Rat Binding pIC50 = 7 7.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 516 5 1 5 6.0 CCn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5cc(Cl)ccc54)CC3)ccc21 10.1021/jm049599u
CHEMBL1188887 12892 None 0 Rat Binding pIC50 = 7 7.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 516 5 1 5 6.0 CCn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5cc(Cl)ccc54)CC3)ccc21 10.1021/jm049599u
CHEMBL537634 12892 None 0 Rat Binding pIC50 = 7 7.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 516 5 1 5 6.0 CCn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5cc(Cl)ccc54)CC3)ccc21 10.1021/jm049599u
44271556 98489 None 0 Human Binding pIC50 = 6 6.0 - 0
Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5
ChEMBL 444 6 1 3 5.2 O=S(=O)(c1cccc2ccccc12)N1CCC(CNCc2ccc3ccccc3c2)CC1 10.1016/s0960-894x(00)00177-3
CHEMBL275610 98489 None 0 Human Binding pIC50 = 6 6.0 - 0
Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5
ChEMBL 444 6 1 3 5.2 O=S(=O)(c1cccc2ccccc12)N1CCC(CNCc2ccc3ccccc3c2)CC1 10.1016/s0960-894x(00)00177-3
44377690 58165 None 0 Human Binding pIC50 = 6 6.0 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 521 9 2 5 4.4 COc1ccc2c(c1)CCCC(NCCN1CCC(CNS(=O)(=O)c3cccc4ccccc34)CC1)C2 10.1016/s0960-894x(02)00002-1
CHEMBL167926 58165 None 0 Human Binding pIC50 = 6 6.0 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 521 9 2 5 4.4 COc1ccc2c(c1)CCCC(NCCN1CCC(CNS(=O)(=O)c3cccc4ccccc34)CC1)C2 10.1016/s0960-894x(02)00002-1
25067562 184304 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 400 2 1 6 4.6 Cc1nnc(-c2ccc3[nH]c([C@H]4CC[C@]5(CC4)OC(=O)c4ccccc45)nc3c2)o1 10.1016/j.bmcl.2008.08.021
CHEMBL483239 184304 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 400 2 1 6 4.6 Cc1nnc(-c2ccc3[nH]c([C@H]4CC[C@]5(CC4)OC(=O)c4ccccc45)nc3c2)o1 10.1016/j.bmcl.2008.08.021
44579862 186979 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 410 2 1 5 4.7 COC(=O)c1cc2[nH]c([C@H]3CC[C@]4(CC3)OC(=O)c3ccccc34)nc2cc1Cl 10.1016/j.bmcl.2008.08.021
CHEMBL489609 186979 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 410 2 1 5 4.7 COC(=O)c1cc2[nH]c([C@H]3CC[C@]4(CC3)OC(=O)c3ccccc34)nc2cc1Cl 10.1016/j.bmcl.2008.08.021
44390110 161786 None 0 Mouse Binding pIC50 = 6 6.0 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 328 5 1 5 4.3 COc1cccc(Nc2ncc(C(=O)c3ccccc3F)s2)c1 10.1016/j.bmcl.2005.01.063
CHEMBL413359 161786 None 0 Mouse Binding pIC50 = 6 6.0 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 328 5 1 5 4.3 COc1cccc(Nc2ncc(C(=O)c3ccccc3F)s2)c1 10.1016/j.bmcl.2005.01.063
44580502 193017 None 0 Human Binding pIC50 = 5 5.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 336 1 0 5 4.0 O=C1OC2(CCN(c3nc4ccccc4s3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL522213 193017 None 0 Human Binding pIC50 = 5 5.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 336 1 0 5 4.0 O=C1OC2(CCN(c3nc4ccccc4s3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
10481364 12994 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 471 6 1 5 5.3 Cc1ccc2c(c1)COC(=O)N2C1CCN(CC(=O)Nc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm049599u
CHEMBL1189619 12994 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 471 6 1 5 5.3 Cc1ccc2c(c1)COC(=O)N2C1CCN(CC(=O)Nc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm049599u
CHEMBL539084 12994 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 471 6 1 5 5.3 Cc1ccc2c(c1)COC(=O)N2C1CCN(CC(=O)Nc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm049599u
10616756 26291 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 298 2 1 3 4.3 Cc1nc(N2CCCCC2)c2nc(C3CCCCC3)cc-2[nH]1 10.1021/jm000269t
CHEMBL135831 26291 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 298 2 1 3 4.3 Cc1nc(N2CCCCC2)c2nc(C3CCCCC3)cc-2[nH]1 10.1021/jm000269t
45481639 200908 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 420 2 1 4 3.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(Cl)nc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL577358 200908 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 420 2 1 4 3.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(Cl)nc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
44379410 58126 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 535 10 3 6 3.5 COc1ccc2c(c1)C(O)(CNCC1CCN(CCNS(=O)(=O)c3cccc(Cl)c3C)CC1)CCC2 10.1016/s0960-894x(02)00018-5
CHEMBL167558 58126 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 535 10 3 6 3.5 COc1ccc2c(c1)C(O)(CNCC1CCN(CCNS(=O)(=O)c3cccc(Cl)c3C)CC1)CCC2 10.1016/s0960-894x(02)00018-5
44344312 103478 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 565 9 2 5 4.8 COc1ccc2c(c1)CCC(NC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c3ccccc3F)CC1)C2Cc1cccnc1 10.1021/jm990468g
CHEMBL3084871 103478 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 565 9 2 5 4.8 COc1ccc2c(c1)CCC(NC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c3ccccc3F)CC1)C2Cc1cccnc1 10.1021/jm990468g
44344356 103484 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 547 9 2 5 4.6 COc1ccc2c(c1)CCC(NC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c3ccccc3)CC1)C2Cc1cccnc1 10.1021/jm990468g
CHEMBL3084877 103484 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 547 9 2 5 4.6 COc1ccc2c(c1)CCC(NC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c3ccccc3)CC1)C2Cc1cccnc1 10.1021/jm990468g
9810707 169518 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 522 8 2 5 3.0 O=C(CN1CCC(NS(=O)(=O)c2ccccc2)C1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1021/jm990468g
CHEMBL442399 169518 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 522 8 2 5 3.0 O=C(CN1CCC(NS(=O)(=O)c2ccccc2)C1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1021/jm990468g
20616889 66953 None 0 Mouse Binding pIC50 = 8.0 8.0 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 421 9 2 7 3.5 Cc1ccccc1C(=O)c1csc(NCCCNS(=O)(=O)c2cccs2)n1 10.1016/j.bmcl.2005.05.009
CHEMBL186620 66953 None 0 Mouse Binding pIC50 = 8.0 8.0 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 421 9 2 7 3.5 Cc1ccccc1C(=O)c1csc(NCCCNS(=O)(=O)c2cccs2)n1 10.1016/j.bmcl.2005.05.009
23442542 67155 None 0 Mouse Binding pIC50 = 8.0 8.0 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 445 10 2 7 3.5 COc1cccc(S(=O)(=O)NCCCNc2ncc(C(=O)c3ccccc3C)s2)c1 10.1016/j.bmcl.2005.05.009
CHEMBL187507 67155 None 0 Mouse Binding pIC50 = 8.0 8.0 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 445 10 2 7 3.5 COc1cccc(S(=O)(=O)NCCCNc2ncc(C(=O)c3ccccc3C)s2)c1 10.1016/j.bmcl.2005.05.009
10325002 13144 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 503 6 1 5 5.1 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc(C(=O)c2ccccc2)cc1 10.1021/jm049599u
CHEMBL1190573 13144 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 503 6 1 5 5.1 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc(C(=O)c2ccccc2)cc1 10.1021/jm049599u
CHEMBL541121 13144 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 503 6 1 5 5.1 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc(C(=O)c2ccccc2)cc1 10.1021/jm049599u
10457755 48441 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 477 6 3 6 3.5 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2cccs2)CC1)c1cc2ccccc2s1 10.1016/j.bmcl.2003.11.070
CHEMBL155553 48441 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 477 6 3 6 3.5 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2cccs2)CC1)c1cc2ccccc2s1 10.1016/j.bmcl.2003.11.070
70688846 76926 None 0 Mouse Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 375 5 1 2 5.7 CCCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3)cc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070144 76926 None 0 Mouse Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 375 5 1 2 5.7 CCCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3)cc2c1 10.1016/j.bmcl.2012.07.020
44580710 188265 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 362 2 2 5 2.3 NC(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
CHEMBL498594 188265 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 362 2 2 5 2.3 NC(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
22934120 97311 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 261 1 1 2 3.6 c1ccc(-c2nc3c([nH]2)-c2ccccc2CCC3)nc1 10.1016/s0960-894x(02)00090-2
CHEMBL268810 97311 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 261 1 1 2 3.6 c1ccc(-c2nc3c([nH]2)-c2ccccc2CCC3)nc1 10.1016/s0960-894x(02)00090-2
22934115 205998 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 291 2 1 3 3.6 COc1ccc2c(c1)-c1nc(-c3ccccn3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
CHEMBL6646 205998 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 291 2 1 3 3.6 COc1ccc2c(c1)-c1nc(-c3ccccn3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
10519637 28536 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 282 2 1 4 3.5 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccco3)cc2n1 10.1021/jm000269t
CHEMBL137619 28536 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 282 2 1 4 3.5 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccco3)cc2n1 10.1021/jm000269t
22257113 102969 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 499 5 2 4 4.4 O=C(NC1=NC2CCc3cc(Cl)ccc3C2C1)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1016/s0960-894x(99)00676-9
CHEMBL306099 102969 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 499 5 2 4 4.4 O=C(NC1=NC2CCc3cc(Cl)ccc3C2C1)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1016/s0960-894x(99)00676-9
71519169 86209 None 0 Mouse Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 376 5 1 3 4.6 CCS(=O)(=O)c1ccc2[nH]c(Cc3ccc(-c4ccccc4)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312078 86209 None 0 Mouse Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 376 5 1 3 4.6 CCS(=O)(=O)c1ccc2[nH]c(Cc3ccc(-c4ccccc4)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
10256047 12822 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 481 5 1 4 5.9 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc(C2CCCCC2)cc1 10.1021/jm049599u
CHEMBL1188309 12822 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 481 5 1 4 5.9 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc(C2CCCCC2)cc1 10.1021/jm049599u
CHEMBL536045 12822 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 481 5 1 4 5.9 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc(C2CCCCC2)cc1 10.1021/jm049599u
44312965 103545 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 472 6 2 5 4.6 Nc1cc(-c2ccc(CNS(=O)(=O)c3ccccc3)cc2)nn1-c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL308508 103545 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 472 6 2 5 4.6 Nc1cc(-c2ccc(CNS(=O)(=O)c3ccccc3)cc2)nn1-c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(01)00448-6
44289816 164191 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 513 8 2 3 5.1 O=C(Cc1ccccc1)NC[C@H]1CC[C@H](C(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1 10.1016/s0960-894x(00)00311-5
CHEMBL42096 164191 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 513 8 2 3 5.1 O=C(Cc1ccccc1)NC[C@H]1CC[C@H](C(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1 10.1016/s0960-894x(00)00311-5
44288395 162667 None 0 Human Binding pIC50 = 4.9 4.9 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 517 10 5 3 4.0 N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccc(Cl)cc1)C(=O)N[C@H]1CCc2ccccc21 10.1016/s0960-894x(00)00292-4
CHEMBL41686 162667 None 0 Human Binding pIC50 = 4.9 4.9 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 517 10 5 3 4.0 N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccc(Cl)cc1)C(=O)N[C@H]1CCc2ccccc21 10.1016/s0960-894x(00)00292-4
11783658 110675 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 373 2 1 3 4.5 CC(C)n1c2ccccc2c2c(F)c(NC(=O)N3CCOCC3)c(F)cc21 10.1021/jm011125x
CHEMBL325639 110675 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 373 2 1 3 4.5 CC(C)n1c2ccccc2c2c(F)c(NC(=O)N3CCOCC3)c(F)cc21 10.1021/jm011125x
44344608 103505 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 553 8 2 4 4.9 O=C(NC1CCc2cc(F)ccc2C1Cc1cccnc1)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2F)CC1 10.1021/jm990468g
CHEMBL3084904 103505 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 553 8 2 4 4.9 O=C(NC1CCc2cc(F)ccc2C1Cc1cccnc1)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2F)CC1 10.1021/jm990468g
71518852 86194 None 0 Mouse Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 366 5 1 4 4.3 CCS(=O)(=O)c1ccc2[nH]c(SCc3cccc(Cl)c3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312063 86194 None 0 Mouse Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 366 5 1 4 4.3 CCS(=O)(=O)c1ccc2[nH]c(SCc3cccc(Cl)c3)nc2c1 10.1016/j.bmcl.2012.11.005
10071200 50281 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 427 6 3 6 2.4 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2cccs2)CC1)c1cccs1 10.1016/j.bmcl.2003.11.070
CHEMBL157157 50281 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 427 6 3 6 2.4 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2cccs2)CC1)c1cccs1 10.1016/j.bmcl.2003.11.070
10547234 118861 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 335 5 2 4 4.4 CCCNc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL342153 118861 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 335 5 2 4 4.4 CCCNc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
44401626 71378 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 558 7 2 6 5.2 O=S(=O)(NCC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
CHEMBL195810 71378 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 558 7 2 6 5.2 O=S(=O)(NCC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
11284878 64364 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(N[C@H]2CC[C@@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181217 64364 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(N[C@H]2CC[C@@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
10779946 116740 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 291 2 1 2 4.5 Cc1cc2cc(-c3ccccc3)[nH]c2c(N2CCCCC2)n1 10.1021/jm000269t
CHEMBL337105 116740 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 291 2 1 2 4.5 Cc1cc2cc(-c3ccccc3)[nH]c2c(N2CCCCC2)n1 10.1021/jm000269t
44308516 167910 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 513 6 2 5 3.9 COc1ccc2c(c1)CCC1N=C(NC(=O)[C@H]3CC[C@H](CNS(=O)(=O)c4ccccc4F)CC3)CC21 10.1016/s0960-894x(99)00676-9
CHEMBL430604 167910 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 513 6 2 5 3.9 COc1ccc2c(c1)CCC1N=C(NC(=O)[C@H]3CC[C@H](CNS(=O)(=O)c4ccccc4F)CC3)CC21 10.1016/s0960-894x(99)00676-9
10916153 207444 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 390 7 2 3 5.5 CCN(C(=O)Nc1ccc(Oc2ccccc2)cc1)[C@H](C)[C@@H](O)c1ccccc1 10.1021/jm0004547
CHEMBL76627 207444 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 390 7 2 3 5.5 CCN(C(=O)Nc1ccc(Oc2ccccc2)cc1)[C@H](C)[C@@H](O)c1ccccc1 10.1021/jm0004547
11824961 207628 None 0 Human Binding pIC50 = 6.9 6.9 - 1
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 376 6 2 3 5.1 C[C@@H]([C@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL78265 207628 None 0 Human Binding pIC50 = 6.9 6.9 - 1
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 376 6 2 3 5.1 C[C@@H]([C@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
9857217 97118 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 291 2 1 3 3.6 COc1ccc2c(c1)-c1nc(-c3ccncc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
CHEMBL267193 97118 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 291 2 1 3 3.6 COc1ccc2c(c1)-c1nc(-c3ccncc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
22934114 97417 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 279 1 1 2 3.8 Fc1ccc2c(c1)-c1nc(-c3ccncc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
CHEMBL269561 97417 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 279 1 1 2 3.8 Fc1ccc2c(c1)-c1nc(-c3ccncc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
44461107 169338 None 0 Human Binding pIC50 = 7.9 7.9 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 437 4 1 5 4.8 CC(C)C(=O)N1CCC(CNc2nc3c(s2)CCOc2cc(F)c(Cl)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL441059 169338 None 0 Human Binding pIC50 = 7.9 7.9 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 437 4 1 5 4.8 CC(C)C(=O)N1CCC(CNc2nc3c(s2)CCOc2cc(F)c(Cl)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44379089 58158 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 501 10 3 6 2.8 COc1ccc2c(c1)C(O)(CNCC1CCN(CCNS(=O)(=O)c3cccc(C)c3)CC1)CCC2 10.1016/s0960-894x(02)00018-5
CHEMBL167860 58158 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 501 10 3 6 2.8 COc1ccc2c(c1)C(O)(CNCC1CCN(CCNS(=O)(=O)c3cccc(C)c3)CC1)CCC2 10.1016/s0960-894x(02)00018-5
44580747 188166 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 376 2 2 5 3.2 CC(=O)Nc1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
CHEMBL497786 188166 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 376 2 2 5 3.2 CC(=O)Nc1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
44573448 187375 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 368 3 1 2 4.9 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccc(Cl)cc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL492779 187375 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 368 3 1 2 4.9 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccc(Cl)cc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
10614625 116709 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 306 2 0 4 3.9 Cc1nc(N2CCCCC2)c2c(cc(-c3ccccc3)n2C)n1 10.1021/jm000269t
CHEMBL336985 116709 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 306 2 0 4 3.9 Cc1nc(N2CCCCC2)c2c(cc(-c3ccccc3)n2C)n1 10.1021/jm000269t
10959714 207420 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 374 6 1 2 6.0 CN(C(=O)Nc1ccc(Oc2ccccc2)cc1)C(C)(C)Cc1ccccc1 10.1021/jm0004547
CHEMBL76478 207420 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 374 6 1 2 6.0 CN(C(=O)Nc1ccc(Oc2ccccc2)cc1)C(C)(C)Cc1ccccc1 10.1021/jm0004547
10455186 13931 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 390 4 1 5 3.1 N#Cc1ccc(NC(=O)CN2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm049599u
CHEMBL1196451 13931 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 390 4 1 5 3.1 N#Cc1ccc(NC(=O)CN2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm049599u
CHEMBL556999 13931 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 390 4 1 5 3.1 N#Cc1ccc(NC(=O)CN2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm049599u
44390156 63520 None 0 Mouse Binding pIC50 = 6.9 6.9 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 416 4 1 4 6.2 O=C(c1cnc(Nc2cccc(C(F)(F)F)c2)s1)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2005.01.063
CHEMBL179979 63520 None 0 Mouse Binding pIC50 = 6.9 6.9 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 416 4 1 4 6.2 O=C(c1cnc(Nc2cccc(C(F)(F)F)c2)s1)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2005.01.063
10481215 12830 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 467 4 1 5 4.5 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1cccc2c1-c1ccccc1C2=O 10.1021/jm049599u
CHEMBL1188388 12830 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 467 4 1 5 4.5 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1cccc2c1-c1ccccc1C2=O 10.1021/jm049599u
CHEMBL536275 12830 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 467 4 1 5 4.5 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1cccc2c1-c1ccccc1C2=O 10.1021/jm049599u
44583437 187891 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 430 3 1 6 3.8 COc1ccc(-c2cnc(NC(=O)N3CCC4(CC3)OC(=O)c3ccccc34)nc2)cc1 10.1016/j.bmcl.2009.05.013
CHEMBL495828 187891 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 430 3 1 6 3.8 COc1ccc(-c2cnc(NC(=O)N3CCC4(CC3)OC(=O)c3ccccc34)nc2)cc1 10.1016/j.bmcl.2009.05.013
44390067 63491 None 0 Mouse Binding pIC50 = 7.9 7.9 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 339 4 1 6 4.7 Cc1cc(C(=O)c2cnc(Nc3cccc(C#N)c3)s2)c(C)s1 10.1016/j.bmcl.2005.01.063
CHEMBL179848 63491 None 0 Mouse Binding pIC50 = 7.9 7.9 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 339 4 1 6 4.7 Cc1cc(C(=O)c2cnc(Nc3cccc(C#N)c3)s2)c(C)s1 10.1016/j.bmcl.2005.01.063
10738836 28038 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 348 2 1 4 5.1 Cc1nc(N2CCCCC2)c2[nH]c(-c3cc4ccccc4s3)cc2n1 10.1021/jm000269t
CHEMBL137260 28038 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 348 2 1 4 5.1 Cc1nc(N2CCCCC2)c2[nH]c(-c3cc4ccccc4s3)cc2n1 10.1021/jm000269t
22325344 193249 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 319 1 1 4 3.2 O=C1OC2(CCN(c3nc4ccccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL522913 193249 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 319 1 1 4 3.2 O=C1OC2(CCN(c3nc4ccccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
44377916 57180 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 523 10 2 6 3.6 COc1ccc2c(c1OC)CC(NCC1CN(CCNS(=O)(=O)c3cccc4ccccc34)C1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL164748 57180 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 523 10 2 6 3.6 COc1ccc2c(c1OC)CC(NCC1CN(CCNS(=O)(=O)c3cccc4ccccc34)C1)CCC2 10.1016/s0960-894x(02)00002-1
44289833 166224 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 495 6 3 4 3.5 CC(C)(C)NC(=O)NC1CCN(CC(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1 10.1016/s0960-894x(00)00311-5
CHEMBL42611 166224 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 495 6 3 4 3.5 CC(C)(C)NC(=O)NC1CCN(CC(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1 10.1016/s0960-894x(00)00311-5
10573317 119313 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 368 3 1 3 5.6 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccc(-c4ccccc4)cc3)cc2n1 10.1021/jm000269t
CHEMBL343564 119313 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 368 3 1 3 5.6 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccc(-c4ccccc4)cc3)cc2n1 10.1021/jm000269t
10520484 165458 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 294 2 1 5 2.7 Cc1nc(N2CCCCC2)c2[nH]c(-c3cnccn3)cc2n1 10.1021/jm000269t
CHEMBL423720 165458 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 294 2 1 5 2.7 Cc1nc(N2CCCCC2)c2[nH]c(-c3cnccn3)cc2n1 10.1021/jm000269t
44580505 188209 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 319 1 1 4 3.7 O=C1O[C@]2(CC[C@@H](c3nc4cccnc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL498197 188209 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 319 1 1 4 3.7 O=C1O[C@]2(CC[C@@H](c3nc4cccnc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
20556258 63786 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5
ChEMBL 419 4 1 7 2.9 COc1cc2nc(N3CCC(N4Cc5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1016/s0960-894x(00)00177-3
CHEMBL18016 63786 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5
ChEMBL 419 4 1 7 2.9 COc1cc2nc(N3CCC(N4Cc5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1016/s0960-894x(00)00177-3
44370270 48058 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 597 9 3 5 6.8 CC(C)c1cc(C(C)C)c(S(=O)(=O)NC[C@H]2CC[C@H](C(=O)NNC(=O)c3cc4ccccc4s3)CC2)c(C(C)C)c1 10.1016/j.bmcl.2003.11.070
CHEMBL155048 48058 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 597 9 3 5 6.8 CC(C)c1cc(C(C)C)c(S(=O)(=O)NC[C@H]2CC[C@H](C(=O)NNC(=O)c3cc4ccccc4s3)CC2)c(C(C)C)c1 10.1016/j.bmcl.2003.11.070
44313078 207284 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 447 6 2 6 4.3 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4cccc(N(C)C)c4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL75369 207284 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 447 6 2 6 4.3 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4cccc(N(C)C)c4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
44370250 51101 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 472 6 3 6 2.8 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2cccc3cccnc23)CC1)c1cccs1 10.1016/j.bmcl.2003.11.070
CHEMBL157905 51101 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 472 6 3 6 2.8 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2cccc3cccnc23)CC1)c1cccs1 10.1016/j.bmcl.2003.11.070
10253263 69513 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 450 4 1 5 4.4 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc2ncccc2c1 10.1021/jm049599u
CHEMBL193382 69513 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 450 4 1 5 4.4 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc2ncccc2c1 10.1021/jm049599u
10883239 169814 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 373 2 1 5 2.5 CS(=O)(=O)n1c2ccccc2c2cc(NC(=O)N3CCOCC3)ccc21 10.1021/jm011125x
CHEMBL443809 169814 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 373 2 1 5 2.5 CS(=O)(=O)n1c2ccccc2c2cc(NC(=O)N3CCOCC3)ccc21 10.1021/jm011125x
9824246 167882 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line by using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line by using [125I]PYY as radioligand
ChEMBL 434 6 2 6 4.2 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4ccc(C)cc4)n3)cc2)cc1 10.1016/s0960-894x(01)00449-8
CHEMBL430414 167882 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line by using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line by using [125I]PYY as radioligand
ChEMBL 434 6 2 6 4.2 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4ccc(C)cc4)n3)cc2)cc1 10.1016/s0960-894x(01)00449-8
9824246 167882 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 434 6 2 6 4.2 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4ccc(C)cc4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL430414 167882 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 434 6 2 6 4.2 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4ccc(C)cc4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
44579864 193205 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 386 2 1 6 4.3 O=C1O[C@]2(CC[C@H](c3nc4cc(-c5nnco5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
CHEMBL522609 193205 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 386 2 1 6 4.3 O=C1O[C@]2(CC[C@H](c3nc4cc(-c5nnco5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
44460811 163437 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 500 6 2 6 5.3 CN(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)-c2ccccc2Sc2ccccc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL419104 163437 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 500 6 2 6 5.3 CN(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)-c2ccccc2Sc2ccccc2-3)CC1 10.1016/j.bmcl.2004.03.014
44461003 208069 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 476 5 1 4 6.5 CC(=O)C1(c2ccccc2)CCC(CC(=O)Nc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL81621 208069 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 476 5 1 4 6.5 CC(=O)C1(c2ccccc2)CCC(CC(=O)Nc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44460943 208070 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 455 5 2 5 5.9 O=C(N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1)c1cccs1 10.1016/j.bmcl.2004.03.014
CHEMBL81636 208070 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 455 5 2 5 5.9 O=C(N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1)c1cccs1 10.1016/j.bmcl.2004.03.014
44461201 208320 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 460 9 2 6 3.7 COCCCNCC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL83748 208320 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 460 9 2 6 3.7 COCCCNCC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
71451429 81372 None 0 Mouse Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 385 5 1 5 3.3 CCCS(=O)(=O)c1ccc2[nH]c(C3CN(c4ccccc4)CCO3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159160 81372 None 0 Mouse Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 385 5 1 5 3.3 CCCS(=O)(=O)c1ccc2[nH]c(C3CN(c4ccccc4)CCO3)nc2c1 10.1016/j.bmcl.2012.09.025
10830247 28254 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 293 2 1 4 3.3 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccn3)cc2n1 10.1021/jm000269t
CHEMBL137403 28254 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 293 2 1 4 3.3 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccn3)cc2n1 10.1021/jm000269t
10810223 118843 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 350 5 1 4 4.0 COc1ccc(CCc2cc3[nH]c(C)nc(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
CHEMBL341993 118843 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 350 5 1 4 4.0 COc1ccc(CCc2cc3[nH]c(C)nc(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
10047390 207428 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 413 3 1 3 5.8 Cc1cc(C(=O)Nc2cc(Cl)cc(Cl)c2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL76512 207428 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 413 3 1 3 5.8 Cc1cc(C(=O)Nc2cc(Cl)cc(Cl)c2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
44460881 207823 None 0 Human Binding pIC50 = 6.8 6.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 484 7 2 5 5.4 O=C(CCN1CCCCC1)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL79815 207823 None 0 Human Binding pIC50 = 6.8 6.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 484 7 2 5 5.4 O=C(CCN1CCCCC1)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
11284878 70465 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(NC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL194602 70465 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(NC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
10736625 119245 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 314 4 2 3 4.5 Cc1nc(NCc2ccccc2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL343102 119245 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 314 4 2 3 4.5 Cc1nc(NCc2ccccc2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
10007341 120129 None 3 Human Binding pIC50 = 7.8 7.8 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 535 10 2 5 4.6 COc1ccc2c(c1)CC(CNCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL350620 120129 None 3 Human Binding pIC50 = 7.8 7.8 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 535 10 2 5 4.6 COc1ccc2c(c1)CC(CNCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
10007341 120129 None 3 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 535 10 2 5 4.6 COc1ccc2c(c1)CC(CNCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00018-5
CHEMBL350620 120129 None 3 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 535 10 2 5 4.6 COc1ccc2c(c1)CC(CNCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00018-5
44289698 173184 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 495 6 2 4 5.3 CC(C)(C)OC(=O)NC[C@H]1CC[C@H](C(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1 10.1016/s0960-894x(00)00311-5
CHEMBL45199 173184 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 495 6 2 4 5.3 CC(C)(C)OC(=O)NC[C@H]1CC[C@H](C(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1 10.1016/s0960-894x(00)00311-5
70695681 78386 None 0 Human Binding pIC50 = 7.8 7.8 - 1
Inhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 383 7 3 3 3.9 O=C(O)CCc1cccc(CC(=O)Nc2cc(-c3ccc(Cl)cc3)n[nH]2)c1 10.1021/jm025513q
CHEMBL2110162 78386 None 0 Human Binding pIC50 = 7.8 7.8 - 1
Inhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 383 7 3 3 3.9 O=C(O)CCc1cccc(CC(=O)Nc2cc(-c3ccc(Cl)cc3)n[nH]2)c1 10.1021/jm025513q
10849420 119286 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 230 1 1 3 2.5 Cc1cc2[nH]c(C)nc(N3CCCCC3)c-2n1 10.1021/jm000269t
CHEMBL343394 119286 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 230 1 1 3 2.5 Cc1cc2[nH]c(C)nc(N3CCCCC3)c-2n1 10.1021/jm000269t
12822578 60374 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5
ChEMBL 481 5 1 8 3.5 COc1cc2nc(N3CCC(N4C(=O)CC(C5CCCCC5)CC4=O)CC3)nc(N)c2cc1OC 10.1016/s0960-894x(00)00177-3
CHEMBL17456 60374 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5
ChEMBL 481 5 1 8 3.5 COc1cc2nc(N3CCC(N4C(=O)CC(C5CCCCC5)CC4=O)CC3)nc(N)c2cc1OC 10.1016/s0960-894x(00)00177-3
44573567 187575 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 335 3 1 3 3.7 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccccn3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL494018 187575 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 335 3 1 3 3.7 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccccn3)=N2)cc1 10.1016/j.bmcl.2009.01.101
44573606 192774 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 335 3 1 3 3.7 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccncc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL521862 192774 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 335 3 1 3 3.7 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccncc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
44573449 193242 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 402 3 1 2 5.3 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccc(C(F)(F)F)cc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL522866 193242 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 402 3 1 2 5.3 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccc(C(F)(F)F)cc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
10617610 28636 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 310 2 1 3 4.1 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)c(F)c2n1 10.1021/jm000269t
CHEMBL137711 28636 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 310 2 1 3 4.1 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)c(F)c2n1 10.1021/jm000269t
44580503 187874 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 320 1 1 5 2.6 O=C1OC2(CCN(c3nc4cccnc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL495725 187874 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 320 1 1 5 2.6 O=C1OC2(CCN(c3nc4cccnc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
1284592 105878 None 30 Human Binding pIC50 = 5.8 5.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 270 3 1 3 4.7 Fc1ccc(-c2csc(Nc3ccccc3)n2)cc1 10.1016/j.bmcl.2004.03.014
CHEMBL312711 105878 None 30 Human Binding pIC50 = 5.8 5.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 270 3 1 3 4.7 Fc1ccc(-c2csc(Nc3ccccc3)n2)cc1 10.1016/j.bmcl.2004.03.014
44313092 168155 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 447 6 2 6 4.3 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc(N(C)C)cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL432352 168155 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 447 6 2 6 4.3 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc(N(C)C)cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
10959285 207518 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 358 4 1 2 5.1 CN(C(=O)Nc1ccc(Oc2ccccc2)cc1)C1Cc2ccccc2C1 10.1021/jm0004547
CHEMBL77208 207518 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 358 4 1 2 5.1 CN(C(=O)Nc1ccc(Oc2ccccc2)cc1)C1Cc2ccccc2C1 10.1021/jm0004547
11068453 103211 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 362 6 3 3 4.7 C[C@@H](NC(=O)Nc1ccc(Oc2ccccc2)cc1)[C@@H](O)c1ccccc1 10.1021/jm0004547
CHEMBL308046 103211 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 362 6 3 3 4.7 C[C@@H](NC(=O)Nc1ccc(Oc2ccccc2)cc1)[C@@H](O)c1ccccc1 10.1021/jm0004547
44390111 62806 None 0 Mouse Binding pIC50 = 5.8 5.8 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 332 4 1 4 4.9 O=C(c1cnc(Nc2ccc(Cl)cc2)s1)c1ccccc1F 10.1016/j.bmcl.2005.01.063
CHEMBL178412 62806 None 0 Mouse Binding pIC50 = 5.8 5.8 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 332 4 1 4 4.9 O=C(c1cnc(Nc2ccc(Cl)cc2)s1)c1ccccc1F 10.1016/j.bmcl.2005.01.063
17965215 28458 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 2 1 3 4.7 Cc1nc2cc(-c3ccccc3)nc-2c(N2C(C)CCCC2C)[nH]1 10.1021/jm000269t
CHEMBL137538 28458 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 2 1 3 4.7 Cc1nc2cc(-c3ccccc3)nc-2c(N2C(C)CCCC2C)[nH]1 10.1021/jm000269t
44580665 193470 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 395 2 1 4 4.9 O=C1OC2(CCN(c3nc4c(-c5ccccc5)cccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL524988 193470 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 395 2 1 4 4.9 O=C1OC2(CCN(c3nc4c(-c5ccccc5)cccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
44573647 193305 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 360 3 1 4 3.5 N#Cc1cncc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
CHEMBL523339 193305 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 360 3 1 4 3.5 N#Cc1cncc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
44460473 208044 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 427 4 1 6 3.9 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)[C@@H]4CCCO4)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
CHEMBL81427 208044 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 427 4 1 6 3.9 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)[C@@H]4CCCO4)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
44461159 208136 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 429 7 1 6 4.6 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(OC)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL82196 208136 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 429 7 1 6 4.6 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(OC)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44289834 168789 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 482 6 2 5 3.6 CC(C)(C)OC(=O)N[C@H]1CCN(CC(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)C1 10.1016/s0960-894x(00)00311-5
CHEMBL43659 168789 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 482 6 2 5 3.6 CC(C)(C)OC(=O)N[C@H]1CCN(CC(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)C1 10.1016/s0960-894x(00)00311-5
23442779 126364 None 0 Mouse Binding pIC50 = 7.8 7.8 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 475 11 2 8 3.5 COc1ccc(OC)c(S(=O)(=O)NCCCNc2nc(C(=O)c3ccccc3C)cs2)c1 10.1016/j.bmcl.2005.05.009
CHEMBL365021 126364 None 0 Mouse Binding pIC50 = 7.8 7.8 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 475 11 2 8 3.5 COc1ccc(OC)c(S(=O)(=O)NCCCNc2nc(C(=O)c3ccccc3C)cs2)c1 10.1016/j.bmcl.2005.05.009
44271382 98580 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 479 4 1 5 4.7 O=C(Nc1cccc2ccccc12)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL276283 98580 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 479 4 1 5 4.7 O=C(Nc1cccc2ccccc12)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
71454970 81371 None 0 Mouse Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 384 5 1 4 4.4 CCCS(=O)(=O)c1ccc2[nH]c(C3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159159 81371 None 0 Mouse Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 384 5 1 4 4.4 CCCS(=O)(=O)c1ccc2[nH]c(C3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
10094963 12881 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 407 5 1 5 3.4 CC(=O)c1ccc(NC(=O)CN2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm049599u
CHEMBL1188798 12881 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 407 5 1 5 3.4 CC(=O)c1ccc(NC(=O)CN2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm049599u
CHEMBL537412 12881 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 407 5 1 5 3.4 CC(=O)c1ccc(NC(=O)CN2CCC(N3C(=O)OCc4ccccc43)CC2)cc1 10.1021/jm049599u
10645275 119361 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 374 3 1 3 4.8 Cc1nc(N2CCCCC2)c2nc(Cc3cccc(C(F)(F)F)c3)cc-2[nH]1 10.1021/jm000269t
CHEMBL343924 119361 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 374 3 1 3 4.8 Cc1nc(N2CCCCC2)c2nc(Cc3cccc(C(F)(F)F)c3)cc-2[nH]1 10.1021/jm000269t
44289857 101362 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 514 7 3 3 5.6 O=C(NC[C@H]1CC[C@H](C(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1)Nc1ccccc1 10.1016/s0960-894x(00)00311-5
CHEMBL296557 101362 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 514 7 3 3 5.6 O=C(NC[C@H]1CC[C@H](C(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1)Nc1ccccc1 10.1016/s0960-894x(00)00311-5
44370180 47311 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 471 6 3 5 3.4 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1)c1cc2ccccc2s1 10.1016/j.bmcl.2003.11.070
CHEMBL154412 47311 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 471 6 3 5 3.4 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1)c1cc2ccccc2s1 10.1016/j.bmcl.2003.11.070
44313061 103198 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 449 6 2 7 4.1 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccccc4[N+](=O)[O-])cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL307901 103198 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 449 6 2 7 4.1 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccccc4[N+](=O)[O-])cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
10498644 26577 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 322 4 1 4 3.8 Cc1nc(N2CCCCC2)c2nc(COc3ccccc3)cc-2[nH]1 10.1021/jm000269t
CHEMBL136093 26577 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 322 4 1 4 3.8 Cc1nc(N2CCCCC2)c2nc(COc3ccccc3)cc-2[nH]1 10.1021/jm000269t
44460788 207764 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 458 7 1 6 3.9 CN(CC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1)CC1CC1 10.1016/j.bmcl.2004.03.014
CHEMBL79301 207764 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 458 7 1 6 3.9 CN(CC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1)CC1CC1 10.1016/j.bmcl.2004.03.014
44460922 208397 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 415 6 1 6 3.7 CCOCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(C)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL84269 208397 None 0 Human Binding pIC50 = 7.8 7.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 415 6 1 6 3.7 CCOCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(C)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44573656 187319 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 460 4 0 3 4.2 CS(=O)(=O)N1CC2(CCN(C(=O)Cc3ccc(-c4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL492393 187319 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 460 4 0 3 4.2 CS(=O)(=O)N1CC2(CCN(C(=O)Cc3ccc(-c4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
13152287 208114 None 0 Human Binding pIC50 = 5.8 5.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 282 0 1 4 4.5 Nc1nc2c(s1)-c1ccccc1Sc1ccccc1-2 10.1016/j.bmcl.2004.03.014
CHEMBL81979 208114 None 0 Human Binding pIC50 = 5.8 5.8 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 282 0 1 4 4.5 Nc1nc2c(s1)-c1ccccc1Sc1ccccc1-2 10.1016/j.bmcl.2004.03.014
10303307 64497 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 565 7 2 6 5.8 CN(C)c1nc(NC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181393 64497 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 565 7 2 6 5.8 CN(C)c1nc(NC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
9924211 192752 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 344 1 1 5 3.1 N#Cc1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
CHEMBL521720 192752 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 344 1 1 5 3.1 N#Cc1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
44460707 105877 None 0 Human Binding pIC50 = 7.7 7.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 431 4 1 6 3.7 O=C([C@@H]1CCCO1)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL312710 105877 None 0 Human Binding pIC50 = 7.7 7.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 431 4 1 6 3.7 O=C([C@@H]1CCCO1)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44344454 103491 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 539 9 2 4 5.4 O=S(=O)(NC[C@H]1CC[C@H](CNC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1)c1ccccc1F 10.1021/jm990468g
CHEMBL3084885 103491 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 539 9 2 4 5.4 O=S(=O)(NC[C@H]1CC[C@H](CNC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1)c1ccccc1F 10.1021/jm990468g
10403909 64565 None 0 Mouse Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 323 4 1 5 4.1 N#Cc1cccc(Nc2ncc(C(=O)c3ccccc3F)s2)c1 10.1016/j.bmcl.2005.01.063
CHEMBL181458 64565 None 0 Mouse Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 323 4 1 5 4.1 N#Cc1cccc(Nc2ncc(C(=O)c3ccccc3F)s2)c1 10.1016/j.bmcl.2005.01.063
2350190 51872 None 3 Mouse Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 423 5 1 5 3.5 O=S(=O)(c1ccc2[nH]c(SCc3cccc(Cl)c3)nc2c1)N1CCOCC1 10.1016/j.bmcl.2012.07.020
CHEMBL1585484 51872 None 3 Mouse Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 423 5 1 5 3.5 O=S(=O)(c1ccc2[nH]c(SCc3cccc(Cl)c3)nc2c1)N1CCOCC1 10.1016/j.bmcl.2012.07.020
2350190 51872 None 3 Mouse Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 423 5 1 5 3.5 O=S(=O)(c1ccc2[nH]c(SCc3cccc(Cl)c3)nc2c1)N1CCOCC1 10.1016/j.bmcl.2012.11.005
CHEMBL1585484 51872 None 3 Mouse Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 423 5 1 5 3.5 O=S(=O)(c1ccc2[nH]c(SCc3cccc(Cl)c3)nc2c1)N1CCOCC1 10.1016/j.bmcl.2012.11.005
10805667 28195 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 2 1 3 4.4 Cc1nc2cc(-c3ccccc3)nc-2c(N2CC(C)CC(C)C2)[nH]1 10.1021/jm000269t
CHEMBL137360 28195 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 2 1 3 4.4 Cc1nc2cc(-c3ccccc3)nc-2c(N2CC(C)CC(C)C2)[nH]1 10.1021/jm000269t
44377476 120100 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 477 8 2 4 3.9 Cc1ccc2c(c1)CC(NCC1CN(CCNS(=O)(=O)c3cccc4ccccc34)C1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL350379 120100 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 477 8 2 4 3.9 Cc1ccc2c(c1)CC(NCC1CN(CCNS(=O)(=O)c3cccc4ccccc34)C1)CCC2 10.1016/s0960-894x(02)00002-1
71458602 81373 None 0 Mouse Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 397 5 1 4 3.7 CCCS(=O)(=O)c1ccc2[nH]c(C3CCC(=O)N(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159161 81373 None 0 Mouse Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 397 5 1 4 3.7 CCCS(=O)(=O)c1ccc2[nH]c(C3CCC(=O)N(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
44313576 105542 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 399 3 1 3 5.3 Cc1cc(C(=O)Nc2cccc3c2CCCC3)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL312086 105542 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 399 3 1 3 5.3 Cc1cc(C(=O)Nc2cccc3c2CCCC3)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
9981738 13951 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 424 4 1 5 3.8 N#Cc1ccc(NC(=O)CN2CCC(N3C(=O)OCc4cc(Cl)ccc43)CC2)cc1 10.1021/jm049599u
CHEMBL1196600 13951 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 424 4 1 5 3.8 N#Cc1ccc(NC(=O)CN2CCC(N3C(=O)OCc4cc(Cl)ccc43)CC2)cc1 10.1021/jm049599u
CHEMBL557583 13951 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 424 4 1 5 3.8 N#Cc1ccc(NC(=O)CN2CCC(N3C(=O)OCc4cc(Cl)ccc43)CC2)cc1 10.1021/jm049599u
44580709 193448 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 391 3 1 6 3.4 CCOC(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
CHEMBL524644 193448 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 391 3 1 6 3.4 CCOC(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
18005004 200302 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 495 5 1 6 3.6 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4cccc(OC)c4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL572431 200302 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 495 5 1 6 3.6 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4cccc(OC)c4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
10970192 11036 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 351 2 1 3 4.5 Cc1cccc2c3cc(NC(=O)N4CCOCC4)ccc3n(C(C)C)c12 10.1021/jm011125x
CHEMBL117563 11036 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 351 2 1 3 4.5 Cc1cccc2c3cc(NC(=O)N4CCOCC4)ccc3n(C(C)C)c12 10.1021/jm011125x
10969955 110651 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 343 5 1 3 4.8 CCn1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
CHEMBL325475 110651 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 343 5 1 3 4.8 CCn1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
9862646 163555 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 337 2 1 3 4.2 CC(C)n1c2ccccc2c2cc(NC(=O)N3CCOCC3)ccc21 10.1021/jm011125x
CHEMBL419951 163555 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 337 2 1 3 4.2 CC(C)n1c2ccccc2c2cc(NC(=O)N3CCOCC3)ccc21 10.1021/jm011125x
9908946 199701 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccncc21 10.1016/j.bmcl.2009.07.103
CHEMBL568370 199701 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccncc21 10.1016/j.bmcl.2009.07.103
45487538 201398 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 432 4 1 6 4.2 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4CF)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
CHEMBL584815 201398 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 432 4 1 6 4.2 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4CF)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
9908946 199701 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccncc21 10.1016/j.bmc.2009.08.019
CHEMBL568370 199701 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ccncc21 10.1016/j.bmc.2009.08.019
46226607 202277 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4cccc(F)c4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL594164 202277 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4cccc(F)c4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
18004891 193397 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 428 3 2 4 2.5 CC(=O)c1ccc(NC(=O)N2CCC3(CC2)CN(S(N)(=O)=O)c2ccccc23)cc1 10.1016/j.bmcl.2009.02.035
CHEMBL524029 193397 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 428 3 2 4 2.5 CC(=O)c1ccc(NC(=O)N2CCC3(CC2)CN(S(N)(=O)=O)c2ccccc23)cc1 10.1016/j.bmcl.2009.02.035
9946965 193181 None 0 Human Binding pIC50 = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 360 3 1 4 3.5 N#Cc1ccnc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
CHEMBL522456 193181 None 0 Human Binding pIC50 = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 360 3 1 4 3.5 N#Cc1ccnc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
44461200 104337 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 446 8 2 6 3.3 COCCNCC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL309967 104337 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 446 8 2 6 3.3 COCCNCC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44460988 105683 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 429 4 1 5 4.3 O=C([C@H]1CCCO1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL312362 105683 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 429 4 1 5 4.3 O=C([C@H]1CCCO1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
10111792 106038 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 403 5 1 5 3.7 COCC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL313087 106038 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 403 5 1 5 3.7 COCC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44461051 106184 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 417 6 1 5 4.1 COCCC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL313454 106184 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 417 6 1 5 4.1 COCCC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44461022 168127 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 429 4 1 5 4.3 O=C([C@@H]1CCCO1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL432169 168127 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 429 4 1 5 4.3 O=C([C@@H]1CCCO1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
10272418 208050 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 401 4 1 4 4.7 CC(C)C(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL81484 208050 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 401 4 1 4 4.7 CC(C)C(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
10226374 208062 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 458 5 1 6 3.4 O=C(CN1CCOCC1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL81586 208062 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 458 5 1 6 3.4 O=C(CN1CCOCC1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44460919 208132 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 403 4 2 5 4.8 COC(=O)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL82158 208132 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 403 4 2 5 4.8 COC(=O)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44461180 208417 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 399 4 1 4 4.5 O=C(C1CC1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL84453 208417 None 0 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 399 4 1 4 4.5 O=C(C1CC1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44271276 59975 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 471 5 1 6 3.8 CC(=O)c1cccc(NC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)c1 10.1016/s0960-894x(02)00113-0
CHEMBL17327 59975 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 471 5 1 6 3.8 CC(=O)c1cccc(NC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)c1 10.1016/s0960-894x(02)00113-0
44573705 187674 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4cccnc4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL494592 187674 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4cccnc4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
9930851 199653 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
CHEMBL568144 199653 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
44579888 186978 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 454 2 1 6 5.4 O=C1O[C@]2(CC[C@H](c3nc4cc(-c5noc(C(F)(F)F)n5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
CHEMBL489608 186978 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 454 2 1 6 5.4 O=C1O[C@]2(CC[C@H](c3nc4cc(-c5noc(C(F)(F)F)n5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
9930851 199653 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
CHEMBL568144 199653 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
22660756 202587 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 389 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)on3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL596264 202587 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 389 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)on3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
46226628 203824 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 399 3 1 5 4.3 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccc(-c4ccccc4)cn3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL604480 203824 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 399 3 1 5 4.3 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccc(-c4ccccc4)cn3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
44573705 187674 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4cccnc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL494592 187674 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4cccnc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
11491176 202499 None 36 Rat Binding pIC50 = 8.7 8.7 - 2
Inhibition of rat Y5 receptorInhibition of rat Y5 receptor
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4F)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL595573 202499 None 36 Rat Binding pIC50 = 8.7 8.7 - 2
Inhibition of rat Y5 receptorInhibition of rat Y5 receptor
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4F)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
11407098 202526 None 0 Rat Binding pIC50 = 8.7 8.7 - 0
Inhibition of rat Y5 receptorInhibition of rat Y5 receptor
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccc(F)cc4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL595790 202526 None 0 Rat Binding pIC50 = 8.7 8.7 - 0
Inhibition of rat Y5 receptorInhibition of rat Y5 receptor
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccc(F)cc4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
10662967 25749 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 276 2 1 3 3.3 Cc1nc(N2CC=CC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL135262 25749 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 276 2 1 3 3.3 Cc1nc(N2CC=CC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
44580223 184307 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 399 1 1 6 3.6 O=C1OC2(CCN(c3nc4cc5c(cc4[nH]3)OC(F)(F)O5)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL483244 184307 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 399 1 1 6 3.6 O=C1OC2(CCN(c3nc4cc5c(cc4[nH]3)OC(F)(F)O5)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
45481804 200306 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 468 3 1 5 4.2 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ncc(-c4ccccc4)s3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL572451 200306 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 468 3 1 5 4.2 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ncc(-c4ccccc4)s3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
45487589 199261 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 448 5 1 7 4.0 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4OCF)cn3)CC2)c2ccncc21 10.1016/j.bmcl.2009.07.103
CHEMBL565624 199261 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 448 5 1 7 4.0 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4OCF)cn3)CC2)c2ccncc21 10.1016/j.bmcl.2009.07.103
45487576 201209 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccc(F)cc4)cn3)CC2)c2ccncc21 10.1016/j.bmcl.2009.07.103
CHEMBL583007 201209 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccc(F)cc4)cn3)CC2)c2ccncc21 10.1016/j.bmcl.2009.07.103
45487628 201400 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(F)c4)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
CHEMBL584902 201400 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(F)c4)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
44583506 193482 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)nc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL525173 193482 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)nc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
44579846 187128 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 428 2 1 3 6.6 O=C1O[C@]2(CC[C@H](c3nc4cc(Cl)c(-c5ccccc5)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
CHEMBL490824 187128 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 428 2 1 3 6.6 O=C1O[C@]2(CC[C@H](c3nc4cc(Cl)c(-c5ccccc5)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
44579862 187179 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 410 2 1 5 4.7 COC(=O)c1cc2[nH]c([C@H]3CC[C@@]4(CC3)OC(=O)c3ccccc34)nc2cc1Cl 10.1016/j.bmcl.2008.08.021
CHEMBL491239 187179 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 410 2 1 5 4.7 COC(=O)c1cc2[nH]c([C@H]3CC[C@@]4(CC3)OC(=O)c3ccccc34)nc2cc1Cl 10.1016/j.bmcl.2008.08.021
46226653 202557 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnn(-c4ccccc4)c3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL596025 202557 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnn(-c4ccccc4)c3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
46226580 204312 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL607144 204312 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
15940921 202496 None 0 Rat Binding pIC50 = 8.7 8.7 - 0
Inhibition of rat Y5 receptorInhibition of rat Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL595560 202496 None 0 Rat Binding pIC50 = 8.7 8.7 - 0
Inhibition of rat Y5 receptorInhibition of rat Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
68605776 125515 None 0 Mouse Binding pIC50 = 8.6 8.6 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 386 6 1 4 4.7 N#Cc1ccccc1O[C@H]1CC[C@@H](C(=O)Nc2ccc(OC(F)F)cc2)CC1 nan
CHEMBL3646142 125515 None 0 Mouse Binding pIC50 = 8.6 8.6 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 386 6 1 4 4.7 N#Cc1ccccc1O[C@H]1CC[C@@H](C(=O)Nc2ccc(OC(F)F)cc2)CC1 nan
22934132 207080 None 9 Human Binding pIC50 = 8.6 8.6 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 275 1 1 2 3.9 Cc1ccc2c(c1)-c1nc(-c3cccnc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
CHEMBL7342 207080 None 9 Human Binding pIC50 = 8.6 8.6 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 275 1 1 2 3.9 Cc1ccc2c(c1)-c1nc(-c3cccnc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
45487530 201389 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 432 4 1 6 4.2 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(CF)c4)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
CHEMBL584732 201389 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 432 4 1 6 4.2 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(CF)c4)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
44583557 187855 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 388 2 1 5 3.6 O=C1OC2(CCN(C(=O)Nc3cnn(-c4ccccc4)c3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL495594 187855 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 388 2 1 5 3.6 O=C1OC2(CCN(C(=O)Nc3cnn(-c4ccccc4)c3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
44579810 186972 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 394 2 1 3 6.0 O=C1O[C@]2(CC[C@H](c3nc4cc(-c5ccccc5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
CHEMBL489587 186972 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 394 2 1 3 6.0 O=C1O[C@]2(CC[C@H](c3nc4cc(-c5ccccc5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
15940921 202496 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL595560 202496 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4)n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
44271373 59558 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 460 5 1 7 3.0 COc1ccc(NC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)cn1 10.1016/s0960-894x(02)00113-0
CHEMBL17165 59558 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 460 5 1 7 3.0 COc1ccc(NC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)cn1 10.1016/s0960-894x(02)00113-0
44271317 60431 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 473 6 1 6 3.3 COc1ccc(CNC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)cc1 10.1016/s0960-894x(02)00113-0
CHEMBL17502 60431 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 473 6 1 6 3.3 COc1ccc(CNC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)cc1 10.1016/s0960-894x(02)00113-0
44303643 203600 None 0 Rat Binding pIC50 = 8.6 8.6 - 0
The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratThe compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in rat
ChEMBL 431 6 2 4 5.0 COc1ccc(-c2cc(NC(=O)CC34CCCC3Cc3ccccc3C4)[nH]n2)cc1OC 10.1021/jm980521l
CHEMBL60319 203600 None 0 Rat Binding pIC50 = 8.6 8.6 - 0
The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratThe compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in rat
ChEMBL 431 6 2 4 5.0 COc1ccc(-c2cc(NC(=O)CC34CCCC3Cc3ccccc3C4)[nH]n2)cc1OC 10.1021/jm980521l
12071667 188127 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 395 2 1 4 4.9 O=C1OC2(CCN(c3nc4cc(-c5ccccc5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL497569 188127 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 395 2 1 4 4.9 O=C1OC2(CCN(c3nc4cc(-c5ccccc5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
9825886 200511 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 468 3 1 5 4.2 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4nccs4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL574088 200511 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 468 3 1 5 4.2 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4nccs4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
45481807 200912 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 451 3 1 5 3.2 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL577372 200912 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 451 3 1 5 3.2 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
9887225 187254 None 2 Human Binding pIC50 = 8.6 8.6 - 1
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL491930 187254 None 2 Human Binding pIC50 = 8.6 8.6 - 1
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
44583462 193288 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 418 2 1 5 4.0 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccc(F)cc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL523228 193288 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 418 2 1 5 4.0 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccc(F)cc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
44579825 187176 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 422 3 1 4 5.5 O=C(c1ccccc1)c1ccc2[nH]c([C@H]3CC[C@@]4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.021
CHEMBL491230 187176 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 422 3 1 4 5.5 O=C(c1ccccc1)c1ccc2[nH]c([C@H]3CC[C@@]4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.021
44579826 187204 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 395 2 1 4 5.3 O=C1O[C@]2(CC[C@H](c3nc4cc(-c5ccccn5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
CHEMBL491427 187204 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 395 2 1 4 5.3 O=C1O[C@]2(CC[C@H](c3nc4cc(-c5ccccn5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
46226636 202393 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 389 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)on3)CC2)c2ncccc21 10.1016/j.bmc.2009.08.019
CHEMBL594888 202393 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 389 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)on3)CC2)c2ncccc21 10.1016/j.bmc.2009.08.019
46226627 202426 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccncc21 10.1016/j.bmc.2009.08.019
CHEMBL595121 202426 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccncc21 10.1016/j.bmc.2009.08.019
45481800 200964 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 436 2 1 4 3.6 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc4ncccc4c3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL577794 200964 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 436 2 1 4 3.6 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc4ncccc4c3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
70693071 76942 None 0 Mouse Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 419 3 1 5 3.7 O=c1ccc(-c2nc3cc(S(=O)(=O)C(F)(F)F)ccc3[nH]2)cn1-c1ccccc1 10.1016/j.bmcl.2012.07.020
CHEMBL2070160 76942 None 0 Mouse Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 419 3 1 5 3.7 O=c1ccc(-c2nc3cc(S(=O)(=O)C(F)(F)F)ccc3[nH]2)cn1-c1ccccc1 10.1016/j.bmcl.2012.07.020
9908890 202274 None 0 Rat Binding pIC50 = 8.6 8.6 - 0
Inhibition of rat Y5 receptorInhibition of rat Y5 receptor
ChEMBL 399 3 1 5 4.3 O=C1OC2(CCC(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.08.019
CHEMBL594156 202274 None 0 Rat Binding pIC50 = 8.6 8.6 - 0
Inhibition of rat Y5 receptorInhibition of rat Y5 receptor
ChEMBL 399 3 1 5 4.3 O=C1OC2(CCC(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.08.019
44401616 70055 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(NCC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL193970 70055 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(NCC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
45481641 200304 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 477 4 1 4 4.8 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(Oc4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL572442 200304 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 477 4 1 4 4.8 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(Oc4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
45487632 199295 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 448 5 1 7 4.0 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4OCF)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
CHEMBL565826 199295 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 448 5 1 7 4.0 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4OCF)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
10477251 174745 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 420 1 1 3 6.0 O=C1O[C@]2(CC[C@H](c3nc4cc(Cl)c(C(F)(F)F)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
CHEMBL455815 174745 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 420 1 1 3 6.0 O=C1O[C@]2(CC[C@H](c3nc4cc(Cl)c(C(F)(F)F)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
44271373 59558 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 460 5 1 7 3.0 COc1ccc(NC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)cn1 10.1016/s0960-894x(02)00113-0
CHEMBL17165 59558 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 460 5 1 7 3.0 COc1ccc(NC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)cn1 10.1016/s0960-894x(02)00113-0
44271289 169292 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 493 12 1 5 5.2 CCCCCCCCCCNC(=O)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL440647 169292 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 493 12 1 5 5.2 CCCCCCCCCCNC(=O)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
71519170 86210 None 0 Mouse Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 390 5 1 4 4.3 CCS(=O)(=O)c1ccc2[nH]c(C(=O)c3ccc(-c4ccccc4)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312079 86210 None 0 Mouse Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 390 5 1 4 4.3 CCS(=O)(=O)c1ccc2[nH]c(C(=O)c3ccc(-c4ccccc4)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
20587808 187962 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 377 2 1 6 3.0 COC(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
CHEMBL496327 187962 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 377 2 1 6 3.0 COC(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
18004934 200639 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 427 3 1 4 3.2 CC(=O)c1ccc(NC(=O)N2CCC3(CC2)CN(S(C)(=O)=O)c2ccccc23)cc1 10.1016/j.bmc.2009.05.064
CHEMBL574996 200639 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 427 3 1 4 3.2 CC(=O)c1ccc(NC(=O)N2CCC3(CC2)CN(S(C)(=O)=O)c2ccccc23)cc1 10.1016/j.bmc.2009.05.064
45487631 199263 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccc(F)cc4)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
CHEMBL565626 199263 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccc(F)cc4)cn3)CC2)c2cnccc21 10.1016/j.bmcl.2009.07.103
46226612 204205 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 2 5 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)[nH]n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
CHEMBL606631 204205 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 2 5 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)[nH]n3)CC2)c2cnccc21 10.1016/j.bmc.2009.08.019
10133076 193365 None 2 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 359 3 1 3 4.1 N#Cc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
CHEMBL523819 193365 None 2 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 359 3 1 3 4.1 N#Cc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
70695118 76928 None 0 Mouse Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 380 4 1 3 4.8 CCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3F)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070146 76928 None 0 Mouse Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 380 4 1 3 4.8 CCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3F)nc2c1 10.1016/j.bmcl.2012.07.020
9895868 69604 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL193438 69604 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
9895868 12904 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL1188966 12904 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL537846 12904 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
45481811 200605 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 468 3 1 5 4.2 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4cscn4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL574771 200605 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 468 3 1 5 4.2 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4cscn4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
46226575 204318 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 389 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)on3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
CHEMBL607192 204318 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 389 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)on3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
10314778 63993 None 0 Mouse Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 333 5 1 5 4.6 CCc1ccccc1C(=O)c1cnc(Nc2cccc(C#N)c2)s1 10.1016/j.bmcl.2005.01.063
CHEMBL180692 63993 None 0 Mouse Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 333 5 1 5 4.6 CCc1ccccc1C(=O)c1cnc(Nc2cccc(C#N)c2)s1 10.1016/j.bmcl.2005.01.063
44271355 59672 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 500 4 1 7 4.5 Cc1ccc2nc(NC(=O)C3CCN(C(=O)Cn4c(=O)sc5ccc(Cl)cc54)CC3)sc2c1 10.1016/s0960-894x(02)00113-0
CHEMBL17214 59672 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 500 4 1 7 4.5 Cc1ccc2nc(NC(=O)C3CCN(C(=O)Cn4c(=O)sc5ccc(Cl)cc54)CC3)sc2c1 10.1016/s0960-894x(02)00113-0
71519165 86204 None 0 Mouse Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 378 5 1 4 4.8 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccc(-c4ccccc4)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312073 86204 None 0 Mouse Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 378 5 1 4 4.8 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccc(-c4ccccc4)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
68615948 125504 None 0 Mouse Binding pIC50 = 8.5 8.5 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 431 5 2 5 3.8 N#Cc1ccccc1C(=O)N[C@H]1CC[C@@H](C(=O)Nc2ccn(-c3ccccc3F)n2)CC1 nan
CHEMBL3646131 125504 None 0 Mouse Binding pIC50 = 8.5 8.5 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 431 5 2 5 3.8 N#Cc1ccccc1C(=O)N[C@H]1CC[C@@H](C(=O)Nc2ccn(-c3ccccc3F)n2)CC1 nan
68605737 125512 None 0 Mouse Binding pIC50 = 8.5 8.5 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 397 5 2 5 4.2 O=C(Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@@H](Nc2cccc(F)n2)CC1 nan
CHEMBL3646139 125512 None 0 Mouse Binding pIC50 = 8.5 8.5 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 397 5 2 5 4.2 O=C(Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@@H](Nc2cccc(F)n2)CC1 nan
1562 899 None 11 Human Binding pIC50 = 8.5 8.5 - 2
Compound was tested for human Neuropeptide Y receptor type 5Compound was tested for human Neuropeptide Y receptor type 5
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/s0960-894x(00)00177-3
5312114 899 None 11 Human Binding pIC50 = 8.5 8.5 - 2
Compound was tested for human Neuropeptide Y receptor type 5Compound was tested for human Neuropeptide Y receptor type 5
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/s0960-894x(00)00177-3
CHEMBL17645 899 None 11 Human Binding pIC50 = 8.5 8.5 - 2
Compound was tested for human Neuropeptide Y receptor type 5Compound was tested for human Neuropeptide Y receptor type 5
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/s0960-894x(00)00177-3
CHEMBL195380 899 None 11 Human Binding pIC50 = 8.5 8.5 - 2
Compound was tested for human Neuropeptide Y receptor type 5Compound was tested for human Neuropeptide Y receptor type 5
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/s0960-894x(00)00177-3
45487565 201479 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ncccc21 10.1016/j.bmcl.2009.07.103
CHEMBL585851 201479 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ncccc21 10.1016/j.bmcl.2009.07.103
44583556 187854 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 388 2 1 5 3.6 O=C1OC2(CCN(C(=O)Nc3ccn(-c4ccccc4)n3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL495593 187854 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 388 2 1 5 3.6 O=C1OC2(CCN(C(=O)Nc3ccn(-c4ccccc4)n3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
45487565 201479 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ncccc21 10.1016/j.bmc.2009.08.019
CHEMBL585851 201479 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4)cn3)CC2)c2ncccc21 10.1016/j.bmc.2009.08.019
46226635 202588 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 2 5 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)[nH]n3)CC2)c2ccncc21 10.1016/j.bmc.2009.08.019
CHEMBL596266 202588 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 2 5 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)[nH]n3)CC2)c2ccncc21 10.1016/j.bmc.2009.08.019
1562 899 None 11 Human Binding pIC50 = 8.5 8.5 - 2
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2003.11.070
5312114 899 None 11 Human Binding pIC50 = 8.5 8.5 - 2
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2003.11.070
CHEMBL17645 899 None 11 Human Binding pIC50 = 8.5 8.5 - 2
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2003.11.070
CHEMBL195380 899 None 11 Human Binding pIC50 = 8.5 8.5 - 2
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2003.11.070
9867212 104951 None 0 Rat Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity against rat neuropeptide Y5 receptorIn vitro binding affinity against rat neuropeptide Y5 receptor
ChEMBL 427 4 1 6 3.9 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)[C@H]4CCCO4)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
CHEMBL311229 104951 None 0 Rat Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity against rat neuropeptide Y5 receptorIn vitro binding affinity against rat neuropeptide Y5 receptor
ChEMBL 427 4 1 6 3.9 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)[C@H]4CCCO4)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
44271267 98840 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 473 6 2 6 3.1 O=C(Nc1ccc(CCO)cc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL278280 98840 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 473 6 2 6 3.1 O=C(Nc1ccc(CCO)cc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
60197259 86206 None 1 Mouse Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 379 5 1 5 4.2 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccc(-c4ccccc4)nc3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312075 86206 None 1 Mouse Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 379 5 1 5 4.2 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccc(-c4ccccc4)nc3)nc2c1 10.1016/j.bmcl.2012.11.005
10831203 119517 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 306 3 1 3 4.2 CCc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL345082 119517 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 306 3 1 3 4.2 CCc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
44580745 193518 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 376 2 2 5 2.6 CNC(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
CHEMBL525908 193518 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 376 2 2 5 2.6 CNC(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
44312754 103466 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 493 6 3 6 4.3 Nc1ccccc1S(=O)(=O)NCC1CCC(c2cc(N)n(-c3ccc(C(F)(F)F)cc3)n2)CC1 10.1016/s0960-894x(01)00448-6
CHEMBL3084800 103466 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 493 6 3 6 4.3 Nc1ccccc1S(=O)(=O)NCC1CCC(c2cc(N)n(-c3ccc(C(F)(F)F)cc3)n2)CC1 10.1016/s0960-894x(01)00448-6
22934129 206544 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 261 1 1 2 3.6 c1ccc2c(c1)CCCc1nc(-c3ccncc3)[nH]c1-2 10.1016/s0960-894x(02)00090-2
CHEMBL7017 206544 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 261 1 1 2 3.6 c1ccc2c(c1)CCCc1nc(-c3ccncc3)[nH]c1-2 10.1016/s0960-894x(02)00090-2
44583505 188150 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 468 2 1 5 4.9 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccc(C(F)(F)F)cc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL497644 188150 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 468 2 1 5 4.9 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccc(C(F)(F)F)cc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
44579806 187094 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 343 1 1 4 4.2 N#Cc1ccc2[nH]c([C@H]3CC[C@@]4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.021
CHEMBL490608 187094 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 343 1 1 4 4.2 N#Cc1ccc2[nH]c([C@H]3CC[C@@]4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.021
44460681 207857 None 0 Human Binding pIC50 = 7.7 7.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 453 4 1 4 5.5 O=C(c1ccccc1F)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL80041 207857 None 0 Human Binding pIC50 = 7.7 7.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 453 4 1 4 5.5 O=C(c1ccccc1F)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44461118 208400 None 0 Human Binding pIC50 = 7.7 7.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 451 6 1 5 5.4 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2cc(F)c(Cl)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL84285 208400 None 0 Human Binding pIC50 = 7.7 7.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 451 6 1 5 5.4 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2cc(F)c(Cl)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
10368454 12823 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 457 6 1 5 5.0 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm049599u
CHEMBL1188311 12823 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 457 6 1 5 5.0 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm049599u
CHEMBL536048 12823 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 457 6 1 5 5.0 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm049599u
10872843 102993 None 0 Human Binding pIC50 = 7.7 7.7 - 1
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 390 7 2 3 4.9 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(OCc2ccccc2)cc1 10.1021/jm0004547
CHEMBL306277 102993 None 0 Human Binding pIC50 = 7.7 7.7 - 1
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 390 7 2 3 4.9 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(OCc2ccccc2)cc1 10.1021/jm0004547
10044852 132554 None 0 Mouse Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 373 4 1 5 5.0 N#Cc1cccc(Nc2ncc(C(=O)c3ccccc3C(F)(F)F)s2)c1 10.1016/j.bmcl.2005.01.063
CHEMBL369763 132554 None 0 Mouse Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 373 4 1 5 5.0 N#Cc1cccc(Nc2ncc(C(=O)c3ccccc3C(F)(F)F)s2)c1 10.1016/j.bmcl.2005.01.063
44370240 47865 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 435 6 3 5 2.6 Cc1ccc(S(=O)(=O)NC[C@H]2CC[C@H](C(=O)NNC(=O)c3cccs3)CC2)cc1 10.1016/j.bmcl.2003.11.070
CHEMBL154889 47865 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 435 6 3 5 2.6 Cc1ccc(S(=O)(=O)NC[C@H]2CC[C@H](C(=O)NNC(=O)c3cccs3)CC2)cc1 10.1016/j.bmcl.2003.11.070
18004985 187344 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 460 4 1 3 5.2 CS(=O)(=O)N1C[C@]2(CC[C@@H](C(=O)Nc3ccc(-c4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL492582 187344 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 460 4 1 3 5.2 CS(=O)(=O)N1C[C@]2(CC[C@@H](C(=O)Nc3ccc(-c4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
44271463 60351 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5
ChEMBL 307 6 3 5 3.0 NCCCCNc1nc(N)c2cc(-c3ccccc3)ccc2n1 10.1016/s0960-894x(00)00177-3
CHEMBL17441 60351 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5
ChEMBL 307 6 3 5 3.0 NCCCCNc1nc(N)c2cc(-c3ccccc3)ccc2n1 10.1016/s0960-894x(00)00177-3
71450852 78614 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 490 8 3 5 2.8 N[C@@H](CCCCNS(=O)(=O)c1ccccc1F)C(=O)NC1=NC2CCc3cc(F)ccc3C2C1 10.1016/s0960-894x(99)00676-9
CHEMBL2112218 78614 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 490 8 3 5 2.8 N[C@@H](CCCCNS(=O)(=O)c1ccccc1F)C(=O)NC1=NC2CCc3cc(F)ccc3C2C1 10.1016/s0960-894x(99)00676-9
44460704 208206 None 0 Human Binding pIC50 = 7.7 7.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 429 6 1 6 4.1 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)COC(C)C)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
CHEMBL82710 208206 None 0 Human Binding pIC50 = 7.7 7.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 429 6 1 6 4.1 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)COC(C)C)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
9934437 103495 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 470 9 2 3 5.2 C=CCC1c2ccc(F)cc2CCC1NC[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1021/jm990468g
CHEMBL3084890 103495 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 470 9 2 3 5.2 C=CCC1c2ccc(F)cc2CCC1NC[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1021/jm990468g
11754800 12872 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 441 5 1 5 4.1 CC(=O)c1ccc(NC(=O)CN2CCC(N3C(=O)OCc4cc(Cl)ccc43)CC2)cc1 10.1021/jm049599u
CHEMBL1188721 12872 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 441 5 1 5 4.1 CC(=O)c1ccc(NC(=O)CN2CCC(N3C(=O)OCc4cc(Cl)ccc43)CC2)cc1 10.1021/jm049599u
CHEMBL537191 12872 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 441 5 1 5 4.1 CC(=O)c1ccc(NC(=O)CN2CCC(N3C(=O)OCc4cc(Cl)ccc43)CC2)cc1 10.1021/jm049599u
70697154 76934 None 0 Mouse Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 376 4 1 3 5.0 CCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3C)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070152 76934 None 0 Mouse Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 376 4 1 3 5.0 CCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3C)nc2c1 10.1016/j.bmcl.2012.07.020
44271460 60365 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5
ChEMBL 473 13 2 5 7.1 CCCCN(CCCC)CCCNc1nc(Nc2cccc(C(F)(F)F)c2)c2ccccc2n1 10.1016/s0960-894x(00)00177-3
CHEMBL17450 60365 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5
ChEMBL 473 13 2 5 7.1 CCCCN(CCCC)CCCNc1nc(Nc2cccc(C(F)(F)F)c2)c2ccccc2n1 10.1016/s0960-894x(00)00177-3
44377734 119928 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 491 8 2 4 4.4 O=S(=O)(NCCN1CCC(CNC2CCCc3ccccc3C2)CC1)c1cccc2ccccc12 10.1016/s0960-894x(02)00002-1
CHEMBL348806 119928 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 491 8 2 4 4.4 O=S(=O)(NCCN1CCC(CNC2CCCc3ccccc3C2)CC1)c1cccc2ccccc12 10.1016/s0960-894x(02)00002-1
44460868 168226 None 0 Human Binding pIC50 = 6.7 6.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 513 7 2 6 4.6 CC(C)N1CCN(CC(=O)N[C@H]2CC[C@H](CNc3nc4c(s3)CCCc3ccc(F)cc3-4)CC2)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL432931 168226 None 0 Human Binding pIC50 = 6.7 6.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 513 7 2 6 4.6 CC(C)N1CCN(CC(=O)N[C@H]2CC[C@H](CNc3nc4c(s3)CCCc3ccc(F)cc3-4)CC2)CC1 10.1016/j.bmcl.2004.03.014
1528 630 None 18 Rat Binding pIC50 = 4.7 4.7 - 1
Radioligand binding assay (rat NPY5R, CHO cells)Radioligand binding assay (rat NPY5R, CHO cells)
ChEMBL 529 13 6 4 1.8 O=C([C@H](NC(=O)C(c1ccccc1)c1ccccc1)CCCN=C(N)N)NCc1ccc(cc1)CNC(=O)N 10.6019/CHEMBL5463723
5311022 630 None 18 Rat Binding pIC50 = 4.7 4.7 - 1
Radioligand binding assay (rat NPY5R, CHO cells)Radioligand binding assay (rat NPY5R, CHO cells)
ChEMBL 529 13 6 4 1.8 O=C([C@H](NC(=O)C(c1ccccc1)c1ccccc1)CCCN=C(N)N)NCc1ccc(cc1)CNC(=O)N 10.6019/CHEMBL5463723
CHEMBL1774204 630 None 18 Rat Binding pIC50 = 4.7 4.7 - 1
Radioligand binding assay (rat NPY5R, CHO cells)Radioligand binding assay (rat NPY5R, CHO cells)
ChEMBL 529 13 6 4 1.8 O=C([C@H](NC(=O)C(c1ccccc1)c1ccccc1)CCCN=C(N)N)NCc1ccc(cc1)CNC(=O)N 10.6019/CHEMBL5463723
10451123 105675 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 359 3 1 3 5.0 Cc1cccc(-n2nc(C(=O)Nc3cc(Cl)cc(Cl)c3)cc2C)c1 10.1016/s0960-894x(01)00449-8
CHEMBL312308 105675 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 359 3 1 3 5.0 Cc1cccc(-n2nc(C(=O)Nc3cc(Cl)cc(Cl)c3)cc2C)c1 10.1016/s0960-894x(01)00449-8
44460712 105567 None 0 Human Binding pIC50 = 7.7 7.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 419 6 1 6 3.6 COCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL312169 105567 None 0 Human Binding pIC50 = 7.7 7.7 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 419 6 1 6 3.6 COCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44344259 113156 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 542 11 3 5 3.6 N[C@@H](CCCCNS(=O)(=O)c1ccccc1F)C(=O)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1021/jm990468g
CHEMBL331319 113156 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 542 11 3 5 3.6 N[C@@H](CCCCNS(=O)(=O)c1ccccc1F)C(=O)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1021/jm990468g
9891987 101569 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 495 6 2 6 4.2 O=C(CN1CCC(n2c(O)nc3ccccc32)CC1)NC1CCc2ccccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
CHEMBL298037 101569 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 495 6 2 6 4.2 O=C(CN1CCC(n2c(O)nc3ccccc32)CC1)NC1CCc2ccccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
71519004 86202 None 0 Mouse Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 386 5 1 5 4.0 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccc(OC(F)(F)F)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312071 86202 None 0 Mouse Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 386 5 1 5 4.0 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccc(OC(F)(F)F)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
9949840 28741 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 340 2 1 3 4.5 Cc1nc(N2CCc3ccccc3C2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL137808 28741 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 340 2 1 3 4.5 Cc1nc(N2CCc3ccccc3C2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
10638643 116775 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 309 2 0 4 4.7 Cc1nc(N2CCCCC2)c2sc(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL337305 116775 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 309 2 0 4 4.7 Cc1nc(N2CCCCC2)c2sc(-c3ccccc3)cc2n1 10.1021/jm000269t
10970360 168617 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 357 5 0 3 4.8 CCn1c2ccccc2c2cc(N(C)C(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
CHEMBL435384 168617 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 357 5 0 3 4.8 CCn1c2ccccc2c2cc(N(C)C(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
44390066 63853 None 0 Mouse Binding pIC50 = 5.7 5.7 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 335 5 1 6 4.0 COc1ccc(C(=O)c2cnc(Nc3cccc(C#N)c3)s2)cc1 10.1016/j.bmcl.2005.01.063
CHEMBL180251 63853 None 0 Mouse Binding pIC50 = 5.7 5.7 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 335 5 1 6 4.0 COc1ccc(C(=O)c2cnc(Nc3cccc(C#N)c3)s2)cc1 10.1016/j.bmcl.2005.01.063
11110676 10166 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 343 5 1 3 4.1 CCn1c2ccccc2c2cc(CC(=O)NCc3ccncc3)ccc21 10.1021/jm011125x
CHEMBL115911 10166 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 343 5 1 3 4.1 CCn1c2ccccc2c2cc(CC(=O)NCc3ccncc3)ccc21 10.1021/jm011125x
44313057 103199 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 419 5 3 6 3.8 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccccc4N)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL307902 103199 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 419 5 3 6 3.8 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccccc4N)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
44573614 187314 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cccc(-c4ccncc4)c3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL492375 187314 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cccc(-c4ccncc4)c3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
44573614 187314 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cccc(-c4ccncc4)c3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL492375 187314 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cccc(-c4ccncc4)c3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
44460842 207999 None 0 Human Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 383 6 2 5 3.5 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)cc3)cs2)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL81000 207999 None 0 Human Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 383 6 2 5 3.5 CS(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(-c3ccc(F)cc3)cs2)CC1 10.1016/j.bmcl.2004.03.014
11757324 103473 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 551 10 2 5 5.2 COc1ccc2c(c1)CCC(NC[C@H]1CC[C@H](CNS(=O)(=O)c3ccccc3F)CC1)C2Cc1cccnc1 10.1021/jm990468g
CHEMBL3084865 103473 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 551 10 2 5 5.2 COc1ccc2c(c1)CCC(NC[C@H]1CC[C@H](CNS(=O)(=O)c3ccccc3F)CC1)C2Cc1cccnc1 10.1021/jm990468g
10051835 14014 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 467 4 1 5 4.5 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2=O 10.1021/jm049599u
CHEMBL1197071 14014 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 467 4 1 5 4.5 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2=O 10.1021/jm049599u
CHEMBL559210 14014 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 467 4 1 5 4.5 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2=O 10.1021/jm049599u
10860014 110682 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 315 4 2 2 4.3 O=C(CCc1ccncc1)Nc1ccc2[nH]c3ccccc3c2c1 10.1021/jm011125x
CHEMBL325666 110682 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 315 4 2 2 4.3 O=C(CCc1ccncc1)Nc1ccc2[nH]c3ccccc3c2c1 10.1021/jm011125x
10519375 29399 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 278 2 1 3 3.6 c1ccc(-c2cc3nc[nH]c(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
CHEMBL138383 29399 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 278 2 1 3 3.6 c1ccc(-c2cc3nc[nH]c(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
6324607 194746 None 1 Rat Binding pIC50 = 4.6 4.6 - 0
Radioligand binding assay (rat NPY5R, CHO cells)Radioligand binding assay (rat NPY5R, CHO cells)
ChEMBL 529 13 7 4 2.1 N=C(N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1 10.6019/CHEMBL5463723
CHEMBL5315638 194746 None 1 Rat Binding pIC50 = 4.6 4.6 - 0
Radioligand binding assay (rat NPY5R, CHO cells)Radioligand binding assay (rat NPY5R, CHO cells)
ChEMBL 529 13 7 4 2.1 N=C(N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1 10.6019/CHEMBL5463723
10430847 207172 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 396 3 1 4 5.0 Cc1cc(C(=O)Nc2cccc3ncccc23)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL74161 207172 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 396 3 1 4 5.0 Cc1cc(C(=O)Nc2cccc3ncccc23)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
44313570 169241 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 381 3 1 3 4.7 Cc1cc(C(=O)Nc2c(F)cccc2F)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL440310 169241 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 381 3 1 3 4.7 Cc1cc(C(=O)Nc2c(F)cccc2F)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
9806557 169610 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 515 7 3 4 4.3 O=C(CN1CCC(NC(=O)Nc2ccccc2)CC1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
CHEMBL44338 169610 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 515 7 3 4 4.3 O=C(CN1CCC(NC(=O)Nc2ccccc2)CC1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
10298981 207815 None 0 Human Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 471 5 1 6 3.3 CN1CCN(CC(=O)N2CCC(CNc3nc4c(s3)CCCc3ccc(F)cc3-4)CC2)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL79714 207815 None 0 Human Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 471 5 1 6 3.3 CN1CCN(CC(=O)N2CCC(CNc3nc4c(s3)CCCc3ccc(F)cc3-4)CC2)CC1 10.1016/j.bmcl.2004.03.014
44379363 57567 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 551 11 3 6 4.0 COc1ccc2c(c1)C(O)(CNCCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00018-5
CHEMBL166399 57567 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 551 11 3 6 4.0 COc1ccc2c(c1)C(O)(CNCCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00018-5
10935409 207533 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 298 5 1 2 4.7 CC[C@@H](C)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL77355 207533 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 298 5 1 2 4.7 CC[C@@H](C)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
12078328 118847 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 336 4 1 4 3.8 COc1ccc(Cc2cc3[nH]c(C)nc(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
CHEMBL342042 118847 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 336 4 1 4 3.8 COc1ccc(Cc2cc3[nH]c(C)nc(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
9807658 64567 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 551 8 2 6 6.1 CN(C)c1nc(NC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181466 64567 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 551 8 2 6 6.1 CN(C)c1nc(NC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
44460812 208067 None 0 Human Binding pIC50 = 5.6 5.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 484 7 1 7 4.3 COc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)CCN4CCCCC4)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
CHEMBL81611 208067 None 0 Human Binding pIC50 = 5.6 5.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 484 7 1 7 4.3 COc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)CCN4CCCCC4)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
10111849 207337 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 404 5 2 5 4.2 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccccc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL75823 207337 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 404 5 2 5 4.2 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccccc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
22934130 206420 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 290 2 1 2 4.2 COc1ccc2c(c1)-c1nc(-c3ccccc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
CHEMBL6938 206420 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 290 2 1 2 4.2 COc1ccc2c(c1)-c1nc(-c3ccccc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
71518998 86196 None 0 Mouse Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 330 6 1 4 3.0 CCS(=O)(=O)c1ccc2[nH]c(OCCc3ccccc3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312065 86196 None 0 Mouse Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 330 6 1 4 3.0 CCS(=O)(=O)c1ccc2[nH]c(OCCc3ccccc3)nc2c1 10.1016/j.bmcl.2012.11.005
44460798 104195 None 0 Human Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 434 4 1 6 4.4 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)c4ccccn4)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
CHEMBL309449 104195 None 0 Human Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 434 4 1 6 4.4 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)c4ccccn4)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
44460830 104447 None 0 Human Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 361 6 1 4 4.1 CN(C)C(=O)CCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2004.03.014
CHEMBL310292 104447 None 0 Human Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 361 6 1 4 4.1 CN(C)C(=O)CCCCNc1nc2c(s1)CCCc1ccc(F)cc1-2 10.1016/j.bmcl.2004.03.014
10414854 13184 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 501 4 1 5 5.1 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2=O 10.1021/jm049599u
CHEMBL1190951 13184 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 501 4 1 5 5.1 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2=O 10.1021/jm049599u
CHEMBL541891 13184 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 501 4 1 5 5.1 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2=O 10.1021/jm049599u
9936263 101282 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 513 6 2 6 4.4 O=C(CN1CCC(n2c(O)nc3ccccc32)CC1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
CHEMBL296022 101282 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 513 6 2 6 4.4 O=C(CN1CCC(n2c(O)nc3ccccc32)CC1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
10831332 27999 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 308 2 2 4 2.9 Cc1nc(N2CCC(O)CC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL137236 27999 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 308 2 2 4 2.9 Cc1nc(N2CCC(O)CC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
44580593 187966 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 349 2 1 5 3.2 COc1cccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc12 10.1016/j.bmcl.2008.08.018
CHEMBL496345 187966 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 349 2 1 5 3.2 COc1cccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc12 10.1016/j.bmcl.2008.08.018
10810784 27595 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 360 2 1 3 4.9 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3C(F)(F)F)cc2n1 10.1021/jm000269t
CHEMBL136944 27595 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 360 2 1 3 4.9 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3C(F)(F)F)cc2n1 10.1021/jm000269t
44288067 166456 None 0 Human Binding pIC50 = 4.6 4.6 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 513 9 5 4 3.2 N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N1CCCc2cc(O)ccc2C1 10.1016/s0960-894x(00)00292-4
CHEMBL42747 166456 None 0 Human Binding pIC50 = 4.6 4.6 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 513 9 5 4 3.2 N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N1CCCc2cc(O)ccc2C1 10.1016/s0960-894x(00)00292-4
9799669 208268 None 0 Human Binding pIC50 = 6.6 6.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ responseIn vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ response
ChEMBL 373 3 1 4 4.1 CC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL83255 208268 None 0 Human Binding pIC50 = 6.6 6.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ responseIn vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ response
ChEMBL 373 3 1 4 4.1 CC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
46226642 202242 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 2 5 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)[nH]n3)CC2)c2ncccc21 10.1016/j.bmc.2009.08.019
CHEMBL593935 202242 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 2 5 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)[nH]n3)CC2)c2ncccc21 10.1016/j.bmc.2009.08.019
11753885 12871 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 421 5 1 5 3.8 CC(=O)c1ccc(NC(=O)CN2CCC(N3C(=O)OCc4cc(C)ccc43)CC2)cc1 10.1021/jm049599u
CHEMBL1188718 12871 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 421 5 1 5 3.8 CC(=O)c1ccc(NC(=O)CN2CCC(N3C(=O)OCc4cc(C)ccc43)CC2)cc1 10.1021/jm049599u
CHEMBL537187 12871 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 421 5 1 5 3.8 CC(=O)c1ccc(NC(=O)CN2CCC(N3C(=O)OCc4cc(C)ccc43)CC2)cc1 10.1021/jm049599u
44289890 166303 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 486 7 2 4 3.5 O=C(CN1CC[C@H](NC(=O)c2ccccc2)C1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
CHEMBL42658 166303 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 486 7 2 4 3.5 O=C(CN1CC[C@H](NC(=O)c2ccccc2)C1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
11792487 28716 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 318 4 2 4 4.4 Cc1nc2cc(-c3ccccc3)nc-2c(NCc2ccc(C)o2)[nH]1 10.1021/jm000269t
CHEMBL137786 28716 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 318 4 2 4 4.4 Cc1nc2cc(-c3ccccc3)nc-2c(NCc2ccc(C)o2)[nH]1 10.1021/jm000269t
44288390 161928 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 491 11 5 3 3.5 N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccc(Cl)cc1)C(=O)NCc1ccccc1 10.1016/s0960-894x(00)00292-4
CHEMBL41457 161928 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 491 11 5 3 3.5 N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccc(Cl)cc1)C(=O)NCc1ccccc1 10.1016/s0960-894x(00)00292-4
44313241 207406 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 436 5 2 4 6.2 Cc1cc(C(=O)Nc2ccccc2Nc2ccccc2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL76413 207406 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 436 5 2 4 6.2 Cc1cc(C(=O)Nc2ccccc2Nc2ccccc2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
44344208 13512 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 522 8 2 5 3.0 O=C(CN1CC[C@@H](NS(=O)(=O)c2ccccc2)C1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1021/jm990468g
CHEMBL119355 13512 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 522 8 2 5 3.0 O=C(CN1CC[C@@H](NS(=O)(=O)c2ccccc2)C1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1021/jm990468g
44344455 103492 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 521 9 2 4 5.2 O=S(=O)(NC[C@H]1CC[C@H](CNC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1)c1ccccc1 10.1021/jm990468g
CHEMBL3084886 103492 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 521 9 2 4 5.2 O=S(=O)(NC[C@H]1CC[C@H](CNC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1)c1ccccc1 10.1021/jm990468g
11143423 11647 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 381 4 1 4 4.6 CCOc1c(NC(=O)N2CCOCC2)ccc2c1c1ccccc1n2C(C)C 10.1021/jm011125x
CHEMBL118098 11647 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 381 4 1 4 4.6 CCOc1c(NC(=O)N2CCOCC2)ccc2c1c1ccccc1n2C(C)C 10.1021/jm011125x
44573532 187568 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 392 4 1 4 4.0 COC(=O)c1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
CHEMBL493997 187568 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 392 4 1 4 4.0 COC(=O)c1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
1305 511 None 14 Human Binding pIC50 = 5.6 5.6 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2005.05.121
9934033 511 None 14 Human Binding pIC50 = 5.6 5.6 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2005.05.121
CHEMBL182150 511 None 14 Human Binding pIC50 = 5.6 5.6 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2005.05.121
44370177 169305 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 505 6 3 5 4.1 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(Cl)cc2)CC1)c1cc2ccccc2s1 10.1016/j.bmcl.2003.11.070
CHEMBL440735 169305 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 505 6 3 5 4.1 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(Cl)cc2)CC1)c1cc2ccccc2s1 10.1016/j.bmcl.2003.11.070
10498512 28680 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 4 1 3 4.6 CCCc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL137758 28680 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 4 1 3 4.6 CCCc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
22325323 193519 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 337 1 1 4 3.4 O=C1OC2(CCN(c3nc4cc(F)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL525918 193519 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 337 1 1 4 3.4 O=C1OC2(CCN(c3nc4cc(F)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
10159053 207826 None 1 Human Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 419 6 1 6 3.6 CCOCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL79849 207826 None 1 Human Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 419 6 1 6 3.6 CCOCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44379102 158877 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 529 7 2 7 3.8 COc1ccc2c(c1)C(O)(CNCC1CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC1)CCC2 10.1016/s0960-894x(02)00018-5
CHEMBL409418 158877 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 529 7 2 7 3.8 COc1ccc2c(c1)C(O)(CNCC1CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC1)CCC2 10.1016/s0960-894x(02)00018-5
9892202 172685 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 500 7 2 4 3.9 O=C(CN1CCC(NC(=O)c2ccccc2)CC1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
CHEMBL44886 172685 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 500 7 2 4 3.9 O=C(CN1CCC(NC(=O)c2ccccc2)CC1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
44370266 46276 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 549 6 3 5 4.2 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(Br)cc2)CC1)c1cc2ccccc2s1 10.1016/j.bmcl.2003.11.070
CHEMBL153522 46276 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 549 6 3 5 4.2 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(Br)cc2)CC1)c1cc2ccccc2s1 10.1016/j.bmcl.2003.11.070
10666064 29282 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 321 3 1 4 3.7 CN(C)c1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL138278 29282 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 321 3 1 4 3.7 CN(C)c1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
6324607 194746 None 1 Human Binding pIC50 = 4.6 4.6 - 0
Radioligand binding assay (human NPY5R, HEK293)Radioligand binding assay (human NPY5R, HEK293)
ChEMBL 529 13 7 4 2.1 N=C(N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1 10.6019/CHEMBL5463723
CHEMBL5315638 194746 None 1 Human Binding pIC50 = 4.6 4.6 - 0
Radioligand binding assay (human NPY5R, HEK293)Radioligand binding assay (human NPY5R, HEK293)
ChEMBL 529 13 7 4 2.1 N=C(N)NCCC[C@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(N)=O)cc1 10.6019/CHEMBL5463723
11811424 207433 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 398 6 2 3 4.4 C[C@H]([C@@H](O)c1ccccc1)N(C)/C(=N/c1ccc(Cc2ccccc2)cc1)NC#N 10.1021/jm0004547
CHEMBL76549 207433 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 398 6 2 3 4.4 C[C@H]([C@@H](O)c1ccccc1)N(C)/C(=N/c1ccc(Cc2ccccc2)cc1)NC#N 10.1021/jm0004547
10617383 27229 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 307 3 2 4 3.7 CNc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL136650 27229 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 307 3 2 4 3.7 CNc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
44312955 206955 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 422 5 2 5 4.4 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc(F)cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL72547 206955 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 422 5 2 5 4.4 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc(F)cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
44460883 105682 None 0 Human Binding pIC50 = 7.5 7.5 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 470 6 2 5 5.0 O=C(CN1CCCCC1)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL312361 105682 None 0 Human Binding pIC50 = 7.5 7.5 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 470 6 2 5 5.0 O=C(CN1CCCCC1)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44460964 163734 None 0 Human Binding pIC50 = 6.5 6.5 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 458 8 2 5 4.9 CN(C)CCCC(=O)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL420399 163734 None 0 Human Binding pIC50 = 6.5 6.5 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 458 8 2 5 4.9 CN(C)CCCC(=O)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
10903122 207385 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 314 5 2 3 3.3 COc1ccc(NC(=O)N(C)[C@H](C)[C@@H](O)c2ccccc2)cc1 10.1021/jm0004547
CHEMBL76265 207385 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 314 5 2 3 3.3 COc1ccc(NC(=O)N(C)[C@H](C)[C@@H](O)c2ccccc2)cc1 10.1021/jm0004547
44313494 104804 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 435 5 1 3 6.0 Cc1cc(C(=O)Nc2ccccc2Cc2ccccc2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL310694 104804 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 435 5 1 3 6.0 Cc1cc(C(=O)Nc2ccccc2Cc2ccccc2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
10807285 27763 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 306 2 1 3 4.3 Cc1nc2cc(-c3ccccc3)nc-2c(N2CCCCC2C)[nH]1 10.1021/jm000269t
CHEMBL137058 27763 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 306 2 1 3 4.3 Cc1nc2cc(-c3ccccc3)nc-2c(N2CCCCC2C)[nH]1 10.1021/jm000269t
68595241 125510 None 0 Mouse Binding pIC50 = 8.5 8.5 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 370 4 2 4 4.2 O=C(N[C@H]1CC[C@@H](c2nc(-c3cccc(Cl)c3)c[nH]2)CC1)c1ccon1 nan
CHEMBL3646137 125510 None 0 Mouse Binding pIC50 = 8.5 8.5 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 370 4 2 4 4.2 O=C(N[C@H]1CC[C@@H](c2nc(-c3cccc(Cl)c3)c[nH]2)CC1)c1ccon1 nan
44573743 187795 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)nn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL495200 187795 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)nn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
44573704 193401 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccn4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL524044 193401 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccn4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
18004938 200915 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 483 4 1 5 3.7 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4cccc(F)c4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL577398 200915 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 483 4 1 5 3.7 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4cccc(F)c4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
11824465 10334 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 357 4 1 4 4.4 CC(=O)n1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
CHEMBL116210 10334 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 357 4 1 4 4.4 CC(=O)n1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
9884833 110615 None 33 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 351 2 1 3 4.5 Cc1c(NC(=O)N2CCOCC2)ccc2c1c1ccccc1n2C(C)C 10.1021/jm011125x
CHEMBL325226 110615 None 33 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 351 2 1 3 4.5 Cc1c(NC(=O)N2CCOCC2)ccc2c1c1ccccc1n2C(C)C 10.1021/jm011125x
11002751 168193 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 355 2 1 3 4.4 CC(C)n1c2ccc(F)cc2c2cc(NC(=O)N3CCOCC3)ccc21 10.1021/jm011125x
CHEMBL432628 168193 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 355 2 1 3 4.4 CC(C)n1c2ccc(F)cc2c2cc(NC(=O)N3CCOCC3)ccc21 10.1021/jm011125x
45487608 199302 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4F)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
CHEMBL565848 199302 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4F)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
18004920 187420 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 478 4 2 4 4.1 NS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(Oc4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL492999 187420 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 478 4 2 4 4.1 NS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(Oc4ccccc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
44573743 187795 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)nn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL495200 187795 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccc4)nn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
44573704 193401 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccn4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL524044 193401 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccccn4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
44271565 98184 None 0 Human Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 461 6 3 6 4.3 Nc1nc(N[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 10.1016/j.bmcl.2004.03.014
CHEMBL273597 98184 None 0 Human Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 461 6 3 6 4.3 Nc1nc(N[C@H]2CC[C@H](CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12 10.1016/j.bmcl.2004.03.014
44461196 104799 None 0 Human Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 456 7 1 5 4.4 CN(CC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1)CC1CC1 10.1016/j.bmcl.2004.03.014
CHEMBL310670 104799 None 0 Human Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 456 7 1 5 4.4 CN(CC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1)CC1CC1 10.1016/j.bmcl.2004.03.014
44461199 208011 None 0 Human Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 486 7 1 6 4.2 COC[C@@H]1CCCN1CC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL81103 208011 None 0 Human Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 486 7 1 6 4.2 COC[C@@H]1CCCN1CC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44461018 208338 None 0 Human Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 470 6 2 6 4.0 CN(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL83830 208338 None 0 Human Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 470 6 2 6 4.0 CN(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc3c(s2)CCSc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
1504 2807 None 7 Human Binding pIC50 = 8.5 8.5 -9 10
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL None None None None 10.1021/jm990468g
1518 2807 None 7 Human Binding pIC50 = 8.5 8.5 -9 10
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL None None None None 10.1021/jm990468g
1521 2807 None 7 Human Binding pIC50 = 8.5 8.5 -9 10
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL None None None None 10.1021/jm990468g
24868177 2807 None 7 Human Binding pIC50 = 8.5 8.5 -9 10
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL None None None None 10.1021/jm990468g
44288922 2807 None 7 Human Binding pIC50 = 8.5 8.5 -9 10
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL None None None None 10.1021/jm990468g
77068007 2807 None 7 Human Binding pIC50 = 8.5 8.5 -9 10
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL None None None None 10.1021/jm990468g
90479759 2807 None 7 Human Binding pIC50 = 8.5 8.5 -9 10
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL None None None None 10.1021/jm990468g
CHEMBL438945 2807 None 7 Human Binding pIC50 = 8.5 8.5 -9 10
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL None None None None 10.1021/jm990468g
71458606 81384 None 0 Mouse Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 401 5 1 6 2.9 CCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccc(OC)cc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159172 81384 None 0 Mouse Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 401 5 1 6 2.9 CCS(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccc(OC)cc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
91755093 128562 None 0 Mouse Binding pIC50 = 8.5 8.5 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 370 6 2 6 2.4 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)F)no2)CC1 nan
CHEMBL3666796 128562 None 0 Mouse Binding pIC50 = 8.5 8.5 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 370 6 2 6 2.4 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)F)no2)CC1 nan
45487630 199262 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 448 5 1 7 4.0 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(OCF)c4)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
CHEMBL565625 199262 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 448 5 1 7 4.0 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4cccc(OCF)c4)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
44579827 192814 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 395 2 1 4 5.3 O=C1O[C@]2(CC[C@H](c3nc4cc(-c5cccnc5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
CHEMBL521959 192814 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 395 2 1 4 5.3 O=C1O[C@]2(CC[C@H](c3nc4cc(-c5cccnc5)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
11013840 207526 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 360 6 1 2 5.6 C[C@H](Cc1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL77273 207526 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 360 6 1 2 5.6 C[C@H](Cc1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
45481642 200307 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 451 3 1 5 3.2 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-n4cccn4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL572456 200307 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 451 3 1 5 3.2 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-n4cccn4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
45481801 200795 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 495 5 1 6 3.6 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccc(OC)cc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL576333 200795 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 495 5 1 6 3.6 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccc(OC)cc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
68597664 125507 None 0 Mouse Binding pIC50 = 8.5 8.5 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 412 5 2 7 3.1 CC(C)n1c(=O)oc2cc(NC(=O)[C@H]3CC[C@@H](NC(=O)c4ccon4)CC3)ccc21 nan
CHEMBL3646134 125507 None 0 Mouse Binding pIC50 = 8.5 8.5 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 412 5 2 7 3.1 CC(C)n1c(=O)oc2cc(NC(=O)[C@H]3CC[C@@H](NC(=O)c4ccon4)CC3)ccc21 nan
18004996 200478 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 483 4 1 5 3.7 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccccc4F)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL573858 200478 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 483 4 1 5 3.7 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccccc4F)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
25067562 187077 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 400 2 1 6 4.6 Cc1nnc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)o1 10.1016/j.bmcl.2008.08.021
CHEMBL490427 187077 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 400 2 1 6 4.6 Cc1nnc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)o1 10.1016/j.bmcl.2008.08.021
44271208 163348 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Tested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor at a concentration of 10e-6 MTested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor at a concentration of 10e-6 M
ChEMBL 488 6 2 7 2.5 Cc1cccc(C(O)CNC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)n1 10.1016/s0960-894x(02)00113-0
CHEMBL418546 163348 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Tested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor at a concentration of 10e-6 MTested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor at a concentration of 10e-6 M
ChEMBL 488 6 2 7 2.5 Cc1cccc(C(O)CNC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)n1 10.1016/s0960-894x(02)00113-0
18004890 200341 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 465 4 1 5 3.6 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL572688 200341 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 465 4 1 5 3.6 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
45481805 200837 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 469 3 1 6 3.6 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3nnc(-c4ccccc4)s3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL576726 200837 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 469 3 1 6 3.6 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3nnc(-c4ccccc4)s3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
44583588 193050 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 406 2 1 6 3.9 O=C1OC2(CCN(C(=O)Nc3nnc(-c4ccccc4)s3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL522237 193050 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 406 2 1 6 3.9 O=C1OC2(CCN(C(=O)Nc3nnc(-c4ccccc4)s3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
10110741 188106 None 2 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 387 1 1 4 4.2 O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL497359 188106 None 2 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 387 1 1 4 4.2 O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
44583558 193168 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 388 2 1 5 3.6 O=C1OC2(CCN(C(=O)Nc3cn(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL522378 193168 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 388 2 1 5 3.6 O=C1OC2(CCN(C(=O)Nc3cn(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
91755095 128567 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 369 6 2 5 3.0 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)F)co2)CC1 nan
CHEMBL3666800 128567 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 369 6 2 5 3.0 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)F)co2)CC1 nan
9822252 184221 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 399 2 2 4 3.4 O=C1NC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL482667 184221 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 399 2 2 4 3.4 O=C1NC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
44379085 57196 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 535 8 2 5 3.9 COc1ccc2c(c1)CC(NCC1CCN(C(=O)CNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00018-5
CHEMBL164873 57196 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 535 8 2 5 3.9 COc1ccc2c(c1)CC(NCC1CCN(C(=O)CNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00018-5
71519168 86208 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 384 5 1 4 4.5 CCS(=O)(=O)c1ccc2[nH]c(O[C@H]3CC[C@H](c4ccccc4)CC3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312077 86208 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 384 5 1 4 4.5 CCS(=O)(=O)c1ccc2[nH]c(O[C@H]3CC[C@H](c4ccccc4)CC3)nc2c1 10.1016/j.bmcl.2012.11.005
46912713 125501 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 441 5 2 5 4.0 O=C(N[C@H]1CC[C@@H](C(=O)Nc2ccn(-c3ccccc3F)n2)CC1)c1cccc(Cl)n1 nan
CHEMBL3646128 125501 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 441 5 2 5 4.0 O=C(N[C@H]1CC[C@@H](C(=O)Nc2ccn(-c3ccccc3F)n2)CC1)c1cccc(Cl)n1 nan
44271318 98493 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 504 4 1 7 4.4 O=C(Nc1nc2cc(Cl)ccc2o1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL275642 98493 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 504 4 1 7 4.4 O=C(Nc1nc2cc(Cl)ccc2o1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
45481803 200305 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 469 3 1 5 3.4 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccccc4F)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL572450 200305 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 469 3 1 5 3.4 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccccc4F)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
44583395 187949 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 434 2 1 5 4.5 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccc(Cl)cc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL496197 187949 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 434 2 1 5 4.5 O=C1OC2(CCN(C(=O)Nc3ncc(-c4ccc(Cl)cc4)cn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
11509561 202183 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ncccc21 10.1016/j.bmc.2009.08.019
CHEMBL593466 202183 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ncccc21 10.1016/j.bmc.2009.08.019
10613667 23063 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 293 2 0 4 4.2 Cc1nc(N2CCCCC2)c2oc(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL133032 23063 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 293 2 0 4 4.2 Cc1nc(N2CCCCC2)c2oc(-c3ccccc3)cc2n1 10.1021/jm000269t
10161870 207112 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 463 7 2 7 4.0 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4cccc(N(C)C)c4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL73643 207112 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 463 7 2 7 4.0 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4cccc(N(C)C)c4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
10154767 188379 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 348 3 1 2 4.6 Cc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
CHEMBL499973 188379 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 348 3 1 2 4.6 Cc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
10414311 12816 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 483 4 2 5 4.6 Cc1cccc2c1N(C1CCN(CC(=O)Nc3ccc4c(c3)-c3ccccc3C4O)CC1)C(=O)OC2 10.1021/jm049599u
CHEMBL1188255 12816 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 483 4 2 5 4.6 Cc1cccc2c1N(C1CCN(CC(=O)Nc3ccc4c(c3)-c3ccccc3C4O)CC1)C(=O)OC2 10.1021/jm049599u
CHEMBL535824 12816 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 483 4 2 5 4.6 Cc1cccc2c1N(C1CCN(CC(=O)Nc3ccc4c(c3)-c3ccccc3C4O)CC1)C(=O)OC2 10.1021/jm049599u
44289909 163657 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 482 6 2 5 3.6 CC(C)(C)OC(=O)N[C@@H]1CCN(CC(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)C1 10.1016/s0960-894x(00)00311-5
CHEMBL42031 163657 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 482 6 2 5 3.6 CC(C)(C)OC(=O)N[C@@H]1CCN(CC(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)C1 10.1016/s0960-894x(00)00311-5
44344633 111450 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 330 6 1 3 3.9 O=C(CCc1ccncc1)Nc1ccc(C(=O)c2ccccc2)cc1 10.1021/jm011125x
CHEMBL327151 111450 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 330 6 1 3 3.9 O=C(CCc1ccncc1)Nc1ccc(C(=O)c2ccccc2)cc1 10.1021/jm011125x
44573565 187598 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 349 3 2 3 3.8 Nc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
CHEMBL494174 187598 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 349 3 2 3 3.8 Nc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
10433145 13981 None 1 Rat Binding pIC50 = 6.5 6.5 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 399 4 1 4 3.9 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc(Cl)cc1 10.1021/jm049599u
CHEMBL1196846 13981 None 1 Rat Binding pIC50 = 6.5 6.5 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 399 4 1 4 3.9 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc(Cl)cc1 10.1021/jm049599u
CHEMBL558393 13981 None 1 Rat Binding pIC50 = 6.5 6.5 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 399 4 1 4 3.9 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc(Cl)cc1 10.1021/jm049599u
44401671 70290 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 587 7 1 7 4.9 CN(C)c1nc(NCC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL194173 70290 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 587 7 1 7 4.9 CN(C)c1nc(NCC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
44313039 103209 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 419 5 3 6 3.8 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4cccc(N)c4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL308034 103209 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 419 5 3 6 3.8 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4cccc(N)c4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
44289818 169248 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 515 7 2 4 5.6 O=C(NC[C@H]1CC[C@H](C(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1)Oc1ccccc1 10.1016/s0960-894x(00)00311-5
CHEMBL44036 169248 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 515 7 2 4 5.6 O=C(NC[C@H]1CC[C@H](C(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1)Oc1ccccc1 10.1016/s0960-894x(00)00311-5
11204090 69858 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 587 7 2 7 5.1 CN(C)c1nc(NC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL193771 69858 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 587 7 2 7 5.1 CN(C)c1nc(NC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
70693068 76932 None 0 Mouse Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 396 4 1 3 5.3 CCS(=O)(=O)c1ccc2[nH]c(-c3cc(-c4ccccc4)ccc3Cl)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070150 76932 None 0 Mouse Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 396 4 1 3 5.3 CCS(=O)(=O)c1ccc2[nH]c(-c3cc(-c4ccccc4)ccc3Cl)nc2c1 10.1016/j.bmcl.2012.07.020
44377915 57189 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 497 8 2 4 4.2 O=S(=O)(NCCN1CC(CNC2CCCc3ccc(Cl)cc3C2)C1)c1cccc2ccccc12 10.1016/s0960-894x(02)00002-1
CHEMBL164805 57189 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 497 8 2 4 4.2 O=S(=O)(NCCN1CC(CNC2CCCc3ccc(Cl)cc3C2)C1)c1cccc2ccccc12 10.1016/s0960-894x(02)00002-1
10848957 28496 None 7 Human Binding pIC50 = 5.5 5.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 224 1 2 3 2.5 Cc1nc(N)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL137572 28496 None 7 Human Binding pIC50 = 5.5 5.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 224 1 2 3 2.5 Cc1nc(N)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
10872140 54029 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 361 4 2 2 5.1 O=C(Cc1cccc2ccccc12)Nc1cc(-c2ccc(Cl)cc2)n[nH]1 10.1021/jm025513q
CHEMBL160595 54029 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 361 4 2 2 5.1 O=C(Cc1cccc2ccccc12)Nc1cc(-c2ccc(Cl)cc2)n[nH]1 10.1021/jm025513q
71519000 86198 None 0 Mouse Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 370 4 1 4 4.2 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccccc3C(F)(F)F)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312067 86198 None 0 Mouse Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 370 4 1 4 4.2 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccccc3C(F)(F)F)nc2c1 10.1016/j.bmcl.2012.11.005
10522130 28440 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 318 3 1 3 4.4 c1ccc(-c2cc3nc(C4CC4)[nH]c(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
CHEMBL137530 28440 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 318 3 1 3 4.4 c1ccc(-c2cc3nc(C4CC4)[nH]c(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
22934144 97287 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 275 1 1 2 3.9 Cc1ccc2c(c1)-c1nc(-c3ccccn3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
CHEMBL268654 97287 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 275 1 1 2 3.9 Cc1ccc2c(c1)-c1nc(-c3ccccn3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
44573407 187561 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 334 3 1 2 4.3 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccccc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL493971 187561 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 334 3 1 2 4.3 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccccc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
44390147 122211 None 0 Mouse Binding pIC50 = 7.5 7.5 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 376 5 1 4 5.7 CCc1ccccc1C(=O)c1cnc(Nc2cccc(C(F)(F)F)c2)s1 10.1016/j.bmcl.2005.01.063
CHEMBL359685 122211 None 0 Mouse Binding pIC50 = 7.5 7.5 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 376 5 1 4 5.7 CCc1ccccc1C(=O)c1cnc(Nc2cccc(C(F)(F)F)c2)s1 10.1016/j.bmcl.2005.01.063
44370179 164985 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 421 6 3 5 2.3 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1)c1cccs1 10.1016/j.bmcl.2003.11.070
CHEMBL422150 164985 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 421 6 3 5 2.3 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1)c1cccs1 10.1016/j.bmcl.2003.11.070
10892838 13011 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 329 4 1 3 4.3 Cn1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
CHEMBL118973 13011 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 329 4 1 3 4.3 Cn1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
10522285 116310 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 3 1 3 4.5 CCc1c(-c2ccccc2)[nH]c2c(N3CCCCC3)nc(C)nc12 10.1021/jm000269t
CHEMBL335861 116310 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 3 1 3 4.5 CCc1c(-c2ccccc2)[nH]c2c(N3CCCCC3)nc(C)nc12 10.1021/jm000269t
23283651 103482 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 583 10 2 5 6.3 COc1ccc2c(c1)CCC(NC[C@H]1CC[C@H](CNS(=O)(=O)c3ccc4ccccc4c3)CC1)C2Cc1cccnc1 10.1021/jm990468g
CHEMBL3084875 103482 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 583 10 2 5 6.3 COc1ccc2c(c1)CCC(NC[C@H]1CC[C@H](CNS(=O)(=O)c3ccc4ccccc4c3)CC1)C2Cc1cccnc1 10.1021/jm990468g
11014171 104158 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 372 4 1 2 5.5 CN(C(=O)Nc1ccc(Oc2ccccc2)cc1)C1CCc2ccccc2C1 10.1021/jm0004547
CHEMBL309370 104158 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 372 4 1 2 5.5 CN(C(=O)Nc1ccc(Oc2ccccc2)cc1)C1CCc2ccccc2C1 10.1021/jm0004547
11067876 11045 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 343 5 1 3 4.1 CCn1c2ccccc2c2cc(CNC(=O)Cc3ccncc3)ccc21 10.1021/jm011125x
CHEMBL117626 11045 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 343 5 1 3 4.1 CCn1c2ccccc2c2cc(CNC(=O)Cc3ccncc3)ccc21 10.1021/jm011125x
136058111 205979 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 499 7 2 5 4.4 COc1ccc2c(c1)CCC1N=C(NC[C@H]3CC[C@H](CNS(=O)(=O)c4ccccc4F)CC3)CC21 10.1016/s0960-894x(99)00676-9
CHEMBL66371 205979 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 499 7 2 5 4.4 COc1ccc2c(c1)CCC1N=C(NC[C@H]3CC[C@H](CNS(=O)(=O)c4ccccc4F)CC3)CC21 10.1016/s0960-894x(99)00676-9
11078514 207449 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 346 6 1 2 5.2 CN(CCc1ccccc1)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL76661 207449 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 346 6 1 2 5.2 CN(CCc1ccccc1)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
11003942 110454 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 402 3 1 5 2.3 CN(C)S(=O)(=O)n1c2ccccc2c2cc(NC(=O)N3CCOCC3)ccc21 10.1021/jm011125x
CHEMBL324366 110454 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 402 3 1 5 2.3 CN(C)S(=O)(=O)n1c2ccccc2c2cc(NC(=O)N3CCOCC3)ccc21 10.1021/jm011125x
44344734 112962 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 348 6 1 4 4.0 O=C(CSc1ccncc1)Nc1ccc(C(=O)c2ccccc2)cc1 10.1021/jm011125x
CHEMBL331019 112962 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 348 6 1 4 4.0 O=C(CSc1ccncc1)Nc1ccc(C(=O)c2ccccc2)cc1 10.1021/jm011125x
44573607 192981 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 336 3 1 4 3.0 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ncccn3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL522192 192981 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 336 3 1 4 3.0 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ncccn3)=N2)cc1 10.1016/j.bmcl.2009.01.101
44313274 207183 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 395 3 1 3 5.6 Cc1cc(C(=O)Nc2cccc3ccccc23)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL74252 207183 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 395 3 1 3 5.6 Cc1cc(C(=O)Nc2cccc3ccccc23)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
44313223 102947 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 423 3 1 3 5.2 Cc1cc(C(=O)Nc2cccc(Br)c2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL305922 102947 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 423 3 1 3 5.2 Cc1cc(C(=O)Nc2cccc(Br)c2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
9903829 116745 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 280 4 1 3 3.7 CCN(CC)c1[nH]c(C)nc2cc(-c3ccccc3)nc1-2 10.1021/jm000269t
CHEMBL337152 116745 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 280 4 1 3 3.7 CCN(CC)c1[nH]c(C)nc2cc(-c3ccccc3)nc1-2 10.1021/jm000269t
22325346 173170 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 333 1 1 4 3.5 Cc1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
CHEMBL451955 173170 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 333 1 1 4 3.5 Cc1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
9806525 100308 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 514 8 2 4 3.8 O=C(Cc1ccccc1)NC1CCN(CC(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1 10.1016/s0960-894x(00)00311-5
CHEMBL288763 100308 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 514 8 2 4 3.8 O=C(Cc1ccccc1)NC1CCN(CC(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1 10.1016/s0960-894x(00)00311-5
22325338 193501 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 349 2 1 5 3.2 COc1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
CHEMBL525543 193501 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 349 2 1 5 3.2 COc1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
44313042 170173 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 434 6 2 6 4.2 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4cccc(C)c4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL444319 170173 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 434 6 2 6 4.2 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4cccc(C)c4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
44312926 207078 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 438 6 2 6 4.1 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4ccc(F)cc4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL73401 207078 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 438 6 2 6 4.1 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4ccc(F)cc4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
44460713 208060 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 405 5 1 6 3.2 COCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL81551 208060 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 405 5 1 6 3.2 COCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
9805850 166240 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 496 6 2 5 4.0 CC(C)(C)OC(=O)NC1CCN(CC(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1 10.1016/s0960-894x(00)00311-5
CHEMBL42620 166240 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 496 6 2 5 4.0 CC(C)(C)OC(=O)NC1CCN(CC(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1 10.1016/s0960-894x(00)00311-5
21336511 57199 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 476 8 2 3 5.3 O=S(=O)(NC[C@H]1CC[C@@H](CNCC2CCc3ccccc3C2)CC1)c1cccc2ccccc12 10.1016/s0960-894x(02)00002-1
CHEMBL164897 57199 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 476 8 2 3 5.3 O=S(=O)(NC[C@H]1CC[C@@H](CNCC2CCc3ccccc3C2)CC1)c1cccc2ccccc12 10.1016/s0960-894x(02)00002-1
44461145 207851 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 435 6 1 5 4.9 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2cc(F)c(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL80006 207851 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 435 6 1 5 4.9 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2cc(F)c(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
70684602 76936 None 0 Mouse Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 363 4 1 4 4.1 CCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)n3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070154 76936 None 0 Mouse Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 363 4 1 4 4.1 CCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)n3)nc2c1 10.1016/j.bmcl.2012.07.020
10832634 28180 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 328 2 1 3 4.2 Cc1nc(N2CCCCC2)c2[nH]c(-c3c(F)cccc3F)cc2n1 10.1021/jm000269t
CHEMBL137350 28180 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 328 2 1 3 4.2 Cc1nc(N2CCCCC2)c2[nH]c(-c3c(F)cccc3F)cc2n1 10.1021/jm000269t
11825270 207413 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 388 7 1 2 6.2 CC(C)C(Cc1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL76439 207413 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 388 7 1 2 6.2 CC(C)C(Cc1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
25881665 179951 None 4 Mouse Binding pIC50 = 5.4 5.4 - 0
Allosteric antagonist activity at NPY5R in mouse descending colon mucosa assessed as reduction in rPP-induced ion transport by electrophysiologyAllosteric antagonist activity at NPY5R in mouse descending colon mucosa assessed as reduction in rPP-induced ion transport by electrophysiology
ChEMBL 397 3 1 7 1.8 CS(=O)(=O)N1CCCC[C@H]1C(=O)Nc1nc2cc3c(cc2s1)OCCO3 10.1021/acs.jmedchem.0c02000
CHEMBL4745232 179951 None 4 Mouse Binding pIC50 = 5.4 5.4 - 0
Allosteric antagonist activity at NPY5R in mouse descending colon mucosa assessed as reduction in rPP-induced ion transport by electrophysiologyAllosteric antagonist activity at NPY5R in mouse descending colon mucosa assessed as reduction in rPP-induced ion transport by electrophysiology
ChEMBL 397 3 1 7 1.8 CS(=O)(=O)N1CCCC[C@H]1C(=O)Nc1nc2cc3c(cc2s1)OCCO3 10.1021/acs.jmedchem.0c02000
25881665 179951 None 4 Mouse Binding pIC50 = 5.4 5.4 - 0
Allosteric antagonist activity at NPY5R in mouse descending colon mucosa assessed as reduction in rPP-induced ion transport by electrophysiologyAllosteric antagonist activity at NPY5R in mouse descending colon mucosa assessed as reduction in rPP-induced ion transport by electrophysiology
ChEMBL 397 3 1 7 1.8 CS(=O)(=O)N1CCCC[C@H]1C(=O)Nc1nc2cc3c(cc2s1)OCCO3 10.1021/acs.jmedchem.0c02000
CHEMBL4745232 179951 None 4 Mouse Binding pIC50 = 5.4 5.4 - 0
Allosteric antagonist activity at NPY5R in mouse descending colon mucosa assessed as reduction in rPP-induced ion transport by electrophysiologyAllosteric antagonist activity at NPY5R in mouse descending colon mucosa assessed as reduction in rPP-induced ion transport by electrophysiology
ChEMBL 397 3 1 7 1.8 CS(=O)(=O)N1CCCC[C@H]1C(=O)Nc1nc2cc3c(cc2s1)OCCO3 10.1021/acs.jmedchem.0c02000
70693069 76935 None 0 Mouse Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 376 4 1 3 5.0 CCS(=O)(=O)c1ccc2[nH]c(-c3cc(-c4ccccc4)ccc3C)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070153 76935 None 0 Mouse Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 376 4 1 3 5.0 CCS(=O)(=O)c1ccc2[nH]c(-c3cc(-c4ccccc4)ccc3C)nc2c1 10.1016/j.bmcl.2012.07.020
135430853 102132 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 451 6 2 4 4.3 O=S(=O)(NC[C@H]1CC[C@H](CNC2=NC3CCc4ccccc4C3C2)CC1)c1ccccc1 10.1016/s0960-894x(99)00676-9
CHEMBL1744020 102132 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 451 6 2 4 4.3 O=S(=O)(NC[C@H]1CC[C@H](CNC2=NC3CCc4ccccc4C3C2)CC1)c1ccccc1 10.1016/s0960-894x(99)00676-9
CHEMBL302126 102132 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 451 6 2 4 4.3 O=S(=O)(NC[C@H]1CC[C@H](CNC2=NC3CCc4ccccc4C3C2)CC1)c1ccccc1 10.1016/s0960-894x(99)00676-9
44377452 120223 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 521 9 2 5 4.4 COc1ccc2c(c1)CC(CNC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL351508 120223 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 521 9 2 5 4.4 COc1ccc2c(c1)CC(CNC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
44579807 193387 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 352 1 1 3 4.9 O=C1O[C@]2(CC[C@H](c3nc4cc(Cl)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
CHEMBL523964 193387 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 352 1 1 3 4.9 O=C1O[C@]2(CC[C@H](c3nc4cc(Cl)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
44573646 187373 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 360 3 1 4 3.5 N#Cc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)n1 10.1016/j.bmcl.2009.01.101
CHEMBL492766 187373 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 360 3 1 4 3.5 N#Cc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)n1 10.1016/j.bmcl.2009.01.101
44289827 165730 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 499 7 2 3 5.2 O=C(NC[C@H]1CC[C@H](C(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1)c1ccccc1 10.1016/s0960-894x(00)00311-5
CHEMBL42437 165730 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 499 7 2 3 5.2 O=C(NC[C@H]1CC[C@H](C(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)CC1)c1ccccc1 10.1016/s0960-894x(00)00311-5
10052377 12831 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 483 6 1 5 4.8 Cc1cccc2c1N(C1CCN(CC(=O)Nc3ccc(C(=O)c4ccccc4)cc3)CC1)C(=O)OC2 10.1021/jm049599u
CHEMBL1188389 12831 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 483 6 1 5 4.8 Cc1cccc2c1N(C1CCN(CC(=O)Nc3ccc(C(=O)c4ccccc4)cc3)CC1)C(=O)OC2 10.1021/jm049599u
CHEMBL536276 12831 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 483 6 1 5 4.8 Cc1cccc2c1N(C1CCN(CC(=O)Nc3ccc(C(=O)c4ccccc4)cc3)CC1)C(=O)OC2 10.1021/jm049599u
11035908 14032 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 365 2 1 3 4.9 Cc1cc2c(c(C)c1NC(=O)N1CCOCC1)c1ccccc1n2C(C)C 10.1021/jm011125x
CHEMBL119726 14032 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 365 2 1 3 4.9 Cc1cc2c(c(C)c1NC(=O)N1CCOCC1)c1ccccc1n2C(C)C 10.1021/jm011125x
44390162 64372 None 0 Mouse Binding pIC50 = 6.4 6.4 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 382 4 1 5 5.8 Cc1cc(C(=O)c2cnc(Nc3cccc(C(F)(F)F)c3)s2)c(C)s1 10.1016/j.bmcl.2005.01.063
CHEMBL181250 64372 None 0 Mouse Binding pIC50 = 6.4 6.4 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 382 4 1 5 5.8 Cc1cc(C(=O)c2cnc(Nc3cccc(C(F)(F)F)c3)s2)c(C)s1 10.1016/j.bmcl.2005.01.063
18004995 187412 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 454 2 2 3 3.6 NS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL492986 187412 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 454 2 2 3 3.6 NS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
44461006 104213 None 0 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 443 4 1 6 3.8 O=C1CC[C@H](C(=O)N2CCC(CNc3nc4c(s3)CCCc3ccc(F)cc3-4)CC2)O1 10.1016/j.bmcl.2004.03.014
CHEMBL309550 104213 None 0 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 443 4 1 6 3.8 O=C1CC[C@H](C(=O)N2CCC(CNc3nc4c(s3)CCCc3ccc(F)cc3-4)CC2)O1 10.1016/j.bmcl.2004.03.014
44460920 164788 None 0 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 416 5 1 5 3.7 CN(C)CC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL421714 164788 None 0 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 416 5 1 5 3.7 CN(C)CC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
10139215 208126 None 0 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 456 5 1 5 4.6 O=C(CN1CCCCC1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL82080 208126 None 0 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 456 5 1 5 4.6 O=C(CN1CCCCC1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
10111791 208342 None 0 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 403 4 1 5 4.7 CCOC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL83860 208342 None 0 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 403 4 1 5 4.7 CCOC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
101138140 104940 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 421 7 2 5 5.0 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2cccc([N+](=O)[O-])c2)cc1 10.1021/jm0004547
10982716 104940 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 421 7 2 5 5.0 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2cccc([N+](=O)[O-])c2)cc1 10.1021/jm0004547
CHEMBL311159 104940 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 421 7 2 5 5.0 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2cccc([N+](=O)[O-])c2)cc1 10.1021/jm0004547
10959710 207531 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 374 4 2 3 5.2 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc2oc3ccccc3c2c1 10.1021/jm0004547
CHEMBL77333 207531 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 374 4 2 3 5.2 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc2oc3ccccc3c2c1 10.1021/jm0004547
71519166 86205 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 379 5 1 5 4.2 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccc(-c4ccccn4)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312074 86205 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 379 5 1 5 4.2 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccc(-c4ccccn4)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
46912902 125502 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 416 5 2 2 5.4 O=C(N[C@H]1CC[C@@H](C(=O)Nc2cccc(-c3ccccc3F)c2)CC1)c1ccccc1 nan
CHEMBL3646129 125502 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 416 5 2 2 5.4 O=C(N[C@H]1CC[C@@H](C(=O)Nc2cccc(-c3ccccc3F)c2)CC1)c1ccccc1 nan
68604357 125505 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 407 5 2 4 4.4 O=C(N[C@H]1CC[C@@H](C(=O)Nc2cccc(-c3ccccc3F)c2)CC1)c1ccon1 nan
CHEMBL3646132 125505 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 407 5 2 4 4.4 O=C(N[C@H]1CC[C@@H](C(=O)Nc2cccc(-c3ccccc3F)c2)CC1)c1ccon1 nan
9890550 193285 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccncc4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL523205 193285 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccncc4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
45481795 200740 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 483 4 1 5 3.7 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccc(F)cc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL575858 200740 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 483 4 1 5 3.7 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccc(F)cc4)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
9890550 193285 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccncc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL523205 193285 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 462 3 1 4 4.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccncc4)cc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
9840567 205131 None 0 Rat Binding pIC50 = 8.4 8.4 - 0
The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratThe compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in rat
ChEMBL 332 3 0 2 5.2 Cc1cc(N2CCCC2)cc(/C=C/c2cccc(C(F)(F)F)c2)n1 10.1021/jm980521l
CHEMBL61488 205131 None 0 Rat Binding pIC50 = 8.4 8.4 - 0
The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratThe compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in rat
ChEMBL 332 3 0 2 5.2 Cc1cc(N2CCCC2)cc(/C=C/c2cccc(C(F)(F)F)c2)n1 10.1021/jm980521l
45481808 200782 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 451 3 1 4 4.3 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccco4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL576159 200782 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 451 3 1 4 4.3 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-c4ccco4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
9887226 202560 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
CHEMBL596031 202560 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 400 3 1 6 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
10018851 63891 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 319 4 1 5 4.3 Cc1ccccc1C(=O)c1cnc(Nc2cccc(C#N)c2)s1 10.1016/j.bmcl.2005.01.063
CHEMBL180359 63891 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 319 4 1 5 4.3 Cc1ccccc1C(=O)c1cnc(Nc2cccc(C#N)c2)s1 10.1016/j.bmcl.2005.01.063
89973939 128563 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 383 5 2 5 3.4 CC(C)(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)F)co2)CC1 nan
CHEMBL3666797 128563 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.Binding Assay: cDNA sequence encoding a mouse NPY Y5 receptor (Biochim. Biophys. Acta 1328:83-89, 1997) was cloned in a vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 8957). The obtained expression vector was transfected into CHO cells as a host by using Lipofect AMINE reagent (Trademark, Gico BRL Co., Ltd.) according to the instruction manual. The cells that stably express NPY Y5 receptor were obtained.The membranes prepared from the CHO cells expressing NPY Y5 receptor, the compound of this invention and 30,000 cpm [125I] peptide YY (60 pM of final concentration: Healthcare) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours, and then the membrane was filtered from the mixture through a glass filter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was quantified with a gamma counter.
ChEMBL 383 5 2 5 3.4 CC(C)(C)S(=O)(=O)NC[C@H]1CC[C@H](Nc2nc(C(F)(F)F)co2)CC1 nan
56836045 81376 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 399 3 1 5 3.7 CC(C)(C)S(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159164 81376 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 399 3 1 5 3.7 CC(C)(C)S(=O)(=O)c1ccc2[nH]c(N3CCOC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
9923839 187146 None 1 Human Binding pIC50 = 8.4 8.4 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 336 3 1 4 3.0 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cnccn3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL490937 187146 None 1 Human Binding pIC50 = 8.4 8.4 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 336 3 1 4 3.0 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cnccn3)=N2)cc1 10.1016/j.bmcl.2009.01.101
10293081 187347 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 379 4 1 4 4.2 O=[N+]([O-])c1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
CHEMBL492594 187347 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 379 4 1 4 4.2 O=[N+]([O-])c1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
71518999 86197 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 366 6 1 4 3.5 CCS(=O)(=O)c1ccc2[nH]c(OCC(F)(F)c3ccccc3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312066 86197 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 366 6 1 4 3.5 CCS(=O)(=O)c1ccc2[nH]c(OCC(F)(F)c3ccccc3)nc2c1 10.1016/j.bmcl.2012.11.005
9952231 202276 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4)n3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
CHEMBL594163 202276 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4)n3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
44271377 59275 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Tested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptorTested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor
ChEMBL 429 4 1 5 3.6 O=C(Nc1ccccc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL17037 59275 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Tested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptorTested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor
ChEMBL 429 4 1 5 3.6 O=C(Nc1ccccc1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
46912987 125503 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 421 5 2 5 4.1 CC(C)n1c(=O)oc2cc(NC(=O)[C@H]3CC[C@@H](NC(=O)c4ccccc4)CC3)ccc21 nan
CHEMBL3646130 125503 None 0 Mouse Binding pIC50 = 8.4 8.4 - 0
Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.Binding Assay: cDNA sequence encoding mouse NPY Y5 receptor (Biochem. Biophys. Acta 1328: 83-89, 1997) was cloned in the expression vector (pME18S, Takebe et al. Mol. Cell. Biol. 8, 466-472). The obtained expression vector was transfected into CHO cells as a host according to the instruction manual using Lipofectamine reagent (Trademark, Gibco BRL Co., Ltd.). The cells that stably express NPY Y5 receptor were obtained.The membrane samples prepared from the CHO cells expressing NPY Y5 receptor, the compound of the invention and 30,000 cpm 125I peptide YY (60 pM of final concentration: Amersham) were incubated in the assay buffer (20 mM HEPES-Hanks buffer containing 0.1% bovine serum albumin, pH 7.4) at 25° C. for 2 hours. The membrane samples were then filtered from the mixture through a glassfilter (GF/C) presoaked with 1% polyethyleneimine. After washing with 50 mM Tris-HCl buffer (pH 7.4), radioactivity retained on the filters was determined using gamma counter.
ChEMBL 421 5 2 5 4.1 CC(C)n1c(=O)oc2cc(NC(=O)[C@H]3CC[C@@H](NC(=O)c4ccccc4)CC3)ccc21 nan
45487629 201481 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 448 5 1 7 4.0 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4OCF)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
CHEMBL585854 201481 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 448 5 1 7 4.0 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccccc4OCF)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
44579863 187206 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 410 2 1 5 4.7 COC(=O)c1ccc2[nH]c([C@H]3CC[C@@]4(CC3)OC(=O)c3ccccc34)nc2c1Cl 10.1016/j.bmcl.2008.08.021
CHEMBL491436 187206 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 410 2 1 5 4.7 COC(=O)c1ccc2[nH]c([C@H]3CC[C@@]4(CC3)OC(=O)c3ccccc34)nc2c1Cl 10.1016/j.bmcl.2008.08.021
20629114 73473 None 42 Mouse Binding pIC50 = 8.3 8.3 - 1
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 407 4 2 4 3.3 CC(C)(C)S(=O)(=O)N[C@H]1CC[C@H](C(=O)Nc2ccc(C(F)(F)F)cn2)CC1 10.1016/j.bmcl.2012.09.025
CHEMBL2016681 73473 None 42 Mouse Binding pIC50 = 8.3 8.3 - 1
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 407 4 2 4 3.3 CC(C)(C)S(=O)(=O)N[C@H]1CC[C@H](C(=O)Nc2ccc(C(F)(F)F)cn2)CC1 10.1016/j.bmcl.2012.09.025
20629114 73473 None 42 Mouse Binding pIC50 = 8.3 8.3 - 1
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 407 4 2 4 3.3 CC(C)(C)S(=O)(=O)N[C@H]1CC[C@H](C(=O)Nc2ccc(C(F)(F)F)cn2)CC1 10.1016/j.bmcl.2012.11.005
CHEMBL2016681 73473 None 42 Mouse Binding pIC50 = 8.3 8.3 - 1
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 407 4 2 4 3.3 CC(C)(C)S(=O)(=O)N[C@H]1CC[C@H](C(=O)Nc2ccc(C(F)(F)F)cn2)CC1 10.1016/j.bmcl.2012.11.005
9952232 202425 None 0 Rat Binding pIC50 = 8.3 8.3 - 0
Inhibition of rat Y5 receptorInhibition of rat Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnn(-c4ccccc4)c3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
CHEMBL595120 202425 None 0 Rat Binding pIC50 = 8.3 8.3 - 0
Inhibition of rat Y5 receptorInhibition of rat Y5 receptor
ChEMBL 388 3 1 6 3.5 O=C1O[C@]2(CC[C@H](C(=O)Nc3cnn(-c4ccccc4)c3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
44271284 58106 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 459 4 2 6 3.6 Cc1cc(O)ccc1NC(=O)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL16740 58106 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 459 4 2 6 3.6 Cc1cc(O)ccc1NC(=O)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
44271318 98493 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 504 4 1 7 4.4 O=C(Nc1nc2cc(Cl)ccc2o1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL275642 98493 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 504 4 1 7 4.4 O=C(Nc1nc2cc(Cl)ccc2o1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
22325320 184311 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 355 1 1 4 3.5 O=C1OC2(CCN(c3nc4cc(F)c(F)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL483252 184311 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 355 1 1 4 3.5 O=C1OC2(CCN(c3nc4cc(F)c(F)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
44573648 172865 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 360 3 1 4 3.5 N#Cc1cc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)ccn1 10.1016/j.bmcl.2009.01.101
CHEMBL451113 172865 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 360 3 1 4 3.5 N#Cc1cc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)ccn1 10.1016/j.bmcl.2009.01.101
10273149 187628 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 412 3 1 2 5.0 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccc(Br)c3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL494398 187628 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 412 3 1 2 5.0 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccc(Br)c3)=N2)cc1 10.1016/j.bmcl.2009.01.101
45481797 200781 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 495 5 1 6 3.6 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccccc4OC)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL576158 200781 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 495 5 1 6 3.6 CCS(=O)(=O)N1CC2(CCN(C(=O)Nc3cn(-c4ccccc4OC)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
44401508 69843 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 433 10 2 6 3.6 CCCCS(=O)(=O)NCC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1 10.1016/j.bmcl.2005.03.052
CHEMBL193666 69843 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 433 10 2 6 3.6 CCCCS(=O)(=O)NCC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1 10.1016/j.bmcl.2005.03.052
56835976 81189 None 0 Mouse Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 398 5 1 5 3.2 CCCS(=O)(=O)c1ccc2[nH]c(N3CCN(C)C(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2158014 81189 None 0 Mouse Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 398 5 1 5 3.2 CCCS(=O)(=O)c1ccc2[nH]c(N3CCN(C)C(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
44344629 110397 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 365 2 1 4 3.6 O=C(Nc1ccc2c(c1)c1ccccc1n2C1CCOC1)N1CCOCC1 10.1021/jm011125x
CHEMBL324028 110397 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 365 2 1 4 3.6 O=C(Nc1ccc2c(c1)c1ccccc1n2C1CCOC1)N1CCOCC1 10.1021/jm011125x
44312981 206885 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 418 5 2 5 4.5 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc(C)cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL72133 206885 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 418 5 2 5 4.5 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc(C)cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
44461040 207782 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 421 4 1 5 4.3 CC(C)C(=O)N1CCC(CNc2nc3c(s2)CCOc2cc(F)c(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL79500 207782 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 421 4 1 5 4.3 CC(C)C(=O)N1CCC(CNc2nc3c(s2)CCOc2cc(F)c(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
9867212 104951 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ responseIn vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ response
ChEMBL 427 4 1 6 3.9 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)[C@H]4CCCO4)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
CHEMBL311229 104951 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ responseIn vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ response
ChEMBL 427 4 1 6 3.9 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)[C@H]4CCCO4)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
44344352 103483 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 535 8 2 4 4.8 O=C(NC1CCc2cc(F)ccc2C1Cc1cccnc1)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1021/jm990468g
CHEMBL3084876 103483 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 535 8 2 4 4.8 O=C(NC1CCc2cc(F)ccc2C1Cc1cccnc1)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1021/jm990468g
70695119 76931 None 0 Mouse Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 396 4 1 3 5.3 CCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3Cl)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070149 76931 None 0 Mouse Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 396 4 1 3 5.3 CCS(=O)(=O)c1ccc2[nH]c(-c3cccc(-c4ccccc4)c3Cl)nc2c1 10.1016/j.bmcl.2012.07.020
10715854 28293 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 361 3 1 4 4.6 c1ccc(-c2cc3nc(N4CCCCC4)nc(N4CCCCC4)c3[nH]2)cc1 10.1021/jm000269t
CHEMBL137428 28293 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 361 3 1 4 4.6 c1ccc(-c2cc3nc(N4CCCCC4)nc(N4CCCCC4)c3[nH]2)cc1 10.1021/jm000269t
10667094 116861 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 337 5 2 5 2.7 Cc1nc(NCCN2CCOCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL337815 116861 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 337 5 2 5 2.7 Cc1nc(NCCN2CCOCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
70695117 76921 None 0 Mouse Binding pIC50 = 5.4 5.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 376 5 1 3 5.1 CCCS(=O)(=O)c1ccc2[nH]c(-c3ccccc3-c3ccccc3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070139 76921 None 0 Mouse Binding pIC50 = 5.4 5.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 376 5 1 3 5.1 CCCS(=O)(=O)c1ccc2[nH]c(-c3ccccc3-c3ccccc3)nc2c1 10.1016/j.bmcl.2012.07.020
10642181 165257 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 322 3 1 4 3.9 COc1ccc(-c2cc3[nH]c(C)nc(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
CHEMBL422816 165257 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 322 3 1 4 3.9 COc1ccc(-c2cc3[nH]c(C)nc(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
45481643 200512 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 452 3 1 6 2.6 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-n4nccn4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL574089 200512 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 452 3 1 6 2.6 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(-n4nccn4)cc3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
44460789 207765 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 460 5 1 7 2.9 O=C(CN1CCOCC1)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL79302 207765 None 0 Human Binding pIC50 = 7.4 7.4 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 460 5 1 7 2.9 O=C(CN1CCOCC1)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44401460 70931 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 391 7 2 6 2.5 CN(C)c1nc(NCC2CCC(CNS(C)(=O)=O)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL195123 70931 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 391 7 2 6 2.5 CN(C)c1nc(NCC2CCC(CNS(C)(=O)=O)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
71519001 86199 None 0 Mouse Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 370 4 1 4 4.2 CCS(=O)(=O)c1ccc2[nH]c(Oc3cccc(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312068 86199 None 0 Mouse Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 370 4 1 4 4.2 CCS(=O)(=O)c1ccc2[nH]c(Oc3cccc(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.11.005
44370176 51607 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 485 6 3 5 3.8 Cc1ccc(S(=O)(=O)NC[C@H]2CC[C@H](C(=O)NNC(=O)c3cc4ccccc4s3)CC2)cc1 10.1016/j.bmcl.2003.11.070
CHEMBL158344 51607 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 485 6 3 5 3.8 Cc1ccc(S(=O)(=O)NC[C@H]2CC[C@H](C(=O)NNC(=O)c3cc4ccccc4s3)CC2)cc1 10.1016/j.bmcl.2003.11.070
10644957 119401 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 368 3 1 3 5.6 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)c(-c3ccccc3)c2n1 10.1021/jm000269t
CHEMBL344228 119401 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 368 3 1 3 5.6 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)c(-c3ccccc3)c2n1 10.1021/jm000269t
10421577 206354 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 235 2 1 2 3.4 Cc1[nH]c(-c2ccccc2)nc1-c1cccnc1 10.1016/s0960-894x(02)00090-2
CHEMBL6893 206354 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 235 2 1 2 3.4 Cc1[nH]c(-c2ccccc2)nc1-c1cccnc1 10.1016/s0960-894x(02)00090-2
44573616 193221 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 461 3 1 3 4.7 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccccc3-c3ccccc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL522702 193221 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 461 3 1 3 4.7 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccccc3-c3ccccc3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
44313596 105912 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 429 4 1 4 5.4 Cc1cc(C(=O)Nc2cccc(OC(F)(F)F)c2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL312748 105912 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 429 4 1 4 5.4 Cc1cc(C(=O)Nc2cccc(OC(F)(F)F)c2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
44312927 103138 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 421 6 2 7 3.3 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4ccccn4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL307462 103138 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 421 6 2 7 3.3 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4ccccn4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
10497816 27696 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 310 2 1 3 4.1 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3F)cc2n1 10.1021/jm000269t
CHEMBL137008 27696 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 310 2 1 3 4.1 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3F)cc2n1 10.1021/jm000269t
44573531 193308 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 376 4 1 3 4.5 CC(=O)c1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
CHEMBL523364 193308 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 376 4 1 3 4.5 CC(=O)c1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
70693067 76924 None 0 Mouse Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 368 4 1 3 4.4 CCCS(=O)(=O)c1ccc2[nH]c(-c3cccc(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070142 76924 None 0 Mouse Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 368 4 1 3 4.4 CCCS(=O)(=O)c1ccc2[nH]c(-c3cccc(C(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.07.020
11110677 11052 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 343 5 1 3 4.8 CCn1c2ccccc2c2cccc(NC(=O)CCc3ccncc3)c21 10.1021/jm011125x
CHEMBL117684 11052 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 343 5 1 3 4.8 CCn1c2ccccc2c2cccc(NC(=O)CCc3ccncc3)c21 10.1021/jm011125x
23283666 103481 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 582 10 2 4 6.9 COc1ccc2c(c1)CCC(NC[C@H]1CC[C@H](CNS(=O)(=O)c3ccc4ccccc4c3)CC1)C2Cc1ccccc1 10.1021/jm990468g
CHEMBL3084874 103481 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 582 10 2 4 6.9 COc1ccc2c(c1)CCC(NC[C@H]1CC[C@H](CNS(=O)(=O)c3ccc4ccccc4c3)CC1)C2Cc1ccccc1 10.1021/jm990468g
11727519 53788 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Inhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 339 6 2 2 4.7 O=C(CCCc1ccccc1)Nc1cc(-c2ccc(Cl)cc2)n[nH]1 10.1021/jm025513q
CHEMBL160389 53788 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Inhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 339 6 2 2 4.7 O=C(CCCc1ccccc1)Nc1cc(-c2ccc(Cl)cc2)n[nH]1 10.1021/jm025513q
10596340 115557 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 350 2 1 3 4.7 Cc1nc(N2CCCCC2)c2[nH]c(C34C[C@H]5C[C@@H](C3)C[C@@H](C4)C5)cc2n1 10.1021/jm000269t
CHEMBL335145 115557 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 350 2 1 3 4.7 Cc1nc(N2CCCCC2)c2[nH]c(C34C[C@H]5C[C@@H](C3)C[C@@H](C4)C5)cc2n1 10.1021/jm000269t
44377450 55594 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 521 9 2 5 4.4 COc1ccc2c(c1)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL162093 55594 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 521 9 2 5 4.4 COc1ccc2c(c1)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
44579809 193383 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 396 1 1 3 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(Br)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
CHEMBL523943 193383 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 396 1 1 3 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(Br)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
18735143 163595 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 482 6 2 5 3.6 CC(C)(C)OC(=O)NC1CCN(CC(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)C1 10.1016/s0960-894x(00)00311-5
CHEMBL42020 163595 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 482 6 2 5 3.6 CC(C)(C)OC(=O)NC1CCN(CC(=O)NC2CCc3cc(F)ccc3C2Cc2cccnc2)C1 10.1016/s0960-894x(00)00311-5
10429613 163434 None 0 Human Binding pIC50 = 7.4 7.4 - 1
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 376 6 2 3 5.1 C[C@H]([C@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL419086 163434 None 0 Human Binding pIC50 = 7.4 7.4 - 1
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 376 6 2 3 5.1 C[C@H]([C@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
11001068 207528 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 300 4 3 3 3.0 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(O)cc1 10.1021/jm0004547
CHEMBL77311 207528 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 300 4 3 3 3.0 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(O)cc1 10.1021/jm0004547
22934131 97090 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 279 1 1 2 3.8 Fc1ccc2c(c1)-c1nc(-c3ccccn3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
CHEMBL266904 97090 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 279 1 1 2 3.8 Fc1ccc2c(c1)-c1nc(-c3ccccn3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
10833009 28343 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 334 4 1 3 4.8 CC(C)Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL137464 28343 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 334 4 1 3 4.8 CC(C)Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
44390369 64631 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 629 9 1 7 5.9 CN(C)c1nc(NCC2CCC(CN(C)S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181727 64631 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 629 9 1 7 5.9 CN(C)c1nc(NCC2CCC(CN(C)S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
70695116 76920 None 0 Mouse Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 300 4 1 3 3.4 CCCS(=O)(=O)c1ccc2[nH]c(-c3ccccc3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070138 76920 None 0 Mouse Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 300 4 1 3 3.4 CCCS(=O)(=O)c1ccc2[nH]c(-c3ccccc3)nc2c1 10.1016/j.bmcl.2012.07.020
10005032 59240 None 0 Human Binding pIC50 = 7.3 7.3 - 1
Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5
ChEMBL 472 8 2 3 5.9 O=S(=O)(NC[C@H]1CC[C@H](CNCc2ccc3ccccc3c2)CC1)c1ccc2ccccc2c1 10.1016/s0960-894x(00)00177-3
CHEMBL17022 59240 None 0 Human Binding pIC50 = 7.3 7.3 - 1
Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5Compound was tested for its affinity to bind with Neuropeptide Y receptor type 5
ChEMBL 472 8 2 3 5.9 O=S(=O)(NC[C@H]1CC[C@H](CNCc2ccc3ccccc3c2)CC1)c1ccc2ccccc2c1 10.1016/s0960-894x(00)00177-3
44579808 173464 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 386 1 1 3 5.3 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
CHEMBL452726 173464 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 386 1 1 3 5.3 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
9967563 187761 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 336 3 1 4 3.0 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cncnc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL495036 187761 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 336 3 1 4 3.0 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cncnc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
11002935 52087 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 361 4 2 2 5.1 O=C(Cc1ccc2ccccc2c1)Nc1cc(-c2ccc(Cl)cc2)n[nH]1 10.1021/jm025513q
CHEMBL158732 52087 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 361 4 2 2 5.1 O=C(Cc1ccc2ccccc2c1)Nc1cc(-c2ccc(Cl)cc2)n[nH]1 10.1021/jm025513q
44370214 47021 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 547 9 3 5 5.7 CC(C)c1cc(C(C)C)c(S(=O)(=O)NC[C@H]2CC[C@H](C(=O)NNC(=O)c3cccs3)CC2)c(C(C)C)c1 10.1016/j.bmcl.2003.11.070
CHEMBL154168 47021 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 547 9 3 5 5.7 CC(C)c1cc(C(C)C)c(S(=O)(=O)NC[C@H]2CC[C@H](C(=O)NNC(=O)c3cccs3)CC2)c(C(C)C)c1 10.1016/j.bmcl.2003.11.070
10517831 115420 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 293 2 1 4 3.3 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)nc2n1 10.1021/jm000269t
CHEMBL334960 115420 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 293 2 1 4 3.3 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)nc2n1 10.1021/jm000269t
44390499 129725 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 579 8 2 6 6.0 CN(C)c1nc(NCC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL367355 129725 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 579 8 2 6 6.0 CN(C)c1nc(NCC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
10496226 28094 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 324 3 1 4 4.3 CSc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL137296 28094 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 324 3 1 4 4.3 CSc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
44313099 103135 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 470 6 2 6 5.1 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4cccc5ccccc45)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL307458 103135 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 470 6 2 6 5.1 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4cccc5ccccc45)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
44370215 169158 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 455 6 3 5 2.9 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(Cl)cc2)CC1)c1cccs1 10.1016/j.bmcl.2003.11.070
CHEMBL439638 169158 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 455 6 3 5 2.9 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(Cl)cc2)CC1)c1cccs1 10.1016/j.bmcl.2003.11.070
71519332 86211 None 0 Mouse Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 412 5 1 3 5.2 CCS(=O)(=O)c1ccc2[nH]c(C(F)(F)c3ccc(-c4ccccc4)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312080 86211 None 0 Mouse Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 412 5 1 3 5.2 CCS(=O)(=O)c1ccc2[nH]c(C(F)(F)c3ccc(-c4ccccc4)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
44287999 162582 None 0 Human Binding pIC50 = 4.3 4.3 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 471 11 4 3 3.2 C[C@@H](NC(=O)C(CCCN=C(N)N)NC(=O)C(c1ccccc1)c1ccccc1)c1ccccc1 10.1016/s0960-894x(00)00292-4
CHEMBL41673 162582 None 0 Human Binding pIC50 = 4.3 4.3 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 471 11 4 3 3.2 C[C@@H](NC(=O)C(CCCN=C(N)N)NC(=O)C(c1ccccc1)c1ccccc1)c1ccccc1 10.1016/s0960-894x(00)00292-4
44312707 207405 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 461 7 2 6 4.8 CNc1cc(-c2ccc(NS(=O)(=O)c3ccc(N(C)C)cc3)cc2)nn1-c1ccc(C)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL76411 207405 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 461 7 2 6 4.8 CNc1cc(-c2ccc(NS(=O)(=O)c3ccc(N(C)C)cc3)cc2)nn1-c1ccc(C)cc1 10.1016/s0960-894x(01)00448-6
44580504 193289 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 333 2 1 4 3.2 O=C1OC2(CCN(Cc3nc4ccccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL523235 193289 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 333 2 1 4 3.2 O=C1OC2(CCN(Cc3nc4ccccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
45481806 200308 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 460 2 1 5 3.8 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3nc4cc(Cl)ccc4o3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL572460 200308 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 460 2 1 5 3.8 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3nc4cc(Cl)ccc4o3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
18004942 187622 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 420 2 2 3 2.9 NS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccccc3Cl)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL494346 187622 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 420 2 2 3 2.9 NS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccccc3Cl)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
44460453 104230 None 0 Human Binding pIC50 = 8.3 8.3 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 431 4 1 6 3.7 O=C([C@H]1CCCO1)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL309685 104230 None 0 Human Binding pIC50 = 8.3 8.3 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 431 4 1 6 3.7 O=C([C@H]1CCCO1)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
9867212 104951 None 0 Human Binding pIC50 = 8.3 8.3 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 427 4 1 6 3.9 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)[C@H]4CCCO4)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
CHEMBL311229 104951 None 0 Human Binding pIC50 = 8.3 8.3 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 427 4 1 6 3.9 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)[C@H]4CCCO4)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
44461116 107192 None 0 Human Binding pIC50 = 8.3 8.3 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 399 4 1 5 4.4 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)C(C)C)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
CHEMBL316153 107192 None 0 Human Binding pIC50 = 8.3 8.3 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 399 4 1 5 4.4 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)C(C)C)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
44460972 207850 None 0 Human Binding pIC50 = 8.3 8.3 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 413 4 1 4 5.0 O=C1CCCN1[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL80003 207850 None 0 Human Binding pIC50 = 8.3 8.3 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 413 4 1 4 5.0 O=C1CCCN1[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44344468 103494 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 468 9 3 4 4.7 C=CCC1c2ccc(O)cc2CCC1NC[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1021/jm990468g
CHEMBL3084889 103494 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 468 9 3 4 4.7 C=CCC1c2ccc(O)cc2CCC1NC[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1021/jm990468g
44344599 110449 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 522 8 2 5 3.0 O=C(CN1CC[C@H](NS(=O)(=O)c2ccccc2)C1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1021/jm990468g
CHEMBL324311 110449 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 522 8 2 5 3.0 O=C(CN1CC[C@H](NS(=O)(=O)c2ccccc2)C1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1021/jm990468g
11133371 207609 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 410 6 2 3 5.7 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccc(Cl)cc2)cc1 10.1021/jm0004547
CHEMBL78109 207609 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 410 6 2 3 5.7 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccc(Cl)cc2)cc1 10.1021/jm0004547
44579887 193202 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 400 2 1 6 4.6 Cc1nc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)no1 10.1016/j.bmcl.2008.08.021
CHEMBL522589 193202 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 400 2 1 6 4.6 Cc1nc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)no1 10.1016/j.bmcl.2008.08.021
11792636 29102 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 4 1 3 4.0 Cc1nc(N2CCCCC2)c2nc(CCc3ccccc3)cc-2[nH]1 10.1021/jm000269t
CHEMBL138118 29102 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 4 1 3 4.0 Cc1nc(N2CCCCC2)c2nc(CCc3ccccc3)cc-2[nH]1 10.1021/jm000269t
45481799 200510 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 436 2 1 4 3.6 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cnc4ccccc4c3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL574085 200510 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 436 2 1 4 3.6 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3cnc4ccccc4c3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
46226606 204300 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 2 5 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)[nH]n3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
CHEMBL607088 204300 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from human recombinant Y5 receptorDisplacement of [125I]PYY from human recombinant Y5 receptor
ChEMBL 388 3 2 5 3.7 O=C1O[C@]2(CC[C@H](C(=O)Nc3cc(-c4ccccc4)[nH]n3)CC2)c2cccnc21 10.1016/j.bmc.2009.08.019
9947469 187374 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 368 3 1 2 4.9 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccc(Cl)c3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL492778 187374 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 368 3 1 2 4.9 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccc(Cl)c3)=N2)cc1 10.1016/j.bmcl.2009.01.101
23442561 67580 None 0 Mouse Binding pIC50 = 8.3 8.3 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 433 9 2 6 3.6 Cc1ccccc1C(=O)c1cnc(NCCCNS(=O)(=O)c2cccc(F)c2)s1 10.1016/j.bmcl.2005.05.009
CHEMBL189810 67580 None 0 Mouse Binding pIC50 = 8.3 8.3 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 433 9 2 6 3.6 Cc1ccccc1C(=O)c1cnc(NCCCNS(=O)(=O)c2cccc(F)c2)s1 10.1016/j.bmcl.2005.05.009
22325333 184433 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 387 1 1 4 4.5 O=C1OC2(CCN(c3nc4c(Cl)cc(Cl)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL484268 184433 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 387 1 1 4 4.5 O=C1OC2(CCN(c3nc4c(Cl)cc(Cl)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
9866472 187978 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 414 2 1 5 3.8 O=C1Cc2ccccc2C2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)O1 10.1016/j.bmcl.2009.05.013
CHEMBL496393 187978 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 414 2 1 5 3.8 O=C1Cc2ccccc2C2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)O1 10.1016/j.bmcl.2009.05.013
22934124 161869 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 260 1 1 1 4.2 c1ccc(-c2nc3c([nH]2)-c2ccccc2CCC3)cc1 10.1016/s0960-894x(02)00090-2
CHEMBL414020 161869 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 260 1 1 1 4.2 c1ccc(-c2nc3c([nH]2)-c2ccccc2CCC3)cc1 10.1016/s0960-894x(02)00090-2
25211875 192758 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 400 2 1 7 3.5 Cn1nnc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)n1 10.1016/j.bmcl.2008.08.021
CHEMBL521750 192758 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 400 2 1 7 3.5 Cn1nnc(-c2ccc3[nH]c([C@H]4CC[C@@]5(CC4)OC(=O)c4ccccc45)nc3c2)n1 10.1016/j.bmcl.2008.08.021
10098098 12930 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 481 4 1 5 4.8 Cc1cccc2c1N(C1CCN(CC(=O)Nc3ccc4c(c3)-c3ccccc3C4=O)CC1)C(=O)OC2 10.1021/jm049599u
CHEMBL1189130 12930 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 481 4 1 5 4.8 Cc1cccc2c1N(C1CCN(CC(=O)Nc3ccc4c(c3)-c3ccccc3C4=O)CC1)C(=O)OC2 10.1021/jm049599u
CHEMBL538079 12930 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 481 4 1 5 4.8 Cc1cccc2c1N(C1CCN(CC(=O)Nc3ccc4c(c3)-c3ccccc3C4=O)CC1)C(=O)OC2 10.1021/jm049599u
9984570 13088 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 496 5 1 5 5.7 CCn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5cccc(C)c54)CC3)ccc21 10.1021/jm049599u
CHEMBL1190216 13088 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 496 5 1 5 5.7 CCn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5cccc(C)c54)CC3)ccc21 10.1021/jm049599u
CHEMBL540365 13088 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 496 5 1 5 5.7 CCn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5cccc(C)c54)CC3)ccc21 10.1021/jm049599u
44580546 188239 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 337 1 1 4 3.4 O=C1OC2(CCN(c3nc4c(F)cccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL498396 188239 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 337 1 1 4 3.4 O=C1OC2(CCN(c3nc4c(F)cccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
10981271 207566 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 360 6 1 2 5.6 C[C@@H](Cc1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL77719 207566 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 360 6 1 2 5.6 C[C@@H](Cc1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
11068838 103635 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 376 6 2 3 5.1 C[C@@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL308625 103635 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 376 6 2 3 5.1 C[C@@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
22325347 188191 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 353 1 1 4 3.9 O=C1OC2(CCN(c3nc4c(Cl)cccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL497972 188191 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 353 1 1 4 3.9 O=C1OC2(CCN(c3nc4c(Cl)cccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
44573534 193188 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 364 4 1 3 4.3 COc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
CHEMBL522513 193188 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 364 4 1 3 4.3 COc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
10640471 29165 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 334 3 1 4 4.1 CC(=O)c1c(-c2ccccc2)[nH]c2c(N3CCCCC3)nc(C)nc12 10.1021/jm000269t
CHEMBL138172 29165 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 334 3 1 4 4.1 CC(=O)c1c(-c2ccccc2)[nH]c2c(N3CCCCC3)nc(C)nc12 10.1021/jm000269t
9905079 28532 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 318 4 1 4 4.1 Cc1nc2cc(-c3ccccc3)nc-2c(N(C)Cc2ccco2)[nH]1 10.1021/jm000269t
CHEMBL137613 28532 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 318 4 1 4 4.1 Cc1nc2cc(-c3ccccc3)nc-2c(N(C)Cc2ccco2)[nH]1 10.1021/jm000269t
44263876 97064 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 276 2 1 2 3.9 COc1ccc2c(c1)-c1nc(-c3ccccc3)[nH]c1CC2 10.1016/s0960-894x(02)00090-2
CHEMBL266637 97064 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 276 2 1 2 3.9 COc1ccc2c(c1)-c1nc(-c3ccccc3)[nH]c1CC2 10.1016/s0960-894x(02)00090-2
44377691 57162 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 506 8 3 5 4.0 Nc1ccc2c(c1)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL164586 57162 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 506 8 3 5 4.0 Nc1ccc2c(c1)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
9871208 178789 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 516 7 2 5 4.2 O=C(CN1CCC(NC(=O)Oc2ccccc2)CC1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
CHEMBL46799 178789 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 516 7 2 5 4.2 O=C(CN1CCC(NC(=O)Oc2ccccc2)CC1)NC1CCc2cc(F)ccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
44313224 103081 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 379 3 1 3 5.1 Cc1cc(C(=O)Nc2cccc(Cl)c2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL306993 103081 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 379 3 1 3 5.1 Cc1cc(C(=O)Nc2cccc(Cl)c2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
10572176 28188 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 349 4 1 4 3.8 Cc1nc2cc(-c3ccccc3)nc-2c(N2CCCCC2CN(C)C)[nH]1 10.1021/jm000269t
CHEMBL137356 28188 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 349 4 1 4 3.8 Cc1nc2cc(-c3ccccc3)nc-2c(N2CCCCC2CN(C)C)[nH]1 10.1021/jm000269t
10688707 28291 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 306 2 1 3 4.2 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)c(C)c2n1 10.1021/jm000269t
CHEMBL137427 28291 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 306 2 1 3 4.2 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)c(C)c2n1 10.1021/jm000269t
9889267 98932 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 436 4 1 7 3.1 O=C(Nc1nccs1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00018-5
CHEMBL279073 98932 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 436 4 1 7 3.1 O=C(Nc1nccs1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00018-5
44344283 12957 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 507 13 2 5 4.9 COc1ccc2c(c1)CCC(NCCCCCCNS(=O)(=O)c1ccccc1)C2Cc1cccnc1 10.1021/jm990468g
CHEMBL118931 12957 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 507 13 2 5 4.9 COc1ccc2c(c1)CCC(NCCCCCCNS(=O)(=O)c1ccccc1)C2Cc1cccnc1 10.1021/jm990468g
9889267 98932 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Tested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptorTested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor
ChEMBL 436 4 1 7 3.1 O=C(Nc1nccs1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
CHEMBL279073 98932 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Tested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptorTested for the inhibition of [125I]PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor
ChEMBL 436 4 1 7 3.1 O=C(Nc1nccs1)C1CCN(C(=O)Cn2c(=O)sc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(02)00113-0
136058109 102210 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 485 6 2 4 4.9 O=S(=O)(NC[C@H]1CC[C@H](CNC2=NC3CCc4cc(Cl)ccc4C3C2)CC1)c1ccccc1 10.1016/s0960-894x(99)00676-9
CHEMBL302584 102210 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 485 6 2 4 4.9 O=S(=O)(NC[C@H]1CC[C@H](CNC2=NC3CCc4cc(Cl)ccc4C3C2)CC1)c1ccccc1 10.1016/s0960-894x(99)00676-9
22054806 187560 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 298 3 1 2 4.0 c1ccc(C2=NC(c3ccccc3)(c3ccccc3)CN2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL493970 187560 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 298 3 1 2 4.0 c1ccc(C2=NC(c3ccccc3)(c3ccccc3)CN2)cc1 10.1016/j.bmcl.2009.01.101
9902517 187599 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 340 3 1 3 4.3 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccs3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL494175 187599 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 340 3 1 3 4.3 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccs3)=N2)cc1 10.1016/j.bmcl.2009.01.101
10437616 60531 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 516 5 1 5 6.0 CCn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5c(Cl)cccc54)CC3)ccc21 10.1021/jm049599u
CHEMBL175657 60531 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 516 5 1 5 6.0 CCn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5c(Cl)cccc54)CC3)ccc21 10.1021/jm049599u
CHEMBL557817 60531 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 516 5 1 5 6.0 CCn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5c(Cl)cccc54)CC3)ccc21 10.1021/jm049599u
10590336 119471 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 300 3 2 3 4.7 Cc1nc(Nc2ccccc2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL344692 119471 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 300 3 2 3 4.7 Cc1nc(Nc2ccccc2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
10518886 119487 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 308 3 1 4 3.6 COc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL344844 119487 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 308 3 1 4 3.6 COc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
44377722 57211 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 535 10 2 5 4.6 COc1ccc2c(c1)CC(CNCCN1CCC(CNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL164971 57211 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 535 10 2 5 4.6 COc1ccc2c(c1)CC(CNCCN1CCC(CNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
10254802 127292 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 485 5 1 6 5.2 COc1cccc2c1N(C1CCN(CC(=O)Nc3ccc4oc5ccccc5c4c3)CC1)C(=O)OC2 10.1021/jm049599u
CHEMBL365777 127292 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 485 5 1 6 5.2 COc1cccc2c1N(C1CCN(CC(=O)Nc3ccc4oc5ccccc5c4c3)CC1)C(=O)OC2 10.1021/jm049599u
44580748 187997 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 412 3 2 6 2.6 CS(=O)(=O)Nc1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
CHEMBL496537 187997 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 412 3 2 6 2.6 CS(=O)(=O)Nc1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
44379364 58134 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 551 10 3 6 3.7 COc1ccc2c(c1)CC(O)(CNCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00018-5
CHEMBL167621 58134 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 551 10 3 6 3.7 COc1ccc2c(c1)CC(O)(CNCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00018-5
10639971 28647 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 291 2 1 3 4.7 Cc1nc(-c2ccsc2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL137724 28647 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 291 2 1 3 4.7 Cc1nc(-c2ccsc2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
9880873 193304 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 336 3 1 4 3.0 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccnn3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL523338 193304 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 336 3 1 4 3.0 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccnn3)=N2)cc1 10.1016/j.bmcl.2009.01.101
44390385 122582 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 565 9 2 6 6.4 CN(C)c1nc(NCC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL360117 122582 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 565 9 2 6 6.4 CN(C)c1nc(NCC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
10685661 119250 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 264 2 1 3 3.1 Cc1nc(N2CCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL343153 119250 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 264 2 1 3 3.1 Cc1nc(N2CCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
136058112 206189 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 481 7 2 5 4.3 COc1ccc2c(c1)CCC1N=C(NC[C@H]3CC[C@H](CNS(=O)(=O)c4ccccc4)CC3)CC21 10.1016/s0960-894x(99)00676-9
CHEMBL67768 206189 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 481 7 2 5 4.3 COc1ccc2c(c1)CCC1N=C(NC[C@H]3CC[C@H](CNS(=O)(=O)c4ccccc4)CC3)CC21 10.1016/s0960-894x(99)00676-9
44263987 206776 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 250 1 2 2 3.0 c1ccc2c(c1)CCCc1nc(-c3c[nH]cn3)[nH]c1-2 10.1016/s0960-894x(02)00090-2
CHEMBL7147 206776 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 250 1 2 2 3.0 c1ccc2c(c1)CCCc1nc(-c3c[nH]cn3)[nH]c1-2 10.1016/s0960-894x(02)00090-2
44313495 207271 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 359 3 1 3 4.8 Cc1ccccc1NC(=O)c1cc(C)n(-c2cccc(C(F)(F)F)c2)n1 10.1016/s0960-894x(01)00449-8
CHEMBL75163 207271 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 359 3 1 3 4.8 Cc1ccccc1NC(=O)c1cc(C)n(-c2cccc(C(F)(F)F)c2)n1 10.1016/s0960-894x(01)00449-8
70695121 76944 None 0 Mouse Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 393 5 1 5 3.6 CCCS(=O)(=O)c1ccc2[nH]c(-c3cn(-c4ccccc4)ccc3=O)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070162 76944 None 0 Mouse Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 393 5 1 5 3.6 CCCS(=O)(=O)c1ccc2[nH]c(-c3cn(-c4ccccc4)ccc3=O)nc2c1 10.1016/j.bmcl.2012.07.020
44580746 188165 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 390 2 1 5 2.9 CN(C)C(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
CHEMBL497785 188165 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 390 2 1 5 2.9 CN(C)C(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
10714258 119342 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 370 2 1 3 4.7 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)c(Br)c2n1 10.1021/jm000269t
CHEMBL343766 119342 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 370 2 1 3 4.7 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)c(Br)c2n1 10.1021/jm000269t
2821670 168559 None 0 Human Binding pIC50 = 7.2 7.2 - 1
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 337 3 2 2 4.1 O=C(Nc1cc(-c2ccc(Cl)cc2)n[nH]1)C1Cc2ccccc2C1 10.1016/j.bmcl.2009.02.035
CHEMBL435036 168559 None 0 Human Binding pIC50 = 7.2 7.2 - 1
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 337 3 2 2 4.1 O=C(Nc1cc(-c2ccc(Cl)cc2)n[nH]1)C1Cc2ccccc2C1 10.1016/j.bmcl.2009.02.035
44573533 187569 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 364 4 2 3 3.8 OCc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
CHEMBL493998 187569 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 364 4 2 3 3.8 OCc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
10833804 119206 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 346 2 1 3 4.6 FC(F)(F)c1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL342818 119206 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 346 2 1 3 4.6 FC(F)(F)c1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
44460907 104421 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 427 6 2 4 5.3 O=C(CC1CC1)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL310119 104421 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 427 6 2 4 5.3 O=C(CC1CC1)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44461208 104801 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 442 7 2 5 4.1 O=C(CNCC1CC1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL310674 104801 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 442 7 2 5 4.1 O=C(CNCC1CC1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44460957 207766 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 458 8 2 5 4.9 CCCN(C)CC(=O)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL79308 207766 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 458 8 2 5 4.9 CCCN(C)CC(=O)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44461198 207804 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 429 7 2 4 5.7 CCCCC(=O)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL79659 207804 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 429 7 2 4 5.7 CCCCC(=O)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44461210 207805 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 472 7 2 6 3.9 O=C(CNCC1CCCO1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL79663 207805 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 472 7 2 6 3.9 O=C(CNCC1CCCO1)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44460963 208012 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 438 5 1 5 4.4 O=C(CN1CCCCC1)N1CCC(CNc2nc3c(s2)CCCc2ccccc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL81104 208012 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 438 5 1 5 4.4 O=C(CN1CCCCC1)N1CCC(CNc2nc3c(s2)CCCc2ccccc2-3)CC1 10.1016/j.bmcl.2004.03.014
44461179 208115 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 413 5 2 4 4.9 O=C(N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1)C1CC1 10.1016/j.bmcl.2004.03.014
CHEMBL81982 208115 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 413 5 2 4 4.9 O=C(N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1)C1CC1 10.1016/j.bmcl.2004.03.014
10295464 208159 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against rat neuropeptide Y5 receptorIn vitro binding affinity against rat neuropeptide Y5 receptor
ChEMBL 417 6 1 5 4.7 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL82374 208159 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against rat neuropeptide Y5 receptorIn vitro binding affinity against rat neuropeptide Y5 receptor
ChEMBL 417 6 1 5 4.7 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
9827743 166480 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 511 6 3 7 3.9 O=C(CN1CCC(n2c(O)nc3ccccc32)CC1)NC1CCc2cc(O)ccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
CHEMBL42762 166480 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 511 6 3 7 3.9 O=C(CN1CCC(n2c(O)nc3ccccc32)CC1)NC1CCc2cc(O)ccc2C1Cc1cccnc1 10.1016/s0960-894x(00)00311-5
9955865 123745 None 0 Mouse Binding pIC50 = 8.2 8.2 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 459 10 2 7 3.8 COc1ccc(C)cc1S(=O)(=O)NCCCNc1nc(C(=O)c2ccccc2C)cs1 10.1016/j.bmcl.2005.05.009
CHEMBL362131 123745 None 0 Mouse Binding pIC50 = 8.2 8.2 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 459 10 2 7 3.8 COc1ccc(C)cc1S(=O)(=O)NCCCNc1nc(C(=O)c2ccccc2C)cs1 10.1016/j.bmcl.2005.05.009
45481810 200991 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 436 2 1 4 3.6 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc4ccccc4n3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL578013 200991 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 436 2 1 4 3.6 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc4ccccc4n3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
44583507 188177 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3ccc(-c4ccccc4)nn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL497839 188177 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3ccc(-c4ccccc4)nn3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
44271231 60448 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 536 7 2 7 2.0 NS(=O)(=O)c1ccc(CCNC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)cc1 10.1016/s0960-894x(02)00113-0
CHEMBL17513 60448 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual synthesis technique)
ChEMBL 536 7 2 7 2.0 NS(=O)(=O)c1ccc(CCNC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)cc1 10.1016/s0960-894x(02)00113-0
10294504 187317 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 402 3 1 2 5.3 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccc(C(F)(F)F)c3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL492388 187317 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 402 3 1 2 5.3 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccc(C(F)(F)F)c3)=N2)cc1 10.1016/j.bmcl.2009.01.101
22934136 167204 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 291 2 1 3 3.6 COc1ccc2c(c1)-c1nc(-c3cccnc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
CHEMBL429006 167204 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 291 2 1 3 3.6 COc1ccc2c(c1)-c1nc(-c3cccnc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
70684601 76923 None 0 Mouse Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 376 5 1 3 5.1 CCCS(=O)(=O)c1ccc2[nH]c(-c3ccc(-c4ccccc4)cc3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070141 76923 None 0 Mouse Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 376 5 1 3 5.1 CCCS(=O)(=O)c1ccc2[nH]c(-c3ccc(-c4ccccc4)cc3)nc2c1 10.1016/j.bmcl.2012.07.020
22934142 206784 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 275 1 1 2 3.9 Cc1ccc2c(c1)-c1nc(-c3ccncc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
CHEMBL7149 206784 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 275 1 1 2 3.9 Cc1ccc2c(c1)-c1nc(-c3ccncc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
22934118 207123 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 279 1 1 2 3.8 Fc1ccc2c(c1)-c1nc(-c3cccnc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
CHEMBL7370 207123 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 279 1 1 2 3.8 Fc1ccc2c(c1)-c1nc(-c3cccnc3)[nH]c1CCC2 10.1016/s0960-894x(02)00090-2
9885994 207556 None 0 Human Binding pIC50 = 8.2 8.2 - 1
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 376 6 2 3 5.1 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL77639 207556 None 0 Human Binding pIC50 = 8.2 8.2 - 1
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 376 6 2 3 5.1 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
22325336 189066 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 353 1 1 4 3.9 O=C1OC2(CCN(c3nc4cc(Cl)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL508271 189066 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 353 1 1 4 3.9 O=C1OC2(CCN(c3nc4cc(Cl)ccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
44580100 187029 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 371 1 1 4 4.0 O=C1OC2(CCN(c3nc4cc(Cl)c(F)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL490008 187029 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 371 1 1 4 4.0 O=C1OC2(CCN(c3nc4cc(Cl)c(F)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
71454969 81369 None 0 Mouse Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 384 5 2 5 2.9 CCCS(=O)(=O)c1ccc2[nH]c(N3CCNC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
CHEMBL2159157 81369 None 0 Mouse Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 384 5 2 5 2.9 CCCS(=O)(=O)c1ccc2[nH]c(N3CCNC(c4ccccc4)C3)nc2c1 10.1016/j.bmcl.2012.09.025
9825755 205952 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 465 5 2 4 3.8 O=C(NC1=NC2CCc3ccccc3C2C1)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1016/s0960-894x(99)00676-9
CHEMBL66168 205952 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 465 5 2 4 3.8 O=C(NC1=NC2CCc3ccccc3C2C1)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1016/s0960-894x(99)00676-9
10459583 12906 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 491 6 1 5 5.7 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm049599u
CHEMBL1188975 12906 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 491 6 1 5 5.7 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm049599u
CHEMBL537858 12906 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 491 6 1 5 5.7 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm049599u
10571295 119216 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 335 2 1 4 2.6 CC(=O)N1CCN(c2[nH]c(C)nc3cc(-c4ccccc4)nc2-3)CC1 10.1021/jm000269t
CHEMBL342918 119216 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 335 2 1 4 2.6 CC(=O)N1CCN(c2[nH]c(C)nc3cc(-c4ccccc4)nc2-3)CC1 10.1021/jm000269t
71519333 86212 None 0 Mouse Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 402 5 1 3 5.1 CCS(=O)(=O)c1ccc2[nH]c(C3(c4ccc(-c5ccccc5)cc4)CC3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312081 86212 None 0 Mouse Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 402 5 1 3 5.1 CCS(=O)(=O)c1ccc2[nH]c(C3(c4ccc(-c5ccccc5)cc4)CC3)nc2c1 10.1016/j.bmcl.2012.11.005
70697152 76927 None 0 Mouse Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 375 5 1 2 5.7 CCCS(=O)(=O)c1ccc2cc(-c3cccc(-c4ccccc4)c3)[nH]c2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070145 76927 None 0 Mouse Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 375 5 1 2 5.7 CCCS(=O)(=O)c1ccc2cc(-c3cccc(-c4ccccc4)c3)[nH]c2c1 10.1016/j.bmcl.2012.07.020
44461116 107192 None 0 Human Binding pIC50 = 7.2 7.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ responseIn vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ response
ChEMBL 399 4 1 5 4.4 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)C(C)C)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
CHEMBL316153 107192 None 0 Human Binding pIC50 = 7.2 7.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ responseIn vitro binding affinity against human neuropeptide Y5 receptor measured as Ca+ response
ChEMBL 399 4 1 5 4.4 Cc1ccc2c(c1)-c1nc(NCC3CCN(C(=O)C(C)C)CC3)sc1CCO2 10.1016/j.bmcl.2004.03.014
44264067 206497 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 262 1 1 2 3.7 c1ccc(-c2nc3c([nH]2)CCOc2ccccc2-3)cc1 10.1016/s0960-894x(02)00090-2
CHEMBL6985 206497 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 262 1 1 2 3.7 c1ccc(-c2nc3c([nH]2)CCOc2ccccc2-3)cc1 10.1016/s0960-894x(02)00090-2
44313510 103860 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 359 3 1 3 4.8 Cc1cccc(NC(=O)c2cc(C)n(-c3cccc(C(F)(F)F)c3)n2)c1 10.1016/s0960-894x(01)00449-8
CHEMBL309055 103860 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 359 3 1 3 4.8 Cc1cccc(NC(=O)c2cc(C)n(-c3cccc(C(F)(F)F)c3)n2)c1 10.1016/s0960-894x(01)00449-8
44312968 207338 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 472 5 2 5 5.3 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc(C(F)(F)F)cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL75827 207338 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 472 5 2 5 5.3 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc(C(F)(F)F)cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
9998721 64396 None 0 Mouse Binding pIC50 = 7.2 7.2 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 362 4 1 4 5.4 Cc1ccccc1C(=O)c1cnc(Nc2cccc(C(F)(F)F)c2)s1 10.1016/j.bmcl.2005.01.063
CHEMBL181304 64396 None 0 Mouse Binding pIC50 = 7.2 7.2 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 362 4 1 4 5.4 Cc1ccccc1C(=O)c1cnc(Nc2cccc(C(F)(F)F)c2)s1 10.1016/j.bmcl.2005.01.063
44573408 192766 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 368 3 1 2 4.9 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccccc3Cl)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL521844 192766 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 368 3 1 2 4.9 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccccc3Cl)=N2)cc1 10.1016/j.bmcl.2009.01.101
23442539 124151 None 0 Mouse Binding pIC50 = 7.2 7.2 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 433 9 2 6 3.6 Cc1ccccc1C(=O)c1csc(NCCCNS(=O)(=O)c2cccc(F)c2)n1 10.1016/j.bmcl.2005.05.009
CHEMBL363279 124151 None 0 Mouse Binding pIC50 = 7.2 7.2 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 433 9 2 6 3.6 Cc1ccccc1C(=O)c1csc(NCCCNS(=O)(=O)c2cccc(F)c2)n1 10.1016/j.bmcl.2005.05.009
10589936 28031 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 258 3 1 3 3.2 CCCc1cc2[nH]c(C)nc(N3CCCCC3)c-2n1 10.1021/jm000269t
CHEMBL137258 28031 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 258 3 1 3 3.2 CCCc1cc2[nH]c(C)nc(N3CCCCC3)c-2n1 10.1021/jm000269t
44377731 57459 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 507 8 2 5 4.1 COc1ccc2c(c1)CC(NC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL165506 57459 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 507 8 2 5 4.1 COc1ccc2c(c1)CC(NC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
44379411 120531 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 523 10 3 6 3.3 COc1ccc2c(c1)C(O)(CNCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CC2 10.1016/s0960-894x(02)00018-5
CHEMBL354111 120531 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5
ChEMBL 523 10 3 6 3.3 COc1ccc2c(c1)C(O)(CNCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CC2 10.1016/s0960-894x(02)00018-5
10808680 28086 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 326 2 1 3 4.6 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3Cl)cc2n1 10.1021/jm000269t
CHEMBL137290 28086 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 326 2 1 3 4.6 Cc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3Cl)cc2n1 10.1021/jm000269t
44312956 103222 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 488 6 2 6 5.1 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc(OC(F)(F)F)cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL308110 103222 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 488 6 2 6 5.1 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc(OC(F)(F)F)cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
10645176 27856 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 372 4 1 4 5.2 Cc1nc(N2CCCCC2)c2nc(CSc3ccc(Cl)cc3)cc-2[nH]1 10.1021/jm000269t
CHEMBL137125 27856 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 372 4 1 4 5.2 Cc1nc(N2CCCCC2)c2nc(CSc3ccc(Cl)cc3)cc-2[nH]1 10.1021/jm000269t
44313486 207230 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 471 3 1 3 5.1 Cc1cc(C(=O)Nc2cccc(I)c2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL74777 207230 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 471 3 1 3 5.1 Cc1cc(C(=O)Nc2cccc(I)c2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
44377440 57468 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 551 10 2 6 4.4 COc1cc2c(cc1OC)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL165556 57468 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 551 10 2 6 4.4 COc1cc2c(cc1OC)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
44377661 119981 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 593 12 2 7 4.3 CCOC(=O)COc1ccc2c(c1)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL349386 119981 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 593 12 2 7 4.3 CCOC(=O)COc1ccc2c(c1)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
44287971 163537 None 0 Human Binding pIC50 = 4.2 4.2 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 487 12 6 4 2.4 N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@H](CO)c1ccccc1 10.1016/s0960-894x(00)00292-4
CHEMBL41981 163537 None 0 Human Binding pIC50 = 4.2 4.2 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 487 12 6 4 2.4 N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)N[C@H](CO)c1ccccc1 10.1016/s0960-894x(00)00292-4
9969726 208046 None 1 Human Binding pIC50 = 7.2 7.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 375 3 1 5 3.6 CC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL81442 208046 None 1 Human Binding pIC50 = 7.2 7.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 375 3 1 5 3.6 CC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
9799669 208268 None 0 Human Binding pIC50 = 7.2 7.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 373 3 1 4 4.1 CC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL83255 208268 None 0 Human Binding pIC50 = 7.2 7.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 373 3 1 4 4.1 CC(=O)N1CCC(CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
10324940 13847 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 501 4 1 5 5.1 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc2c(c1)C(=O)c1ccccc1-2 10.1021/jm049599u
CHEMBL1195875 13847 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 501 4 1 5 5.1 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc2c(c1)C(=O)c1ccccc1-2 10.1021/jm049599u
CHEMBL555513 13847 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 501 4 1 5 5.1 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc2c(c1)C(=O)c1ccccc1-2 10.1021/jm049599u
10969955 110651 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Binding affinity against rat Neuropeptide Y receptor Y5Binding affinity against rat Neuropeptide Y receptor Y5
ChEMBL 343 5 1 3 4.8 CCn1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
CHEMBL325475 110651 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Binding affinity against rat Neuropeptide Y receptor Y5Binding affinity against rat Neuropeptide Y receptor Y5
ChEMBL 343 5 1 3 4.8 CCn1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
1639804 13377 None 7 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 323 2 1 3 3.7 CCn1c2ccccc2c2cc(NC(=O)N3CCOCC3)ccc21 10.1021/jm011125x
CHEMBL119247 13377 None 7 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 323 2 1 3 3.7 CCn1c2ccccc2c2cc(NC(=O)N3CCOCC3)ccc21 10.1021/jm011125x
44460467 164652 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 413 6 1 5 4.9 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(C)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL421521 164652 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 413 6 1 5 4.9 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(C)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44460946 208003 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 472 5 1 5 5.1 O=C(CN1CCCCC1)N1CCC(CNc2nc3c(s2)CCCc2ccc(Cl)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL81024 208003 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 472 5 1 5 5.1 O=C(CN1CCCCC1)N1CCC(CNc2nc3c(s2)CCCc2ccc(Cl)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
10295464 208159 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 417 6 1 5 4.7 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL82374 208159 None 0 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 417 6 1 5 4.7 CCCCC(=O)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
23283663 103472 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 537 9 3 5 4.9 O=S(=O)(NC[C@H]1CC[C@H](CNC2CCc3cc(O)ccc3C2Cc2cccnc2)CC1)c1ccccc1F 10.1021/jm990468g
CHEMBL3084864 103472 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 537 9 3 5 4.9 O=S(=O)(NC[C@H]1CC[C@H](CNC2CCc3cc(O)ccc3C2Cc2cccnc2)CC1)c1ccccc1F 10.1021/jm990468g
45481640 200366 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 420 2 1 4 3.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(Cl)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL572909 200366 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 420 2 1 4 3.1 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccc(Cl)cn3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
71519003 86201 None 0 Mouse Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 386 5 1 5 4.0 CCS(=O)(=O)c1ccc2[nH]c(Oc3cccc(OC(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312070 86201 None 0 Mouse Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 386 5 1 5 4.0 CCS(=O)(=O)c1ccc2[nH]c(Oc3cccc(OC(F)(F)F)c3)nc2c1 10.1016/j.bmcl.2012.11.005
9880835 187760 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 335 3 1 3 3.7 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccnc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL495034 187760 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 335 3 1 3 3.7 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3cccnc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
22934127 161892 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 261 1 1 2 3.6 c1cncc(-c2nc3c([nH]2)-c2ccccc2CCC3)c1 10.1016/s0960-894x(02)00090-2
CHEMBL414205 161892 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5
ChEMBL 261 1 1 2 3.6 c1cncc(-c2nc3c([nH]2)-c2ccccc2CCC3)c1 10.1016/s0960-894x(02)00090-2
44573575 187311 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccnc(-c4ccccc4)n3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL492371 187311 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccnc(-c4ccccc4)n3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
45487535 199694 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccc(F)cc4)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
CHEMBL568337 199694 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk cells
ChEMBL 418 3 1 6 3.9 O=C1O[C@]2(CC[C@H](C(=O)Nc3ncc(-c4ccc(F)cc4)cn3)CC2)c2cccnc21 10.1016/j.bmcl.2009.07.103
44573575 187311 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccnc(-c4ccccc4)n3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL492371 187311 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3ccnc(-c4ccccc4)n3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
70693070 76941 None 0 Mouse Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 407 3 1 5 4.0 CC(C)(C)S(=O)(=O)c1ccc2[nH]c(-c3ccc(=O)n(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
CHEMBL2070159 76941 None 0 Mouse Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from mouse NPY Y5 receptorDisplacement of [125I]PYY from mouse NPY Y5 receptor
ChEMBL 407 3 1 5 4.0 CC(C)(C)S(=O)(=O)c1ccc2[nH]c(-c3ccc(=O)n(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.07.020
10096226 63516 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 469 6 1 5 4.5 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc(C(=O)c2ccccc2)cc1 10.1021/jm049599u
CHEMBL179972 63516 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 469 6 1 5 4.5 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc(C(=O)c2ccccc2)cc1 10.1021/jm049599u
21956072 193229 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 376 2 1 5 4.1 COC(=O)c1ccc2[nH]c([C@H]3CC[C@@]4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.021
CHEMBL522768 193229 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 376 2 1 5 4.1 COC(=O)c1ccc2[nH]c([C@H]3CC[C@@]4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.021
10051692 44603 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 499 6 3 5 3.1 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(Br)cc2)CC1)c1cccs1 10.1016/j.bmcl.2003.11.070
CHEMBL152016 44603 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 499 6 3 5 3.1 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccc(Br)cc2)CC1)c1cccs1 10.1016/j.bmcl.2003.11.070
10025916 63286 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 434 4 1 5 3.9 O=C(CN1CCC(N2C(=O)OCc3cc(F)ccc32)CC1)Nc1ccc2ncccc2c1 10.1021/jm049599u
CHEMBL179154 63286 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 434 4 1 5 3.9 O=C(CN1CCC(N2C(=O)OCc3cc(F)ccc32)CC1)Nc1ccc2ncccc2c1 10.1021/jm049599u
44583560 192753 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 405 2 1 5 4.5 O=C1OC2(CCN(C(=O)Nc3nc(-c4ccccc4)cs3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
CHEMBL521723 192753 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells
ChEMBL 405 2 1 5 4.5 O=C1OC2(CCN(C(=O)Nc3nc(-c4ccccc4)cs3)CC2)c2ccccc21 10.1016/j.bmcl.2009.05.013
10971233 207491 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 392 6 2 3 5.5 C[C@H]([C@@H](O)c1ccccc1)N(C)/C(S)=N/c1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL77010 207491 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 392 6 2 3 5.5 C[C@H]([C@@H](O)c1ccccc1)N(C)/C(S)=N/c1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
10958843 111281 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 343 5 1 3 4.2 CCn1c2ccccc2c2cc(C(=O)NCCc3ccncc3)ccc21 10.1021/jm011125x
CHEMBL326491 111281 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 343 5 1 3 4.2 CCn1c2ccccc2c2cc(C(=O)NCCc3ccncc3)ccc21 10.1021/jm011125x
44312687 207108 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 491 6 2 7 3.1 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4c[n+](C(F)(F)F)ccn4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL73619 207108 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 491 6 2 7 3.1 COc1ccc(S(=O)(=O)Nc2ccc(-c3cc(N)n(-c4c[n+](C(F)(F)F)ccn4)n3)cc2)cc1 10.1016/s0960-894x(01)00448-6
44460506 105466 None 0 Human Binding pIC50 = 7.2 7.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 458 5 1 6 4.0 O=C(CN1CCCCC1)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL311824 105466 None 0 Human Binding pIC50 = 7.2 7.2 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 458 5 1 6 4.0 O=C(CN1CCCCC1)N1CCC(CNc2nc3c(s2)CCOc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
11079077 207410 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 366 6 1 2 6.3 CC(CC1CCCCC1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL76422 207410 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 366 6 1 2 6.3 CC(CC1CCCCC1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
11089837 11024 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 365 2 1 3 4.9 Cc1c(NC(=O)N2CCOCC2)cc(C)c2c1c1ccccc1n2C(C)C 10.1021/jm011125x
CHEMBL117469 11024 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 365 2 1 3 4.9 Cc1c(NC(=O)N2CCOCC2)cc(C)c2c1c1ccccc1n2C(C)C 10.1021/jm011125x
44377461 55595 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 505 8 2 4 4.7 Cc1ccc2c(c1)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL162094 55595 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 505 8 2 4 4.7 Cc1ccc2c(c1)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
10637486 27589 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 293 2 2 4 2.3 Cc1nc(N2CCNCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL136940 27589 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 293 2 2 4 2.3 Cc1nc(N2CCNCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
10667042 26023 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 336 4 2 4 3.7 Cc1nc(N2CCCCC2CCO)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL135485 26023 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 336 4 2 4 3.7 Cc1nc(N2CCCCC2CCO)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
10641357 28481 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 310 7 2 4 3.7 CCOCCCNc1[nH]c(C)nc2cc(-c3ccccc3)nc1-2 10.1021/jm000269t
CHEMBL137557 28481 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 310 7 2 4 3.7 CCOCCCNc1[nH]c(C)nc2cc(-c3ccccc3)nc1-2 10.1021/jm000269t
10642052 115190 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 3 1 3 4.7 CCC1CCCCN1c1[nH]c(C)nc2cc(-c3ccccc3)nc1-2 10.1021/jm000269t
CHEMBL334373 115190 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 3 1 3 4.7 CCC1CCCCN1c1[nH]c(C)nc2cc(-c3ccccc3)nc1-2 10.1021/jm000269t
44580547 193589 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 333 1 1 4 3.5 Cc1cccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc12 10.1016/j.bmcl.2008.08.018
CHEMBL526641 193589 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 333 1 1 4 3.5 Cc1cccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc12 10.1016/j.bmcl.2008.08.018
12018680 164778 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 419 5 3 6 3.8 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc(N)cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL421695 164778 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 419 5 3 6 3.8 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc(N)cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
44377689 58099 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 521 9 2 5 4.4 COc1ccc2c(c1)CC(NCCN1CCC(CNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL167318 58099 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 521 9 2 5 4.4 COc1ccc2c(c1)CC(NCCN1CCC(CNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
44344244 103471 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 484 8 2 3 4.7 C=CCC1c2ccc(F)cc2CCC1NC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1021/jm990468g
CHEMBL3084863 103471 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 484 8 2 3 4.7 C=CCC1c2ccc(F)cc2CCC1NC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1021/jm990468g
9871512 166488 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 525 7 2 7 4.2 COc1ccc2c(c1)CCC(NC(=O)CN1CCC(n3c(O)nc4ccccc43)CC1)C2Cc1cccnc1 10.1016/s0960-894x(00)00311-5
CHEMBL42768 166488 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell lineInhibition of binding of radioligand [125I]PYY to the human Neuropeptide Y receptor type 5, using a stably transfected HEK293 cell line
ChEMBL 525 7 2 7 4.2 COc1ccc2c(c1)CCC(NC(=O)CN1CCC(n3c(O)nc4ccccc43)CC1)C2Cc1cccnc1 10.1016/s0960-894x(00)00311-5
11795098 116478 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 397 4 2 4 4.9 O=C(Nc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1)c1ccccc1 10.1021/jm000269t
CHEMBL336029 116478 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 397 4 2 4 4.9 O=C(Nc1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1)c1ccccc1 10.1021/jm000269t
10549405 30466 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 371 3 1 5 2.0 Cc1nc(N2CCN(S(C)(=O)=O)CC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL139270 30466 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 371 3 1 5 2.0 Cc1nc(N2CCN(S(C)(=O)=O)CC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
10948789 103634 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 375 7 1 3 4.6 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Cc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL308623 103634 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 375 7 1 3 4.6 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Cc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
44288112 100262 None 2 Human Binding pIC50 = 4.1 4.1 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 487 11 5 4 2.9 CC(NC(=O)C(CCCN=C(N)N)NC(=O)C(c1ccccc1)c1ccccc1)c1ccc(O)cc1 10.1016/s0960-894x(00)00292-4
CHEMBL288355 100262 None 2 Human Binding pIC50 = 4.1 4.1 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 487 11 5 4 2.9 CC(NC(=O)C(CCCN=C(N)N)NC(=O)C(c1ccccc1)c1ccccc1)c1ccc(O)cc1 10.1016/s0960-894x(00)00292-4
44313496 207272 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 345 3 1 3 4.7 Cc1cc(C(=O)Nc2cc(Cl)cc(Cl)c2)nn1-c1ccccc1 10.1016/s0960-894x(01)00449-8
CHEMBL75193 207272 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 345 3 1 3 4.7 Cc1cc(C(=O)Nc2cc(Cl)cc(Cl)c2)nn1-c1ccccc1 10.1016/s0960-894x(01)00449-8
44313228 207073 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 410 4 1 4 5.2 Cc1cc(C(=O)Nc2ccccc2-n2cccc2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL73351 207073 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 410 4 1 4 5.2 Cc1cc(C(=O)Nc2ccccc2-n2cccc2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
44401578 12966 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 512 6 1 6 5.4 CCn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5cccc(OC)c54)CC3)ccc21 10.1021/jm049599u
CHEMBL1189371 12966 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 512 6 1 6 5.4 CCn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5cccc(OC)c54)CC3)ccc21 10.1021/jm049599u
CHEMBL538569 12966 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 512 6 1 6 5.4 CCn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5cccc(OC)c54)CC3)ccc21 10.1021/jm049599u
10926986 12633 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 379 3 1 3 5.4 CC(C)c1c(NC(=O)N2CCOCC2)ccc2c1c1ccccc1n2C(C)C 10.1021/jm011125x
CHEMBL118710 12633 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 379 3 1 3 5.4 CC(C)c1c(NC(=O)N2CCOCC2)ccc2c1c1ccccc1n2C(C)C 10.1021/jm011125x
44287938 100464 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 631 13 4 4 5.4 N/C(=N/CCCC(NC(=O)Cc1ccc(-c2ccccc2)cc1)C(=O)N1CCCc2cc(O)ccc2C1)NCCCc1ccccc1 10.1016/s0960-894x(00)00292-4
CHEMBL290175 100464 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 631 13 4 4 5.4 N/C(=N/CCCC(NC(=O)Cc1ccc(-c2ccccc2)cc1)C(=O)N1CCCc2cc(O)ccc2C1)NCCCc1ccccc1 10.1016/s0960-894x(00)00292-4
10893873 13621 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 365 2 1 3 4.7 CC(C)(C)Cn1c2ccccc2c2cc(NC(=O)N3CCOCC3)ccc21 10.1021/jm011125x
CHEMBL119426 13621 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 365 2 1 3 4.7 CC(C)(C)Cn1c2ccccc2c2cc(NC(=O)N3CCOCC3)ccc21 10.1021/jm011125x
44460815 207710 None 0 Human Binding pIC50 = 7.1 7.1 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 416 4 2 5 3.0 CC(=O)NC1CCN(CC(=O)Nc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL78901 207710 None 0 Human Binding pIC50 = 7.1 7.1 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 416 4 2 5 3.0 CC(=O)NC1CCN(CC(=O)Nc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
44401552 166001 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 572 8 2 6 5.5 O=S(=O)(NCC1CCC(CNc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
CHEMBL425012 166001 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 572 8 2 6 5.5 O=S(=O)(NCC1CCC(CNc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
10500401 27827 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 350 9 2 3 5.9 CCCCCC(CC)CNc1[nH]c(C)nc2cc(-c3ccccc3)nc1-2 10.1021/jm000269t
CHEMBL137102 27827 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 350 9 2 3 5.9 CCCCCC(CC)CNc1[nH]c(C)nc2cc(-c3ccccc3)nc1-2 10.1021/jm000269t
10737530 119485 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 328 2 1 3 4.2 Cc1nc(N2CCCCC2)c2[nH]c(-c3cc(F)ccc3F)cc2n1 10.1021/jm000269t
CHEMBL344820 119485 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 328 2 1 3 4.2 Cc1nc(N2CCCCC2)c2[nH]c(-c3cc(F)ccc3F)cc2n1 10.1021/jm000269t
12018679 207062 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 449 6 2 7 4.1 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc([N+](=O)[O-])cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
CHEMBL73251 207062 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 in HEK 293 cell line, using [125I]PYY as radioligand
ChEMBL 449 6 2 7 4.1 Cc1ccc(-n2nc(-c3ccc(NS(=O)(=O)c4ccc([N+](=O)[O-])cc4)cc3)cc2N)cc1 10.1016/s0960-894x(01)00448-6
44377460 52751 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 536 9 2 6 4.3 O=[N+]([O-])c1ccc2c(c1)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL159450 52751 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 536 9 2 6 4.3 O=[N+]([O-])c1ccc2c(c1)CC(NCC1CCN(CCNS(=O)(=O)c3cccc4ccccc34)CC1)CCC2 10.1016/s0960-894x(02)00002-1
11015360 11296 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 422 6 1 5 3.4 CN(C)S(=O)(=O)n1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
CHEMBL117922 11296 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 422 6 1 5 3.4 CN(C)S(=O)(=O)n1c2ccccc2c2cc(NC(=O)CCc3ccncc3)ccc21 10.1021/jm011125x
44579845 193232 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 386 1 1 3 5.6 O=C1O[C@]2(CC[C@H](c3nc4cc(Cl)c(Cl)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
CHEMBL522788 193232 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 386 1 1 3 5.6 O=C1O[C@]2(CC[C@H](c3nc4cc(Cl)c(Cl)cc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
10347241 13937 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 503 4 2 5 5.0 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2O 10.1021/jm049599u
CHEMBL1196486 13937 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 503 4 2 5 5.0 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2O 10.1021/jm049599u
CHEMBL557172 13937 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 503 4 2 5 5.0 O=C(CN1CCC(N2C(=O)OCc3cc(Cl)ccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2O 10.1021/jm049599u
10971892 103228 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 422 7 1 2 6.9 CN(C(=O)Nc1ccc(Oc2ccccc2)cc1)C(Cc1ccccc1)c1ccccc1 10.1021/jm0004547
CHEMBL308130 103228 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 422 7 1 2 6.9 CN(C(=O)Nc1ccc(Oc2ccccc2)cc1)C(Cc1ccccc1)c1ccccc1 10.1021/jm0004547
44573697 187316 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 351 3 2 3 2.9 O=c1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)[nH]1 10.1016/j.bmcl.2009.01.101
CHEMBL492377 187316 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 351 3 2 3 2.9 O=c1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)[nH]1 10.1016/j.bmcl.2009.01.101
9952193 100640 None 0 Rat Binding pIC50 = 8.1 8.1 - 1
The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratThe compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in rat
ChEMBL 387 6 2 4 4.4 COc1ccc(-c2cc(NC(=O)Cc3ccc4ccccc4c3)[nH]n2)cc1OC 10.1021/jm980521l
CHEMBL291666 100640 None 0 Rat Binding pIC50 = 8.1 8.1 - 1
The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratThe compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in rat
ChEMBL 387 6 2 4 4.4 COc1ccc(-c2cc(NC(=O)Cc3ccc4ccccc4c3)[nH]n2)cc1OC 10.1021/jm980521l
10689108 25748 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 312 3 1 3 4.3 Cc1nc(N2CCCCC2)c2nc(CC3CCCCC3)cc-2[nH]1 10.1021/jm000269t
CHEMBL135261 25748 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 312 3 1 3 4.3 Cc1nc(N2CCCCC2)c2nc(CC3CCCCC3)cc-2[nH]1 10.1021/jm000269t
9947073 193195 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 362 4 1 3 4.1 O=Cc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
CHEMBL522539 193195 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 362 4 1 3 4.1 O=Cc1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
9983662 13961 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 469 4 2 5 4.3 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2O 10.1021/jm049599u
CHEMBL1196677 13961 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 469 4 2 5 4.3 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2O 10.1021/jm049599u
CHEMBL557802 13961 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 469 4 2 5 4.3 O=C(CN1CCC(N2C(=O)OCc3ccccc32)CC1)Nc1ccc2c(c1)-c1ccccc1C2O 10.1021/jm049599u
45481802 200864 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 472 3 1 6 3.7 COc1cccc2sc(NC(=O)N3CCC4(CC3)CN(S(C)(=O)=O)c3ccccc34)nc12 10.1016/j.bmc.2009.05.064
CHEMBL576941 200864 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 472 3 1 6 3.7 COc1cccc2sc(NC(=O)N3CCC4(CC3)CN(S(C)(=O)=O)c3ccccc34)nc12 10.1016/j.bmc.2009.05.064
9908720 207094 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 396 3 1 4 5.0 Cc1cc(C(=O)Nc2cccc3cnccc23)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL73534 207094 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 396 3 1 4 5.0 Cc1cc(C(=O)Nc2cccc3cnccc23)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
71518853 86195 None 0 Mouse Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 350 5 1 4 3.6 CCS(=O)(=O)c1ccc2[nH]c(OCc3cccc(Cl)c3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312064 86195 None 0 Mouse Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 350 5 1 4 3.6 CCS(=O)(=O)c1ccc2[nH]c(OCc3cccc(Cl)c3)nc2c1 10.1016/j.bmcl.2012.11.005
44313572 207380 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 363 3 1 3 4.6 Cc1cc(C(=O)Nc2ccc(F)cc2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
CHEMBL76218 207380 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligandBinding affinity to human neuropeptide Y receptor type 5 (NPY5) in HEK 293 cell line assayed by using [125I]PYY as radioligand
ChEMBL 363 3 1 3 4.6 Cc1cc(C(=O)Nc2ccc(F)cc2)nn1-c1cccc(C(F)(F)F)c1 10.1016/s0960-894x(01)00449-8
11099994 10132 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 343 5 1 3 4.8 CCn1c2ccccc2c2ccc(NC(=O)CCc3ccncc3)cc21 10.1021/jm011125x
CHEMBL115690 10132 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)
ChEMBL 343 5 1 3 4.8 CCn1c2ccccc2c2ccc(NC(=O)CCc3ccncc3)cc21 10.1021/jm011125x
21129772 169527 None 4 Human Binding pIC50 = 4.1 4.1 -309 8
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 473 11 6 4 2.6 N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1 10.1016/s0960-894x(00)00292-4
CHEMBL44246 169527 None 4 Human Binding pIC50 = 4.1 4.1 -309 8
Inhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cellsInhibition of binding of [3H]propionyl-NPY (1 nM) to Neuropeptide Y receptor type 5 in HEC-1-B cells
ChEMBL 473 11 6 4 2.6 N=C(N)NCCCC(NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1 10.1016/s0960-894x(00)00292-4
11056043 120114 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 311 4 2 2 3.9 O=C(Cc1ccccc1)Nc1cc(-c2ccc(Cl)cc2)n[nH]1 10.1021/jm025513q
CHEMBL350463 120114 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 311 4 2 2 3.9 O=C(Cc1ccccc1)Nc1cc(-c2ccc(Cl)cc2)n[nH]1 10.1021/jm025513q
44460921 208164 None 0 Human Binding pIC50 = 7.1 7.1 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 430 6 2 5 4.1 CN(C)CC(=O)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL82408 208164 None 0 Human Binding pIC50 = 7.1 7.1 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 430 6 2 5 4.1 CN(C)CC(=O)N[C@H]1CC[C@H](CNc2nc3c(s2)CCCc2ccc(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
10779945 168683 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 291 2 1 2 5.0 Cc1nc(C2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL435825 168683 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 291 2 1 2 5.0 Cc1nc(C2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
44580594 188208 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 387 1 1 4 4.2 O=C1OC2(CCN(c3nc4c(C(F)(F)F)cccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL498166 188208 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 387 1 1 4 4.2 O=C1OC2(CCN(c3nc4c(C(F)(F)F)cccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
10498514 119280 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 3 1 3 4.7 CC(C)c1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL343330 119280 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 320 3 1 3 4.7 CC(C)c1nc(N2CCCCC2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
22325350 184432 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 397 2 1 6 2.6 CS(=O)(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
CHEMBL484267 184432 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 397 2 1 6 2.6 CS(=O)(=O)c1ccc2[nH]c(N3CCC4(CC3)OC(=O)c3ccccc34)nc2c1 10.1016/j.bmcl.2008.08.018
44377468 56516 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 525 8 2 4 5.0 O=S(=O)(NCCN1CCC(CNC2CCCc3ccc(Cl)cc3C2)CC1)c1cccc2ccccc12 10.1016/s0960-894x(02)00002-1
CHEMBL163470 56516 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 525 8 2 4 5.0 O=S(=O)(NCCN1CCC(CNC2CCCc3ccc(Cl)cc3C2)CC1)c1cccc2ccccc12 10.1016/s0960-894x(02)00002-1
10734658 27612 None 1 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 286 2 1 3 4.0 Cc1nc(-c2cccnc2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
CHEMBL136959 27612 None 1 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 286 2 1 3 4.0 Cc1nc(-c2cccnc2)c2[nH]c(-c3ccccc3)cc2n1 10.1021/jm000269t
10789271 164951 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 404 4 1 5 3.8 Cc1nc(N2CCCCC2)c2nc(CS(=O)(=O)c3ccc(Cl)cc3)cc-2[nH]1 10.1021/jm000269t
CHEMBL421913 164951 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 404 4 1 5 3.8 Cc1nc(N2CCCCC2)c2nc(CS(=O)(=O)c3ccc(Cl)cc3)cc-2[nH]1 10.1021/jm000269t
44377854 120177 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 507 10 2 5 3.8 COc1ccc2c(c1)CC(CNCC1CN(CCNS(=O)(=O)c3cccc4ccccc34)C1)CCC2 10.1016/s0960-894x(02)00002-1
CHEMBL351082 120177 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Concentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptorConcentration that inhibited 50% of total specific binding of [125I]PYY ligand to human NPY-Y5 receptor
ChEMBL 507 10 2 5 3.8 COc1ccc2c(c1)CC(CNCC1CN(CCNS(=O)(=O)c3cccc4ccccc34)C1)CCC2 10.1016/s0960-894x(02)00002-1
10075283 12984 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 481 4 1 5 4.8 Cc1ccc2c(c1)COC(=O)N2C1CCN(CC(=O)Nc2ccc3c(c2)C(=O)c2ccccc2-3)CC1 10.1021/jm049599u
CHEMBL1189496 12984 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 481 4 1 5 4.8 Cc1ccc2c(c1)COC(=O)N2C1CCN(CC(=O)Nc2ccc3c(c2)C(=O)c2ccccc2-3)CC1 10.1021/jm049599u
CHEMBL538823 12984 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 481 4 1 5 4.8 Cc1ccc2c(c1)COC(=O)N2C1CCN(CC(=O)Nc2ccc3c(c2)C(=O)c2ccccc2-3)CC1 10.1021/jm049599u
12078329 29455 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 324 3 1 3 3.9 Cc1nc(N2CCCCC2)c2nc(Cc3ccc(F)cc3)cc-2[nH]1 10.1021/jm000269t
CHEMBL138435 29455 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 324 3 1 3 3.9 Cc1nc(N2CCCCC2)c2nc(Cc3ccc(F)cc3)cc-2[nH]1 10.1021/jm000269t
44401449 71118 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 544 6 2 6 5.0 O=S(=O)(NC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
CHEMBL195346 71118 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 544 6 2 6 5.0 O=S(=O)(NC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
11204090 63527 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 587 7 2 7 5.1 CN(C)c1nc(N[C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL180003 63527 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 587 7 2 7 5.1 CN(C)c1nc(N[C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
44390118 123976 None 0 Mouse Binding pIC50 = 6.1 6.1 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 366 4 1 4 5.3 O=C(c1cccc(F)c1)c1cnc(Nc2cccc(C(F)(F)F)c2)s1 10.1016/j.bmcl.2005.01.063
CHEMBL362795 123976 None 0 Mouse Binding pIC50 = 6.1 6.1 - 0
Inhibitory concentration against Neuropeptide Y receptor type 5 in mouseInhibitory concentration against Neuropeptide Y receptor type 5 in mouse
ChEMBL 366 4 1 4 5.3 O=C(c1cccc(F)c1)c1cnc(Nc2cccc(C(F)(F)F)c2)s1 10.1016/j.bmcl.2005.01.063
11342160 123001 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 573 6 1 7 4.6 CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL360671 123001 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Inhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYYInhibitory activity against constitutively activated human Neuropeptide Y receptor Y5 transiently expressed in COS-1 cells using [125I]PYY
ChEMBL 573 6 1 7 4.6 CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
11342160 123001 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 573 6 1 7 4.6 CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL360671 123001 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Inhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cellsInhibitory activity against neuropeptide Y receptor type 5 by using [125I]PYY as radioligand expressed in COS-1 cells
ChEMBL 573 6 1 7 4.6 CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
9934923 102696 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 481 5 3 5 3.5 O=C(NC1=NC2CCc3cc(O)ccc3C2C1)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1016/s0960-894x(99)00676-9
CHEMBL304353 102696 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 481 5 3 5 3.5 O=C(NC1=NC2CCc3cc(O)ccc3C2C1)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2)CC1 10.1016/s0960-894x(99)00676-9
9847333 200606 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 465 3 1 5 3.4 Cn1ccnc1-c1ccc(NC(=O)N2CCC3(CC2)CN(S(C)(=O)=O)c2ccccc23)cc1 10.1016/j.bmc.2009.05.064
CHEMBL574772 200606 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 465 3 1 5 3.4 Cn1ccnc1-c1ccc(NC(=O)N2CCC3(CC2)CN(S(C)(=O)=O)c2ccccc23)cc1 10.1016/j.bmc.2009.05.064
11057893 207572 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 376 6 2 3 5.1 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1cccc(Oc2ccccc2)c1 10.1021/jm0004547
CHEMBL77769 207572 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 376 6 2 3 5.1 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Nc1cccc(Oc2ccccc2)c1 10.1021/jm0004547
23442513 67021 None 0 Mouse Binding pIC50 = 8.1 8.1 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 517 9 2 6 5.1 Cc1ccccc1C(=O)c1csc(NCCCNS(=O)(=O)c2cc(C(F)(F)F)ccc2Cl)n1 10.1016/j.bmcl.2005.05.009
CHEMBL186916 67021 None 0 Mouse Binding pIC50 = 8.1 8.1 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 517 9 2 6 5.1 Cc1ccccc1C(=O)c1csc(NCCCNS(=O)(=O)c2cc(C(F)(F)F)ccc2Cl)n1 10.1016/j.bmcl.2005.05.009
44271231 60448 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 536 7 2 7 2.0 NS(=O)(=O)c1ccc(CCNC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)cc1 10.1016/s0960-894x(02)00113-0
CHEMBL17513 60448 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by parallel synthesis technique)
ChEMBL 536 7 2 7 2.0 NS(=O)(=O)c1ccc(CCNC(=O)C2CCN(C(=O)Cn3c(=O)sc4ccc(Cl)cc43)CC2)cc1 10.1016/s0960-894x(02)00113-0
20587799 191787 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 347 1 1 4 3.8 Cc1cc2nc(N3CCC4(CC3)OC(=O)c3ccccc34)[nH]c2cc1C 10.1016/j.bmcl.2008.08.018
CHEMBL519651 191787 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 347 1 1 4 3.8 Cc1cc2nc(N3CCC4(CC3)OC(=O)c3ccccc34)[nH]c2cc1C 10.1016/j.bmcl.2008.08.018
10223395 187828 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 412 4 1 4 3.7 CS(=O)(=O)c1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
CHEMBL495369 187828 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 412 4 1 4 3.7 CS(=O)(=O)c1cccc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1016/j.bmcl.2009.01.101
44580222 184278 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 363 1 1 6 3.0 O=C1OC2(CCN(c3nc4cc5c(cc4[nH]3)OCO5)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL483040 184278 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 363 1 1 6 3.0 O=C1OC2(CCN(c3nc4cc5c(cc4[nH]3)OCO5)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
71519164 86203 None 0 Mouse Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 378 5 1 4 4.8 CCS(=O)(=O)c1ccc2[nH]c(Oc3cccc(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312072 86203 None 0 Mouse Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 378 5 1 4 4.8 CCS(=O)(=O)c1ccc2[nH]c(Oc3cccc(-c4ccccc4)c3)nc2c1 10.1016/j.bmcl.2012.11.005
9983624 13946 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 468 4 1 5 4.9 Cn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1021/jm049599u
CHEMBL1196584 13946 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 468 4 1 5 4.9 Cn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1021/jm049599u
CHEMBL557540 13946 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cellsInhibition of [125I]PYY binding to the rat NPY Y5 receptor in C6 cells
ChEMBL 468 4 1 5 4.9 Cn1c2ccccc2c2cc(NC(=O)CN3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1021/jm049599u
44573615 187339 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3nccc(-c4ccccc4)n3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
CHEMBL492567 187339 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Binding affinity to human neuropeptide Y5 receptorBinding affinity to human neuropeptide Y5 receptor
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3nccc(-c4ccccc4)n3)CC2)c2ccccc21 10.1016/j.bmc.2009.05.064
44573615 187339 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3nccc(-c4ccccc4)n3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
CHEMBL492567 187339 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant Y5 receptor expressed in mouse LMtk cells
ChEMBL 463 3 1 5 3.5 CS(=O)(=O)N1CC2(CCN(C(=O)Nc3nccc(-c4ccccc4)n3)CC2)c2ccccc21 10.1016/j.bmcl.2009.02.035
9888989 206282 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 431 9 1 4 5.2 COc1ccc2c(c1)CCC(NCCc1ccc(OC)c(OC)c1)C2Cc1ccccc1 10.1021/jm990468g
CHEMBL68467 206282 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.Inhibition of [125I]-PYY binding to recombinant NPY Y5 receptor on HEK293 cell membranes.
ChEMBL 431 9 1 4 5.2 COc1ccc2c(c1)CCC(NCCc1ccc(OC)c(OC)c1)C2Cc1ccccc1 10.1021/jm990468g
22257112 102957 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 495 6 2 5 3.8 COc1ccc2c(c1)CCC1N=C(NC(=O)[C@H]3CC[C@H](CNS(=O)(=O)c4ccccc4)CC3)CC21 10.1016/s0960-894x(99)00676-9
CHEMBL305987 102957 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding affinity for human Neuropeptide Y receptor type 5 in HEK293 cellsBinding affinity for human Neuropeptide Y receptor type 5 in HEK293 cells
ChEMBL 495 6 2 5 3.8 COc1ccc2c(c1)CCC1N=C(NC(=O)[C@H]3CC[C@H](CNS(=O)(=O)c4ccccc4)CC3)CC21 10.1016/s0960-894x(99)00676-9
44580505 187915 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 319 1 1 4 3.7 O=C1O[C@]2(CC[C@H](c3nc4cccnc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
CHEMBL495930 187915 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding affinity to human NPY Y5 receptor transfected in mouse LMtk cellsBinding affinity to human NPY Y5 receptor transfected in mouse LMtk cells
ChEMBL 319 1 1 4 3.7 O=C1O[C@]2(CC[C@H](c3nc4cccnc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.018
44579794 187151 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 318 1 1 3 4.3 O=C1O[C@]2(CC[C@H](c3nc4ccccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
CHEMBL491020 187151 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cellsDisplacement of [125I]PYY from human recombinant NPYY5 receptor expressed in mouse LMtk cells
ChEMBL 318 1 1 3 4.3 O=C1O[C@]2(CC[C@H](c3nc4ccccc4[nH]3)CC2)c2ccccc21 10.1016/j.bmcl.2008.08.021
10758195 78550 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 322 3 1 4 3.9 COc1c(-c2ccccc2)[nH]c2c(N3CCCCC3)nc(C)nc12 10.1021/jm000269t
CHEMBL2111927 78550 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 322 3 1 4 3.9 COc1c(-c2ccccc2)[nH]c2c(N3CCCCC3)nc(C)nc12 10.1021/jm000269t
44370202 120138 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 522 6 3 6 4.0 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2cccc3cccnc23)CC1)c1cc2ccccc2s1 10.1016/j.bmcl.2003.11.070
CHEMBL350684 120138 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Human Neuropeptide Y5 receptor binding affinityHuman Neuropeptide Y5 receptor binding affinity
ChEMBL 522 6 3 6 4.0 O=C(NNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2cccc3cccnc23)CC1)c1cc2ccccc2s1 10.1016/j.bmcl.2003.11.070
9967784 188964 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 340 3 1 3 4.3 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccsc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
CHEMBL506812 188964 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 340 3 1 3 4.3 Fc1ccc(C2(c3ccc(F)cc3)CNC(c3ccsc3)=N2)cc1 10.1016/j.bmcl.2009.01.101
9819988 28600 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 354 3 1 3 5.2 c1ccc(-c2cc3nc(-c4ccccc4)[nH]c(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
CHEMBL137669 28600 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Affinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assayAffinity for human neuropeptide Y receptor Y5, binding was evaluated in an in vitro radioligand [125I]PYY binding assay
ChEMBL 354 3 1 3 5.2 c1ccc(-c2cc3nc(-c4ccccc4)[nH]c(N4CCCCC4)c-3n2)cc1 10.1021/jm000269t
10970790 207524 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 374 6 1 3 5.2 C[C@H](C(=O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL77255 207524 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 374 6 1 3 5.2 C[C@H](C(=O)c1ccccc1)N(C)C(=O)Nc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
11111618 207928 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 377 6 1 4 5.0 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Oc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
CHEMBL80465 207928 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Inhibitory activity tested against Human Neuropeptide Y5 Receptor.Inhibitory activity tested against Human Neuropeptide Y5 Receptor.
ChEMBL 377 6 1 4 5.0 C[C@H]([C@@H](O)c1ccccc1)N(C)C(=O)Oc1ccc(Oc2ccccc2)cc1 10.1021/jm0004547
71519167 86207 None 0 Mouse Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 379 5 1 5 4.2 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccc(-c4ccccc4)cn3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312076 86207 None 0 Mouse Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 379 5 1 5 4.2 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccc(-c4ccccc4)cn3)nc2c1 10.1016/j.bmcl.2012.11.005
71519002 86200 None 0 Mouse Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 370 4 1 4 4.2 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccc(C(F)(F)F)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
CHEMBL2312069 86200 None 0 Mouse Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]PYY from mouse NPY-Y5 receptorDisplacement of [125I]PYY from mouse NPY-Y5 receptor
ChEMBL 370 4 1 4 4.2 CCS(=O)(=O)c1ccc2[nH]c(Oc3ccc(C(F)(F)F)cc3)nc2c1 10.1016/j.bmcl.2012.11.005
44461106 208033 None 0 Human Binding pIC50 = 7 7.0 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 437 4 1 5 4.8 CC(C)C(=O)N1CCC(CNc2nc3c(s2)CCOc2cc(Cl)c(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
CHEMBL81337 208033 None 0 Human Binding pIC50 = 7 7.0 - 0
In vitro binding affinity against human neuropeptide Y5 receptorIn vitro binding affinity against human neuropeptide Y5 receptor
ChEMBL 437 4 1 5 4.8 CC(C)C(=O)N1CCC(CNc2nc3c(s2)CCOc2cc(Cl)c(F)cc2-3)CC1 10.1016/j.bmcl.2004.03.014
23442587 67198 None 0 Mouse Binding pIC50 = 5 5.0 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 433 9 2 6 3.6 Cc1ccccc1C(=O)c1cnc(NCCCNS(=O)(=O)c2ccc(F)cc2)s1 10.1016/j.bmcl.2005.05.009
CHEMBL187729 67198 None 0 Mouse Binding pIC50 = 5 5.0 - 0
Inhibitory concentration against mouse NPY5 receptor at 1 umInhibitory concentration against mouse NPY5 receptor at 1 um
ChEMBL 433 9 2 6 3.6 Cc1ccccc1C(=O)c1cnc(NCCCNS(=O)(=O)c2ccc(F)cc2)s1 10.1016/j.bmcl.2005.05.009
44302732 205193 None 0 Human Binding pKi = 9.5 9.5 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 363 6 1 3 4.9 CC(C)Cn1c2ccccc2c2cc(NC(=O)CCN3CCCC3)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL61880 205193 None 0 Human Binding pKi = 9.5 9.5 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 363 6 1 3 4.9 CC(C)Cn1c2ccccc2c2cc(NC(=O)CCN3CCCC3)ccc21 10.1016/s0960-894x(03)00329-9
56683704 65391 None 0 Human Binding pKi = 9.5 9.5 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 457 7 2 5 2.1 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)COc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL1829320 65391 None 0 Human Binding pKi = 9.5 9.5 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 457 7 2 5 2.1 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)COc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
57345521 73337 None 0 Human Binding pKi = 9.5 9.5 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 425 7 2 4 3.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013020 73337 None 0 Human Binding pKi = 9.5 9.5 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 425 7 2 4 3.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL4284905 215911 None 0 Human Binding pKi = 9.4 9.4 -1 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC 10.1021/acs.jmedchem.8b01046
CHEMBL4284905 215911 None 0 Human Binding pKi = 9.4 9.4 -1 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC 10.1021/acs.jmedchem.8b01046
10273848 155459 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 423 4 1 3 3.5 CN(C(=O)Nc1ccc(-c2cc(F)cc(F)c2)cc1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL403414 155459 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 423 4 1 3 3.5 CN(C(=O)Nc1ccc(-c2cc(F)cc(F)c2)cc1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
56841989 215881 None 6 Human Binding pKi = 9.3 9.3 -2 7
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4281479 215881 None 6 Human Binding pKi = 9.3 9.3 -2 7
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
57345520 73329 None 0 Human Binding pKi = 9.3 9.3 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 427 7 2 4 2.7 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013012 73329 None 0 Human Binding pKi = 9.3 9.3 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 427 7 2 4 2.7 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
56841989 215881 None 6 Human Binding pKi = 9.3 9.3 -2 7
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4281479 215881 None 6 Human Binding pKi = 9.3 9.3 -2 7
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
56666778 65394 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 459 7 2 5 3.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCSc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829323 65394 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 459 7 2 5 3.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCSc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL4277590 215834 None 0 Human Binding pKi = 9.2 9.2 -1 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4286615 215925 None 0 Human Binding pKi = 9.2 9.2 -63 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O 10.1021/acs.jmedchem.8b01046
CHEMBL4277590 215834 None 0 Human Binding pKi = 9.2 9.2 -1 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4286615 215925 None 0 Human Binding pKi = 9.2 9.2 -63 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O 10.1021/acs.jmedchem.8b01046
70685339 73508 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 434 3 1 5 4.5 CN(C(=O)Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@]2(CC1)OC(=O)c1ccccc12 10.1016/j.bmcl.2012.02.098
CHEMBL2016732 73508 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 434 3 1 5 4.5 CN(C(=O)Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@]2(CC1)OC(=O)c1ccccc12 10.1016/j.bmcl.2012.02.098
10203845 155674 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 443 5 1 3 3.4 CCS(=O)(=O)N1CCC(N(C)C(=O)N[C@H]2CC[C@H](c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL404461 155674 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 443 5 1 3 3.4 CCS(=O)(=O)N1CCC(N(C)C(=O)N[C@H]2CC[C@H](c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
70681111 73474 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 435 3 1 6 3.9 CN(C(=O)Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@]2(CC1)OC(=O)c1ccncc12 10.1016/j.bmcl.2012.02.098
CHEMBL2016682 73474 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 435 3 1 6 3.9 CN(C(=O)Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@]2(CC1)OC(=O)c1ccncc12 10.1016/j.bmcl.2012.02.098
56683705 65393 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 473 7 2 5 2.8 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)CSc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829322 65393 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 473 7 2 5 2.8 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)CSc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
44139479 192810 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 374 3 1 4 3.9 C[C@@H]1NC(c2cccc(C#N)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL521947 192810 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 374 3 1 4 3.9 C[C@@H]1NC(c2cccc(C#N)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
56666779 65397 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 441 7 2 4 3.1 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL1829326 65397 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 441 7 2 4 3.1 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
22458813 202676 None 0 Human Binding pKi = 9.1 9.1 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 351 5 1 4 3.5 CCn1c2ccccc2c2cc(NC(=O)CCN3CCOCC3)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL59680 202676 None 0 Human Binding pKi = 9.1 9.1 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 351 5 1 4 3.5 CCn1c2ccccc2c2cc(NC(=O)CCN3CCOCC3)ccc21 10.1016/s0960-894x(03)00329-9
57404430 73516 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 429 3 1 6 4.0 CN(C(=O)Nc1cnc(-c2ccccc2)cn1)[C@H]1CC[C@@]2(CC1)OC(=O)c1ccncc12 10.1016/j.bmcl.2012.02.098
CHEMBL2016740 73516 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 429 3 1 6 4.0 CN(C(=O)Nc1cnc(-c2ccccc2)cn1)[C@H]1CC[C@@]2(CC1)OC(=O)c1ccncc12 10.1016/j.bmcl.2012.02.098
56666779 65397 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 441 7 2 4 3.1 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829326 65397 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 441 7 2 4 3.1 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
56666777 65392 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 443 7 2 5 2.5 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCOc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL1829321 65392 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 443 7 2 5 2.5 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCOc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
70687454 73327 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 459 7 2 6 2.7 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2c(=O)sc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013010 73327 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 459 7 2 6 2.7 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2c(=O)sc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
70683225 73339 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 425 7 2 4 3.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3cccc(Cl)c32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013022 73339 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 425 7 2 4 3.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3cccc(Cl)c32)CC1 10.1016/j.bmcl.2012.01.117
70681101 73342 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 427 7 2 4 2.9 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3cc(F)c(F)cc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013025 73342 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 427 7 2 4 2.9 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3cc(F)c(F)cc32)CC1 10.1016/j.bmcl.2012.01.117
57404430 73515 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 429 3 1 6 4.0 CN(C(=O)Nc1cnc(-c2ccccc2)cn1)[C@H]1CC[C@]2(CC1)OC(=O)c1ccncc12 10.1016/j.bmcl.2012.02.098
CHEMBL2016739 73515 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 429 3 1 6 4.0 CN(C(=O)Nc1cnc(-c2ccccc2)cn1)[C@H]1CC[C@]2(CC1)OC(=O)c1ccncc12 10.1016/j.bmcl.2012.02.098
56683704 65391 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 457 7 2 5 2.1 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)COc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829320 65391 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 457 7 2 5 2.1 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)COc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
44138706 187083 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 375 3 1 5 3.3 C[C@@H]1NC(c2ccnc(C#N)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL490561 187083 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 375 3 1 5 3.3 C[C@@H]1NC(c2ccnc(C#N)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
44139234 193277 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 374 3 1 4 3.9 C[C@@H]1NC(c2cc(C#N)ccn2)=NC1(c1ccc(F)cc1)c1ccc(F)cc1 10.1021/jm900110t
CHEMBL523134 193277 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 374 3 1 4 3.9 C[C@@H]1NC(c2cc(C#N)ccn2)=NC1(c1ccc(F)cc1)c1ccc(F)cc1 10.1021/jm900110t
70685315 73338 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 425 7 2 4 3.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3ccc(Cl)cc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013021 73338 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 425 7 2 4 3.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3ccc(Cl)cc32)CC1 10.1016/j.bmcl.2012.01.117
44139732 12702 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 387 4 1 6 3.2 COc1ccc([C@]2(c3ccc(F)cc3)N=C(c3cc(C#N)ccn3)N[C@H]2C)cn1 10.1021/jm900110t
CHEMBL1187514 12702 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 387 4 1 6 3.2 COc1ccc([C@]2(c3ccc(F)cc3)N=C(c3cc(C#N)ccn3)N[C@H]2C)cn1 10.1021/jm900110t
CHEMBL506163 12702 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 387 4 1 6 3.2 COc1ccc([C@]2(c3ccc(F)cc3)N=C(c3cc(C#N)ccn3)N[C@H]2C)cn1 10.1021/jm900110t
70693715 73333 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 455 7 2 4 3.4 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CC(C)(C)c3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013016 73333 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 455 7 2 4 3.4 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CC(C)(C)c3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2012.01.117
10298415 166888 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 462 4 1 4 3.0 CN(C(=O)NC1CCN(c2cc(Cl)cc(Cl)c2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL428423 166888 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 462 4 1 4 3.0 CN(C(=O)NC1CCN(c2cc(Cl)cc(Cl)c2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
9930778 55164 None 0 Human Binding pKi = 8.9 8.9 1 2
Binding affinity to the human Neuropeptide Y receptor type 5 was determined using [125I]- [PYY] as radioligandBinding affinity to the human Neuropeptide Y receptor type 5 was determined using [125I]- [PYY] as radioligand
ChEMBL 362 6 1 5 4.2 CC(C)(C)OCCOc1ccc(-c2nc(-c3cccc(C#N)c3)c[nH]2)cn1 10.1021/jm025584p
CHEMBL161724 55164 None 0 Human Binding pKi = 8.9 8.9 1 2
Binding affinity to the human Neuropeptide Y receptor type 5 was determined using [125I]- [PYY] as radioligandBinding affinity to the human Neuropeptide Y receptor type 5 was determined using [125I]- [PYY] as radioligand
ChEMBL 362 6 1 5 4.2 CC(C)(C)OCCOc1ccc(-c2nc(-c3cccc(C#N)c3)c[nH]2)cn1 10.1021/jm025584p
9930778 55164 None 0 Human Binding pKi = 8.9 8.9 1 2
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 362 6 1 5 4.2 CC(C)(C)OCCOc1ccc(-c2nc(-c3cccc(C#N)c3)c[nH]2)cn1 10.1016/j.bmcl.2012.02.098
CHEMBL161724 55164 None 0 Human Binding pKi = 8.9 8.9 1 2
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 362 6 1 5 4.2 CC(C)(C)OCCOc1ccc(-c2nc(-c3cccc(C#N)c3)c[nH]2)cn1 10.1016/j.bmcl.2012.02.098
70685316 73341 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 409 7 2 4 2.8 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3ccc(F)cc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013024 73341 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 409 7 2 4 2.8 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3ccc(F)cc32)CC1 10.1016/j.bmcl.2012.01.117
10159722 95138 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 429 4 1 3 3.1 CN(C(=O)N[C@H]1CC[C@H](c2cc(F)cc(F)c2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL255353 95138 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 429 4 1 3 3.1 CN(C(=O)N[C@H]1CC[C@H](c2cc(F)cc(F)c2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL4278700 215851 None 0 Human Binding pKi = 8.9 8.9 -12 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O 10.1021/acs.jmedchem.8b01046
42630820 187184 None 7 Human Binding pKi = 8.9 8.9 - 1
Binding affinity to human NPYY5 receptorBinding affinity to human NPYY5 receptor
ChEMBL 375 3 1 5 3.3 C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
CHEMBL491288 187184 None 7 Human Binding pKi = 8.9 8.9 - 1
Binding affinity to human NPYY5 receptorBinding affinity to human NPYY5 receptor
ChEMBL 375 3 1 5 3.3 C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
CHEMBL4278700 215851 None 0 Human Binding pKi = 8.9 8.9 -12 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O 10.1021/acs.jmedchem.8b01046
42630820 187184 None 7 Human Binding pKi = 8.9 8.9 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 375 3 1 5 3.3 C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL491288 187184 None 7 Human Binding pKi = 8.9 8.9 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 375 3 1 5 3.3 C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
54141274 66638 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity to NPY5 receptorBinding affinity to NPY5 receptor
ChEMBL 475 7 3 6 4.6 Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc4ccccc4c3)CC2)nc2ccccc12 10.1016/j.bmcl.2011.06.124
CHEMBL1836102 66638 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity to NPY5 receptorBinding affinity to NPY5 receptor
ChEMBL 475 7 3 6 4.6 Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc4ccccc4c3)CC2)nc2ccccc12 10.1016/j.bmcl.2011.06.124
CHEMBL1852685 66638 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity to NPY5 receptorBinding affinity to NPY5 receptor
ChEMBL 475 7 3 6 4.6 Nc1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc4ccccc4c3)CC2)nc2ccccc12 10.1016/j.bmcl.2011.06.124
10177846 197123 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity to nucleotide Y5 receptor (unknown origin) assessed as inhibition constantBinding affinity to nucleotide Y5 receptor (unknown origin) assessed as inhibition constant
ChEMBL 381 4 2 3 4.1 CS(=O)(=O)Nc1cccc(-c2nc(-c3cccc(C(F)(F)F)c3)c[nH]2)c1 10.1021/acsmedchemlett.3c00041
CHEMBL5439288 197123 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity to nucleotide Y5 receptor (unknown origin) assessed as inhibition constantBinding affinity to nucleotide Y5 receptor (unknown origin) assessed as inhibition constant
ChEMBL 381 4 2 3 4.1 CS(=O)(=O)Nc1cccc(-c2nc(-c3cccc(C(F)(F)F)c3)c[nH]2)c1 10.1021/acsmedchemlett.3c00041
44138709 186996 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 366 3 2 4 2.7 C[C@@H]1NC(c2cccc(=O)[nH]2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
CHEMBL489726 186996 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 366 3 2 4 2.7 C[C@@H]1NC(c2cccc(=O)[nH]2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
44138709 186996 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 366 3 2 4 2.7 C[C@@H]1NC(c2cccc(=O)[nH]2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL489726 186996 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 366 3 2 4 2.7 C[C@@H]1NC(c2cccc(=O)[nH]2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
10041217 101086 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 312 2 1 3 4.7 CCn1c2ccccc2c2cc(-c3nc4ccc[nH]c-4n3)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL294560 101086 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 312 2 1 3 4.7 CCn1c2ccccc2c2cc(-c3nc4ccc[nH]c-4n3)ccc21 10.1016/s0960-894x(03)00329-9
70693714 73332 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 429 7 2 4 2.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCc3c2ccc(F)c3F)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013015 73332 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 429 7 2 4 2.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCc3c2ccc(F)c3F)CC1 10.1016/j.bmcl.2012.01.117
70693717 73335 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 391 7 2 4 2.6 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3ccccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013018 73335 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 391 7 2 4 2.6 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3ccccc32)CC1 10.1016/j.bmcl.2012.01.117
10272799 155549 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 407 4 1 2 4.0 CCC(=O)N1CCC(N(C)C(=O)N[C@H]2CC[C@H](c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL403918 155549 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 407 4 1 2 4.0 CCC(=O)N1CCC(N(C)C(=O)N[C@H]2CC[C@H](c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL4279973 215862 None 0 Human Binding pKi = 8.8 8.8 -10 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
10062681 111279 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 289 2 1 2 4.2 FC(F)(F)c1cccc(-c2c[nH]c(-c3cccnc3)n2)c1 10.1016/s0960-894x(03)00747-9
CHEMBL326483 111279 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 289 2 1 2 4.2 FC(F)(F)c1cccc(-c2c[nH]c(-c3cccnc3)n2)c1 10.1016/s0960-894x(03)00747-9
CHEMBL4279973 215862 None 0 Human Binding pKi = 8.8 8.8 -10 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
11491176 202499 None 36 Human Binding pKi = 8.8 8.8 2238 2
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4F)n3)CC2)c2cnccc21 10.1016/j.bmcl.2012.02.098
CHEMBL595573 202499 None 36 Human Binding pKi = 8.8 8.8 2238 2
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 406 3 1 6 3.6 O=C1O[C@]2(CC[C@H](C(=O)Nc3ccn(-c4ccccc4F)n3)CC2)c2cnccc21 10.1016/j.bmcl.2012.02.098
44139478 187047 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 375 3 1 5 3.3 C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL490123 187047 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 375 3 1 5 3.3 C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
9930778 55164 None 0 Rat Binding pKi = 8.8 8.8 -1 2
Binding affinity to the rat Neuropeptide Y receptor type 5 was determined using [125I]- [Leu31,Pro34]PYY as radioligandBinding affinity to the rat Neuropeptide Y receptor type 5 was determined using [125I]- [Leu31,Pro34]PYY as radioligand
ChEMBL 362 6 1 5 4.2 CC(C)(C)OCCOc1ccc(-c2nc(-c3cccc(C#N)c3)c[nH]2)cn1 10.1021/jm025584p
CHEMBL161724 55164 None 0 Rat Binding pKi = 8.8 8.8 -1 2
Binding affinity to the rat Neuropeptide Y receptor type 5 was determined using [125I]- [Leu31,Pro34]PYY as radioligandBinding affinity to the rat Neuropeptide Y receptor type 5 was determined using [125I]- [Leu31,Pro34]PYY as radioligand
ChEMBL 362 6 1 5 4.2 CC(C)(C)OCCOc1ccc(-c2nc(-c3cccc(C#N)c3)c[nH]2)cn1 10.1021/jm025584p
70691635 73336 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 425 7 2 4 3.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3c(Cl)cccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013019 73336 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 425 7 2 4 3.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3c(Cl)cccc32)CC1 10.1016/j.bmcl.2012.01.117
20647089 67843 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 397 12 2 6 3.0 CCN(CC)S(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
CHEMBL1909727 67843 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 397 12 2 6 3.0 CCN(CC)S(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
56663345 65395 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 491 7 2 6 1.9 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCS(=O)(=O)c3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829324 65395 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 491 7 2 6 1.9 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCS(=O)(=O)c3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
44138708 12635 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 384 3 1 4 4.1 C[C@@H]1NC(c2cc(Cl)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL1187117 12635 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 384 3 1 4 4.1 C[C@@H]1NC(c2cc(Cl)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL490903 12635 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 384 3 1 4 4.1 C[C@@H]1NC(c2cc(Cl)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
70693716 73334 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 407 8 2 4 2.4 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CCN2CCc3ccccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013017 73334 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 407 8 2 4 2.4 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CCN2CCc3ccccc32)CC1 10.1016/j.bmcl.2012.01.117
10293988 95697 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 393 3 1 2 3.6 CC(=O)N1CCC(N(C)C(=O)N[C@H]2CC[C@H](c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL257940 95697 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 393 3 1 2 3.6 CC(=O)N1CCC(N(C)C(=O)N[C@H]2CC[C@H](c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
20647101 68027 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 446 11 2 7 4.1 COc1ccc(C)cc1S(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
CHEMBL1912082 68027 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 446 11 2 7 4.1 COc1ccc(C)cc1S(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
44138579 12636 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 350 3 1 4 3.4 C[C@@H]1NC(c2cnccn2)=NC1(c1ccc(F)cc1)c1ccc(F)cc1 10.1021/jm900110t
CHEMBL1187124 12636 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 350 3 1 4 3.4 C[C@@H]1NC(c2cnccn2)=NC1(c1ccc(F)cc1)c1ccc(F)cc1 10.1021/jm900110t
CHEMBL491119 12636 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 350 3 1 4 3.4 C[C@@H]1NC(c2cnccn2)=NC1(c1ccc(F)cc1)c1ccc(F)cc1 10.1021/jm900110t
10017062 205200 None 0 Human Binding pKi = 8 8.0 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 289 2 1 2 4.8 CCn1c2ccccc2c2cc(-c3nc(C)c(C)[nH]3)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL61934 205200 None 0 Human Binding pKi = 8 8.0 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 289 2 1 2 4.8 CCn1c2ccccc2c2cc(-c3nc(C)c(C)[nH]3)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL4276961 215829 None 0 Human Binding pKi = 8 8.0 -1000 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O 10.1021/acs.jmedchem.8b01046
70689521 73511 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 420 3 1 4 4.8 CN(C(=O)Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@]2(CC1)OCc1ccccc12 10.1016/j.bmcl.2012.02.098
CHEMBL2016735 73511 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 420 3 1 4 4.8 CN(C(=O)Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@]2(CC1)OCc1ccccc12 10.1016/j.bmcl.2012.02.098
76321859 105776 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation countingDisplacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation counting
ChEMBL 428 5 1 3 4.3 CCN1CCN([C@H]2CC[C@@H](C(=O)Nc3ccc(-c4cc(F)cc(F)c4)cn3)CC2)C1=O 10.1016/j.bmcl.2014.02.023
CHEMBL3126050 105776 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation countingDisplacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation counting
ChEMBL 428 5 1 3 4.3 CCN1CCN([C@H]2CC[C@@H](C(=O)Nc3ccc(-c4cc(F)cc(F)c4)cn3)CC2)C1=O 10.1016/j.bmcl.2014.02.023
70693713 73328 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 409 7 2 6 1.6 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2c(=O)oc3ccccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013011 73328 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 409 7 2 6 1.6 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2c(=O)oc3ccccc32)CC1 10.1016/j.bmcl.2012.01.117
10970274 120139 None 0 Human Binding pKi = 8 8.0 - 1
Inhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 354 3 2 3 4.0 O=C(Nc1cc(-c2ccncc2)[nH]n1)C1Cc2ccc3ccccc3c2C1 10.1021/jm025513q
CHEMBL350690 120139 None 0 Human Binding pKi = 8 8.0 - 1
Inhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 354 3 2 3 4.0 O=C(Nc1cc(-c2ccncc2)[nH]n1)C1Cc2ccc3ccccc3c2C1 10.1021/jm025513q
21336489 79527 None 0 Human Binding pKi = 8 8.0 1737 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 441 8 3 4 3.7 Nc1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1 10.1016/s0960-894x(02)00287-1
CHEMBL2113711 79527 None 0 Human Binding pKi = 8 8.0 1737 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 441 8 3 4 3.7 Nc1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1 10.1016/s0960-894x(02)00287-1
21336507 189801 None 0 Human Binding pKi = 8 8.0 1288 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 490 8 2 3 5.7 O=S(=O)(NC[C@H]1CC[C@H](CNCc2ccc3ccccc3c2)CC1)c1ccccc1C(F)(F)F 10.1016/s0960-894x(02)00287-1
CHEMBL51542 189801 None 0 Human Binding pKi = 8 8.0 1288 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 490 8 2 3 5.7 O=S(=O)(NC[C@H]1CC[C@H](CNCc2ccc3ccccc3c2)CC1)c1ccccc1C(F)(F)F 10.1016/s0960-894x(02)00287-1
CHEMBL4285633 215918 None 0 Human Binding pKi = 7 7.0 -39 3
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4287469 215931 None 0 Human Binding pKi = 7 7.0 -1 3
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C)CC(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4288294 215939 None 0 Human Binding pKi = 7 7.0 -15 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(C)[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4277697 215837 None 0 Human Binding pKi = 6 6.0 -25 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4281120 215875 None 0 Human Binding pKi = 6 6.0 -3 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4290488 215957 None 0 Human Binding pKi = 6 6.0 -1 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
164626032 186640 None 0 Human Binding pKi = 5 5.0 -1000 2
Displacement of [3H]propionyl-pNPY from human neuropeptide Y Y5 receptor in human HEC-1B cells measured after 90 mins by scintillation counting analysisDisplacement of [3H]propionyl-pNPY from human neuropeptide Y Y5 receptor in human HEC-1B cells measured after 90 mins by scintillation counting analysis
ChEMBL 976 33 19 13 -3.4 CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.1c01574
CHEMBL4877802 186640 None 0 Human Binding pKi = 5 5.0 -1000 2
Displacement of [3H]propionyl-pNPY from human neuropeptide Y Y5 receptor in human HEC-1B cells measured after 90 mins by scintillation counting analysisDisplacement of [3H]propionyl-pNPY from human neuropeptide Y Y5 receptor in human HEC-1B cells measured after 90 mins by scintillation counting analysis
ChEMBL 976 33 19 13 -3.4 CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)NC(=O)NCCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.1c01574
10020909 101907 None 0 Human Binding pKi = 7 7.0 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 352 3 1 3 5.6 CCn1c2ccccc2c2cc(-c3nc(C)c(-c4ccccn4)[nH]3)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL300543 101907 None 0 Human Binding pKi = 7 7.0 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 352 3 1 3 5.6 CCn1c2ccccc2c2cc(-c3nc(C)c(-c4ccccn4)[nH]3)ccc21 10.1016/s0960-894x(03)00329-9
44294762 101581 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranesDisplacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranes
ChEMBL 496 8 3 5 4.7 O=C(NC[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2[N+](=O)[O-])CC1)Nc1cccc2ccccc12 10.1016/s0960-894x(02)00288-3
CHEMBL298168 101581 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranesDisplacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranes
ChEMBL 496 8 3 5 4.7 O=C(NC[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2[N+](=O)[O-])CC1)Nc1cccc2ccccc12 10.1016/s0960-894x(02)00288-3
20647087 68012 None 0 Human Binding pKi = 7.0 7.0 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 394 9 2 6 3.2 O=S(=O)(NCCCCCNc1nc(-c2ccccn2)cs1)C(F)(F)F 10.1016/j.bmcl.2011.08.072
CHEMBL1912067 68012 None 0 Human Binding pKi = 7.0 7.0 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 394 9 2 6 3.2 O=S(=O)(NCCCCCNc1nc(-c2ccccn2)cs1)C(F)(F)F 10.1016/j.bmcl.2011.08.072
22458796 100794 None 0 Human Binding pKi = 8.0 8.0 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 335 5 1 3 4.2 CCn1c2ccccc2c2cc(NC(=O)CCN3CCCC3)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL292729 100794 None 0 Human Binding pKi = 8.0 8.0 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 335 5 1 3 4.2 CCn1c2ccccc2c2cc(NC(=O)CCN3CCCC3)ccc21 10.1016/s0960-894x(03)00329-9
70687474 73519 None 0 Human Binding pKi = 8.0 8.0 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 456 4 1 5 5.1 CCN(C(=O)Nc1cnc(-c2ccccc2)cn1)[C@H]1CC[C@@]2(CC1)Cc1ccccc1C(=O)O2 10.1016/j.bmcl.2012.02.098
CHEMBL2016743 73519 None 0 Human Binding pKi = 8.0 8.0 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 456 4 1 5 5.1 CCN(C(=O)Nc1cnc(-c2ccccc2)cn1)[C@H]1CC[C@@]2(CC1)Cc1ccccc1C(=O)O2 10.1016/j.bmcl.2012.02.098
136000676 62808 None 0 Human Binding pKi = 8.0 8.0 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 384 3 2 4 2.9 C[C@@H]1NC(c2c[nH]c(=O)c(F)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
CHEMBL1784123 62808 None 0 Human Binding pKi = 8.0 8.0 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 384 3 2 4 2.9 C[C@@H]1NC(c2c[nH]c(=O)c(F)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
21336511 191256 None 0 Human Binding pKi = 8.0 8.0 323 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 476 8 2 3 5.3 O=S(=O)(NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1)c1cccc2ccccc12 10.1016/s0960-894x(02)00287-1
CHEMBL51884 191256 None 0 Human Binding pKi = 8.0 8.0 323 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 476 8 2 3 5.3 O=S(=O)(NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1)c1cccc2ccccc12 10.1016/s0960-894x(02)00287-1
57392816 68023 None 0 Human Binding pKi = 7.0 7.0 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 408 10 2 6 4.0 O=S(=O)(NCCCCCNc1nc(-c2ccccn2)cs1)C1CCCCC1 10.1016/j.bmcl.2011.08.072
CHEMBL1912078 68023 None 0 Human Binding pKi = 7.0 7.0 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 408 10 2 6 4.0 O=S(=O)(NCCCCCNc1nc(-c2ccccn2)cs1)C1CCCCC1 10.1016/j.bmcl.2011.08.072
56683706 65399 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 431 8 2 5 2.6 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NCCN2CCOc3cc(F)c(F)cc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829328 65399 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 431 8 2 5 2.6 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NCCN2CCOc3cc(F)c(F)cc32)CC1 10.1016/j.bmcl.2011.06.078
57403258 68029 None 0 Human Binding pKi = 6.0 6.0 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 406 10 2 8 2.5 Cn1cnc(S(=O)(=O)NCCCCCNc2nc(-c3ccccn3)cs2)c1 10.1016/j.bmcl.2011.08.072
CHEMBL1912084 68029 None 0 Human Binding pKi = 6.0 6.0 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 406 10 2 8 2.5 Cn1cnc(S(=O)(=O)NCCCCCNc2nc(-c3ccccn3)cs2)c1 10.1016/j.bmcl.2011.08.072
CHEMBL2110365 211672 None 1 Human Binding pKi = 6.9 6.9 -426 4
Affinity for cloned Y5 receptor using [125I]PYY as radioligandAffinity for cloned Y5 receptor using [125I]PYY as radioligand
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@H]1CCC(=O)NC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)CC)CCC(=O)NC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@@H]2CCCN2C1=O 10.1021/jm010031k
44345744 114029 None 0 Human Binding pKi = 6.9 6.9 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 339 2 1 2 5.6 Clc1ccc(-c2c[nH]c(-c3nccc4ccccc34)n2)cc1Cl 10.1016/s0960-894x(03)00747-9
CHEMBL332598 114029 None 0 Human Binding pKi = 6.9 6.9 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 339 2 1 2 5.6 Clc1ccc(-c2c[nH]c(-c3nccc4ccccc34)n2)cc1Cl 10.1016/s0960-894x(03)00747-9
CHEMBL2440183 212933 None 0 Human Binding pKi = 6.9 6.9 -4 2
Binding affinity to Y5 receptor (unknown origin)Binding affinity to Y5 receptor (unknown origin)
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]1[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)[C@H]1C(=O)OC)[C@@H](C)O)[C@@H](C)CC 10.1021/jm4008505
46209585 68013 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 368 10 2 6 3.1 CC(C)S(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
CHEMBL1912068 68013 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 368 10 2 6 3.1 CC(C)S(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
10247746 102781 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 357 4 1 4 3.8 CCn1c(=O)c2ccc(NC(=O)Cc3ccncc3)cc2c2ccccc21 10.1016/s0960-894x(03)00329-9
CHEMBL304896 102781 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 357 4 1 4 3.8 CCn1c(=O)c2ccc(NC(=O)Cc3ccncc3)cc2c2ccccc21 10.1016/s0960-894x(03)00329-9
46912327 105775 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation countingDisplacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation counting
ChEMBL 428 4 1 3 4.3 CN1CCCN([C@H]2CC[C@@H](C(=O)Nc3ccc(-c4cc(F)cc(F)c4)cn3)CC2)C1=O 10.1016/j.bmcl.2014.02.023
CHEMBL3126049 105775 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation countingDisplacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation counting
ChEMBL 428 4 1 3 4.3 CN1CCCN([C@H]2CC[C@@H](C(=O)Nc3ccc(-c4cc(F)cc(F)c4)cn3)CC2)C1=O 10.1016/j.bmcl.2014.02.023
10435289 171086 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranesDisplacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranes
ChEMBL 480 8 2 5 4.5 O=S(=O)(NC[C@H]1CC[C@H](CNCc2ccc3c(c2)OCCO3)CC1)c1cccc2ccccc12 10.1016/s0960-894x(02)00288-3
CHEMBL445613 171086 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranesDisplacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranes
ChEMBL 480 8 2 5 4.5 O=S(=O)(NC[C@H]1CC[C@H](CNCc2ccc3c(c2)OCCO3)CC1)c1cccc2ccccc12 10.1016/s0960-894x(02)00288-3
70689510 73345 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 391 7 3 3 2.7 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cc2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013028 73345 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 391 7 3 3 2.7 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cc2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2012.01.117
11078256 52328 None 0 Human Binding pKi = 6.9 6.9 - 1
Inhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 337 3 2 2 4.1 O=C(Nc1cc(-c2cccc(Cl)c2)n[nH]1)C1Cc2ccccc2C1 10.1021/jm025513q
CHEMBL158940 52328 None 0 Human Binding pKi = 6.9 6.9 - 1
Inhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 337 3 2 2 4.1 O=C(Nc1cc(-c2cccc(Cl)c2)n[nH]1)C1Cc2ccccc2C1 10.1021/jm025513q
44294942 186633 None 0 Human Binding pKi = 6.9 6.9 58 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 446 11 2 3 5.6 O=S(=O)(NCCCCCCNCc1ccc2ccccc2c1)c1ccc2ccccc2c1 10.1016/s0960-894x(02)00287-1
CHEMBL48777 186633 None 0 Human Binding pKi = 6.9 6.9 58 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 446 11 2 3 5.6 O=S(=O)(NCCCCCCNCc1ccc2ccccc2c1)c1ccc2ccccc2c1 10.1016/s0960-894x(02)00287-1
CHEMBL4280392 215867 None 0 Human Binding pKi = 6.9 6.9 -100 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
44350924 169091 None 0 Human Binding pKi = 5.9 5.9 -234 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL 2220 73 32 30 -7.4 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC 10.1021/acs.jmedchem.8b01046
91929378 169091 None 0 Human Binding pKi = 5.9 5.9 -234 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL 2220 73 32 30 -7.4 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC 10.1021/acs.jmedchem.8b01046
CHEMBL439122 169091 None 0 Human Binding pKi = 5.9 5.9 -234 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL 2220 73 32 30 -7.4 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC 10.1021/acs.jmedchem.8b01046
CHEMBL4280898 215871 None 0 Human Binding pKi = 5.9 5.9 -2 3
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(CC(=O)O)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4283257 215898 None 0 Human Binding pKi = 5.9 5.9 -645 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4289416 215947 None 0 Human Binding pKi = 5.9 5.9 -8 3
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4291705 215971 None 0 Human Binding pKi = 5.9 5.9 -1 3
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NC)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
10045322 62537 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 380 3 1 5 2.7 C[C@@H]1NC(c2ccc(=O)n(C)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
CHEMBL1782077 62537 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 380 3 1 5 2.7 C[C@@H]1NC(c2ccc(=O)n(C)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
10202875 95137 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 428 4 1 4 2.4 CN(C(=O)NC1CCN(c2cccc(Cl)c2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL255352 95137 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 428 4 1 4 2.4 CN(C(=O)NC1CCN(c2cccc(Cl)c2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL4280392 215867 None 0 Human Binding pKi = 6.9 6.9 -100 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
20610118 155494 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 428 4 1 4 2.4 CN(C(=O)NC1CCN(c2ccc(Cl)cc2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL403622 155494 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 428 4 1 4 2.4 CN(C(=O)NC1CCN(c2ccc(Cl)cc2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
44350924 169091 None 0 Human Binding pKi = 5.9 5.9 -234 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL 2220 73 32 30 -7.4 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC 10.1021/acs.jmedchem.8b01046
91929378 169091 None 0 Human Binding pKi = 5.9 5.9 -234 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL 2220 73 32 30 -7.4 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC 10.1021/acs.jmedchem.8b01046
CHEMBL439122 169091 None 0 Human Binding pKi = 5.9 5.9 -234 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL 2220 73 32 30 -7.4 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CCCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)[C@@H](C)CC 10.1021/acs.jmedchem.8b01046
CHEMBL4280898 215871 None 0 Human Binding pKi = 5.9 5.9 -2 3
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N(CC(=O)O)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4283257 215898 None 0 Human Binding pKi = 5.9 5.9 -645 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4289416 215947 None 0 Human Binding pKi = 5.9 5.9 -8 3
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCNC(=N)N)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4291705 215971 None 0 Human Binding pKi = 5.9 5.9 -1 3
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NC)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
2226619 205192 None 6 Human Binding pKi = 7.9 7.9 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 306 2 1 2 4.3 CCn1c2ccccc2c2cc(NC(=O)C(F)(F)F)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL61879 205192 None 6 Human Binding pKi = 7.9 7.9 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 306 2 1 2 4.3 CCn1c2ccccc2c2cc(NC(=O)C(F)(F)F)ccc21 10.1016/s0960-894x(03)00329-9
44345803 117364 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 235 2 1 2 3.4 Cc1cccc(-c2c[nH]c(-c3cccnc3)n2)c1 10.1016/s0960-894x(03)00747-9
CHEMBL339652 117364 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 235 2 1 2 3.4 Cc1cccc(-c2c[nH]c(-c3cccnc3)n2)c1 10.1016/s0960-894x(03)00747-9
56673734 65402 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 429 8 2 5 3.0 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NCCN2CCOc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829331 65402 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 429 8 2 5 3.0 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NCCN2CCOc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
9886706 178747 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 390 1 1 4 5.3 O=C1CC2(CCC2)CC(O)=C1C1C2=C(CC3(CCC3)CC2=O)Oc2ccccc21 10.1021/jm8003587
CHEMBL467558 178747 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 390 1 1 4 5.3 O=C1CC2(CCC2)CC(O)=C1C1C2=C(CC3(CCC3)CC2=O)Oc2ccccc21 10.1021/jm8003587
1202745 189110 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 366 1 1 4 5.0 CC1(C)CC(=O)C([C@H]2C3=C(CC(C)(C)CC3=O)Oc3ccccc32)=C(O)C1 10.1021/jm8003587
CHEMBL508770 189110 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 366 1 1 4 5.0 CC1(C)CC(=O)C([C@H]2C3=C(CC(C)(C)CC3=O)Oc3ccccc32)=C(O)C1 10.1021/jm8003587
9806472 162085 None 0 Human Binding pKi = 7.9 7.9 257 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 476 8 2 3 5.3 O=S(=O)(NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1)c1ccc2ccccc2c1 10.1016/s0960-894x(02)00287-1
CHEMBL415926 162085 None 0 Human Binding pKi = 7.9 7.9 257 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 476 8 2 3 5.3 O=S(=O)(NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1)c1ccc2ccccc2c1 10.1016/s0960-894x(02)00287-1
21336493 189316 None 0 Human Binding pKi = 7.9 7.9 1698 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 468 9 2 6 4.0 O=[N+]([O-])c1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCc2ccc3ccccc3n2)CC1 10.1016/s0960-894x(02)00287-1
CHEMBL51138 189316 None 0 Human Binding pKi = 7.9 7.9 1698 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 468 9 2 6 4.0 O=[N+]([O-])c1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCc2ccc3ccccc3n2)CC1 10.1016/s0960-894x(02)00287-1
127031281 139293 None 0 Human Binding pKi = 6.9 6.9 -104 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1789 59 29 21 -2.0 CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN/C(N)=N/C(=O)NCCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
CHEMBL3785569 139293 None 0 Human Binding pKi = 6.9 6.9 -104 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1789 59 29 21 -2.0 CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN/C(N)=N/C(=O)NCCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
CHEMBL3787712 139293 None 0 Human Binding pKi = 6.9 6.9 -104 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1789 59 29 21 -2.0 CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN/C(N)=N/C(=O)NCCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
12250898 110605 None 0 Human Binding pKi = 5.8 5.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 221 2 1 2 3.1 c1ccc(-c2c[nH]c(-c3ccccn3)n2)cc1 10.1016/s0960-894x(03)00747-9
CHEMBL325171 110605 None 0 Human Binding pKi = 5.8 5.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 221 2 1 2 3.1 c1ccc(-c2c[nH]c(-c3ccccn3)n2)cc1 10.1016/s0960-894x(03)00747-9
44138575 187142 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 373 3 2 5 2.5 C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(=O)[nH]c1 10.1021/jm900110t
CHEMBL490901 187142 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 373 3 2 5 2.5 C[C@@H]1NC(c2cc(C#N)ccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(=O)[nH]c1 10.1021/jm900110t
44345940 15590 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 281 4 1 4 3.2 COc1ccc(-c2c[nH]c(-c3cccnc3)n2)cc1OC 10.1016/s0960-894x(03)00747-9
CHEMBL122120 15590 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 281 4 1 4 3.2 COc1ccc(-c2c[nH]c(-c3cccnc3)n2)cc1OC 10.1016/s0960-894x(03)00747-9
9858246 101131 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 320 2 1 2 4.9 CC(C)n1c2ccccc2c2cc(NC(=O)C(F)(F)F)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL294842 101131 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 320 2 1 2 4.9 CC(C)n1c2ccccc2c2cc(NC(=O)C(F)(F)F)ccc21 10.1016/s0960-894x(03)00329-9
10450609 102336 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 351 3 1 2 6.2 CCn1c2ccccc2c2cc(-c3nc(C)c(-c4ccccc4)[nH]3)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL303325 102336 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 351 3 1 2 6.2 CCn1c2ccccc2c2cc(-c3nc(C)c(-c4ccccc4)[nH]3)ccc21 10.1016/s0960-894x(03)00329-9
10245014 162888 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 312 2 1 3 4.7 CCn1c2ccccc2c2cc(-c3nc4cc[nH]cc-4n3)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL417225 162888 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 312 2 1 3 4.7 CCn1c2ccccc2c2cc(-c3nc4cc[nH]cc-4n3)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL4279794 215860 None 0 Human Binding pKi = 7.8 7.8 -63 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4287140 215929 None 0 Human Binding pKi = 7.8 7.8 -10 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
20647122 68010 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 354 10 2 6 2.7 CCS(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
CHEMBL1912065 68010 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 354 10 2 6 2.7 CCS(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
57399737 68020 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 374 9 2 7 3.0 Cc1nc(C)c(-c2csc(NCCCCCNS(C)(=O)=O)n2)s1 10.1016/j.bmcl.2011.08.072
CHEMBL1912075 68020 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 374 9 2 7 3.0 Cc1nc(C)c(-c2csc(NCCCCCNS(C)(=O)=O)n2)s1 10.1016/j.bmcl.2011.08.072
155524657 171092 None 0 Human Binding pKi = 5.8 5.8 -2754 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1705 55 30 22 -4.0 CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](N)CCCC[C@@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
CHEMBL4456247 171092 None 0 Human Binding pKi = 5.8 5.8 -2754 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1705 55 30 22 -4.0 CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](N)CCCC[C@@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
44294740 101604 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranesDisplacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranes
ChEMBL 470 11 3 5 4.4 O=C(NCCCCCCNS(=O)(=O)c1ccccc1[N+](=O)[O-])Nc1cccc2ccccc12 10.1016/s0960-894x(02)00288-3
CHEMBL298342 101604 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranesDisplacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranes
ChEMBL 470 11 3 5 4.4 O=C(NCCCCCCNS(=O)(=O)c1ccccc1[N+](=O)[O-])Nc1cccc2ccccc12 10.1016/s0960-894x(02)00288-3
12250900 111381 None 0 Human Binding pKi = 5.8 5.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 221 2 1 2 3.1 c1ccc(-c2c[nH]c(-c3ccncc3)n2)cc1 10.1016/s0960-894x(03)00747-9
CHEMBL326736 111381 None 0 Human Binding pKi = 5.8 5.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 221 2 1 2 3.1 c1ccc(-c2c[nH]c(-c3ccncc3)n2)cc1 10.1016/s0960-894x(03)00747-9
CHEMBL4283846 215904 None 0 Human Binding pKi = 6.8 6.8 -3 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CO)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
57391020 68030 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 434 10 2 8 3.1 Cc1nn(C)c(C)c1S(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
CHEMBL1912085 68030 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 434 10 2 8 3.1 Cc1nn(C)c(C)c1S(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
10384590 202948 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 371 4 1 4 4.3 CC(C)n1c(=O)c2ccc(NC(=O)Cc3ccncc3)cc2c2ccccc21 10.1016/s0960-894x(03)00329-9
CHEMBL59866 202948 None 0 Human Binding pKi = 7.8 7.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 371 4 1 4 4.3 CC(C)n1c(=O)c2ccc(NC(=O)Cc3ccncc3)cc2c2ccccc21 10.1016/s0960-894x(03)00329-9
10332613 114505 None 1 Human Binding pKi = 7.8 7.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 255 2 1 2 3.8 Clc1ccc(-c2c[nH]c(-c3cccnc3)n2)cc1 10.1016/s0960-894x(03)00747-9
CHEMBL333310 114505 None 1 Human Binding pKi = 7.8 7.8 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 255 2 1 2 3.8 Clc1ccc(-c2c[nH]c(-c3cccnc3)n2)cc1 10.1016/s0960-894x(03)00747-9
CHEMBL4279794 215860 None 0 Human Binding pKi = 7.8 7.8 -63 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4287140 215929 None 0 Human Binding pKi = 7.8 7.8 -10 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
70695681 78386 None 0 Human Binding pKi = 7.8 7.8 - 1
Inhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 383 7 3 3 3.9 O=C(O)CCc1cccc(CC(=O)Nc2cc(-c3ccc(Cl)cc3)n[nH]2)c1 10.1021/jm025513q
CHEMBL2110162 78386 None 0 Human Binding pKi = 7.8 7.8 - 1
Inhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 383 7 3 3 3.9 O=C(O)CCc1cccc(CC(=O)Nc2cc(-c3ccc(Cl)cc3)n[nH]2)c1 10.1021/jm025513q
CHEMBL4283846 215904 None 0 Human Binding pKi = 6.8 6.8 -3 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](CO)Cc1ccc(O)cc1)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
10160875 95449 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 446 4 1 4 2.5 CN(C(=O)NC1CCN(c2ccc(F)c(Cl)c2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL256885 95449 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 446 4 1 4 2.5 CN(C(=O)NC1CCN(c2ccc(F)c(Cl)c2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
20610116 98076 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 436 5 1 5 1.9 CC(=O)c1cccc(N2CCC(NC(=O)N(C)C3CCN(S(C)(=O)=O)CC3)CC2)c1 10.1016/j.bmcl.2007.11.132
CHEMBL272964 98076 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 436 5 1 5 1.9 CC(=O)c1cccc(N2CCC(NC(=O)N(C)C3CCN(S(C)(=O)=O)CC3)CC2)c1 10.1016/j.bmcl.2007.11.132
CHEMBL2440192 212940 None 0 Human Binding pKi = 7.8 7.8 -32 3
Displacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometryDisplacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometry
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](N)Cc1ccc(O)cc1 10.1021/jm4008505
24950710 178920 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 418 1 1 4 6.1 O=C1CC2(CCCC2)CC(O)=C1C1C2=C(CC3(CCCC3)CC2=O)Oc2ccccc21 10.1021/jm8003587
CHEMBL469173 178920 None 0 Human Binding pKi = 7.8 7.8 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 418 1 1 4 6.1 O=C1CC2(CCCC2)CC(O)=C1C1C2=C(CC3(CCCC3)CC2=O)Oc2ccccc21 10.1021/jm8003587
CHEMBL4540843 216461 None 17 Human Binding pKi = 7.8 7.8 -83 3
Displacement of [3H]propionyl-pNPY from human neuropeptide Y Y5 receptor in human HEC-1B cells measured after 90 mins by scintillation counting analysisDisplacement of [3H]propionyl-pNPY from human neuropeptide Y Y5 receptor in human HEC-1B cells measured after 90 mins by scintillation counting analysis
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O 10.1021/acs.jmedchem.1c01574
21336500 101729 None 0 Human Binding pKi = 7.8 7.8 190 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 500 10 3 4 4.8 O=S(=O)(NC[C@H]1CC[C@H](CNC(CO)Cc2ccc(Cl)cc2)CC1)c1cccc2ccccc12 10.1016/s0960-894x(02)00287-1
CHEMBL299295 101729 None 0 Human Binding pKi = 7.8 7.8 190 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 500 10 3 4 4.8 O=S(=O)(NC[C@H]1CC[C@H](CNC(CO)Cc2ccc(Cl)cc2)CC1)c1cccc2ccccc12 10.1016/s0960-894x(02)00287-1
CHEMBL4540843 216461 None 17 Human Binding pKi = 7.8 7.8 -83 3
Displacement of [3H]propionyl-pNPY from human neuropeptide Y Y5 receptor in human HEC-1B cells measured after 90 mins by scintillation counting analysisDisplacement of [3H]propionyl-pNPY from human neuropeptide Y Y5 receptor in human HEC-1B cells measured after 90 mins by scintillation counting analysis
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O 10.1021/acs.jmedchem.1c01574
57394524 67846 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 424 10 2 7 1.9 CN1CCN(S(=O)(=O)NCCCCCNc2nc(-c3ccccn3)cs2)CC1 10.1016/j.bmcl.2011.08.072
CHEMBL1909730 67846 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 424 10 2 7 1.9 CN1CCN(S(=O)(=O)NCCCCCNc2nc(-c3ccccn3)cs2)CC1 10.1016/j.bmcl.2011.08.072
57392815 68015 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 345 9 2 6 3.0 CS(=O)(=O)NCCCCCNc1nc(-c2cccs2)cs1 10.1016/j.bmcl.2011.08.072
CHEMBL1912070 68015 None 0 Human Binding pKi = 6.8 6.8 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 345 9 2 6 3.0 CS(=O)(=O)NCCCCCNc1nc(-c2cccs2)cs1 10.1016/j.bmcl.2011.08.072
56663346 65398 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 413 8 2 5 2.5 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NCCN2CCOc3ccc(F)cc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829327 65398 None 0 Human Binding pKi = 6.8 6.8 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 413 8 2 5 2.5 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NCCN2CCOc3ccc(F)cc32)CC1 10.1016/j.bmcl.2011.06.078
57399726 67835 None 0 Human Binding pKi = 5.7 5.7 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 383 10 2 7 2.8 Cc1nccnc1-c1csc(NCCCCCNS(=O)(=O)C(C)C)n1 10.1016/j.bmcl.2011.08.072
CHEMBL1909719 67835 None 0 Human Binding pKi = 5.7 5.7 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 383 10 2 7 2.8 Cc1nccnc1-c1csc(NCCCCCNS(=O)(=O)C(C)C)n1 10.1016/j.bmcl.2011.08.072
70685340 73514 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 449 3 1 6 4.0 CN(C(=O)Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@@]2(CC1)Cc1cnccc1C(=O)O2 10.1016/j.bmcl.2012.02.098
CHEMBL2016738 73514 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 449 3 1 6 4.0 CN(C(=O)Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@@]2(CC1)Cc1cnccc1C(=O)O2 10.1016/j.bmcl.2012.02.098
20647107 68031 None 0 Human Binding pKi = 7.7 7.7 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 421 10 2 8 3.4 Cc1noc(C)c1S(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
CHEMBL1912086 68031 None 0 Human Binding pKi = 7.7 7.7 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 421 10 2 8 3.4 Cc1noc(C)c1S(=O)(=O)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
44345818 13734 None 0 Human Binding pKi = 7.7 7.7 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 269 2 1 2 4.1 Cc1[nH]c(-c2cccnc2)nc1-c1cccc(Cl)c1 10.1016/s0960-894x(03)00747-9
CHEMBL119507 13734 None 0 Human Binding pKi = 7.7 7.7 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 269 2 1 2 4.1 Cc1[nH]c(-c2cccnc2)nc1-c1cccc(Cl)c1 10.1016/s0960-894x(03)00747-9
56683702 65385 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 481 7 2 5 3.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)CC(C)(C)Sc3ccccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829314 65385 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 481 7 2 5 3.3 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)CC(C)(C)Sc3ccccc32)CC1 10.1016/j.bmcl.2011.06.078
56677038 65382 None 0 Human Binding pKi = 5.7 5.7 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 453 6 2 5 2.5 CC1(C)CC(=O)N(CC(=O)N[C@H]2CC[C@H](CNS(C)(=O)=O)CC2)c2ccccc2S1 10.1016/j.bmcl.2011.06.078
CHEMBL1829311 65382 None 0 Human Binding pKi = 5.7 5.7 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 453 6 2 5 2.5 CC1(C)CC(=O)N(CC(=O)N[C@H]2CC[C@H](CNS(C)(=O)=O)CC2)c2ccccc2S1 10.1016/j.bmcl.2011.06.078
12260207 178827 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 338 1 1 4 4.2 CC1CC(=O)C(C2C3=C(CC(C)CC3=O)Oc3ccccc32)=C(O)C1 10.1021/jm8003587
CHEMBL468414 178827 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 338 1 1 4 4.2 CC1CC(=O)C(C2C3=C(CC(C)CC3=O)Oc3ccccc32)=C(O)C1 10.1021/jm8003587
11475091 178659 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 400 1 1 4 5.7 CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3ccc(Cl)cc32)=C(O)C1 10.1021/jm8003587
CHEMBL466946 178659 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 400 1 1 4 5.7 CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3ccc(Cl)cc32)=C(O)C1 10.1021/jm8003587
44295007 101802 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranesDisplacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranes
ChEMBL 633 12 3 5 4.9 Cc1ccc(S(=O)(=O)NC(Cc2ccccc2)C(=O)NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc4ccccc4c3)CC2)cc1 10.1016/s0960-894x(02)00288-3
CHEMBL299742 101802 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranesDisplacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranes
ChEMBL 633 12 3 5 4.9 Cc1ccc(S(=O)(=O)NC(Cc2ccccc2)C(=O)NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc4ccccc4c3)CC2)cc1 10.1016/s0960-894x(02)00288-3
CHEMBL4289021 215944 None 0 Human Binding pKi = 6.7 6.7 -7 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4290615 215958 None 0 Human Binding pKi = 6.7 6.7 -1 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4282168 215890 None 0 Human Binding pKi = 5.7 5.7 -630 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
57399727 67838 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 425 9 2 6 4.4 CC(C)S(=O)(=O)NCCCCCNc1nc2c(s1)CCSc1ccccc1-2 10.1016/j.bmcl.2011.08.072
CHEMBL1909722 67838 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 425 9 2 6 4.4 CC(C)S(=O)(=O)NCCCCCNc1nc2c(s1)CCSc1ccccc1-2 10.1016/j.bmcl.2011.08.072
46913706 105767 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation countingDisplacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation counting
ChEMBL 413 4 1 3 4.5 O=C1CCCCN1[C@H]1CC[C@@H](C(=O)Nc2ccc(-c3cc(F)cc(F)c3)cn2)CC1 10.1016/j.bmcl.2014.02.023
CHEMBL3126041 105767 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation countingDisplacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation counting
ChEMBL 413 4 1 3 4.5 O=C1CCCCN1[C@H]1CC[C@@H](C(=O)Nc2ccc(-c3cc(F)cc(F)c3)cn2)CC1 10.1016/j.bmcl.2014.02.023
9946965 193181 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 360 3 1 4 3.5 N#Cc1ccnc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1021/jm900110t
CHEMBL522456 193181 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 360 3 1 4 3.5 N#Cc1ccnc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)CN2)c1 10.1021/jm900110t
44139602 193384 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 357 3 1 6 2.9 C[C@@H]1NC(c2cnsn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL523945 193384 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 357 3 1 6 2.9 C[C@@H]1NC(c2cnsn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
70687457 73346 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 405 7 2 4 2.7 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cc2cn(C)c3ccccc23)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013029 73346 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 405 7 2 4 2.7 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cc2cn(C)c3ccccc23)CC1 10.1016/j.bmcl.2012.01.117
10112931 95103 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 421 5 1 2 4.4 CCCC(=O)N1CCC(N(C)C(=O)N[C@H]2CC[C@H](c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL255147 95103 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 421 5 1 2 4.4 CCCC(=O)N1CCC(N(C)C(=O)N[C@H]2CC[C@H](c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
1504 2807 None 7 Human Binding pKi = 8.7 8.7 -9 10
Displacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometryDisplacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometry
ChEMBL None None None None 10.1021/jm4008505
1518 2807 None 7 Human Binding pKi = 8.7 8.7 -9 10
Displacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometryDisplacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometry
ChEMBL None None None None 10.1021/jm4008505
1521 2807 None 7 Human Binding pKi = 8.7 8.7 -9 10
Displacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometryDisplacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometry
ChEMBL None None None None 10.1021/jm4008505
24868177 2807 None 7 Human Binding pKi = 8.7 8.7 -9 10
Displacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometryDisplacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometry
ChEMBL None None None None 10.1021/jm4008505
44288922 2807 None 7 Human Binding pKi = 8.7 8.7 -9 10
Displacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometryDisplacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometry
ChEMBL None None None None 10.1021/jm4008505
77068007 2807 None 7 Human Binding pKi = 8.7 8.7 -9 10
Displacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometryDisplacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometry
ChEMBL None None None None 10.1021/jm4008505
90479759 2807 None 7 Human Binding pKi = 8.7 8.7 -9 10
Displacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometryDisplacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometry
ChEMBL None None None None 10.1021/jm4008505
CHEMBL438945 2807 None 7 Human Binding pKi = 8.7 8.7 -9 10
Displacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometryDisplacement of Cy5-pNPY from human Y5 receptor expressed in human HEC-1B cells after 90 to 120 mins by flow cytometry
ChEMBL None None None None 10.1021/jm4008505
44139601 193358 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 351 3 1 5 2.8 C[C@@H]1NC(c2cnccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL523776 193358 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 351 3 1 5 2.8 C[C@@H]1NC(c2cnccn2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
70687455 73340 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 409 7 2 4 2.8 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3cc(F)ccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013023 73340 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 409 7 2 4 2.8 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)Cn2ccc3cc(F)ccc32)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL429531 215998 None 17 Human Binding pKi = 8.7 8.7 -27 4
Affinity for cloned Y5 receptor using [125I]PYY as radioligandAffinity for cloned Y5 receptor using [125I]PYY as radioligand
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O 10.1021/jm010031k
70683239 73513 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 448 3 1 5 4.6 CN(C(=O)Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@@]2(CC1)Cc1ccccc1C(=O)O2 10.1016/j.bmcl.2012.02.098
CHEMBL2016737 73513 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 448 3 1 5 4.6 CN(C(=O)Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@@]2(CC1)Cc1ccccc1C(=O)O2 10.1016/j.bmcl.2012.02.098
9887225 187254 None 2 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1021/jm900110t
CHEMBL491930 187254 None 2 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 400 2 1 5 3.8 O=C1OC2(CCN(C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)c2ccccc21 10.1021/jm900110t
10112931 95103 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 421 5 1 2 4.4 CCCC(=O)N1CCC(N(C)C(=O)N[C@H]2CC[C@H](c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL255147 95103 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 421 5 1 2 4.4 CCCC(=O)N1CCC(N(C)C(=O)N[C@H]2CC[C@H](c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
44139599 187143 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 380 4 1 5 3.4 COc1ccnc(C2=N[C@@](c3ccc(F)cc3)(c3ccc(F)nc3)[C@H](C)N2)c1 10.1021/jm900110t
CHEMBL490902 187143 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 380 4 1 5 3.4 COc1ccnc(C2=N[C@@](c3ccc(F)cc3)(c3ccc(F)nc3)[C@H](C)N2)c1 10.1021/jm900110t
44138581 187248 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 427 4 1 5 3.4 C[C@@H]1NC(c2cccc(S(C)(=O)=O)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL491894 187248 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 427 4 1 5 3.4 C[C@@H]1NC(c2cccc(S(C)(=O)=O)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
10155282 201340 None 0 Human Binding pKi = 8.6 8.6 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 357 6 2 3 4.5 CCn1c2ccccc2c2cc(NC(=O)CNCc3ccccc3)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL58424 201340 None 0 Human Binding pKi = 8.6 8.6 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 357 6 2 3 4.5 CCn1c2ccccc2c2cc(NC(=O)CNCc3ccccc3)ccc21 10.1016/s0960-894x(03)00329-9
54580489 62725 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 380 3 2 4 3.0 Cc1ccc(C2=N[C@@](c3ccc(F)cc3)(c3ccc(F)nc3)[C@H](C)N2)[nH]c1=O 10.1016/j.bmc.2009.05.069
CHEMBL1783923 62725 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 380 3 2 4 3.0 Cc1ccc(C2=N[C@@](c3ccc(F)cc3)(c3ccc(F)nc3)[C@H](C)N2)[nH]c1=O 10.1016/j.bmc.2009.05.069
44138577 193234 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 388 4 1 4 4.3 CC[C@@H]1NC(c2cc(C#N)ccn2)=NC1(c1ccc(F)cc1)c1ccc(F)cc1 10.1021/jm900110t
CHEMBL522793 193234 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 388 4 1 4 4.3 CC[C@@H]1NC(c2cc(C#N)ccn2)=NC1(c1ccc(F)cc1)c1ccc(F)cc1 10.1021/jm900110t
10202456 95481 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 422 4 1 3 3.2 CC(C)C(=O)N1CCC(N(C)C(=O)NC2CCN(c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL257022 95481 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 422 4 1 3 3.2 CC(C)C(=O)N1CCC(N(C)C(=O)NC2CCN(c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
10047509 62815 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 416 4 1 5 3.6 C[C@@H]1NC(c2ccc(=O)n(C(F)F)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
CHEMBL1784130 62815 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 416 4 1 5 3.6 C[C@@H]1NC(c2ccc(=O)n(C(F)F)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
10046270 62816 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 396 4 1 6 2.3 COn1cc(C2=N[C@@](c3ccc(F)cc3)(c3ccc(F)nc3)[C@H](C)N2)ccc1=O 10.1016/j.bmc.2009.05.069
CHEMBL1784131 62816 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 396 4 1 6 2.3 COn1cc(C2=N[C@@](c3ccc(F)cc3)(c3ccc(F)nc3)[C@H](C)N2)ccc1=O 10.1016/j.bmc.2009.05.069
10275303 95630 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 444 5 1 4 2.4 CCS(=O)(=O)N1CCC(N(C)C(=O)NC2CCN(c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL257707 95630 None 0 Human Binding pKi = 8.6 8.6 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 444 5 1 4 2.4 CCS(=O)(=O)N1CCC(N(C)C(=O)NC2CCN(c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
11729353 52296 None 0 Human Binding pKi = 8.6 8.6 - 1
Inhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 413 5 2 4 4.6 COc1ccc(-c2cc(NC(=O)C3Cc4ccc5ccccc5c4C3)[nH]n2)cc1OC 10.1021/jm025513q
CHEMBL158913 52296 None 0 Human Binding pKi = 8.6 8.6 - 1
Inhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 413 5 2 4 4.6 COc1ccc(-c2cc(NC(=O)C3Cc4ccc5ccccc5c4C3)[nH]n2)cc1OC 10.1021/jm025513q
10363209 62812 None 1 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 394 4 1 5 3.2 CCn1cc(C2=N[C@@](c3ccc(F)cc3)(c3ccc(F)nc3)[C@H](C)N2)ccc1=O 10.1016/j.bmc.2009.05.069
CHEMBL1784127 62812 None 1 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 394 4 1 5 3.2 CCn1cc(C2=N[C@@](c3ccc(F)cc3)(c3ccc(F)nc3)[C@H](C)N2)ccc1=O 10.1016/j.bmc.2009.05.069
CHEMBL439904 216315 None 12 Human Binding pKi = 7.7 7.7 -50 3
Displacement of [125I]PYY from NPY5 receptor expressed in human HEK293 cellsDisplacement of [125I]PYY from NPY5 receptor expressed in human HEK293 cells
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C 10.1016/j.bmcl.2006.10.007
44577739 189500 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 422 5 1 4 6.6 CCC1(CC)CC(=O)C(C2C3=C(CC(CC)(CC)CC3=O)Oc3ccccc32)=C(O)C1 10.1021/jm8003587
CHEMBL512996 189500 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 422 5 1 4 6.6 CCC1(CC)CC(=O)C(C2C3=C(CC(CC)(CC)CC3=O)Oc3ccccc32)=C(O)C1 10.1021/jm8003587
10223183 155663 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 408 4 1 4 2.0 Cc1cccc(N2CCC(NC(=O)N(C)C3CCN(S(C)(=O)=O)CC3)CC2)c1 10.1016/j.bmcl.2007.11.132
CHEMBL404398 155663 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 408 4 1 4 2.0 Cc1cccc(N2CCC(NC(=O)N(C)C3CCN(S(C)(=O)=O)CC3)CC2)c1 10.1016/j.bmcl.2007.11.132
CHEMBL4289021 215944 None 0 Human Binding pKi = 6.7 6.7 -7 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4290615 215958 None 0 Human Binding pKi = 6.7 6.7 -1 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N(C)[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
56659886 65383 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 467 7 2 5 2.9 CCS(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)CC(C)(C)Sc3ccccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829312 65383 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 467 7 2 5 2.9 CCS(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)CC(C)(C)Sc3ccccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL4282168 215890 None 0 Human Binding pKi = 5.7 5.7 -630 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
9922187 101038 None 0 Human Binding pKi = 7.7 7.7 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 295 4 1 3 3.3 CCn1c2ccccc2c2cc(NC(=O)CN(C)C)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL294286 101038 None 0 Human Binding pKi = 7.7 7.7 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 295 4 1 3 3.3 CCn1c2ccccc2c2cc(NC(=O)CN(C)C)ccc21 10.1016/s0960-894x(03)00329-9
44345949 14555 None 1 Human Binding pKi = 7.7 7.7 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 255 2 1 2 3.8 Clc1ccccc1-c1c[nH]c(-c2cccnc2)n1 10.1016/s0960-894x(03)00747-9
CHEMBL120332 14555 None 1 Human Binding pKi = 7.7 7.7 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 255 2 1 2 3.8 Clc1ccccc1-c1c[nH]c(-c2cccnc2)n1 10.1016/s0960-894x(03)00747-9
56677039 65388 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 423 7 2 5 1.4 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)COc3ccccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829317 65388 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 423 7 2 5 1.4 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)COc3ccccc32)CC1 10.1016/j.bmcl.2011.06.078
44345638 110208 None 0 Human Binding pKi = 6.7 6.7 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 305 3 1 3 4.0 FC(F)(F)Oc1ccc(-c2c[nH]c(-c3cccnc3)n2)cc1 10.1016/s0960-894x(03)00747-9
CHEMBL323658 110208 None 0 Human Binding pKi = 6.7 6.7 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 305 3 1 3 4.0 FC(F)(F)Oc1ccc(-c2c[nH]c(-c3cccnc3)n2)cc1 10.1016/s0960-894x(03)00747-9
56670210 65384 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 479 7 2 5 3.1 CC1(C)CC(=O)N(CC(=O)N[C@H]2CC[C@H](CNS(=O)(=O)C3CC3)CC2)c2ccccc2S1 10.1016/j.bmcl.2011.06.078
CHEMBL1829313 65384 None 0 Human Binding pKi = 6.7 6.7 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 479 7 2 5 3.1 CC1(C)CC(=O)N(CC(=O)N[C@H]2CC[C@H](CNS(=O)(=O)C3CC3)CC2)c2ccccc2S1 10.1016/j.bmcl.2011.06.078
85472343 172405 None 0 Human Binding pKi = 5.7 5.7 -338 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1705 55 30 22 -4.0 CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
CHEMBL4475071 172405 None 0 Human Binding pKi = 5.7 5.7 -338 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1705 55 30 22 -4.0 CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
23397122 204212 None 0 Human Binding pKi = 5.7 5.7 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 323 4 1 4 2.7 CCn1c(=O)c2cc(NC(=O)CN(C)C)ccc2c2ccccc21 10.1016/s0960-894x(03)00329-9
CHEMBL60667 204212 None 0 Human Binding pKi = 5.7 5.7 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 323 4 1 4 2.7 CCn1c(=O)c2cc(NC(=O)CN(C)C)ccc2c2ccccc21 10.1016/s0960-894x(03)00329-9
24950555 178879 None 1 Human Binding pKi = 5.7 5.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 396 2 1 5 5.0 COc1cccc2c1OC1=C(C(=O)CC(C)(C)C1)C2C1=C(O)CC(C)(C)CC1=O 10.1021/jm8003587
CHEMBL468847 178879 None 1 Human Binding pKi = 5.7 5.7 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 396 2 1 5 5.0 COc1cccc2c1OC1=C(C(=O)CC(C)(C)C1)C2C1=C(O)CC(C)(C)CC1=O 10.1021/jm8003587
70685339 73509 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 434 3 1 5 4.5 CN(C(=O)Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@@]2(CC1)OC(=O)c1ccccc12 10.1016/j.bmcl.2012.02.098
CHEMBL2016733 73509 None 0 Human Binding pKi = 7.7 7.7 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 434 3 1 5 4.5 CN(C(=O)Nc1ccn(-c2ccccc2F)n1)[C@H]1CC[C@@]2(CC1)OC(=O)c1ccccc12 10.1016/j.bmcl.2012.02.098
127030359 139294 None 0 Human Binding pKi = 6.7 6.7 -186 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1845 61 29 21 -1.5 CCC(=O)NCCCCNC(=O)/N=C(\N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
CHEMBL3787528 139294 None 0 Human Binding pKi = 6.7 6.7 -186 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1845 61 29 21 -1.5 CCC(=O)NCCCCNC(=O)/N=C(\N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
CHEMBL3787713 139294 None 0 Human Binding pKi = 6.7 6.7 -186 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1845 61 29 21 -1.5 CCC(=O)NCCCCNC(=O)/N=C(\N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
CHEMBL4535525 139294 None 0 Human Binding pKi = 6.7 6.7 -186 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1845 61 29 21 -1.5 CCC(=O)NCCCCNC(=O)/N=C(\N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
155561620 175754 None 0 Human Binding pKi = 6.7 6.7 -18 3
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1590 51 25 19 -1.2 CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
CHEMBL4581256 175754 None 0 Human Binding pKi = 6.7 6.7 -18 3
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1590 51 25 19 -1.2 CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
56659887 65387 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 499 7 2 6 2.5 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCC(C)(C)S(=O)(=O)c3ccccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829316 65387 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 499 7 2 6 2.5 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCC(C)(C)S(=O)(=O)c3ccccc32)CC1 10.1016/j.bmcl.2011.06.078
44345719 113851 None 0 Human Binding pKi = 6.6 6.6 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 227 2 1 2 3.5 c1cncc(-c2nc(C3CCCCC3)c[nH]2)c1 10.1016/s0960-894x(03)00747-9
CHEMBL332381 113851 None 0 Human Binding pKi = 6.6 6.6 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 227 2 1 2 3.5 c1cncc(-c2nc(C3CCCCC3)c[nH]2)c1 10.1016/s0960-894x(03)00747-9
21336486 101403 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranesDisplacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranes
ChEMBL 475 10 3 3 5.7 O=C(NCCCCCCNS(=O)(=O)c1cccc2ccccc12)Nc1cccc2ccccc12 10.1016/s0960-894x(02)00288-3
CHEMBL296906 101403 None 0 Human Binding pKi = 6.6 6.6 - 1
Displacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranesDisplacement of [125I]PYY from human Neuropeptide Y receptor type 5 in COS-7 cell membranes
ChEMBL 475 10 3 3 5.7 O=C(NCCCCCCNS(=O)(=O)c1cccc2ccccc12)Nc1cccc2ccccc12 10.1016/s0960-894x(02)00288-3
70695858 73520 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 510 4 1 5 5.6 O=C1O[C@]2(CC[C@@H](N(CC(F)(F)F)C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)Cc2ccccc21 10.1016/j.bmcl.2012.02.098
CHEMBL2016744 73520 None 0 Human Binding pKi = 5.6 5.6 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranesDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in insect Sf9 membranes
ChEMBL 510 4 1 5 5.6 O=C1O[C@]2(CC[C@@H](N(CC(F)(F)F)C(=O)Nc3cnc(-c4ccccc4)cn3)CC2)Cc2ccccc21 10.1016/j.bmcl.2012.02.098
44283143 161792 None 0 Human Binding pKi = 5.6 5.6 -1023 4
Affinity for cloned Y5 receptor using [125I]PYY as radioligandAffinity for cloned Y5 receptor using [125I]PYY as radioligand
ChEMBL 2361 75 32 32 -6.3 CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CSSC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm010031k
91931648 161792 None 0 Human Binding pKi = 5.6 5.6 -1023 4
Affinity for cloned Y5 receptor using [125I]PYY as radioligandAffinity for cloned Y5 receptor using [125I]PYY as radioligand
ChEMBL 2361 75 32 32 -6.3 CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CSSC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm010031k
CHEMBL413455 161792 None 0 Human Binding pKi = 5.6 5.6 -1023 4
Affinity for cloned Y5 receptor using [125I]PYY as radioligandAffinity for cloned Y5 receptor using [125I]PYY as radioligand
ChEMBL 2361 75 32 32 -6.3 CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CSSC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)CN[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm010031k
24950871 178634 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 446 1 1 4 6.9 O=C1CC2(CCCCC2)CC(O)=C1C1C2=C(CC3(CCCCC3)CC2=O)Oc2ccccc21 10.1021/jm8003587
CHEMBL466756 178634 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 446 1 1 4 6.9 O=C1CC2(CCCCC2)CC(O)=C1C1C2=C(CC3(CCCCC3)CC2=O)Oc2ccccc21 10.1021/jm8003587
57391019 68025 None 0 Human Binding pKi = 6.6 6.6 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 543 12 2 8 4.5 O=C(OCc1ccccc1)N1CCC(S(=O)(=O)NCCCCCNc2nc(-c3ccccn3)cs2)CC1 10.1016/j.bmcl.2011.08.072
CHEMBL1912080 68025 None 0 Human Binding pKi = 6.6 6.6 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 543 12 2 8 4.5 O=C(OCc1ccccc1)N1CCC(S(=O)(=O)NCCCCCNc2nc(-c3ccccn3)cs2)CC1 10.1016/j.bmcl.2011.08.072
CHEMBL4294277 215991 None 0 Human Binding pKi = 7.6 7.6 -10 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
9907999 164963 None 0 Human Binding pKi = 7.6 7.6 - 1
Inhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 382 4 2 3 4.5 CCc1cc(-c2cc(NC(=O)C3Cc4ccc5ccccc5c4C3)[nH]n2)ccn1 10.1021/jm025513q
CHEMBL422012 164963 None 0 Human Binding pKi = 7.6 7.6 - 1
Inhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 382 4 2 3 4.5 CCc1cc(-c2cc(NC(=O)C3Cc4ccc5ccccc5c4C3)[nH]n2)ccn1 10.1021/jm025513q
CHEMBL4294277 215991 None 0 Human Binding pKi = 7.6 7.6 -10 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
57396288 68018 None 0 Human Binding pKi = 6.6 6.6 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 408 11 2 6 3.9 O=S(=O)(CC1CCCC1)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
CHEMBL1912073 68018 None 0 Human Binding pKi = 6.6 6.6 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 408 11 2 6 3.9 O=S(=O)(CC1CCCC1)NCCCCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
CHEMBL4282216 215891 None 0 Human Binding pKi = 6.6 6.6 -39 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CN(C(=N)N)C[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4282216 215891 None 0 Human Binding pKi = 6.6 6.6 -39 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CN(C(=N)N)C[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
21336503 191178 None 0 Human Binding pKi = 7.6 7.6 549 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 490 8 2 3 5.7 O=S(=O)(NC[C@H]1CC[C@H](CNCc2cccc3ccccc23)CC1)c1ccccc1C(F)(F)F 10.1016/s0960-894x(02)00287-1
CHEMBL51874 191178 None 0 Human Binding pKi = 7.6 7.6 549 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 490 8 2 3 5.7 O=S(=O)(NC[C@H]1CC[C@H](CNCc2cccc3ccccc23)CC1)c1ccccc1C(F)(F)F 10.1016/s0960-894x(02)00287-1
11130476 54948 None 0 Human Binding pKi = 6.6 6.6 - 1
Inhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 303 3 2 2 3.4 O=C(Nc1cc(-c2ccccc2)[nH]n1)C1Cc2ccccc2C1 10.1021/jm025513q
CHEMBL161398 54948 None 0 Human Binding pKi = 6.6 6.6 - 1
Inhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cellsInhibition of [125I]PYY binding to human recombinant Neuropeptide Y receptor type 5 in LMtk-cells
ChEMBL 303 3 2 2 3.4 O=C(Nc1cc(-c2ccccc2)[nH]n1)C1Cc2ccccc2C1 10.1021/jm025513q
44345971 14468 None 0 Human Binding pKi = 7.6 7.6 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 289 2 1 2 4.2 FC(F)(F)c1ccccc1-c1c[nH]c(-c2cccnc2)n1 10.1016/s0960-894x(03)00747-9
CHEMBL120117 14468 None 0 Human Binding pKi = 7.6 7.6 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 289 2 1 2 4.2 FC(F)(F)c1ccccc1-c1c[nH]c(-c2cccnc2)n1 10.1016/s0960-894x(03)00747-9
56673731 65380 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 482 7 2 5 2.4 CN(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)CC(C)(C)Sc3ccccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829309 65380 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 482 7 2 5 2.4 CN(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)CC(C)(C)Sc3ccccc32)CC1 10.1016/j.bmcl.2011.06.078
10223847 155644 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 419 4 1 5 1.6 CN(C(=O)NC1CCN(c2cccc(C#N)c2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL404304 155644 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 419 4 1 5 1.6 CN(C(=O)NC1CCN(c2cccc(C#N)c2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
57398084 68024 None 0 Human Binding pKi = 5.6 5.6 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 409 10 3 7 2.5 O=S(=O)(NCCCCCNc1nc(-c2ccccn2)cs1)C1CCNCC1 10.1016/j.bmcl.2011.08.072
CHEMBL1912079 68024 None 0 Human Binding pKi = 5.6 5.6 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 409 10 3 7 2.5 O=S(=O)(NCCCCCNc1nc(-c2ccccn2)cs1)C1CCNCC1 10.1016/j.bmcl.2011.08.072
54584448 62727 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 380 3 2 4 3.0 Cc1ccc(=O)[nH]c1C1=N[C@@](c2ccc(F)cc2)(c2ccc(F)nc2)[C@H](C)N1 10.1016/j.bmc.2009.05.069
CHEMBL1783925 62727 None 0 Human Binding pKi = 7.6 7.6 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 380 3 2 4 3.0 Cc1ccc(=O)[nH]c1C1=N[C@@](c2ccc(F)cc2)(c2ccc(F)nc2)[C@H](C)N1 10.1016/j.bmc.2009.05.069
21336495 102079 None 0 Human Binding pKi = 7.6 7.6 1737 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 468 9 2 6 4.0 O=[N+]([O-])c1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCc2ccnc3ccccc23)CC1 10.1016/s0960-894x(02)00287-1
CHEMBL301747 102079 None 0 Human Binding pKi = 7.6 7.6 1737 2
Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5Tested for radioligand binding affinity against membranes from COS-7 cells transiently transfected with Neuropeptide Y receptor type 5
ChEMBL 468 9 2 6 4.0 O=[N+]([O-])c1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCc2ccnc3ccccc23)CC1 10.1016/s0960-894x(02)00287-1
127029975 139303 None 0 Human Binding pKi = 6.6 6.6 -56 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1675 55 28 20 -1.9 CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
CHEMBL3785576 139303 None 0 Human Binding pKi = 6.6 6.6 -56 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1675 55 28 20 -1.9 CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
CHEMBL3787766 139303 None 0 Human Binding pKi = 6.6 6.6 -56 4
Displacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation countingDisplacement of [3H]propionyl-pNPY from human NPY Y5 receptor expressed in human HEC1b cells after 120 mins by liquid scintillation counting
ChEMBL 1675 55 28 20 -1.9 CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/acs.jmedchem.6b00309
24950556 189580 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 384 1 1 4 5.1 CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3cc(F)ccc32)=C(O)C1 10.1021/jm8003587
CHEMBL513701 189580 None 0 Human Binding pKi = 7.5 7.5 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in thymidine kinase deficient human LM cells
ChEMBL 384 1 1 4 5.1 CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3cc(F)ccc32)=C(O)C1 10.1021/jm8003587
57398069 67839 None 0 Human Binding pKi = 6.5 6.5 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 370 10 2 7 2.0 CC(C)S(=O)(=O)NCCOCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
CHEMBL1909723 67839 None 0 Human Binding pKi = 6.5 6.5 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 370 10 2 7 2.0 CC(C)S(=O)(=O)NCCOCCNc1nc(-c2ccccn2)cs1 10.1016/j.bmcl.2011.08.072
76332712 105769 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation countingDisplacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation counting
ChEMBL 415 4 1 4 4.4 C[C@@H]1CN([C@H]2CC[C@@H](C(=O)Nc3ccc(-c4cc(F)cc(F)c4)cn3)CC2)C(=O)O1 10.1016/j.bmcl.2014.02.023
CHEMBL3126043 105769 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation countingDisplacement of [125I]PYY from human NPY5 receptor transfected in LM(tk-) cell membranes after 120 mins by solid scintillation counting
ChEMBL 415 4 1 4 4.4 C[C@@H]1CN([C@H]2CC[C@@H](C(=O)Nc3ccc(-c4cc(F)cc(F)c4)cn3)CC2)C(=O)O1 10.1016/j.bmcl.2014.02.023
10178465 193300 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 390 4 2 5 2.9 N#Cc1ccnc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)[C@H](CO)N2)c1 10.1021/jm900110t
CHEMBL523305 193300 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 390 4 2 5 2.9 N#Cc1ccnc(C2=NC(c3ccc(F)cc3)(c3ccc(F)cc3)[C@H](CO)N2)c1 10.1021/jm900110t
44139356 192803 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 376 3 1 6 2.7 C[C@@H]1NC(c2cc(C#N)ccn2)=NC1(c1ccc(F)nc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL521932 192803 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 376 3 1 6 2.7 C[C@@H]1NC(c2cc(C#N)ccn2)=NC1(c1ccc(F)nc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL4292105 215974 None 0 Human Binding pKi = 8.5 8.5 -7 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
CHEMBL4292105 215974 None 0 Human Binding pKi = 8.5 8.5 -7 4
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assayDisplacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay
ChEMBL None None None CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C 10.1021/acs.jmedchem.8b01046
44139480 187249 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 375 3 1 5 3.3 C[C@@H]1NC(c2cncc(C#N)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
CHEMBL491895 187249 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PYY from human recombinant neuropeptide Y5 receptor expressed in mouse LMtk- cells
ChEMBL 375 3 1 5 3.3 C[C@@H]1NC(c2cncc(C#N)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1021/jm900110t
10181110 167167 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 430 4 1 4 2.0 CN(C(=O)NC1CCN(c2cc(F)cc(F)c2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL428953 167167 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 430 4 1 4 2.0 CN(C(=O)NC1CCN(c2cc(F)cc(F)c2)CC1)C1CCN(S(C)(=O)=O)CC1 10.1016/j.bmcl.2007.11.132
10139329 167516 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 458 5 1 4 2.8 CC(C)S(=O)(=O)N1CCC(N(C)C(=O)NC2CCN(c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL429679 167516 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 458 5 1 4 2.8 CC(C)S(=O)(=O)N1CCC(N(C)C(=O)NC2CCN(c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
57398085 68032 None 0 Human Binding pKi = 8.5 8.5 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 437 10 2 8 3.8 Cc1nc(C)c(S(=O)(=O)NCCCCCNc2nc(-c3ccccn3)cs2)s1 10.1016/j.bmcl.2011.08.072
CHEMBL1912087 68032 None 0 Human Binding pKi = 8.5 8.5 - 1
Binding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assayBinding affinity to human cloned NPY Y5 receptor expressed in african green monkey COS7 cells by radioligand binding assay
ChEMBL 437 10 2 8 3.8 Cc1nc(C)c(S(=O)(=O)NCCCCCNc2nc(-c3ccccn3)cs2)s1 10.1016/j.bmcl.2011.08.072
22458823 102060 None 0 Human Binding pKi = 8.5 8.5 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 349 5 1 3 4.8 CC(C)n1c2ccccc2c2cc(NC(=O)CCN3CCCC3)ccc21 10.1016/s0960-894x(03)00329-9
CHEMBL301638 102060 None 0 Human Binding pKi = 8.5 8.5 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligandBinding affinity towards human neuropeptide Y receptor type 5 using 125[I]-PYY as radioligand
ChEMBL 349 5 1 3 4.8 CC(C)n1c2ccccc2c2cc(NC(=O)CCN3CCCC3)ccc21 10.1016/s0960-894x(03)00329-9
136088970 62809 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 400 3 2 4 3.4 C[C@@H]1NC(c2c[nH]c(=O)c(Cl)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
CHEMBL1784124 62809 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cellsDisplacement of [125I]PPY from human recombinant NPYY5 receptor expressed in mouse LMtk- cells
ChEMBL 400 3 2 4 3.4 C[C@@H]1NC(c2c[nH]c(=O)c(Cl)c2)=N[C@@]1(c1ccc(F)cc1)c1ccc(F)nc1 10.1016/j.bmc.2009.05.069
56677041 65396 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 455 7 2 4 2.6 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)CCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829325 65396 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 455 7 2 4 2.6 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2C(=O)CCc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
10161574 95631 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 458 6 1 4 2.8 CCCS(=O)(=O)N1CCC(N(C)C(=O)NC2CCN(c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
CHEMBL257708 95631 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cellsDisplacement of [125]PYY from human chimeric NPY Y5 receptor expressed in CHOK1 cells
ChEMBL 458 6 1 4 2.8 CCCS(=O)(=O)N1CCC(N(C)C(=O)NC2CCN(c3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.132
44345933 16307 None 0 Human Binding pKi = 8.5 8.5 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 289 2 1 2 4.4 Clc1ccc(-c2c[nH]c(-c3ccncc3)n2)cc1Cl 10.1016/s0960-894x(03)00747-9
CHEMBL122527 16307 None 0 Human Binding pKi = 8.5 8.5 - 1
Binding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cellsBinding affinity towards human neuropeptide Y receptor type 5 using [125I]-PYY as radioligand in baculovirus-infected Sf9 cells
ChEMBL 289 2 1 2 4.4 Clc1ccc(-c2c[nH]c(-c3ccncc3)n2)cc1Cl 10.1016/s0960-894x(03)00747-9
56666777 65392 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 443 7 2 5 2.5 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCOc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
CHEMBL1829321 65392 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation countingDisplacement of [125I]PYY from human NPY5 receptor expressed in thymidine kinase deficient mouse LM cells after 120 mins by scintillation counting
ChEMBL 443 7 2 5 2.5 CC(C)S(=O)(=O)NC[C@H]1CC[C@H](NC(=O)CN2CCOc3cc(Cl)ccc32)CC1 10.1016/j.bmcl.2011.06.078
70685314 73330 None 0 Human Binding pKi = 8.5 8.5 - 1
Displacement of [125I]peptide YY from human NPY5 receptorDisplacement of [125I]peptide YY from human NPY5 receptor
ChEMBL 407 7 2 4 2.4 Cc1ccc2c(c1)CCN2CC(=O)N[C@H]1CC[C@H](CNS(=O)(=O)C(C)C)CC1 10.1016/j.bmcl.2012.01.117
CHEMBL2013013 73330 None